cobalamin
concentr
previous
investig
cat
littl
inform
avail
concern
follow
hypocobalaminem
cat
aim
assess
frequenc
hypocobalaminemia
within
larg
cohort
cat
gastrointestin
sign
describ
epidemiolog
clinic
biolog
followup
characterist
hypocobalaminem
cat
cat
gastrointestin
sign
cobalamin
assay
simultracsnb
radioassay
kit
mpbiomed
perform
ldhvet
laboratori
retrospect
includ
studi
cat
present
gastrointestin
sign
hypocobalaminemia
major
domest
short
hair
male
castrat
femal
castrat
age
month
year
main
clinic
sign
includ
chronic
diarrhea
weight
loss
polyuropolydypsia
vomit
polyphagia
fatig
dysorexia
median
durat
month
diagnosi
cobalamin
valu
rang
ngl
median
ngl
hypocobalaminem
cat
also
hyperfolatemia
folat
ngl
diagnosi
measur
older
cat
year
reveal
hyperthyroid
pmoll
case
hypocobalaminem
cat
known
clinic
biolog
followup
median
time
followup
day
cobalamin
significantli
improv
month
treatment
lgkg
im
cyanocobalamin
singl
dose
cat
even
remain
hypocobalaminem
follow
cat
clinic
improv
associ
higher
cobalamin
valu
clinic
biolog
improv
cobalamin
supplement
significantli
associ
increas
folat
concentr
pvalu
howev
cat
improv
cobalamin
valu
show
clinic
improv
hypocobalaminemia
frequent
observ
cat
consequ
gastrointestin
sign
cobalamin
concentr
could
use
indic
sever
variou
gut
diseas
primari
caus
one
third
cat
show
clinic
improv
despit
improv
cobalamin
valu
hyperfolatemia
appear
treatment
hypocobalaminemia
seem
good
indic
clinic
improv
associ
return
normal
intestin
integr
disclosur
disclosur
report
cobalamin
malabsorpt
common
old
cat
weight
loss
macronutri
malabsorpt
enter
protein
loss
due
idiopath
chronic
enteropathi
ice
patil
ap
cupp
cj
proc
nestlepurina
compan
anim
nutr
summit
william
czarneckimaulden
proc
ecvimca
congress
high
dose
oral
cobalamin
supplement
revers
subnorm
serum
concentr
within
week
serum
cobalamin
becom
undetect
within
littl
month
follow
cessat
supplement
william
czarneckimaulden
proc
ecvimca
congress
object
studi
determin
serum
cobalamin
concentr
cat
ice
respons
oral
supplement
withdraw
associ
differ
intestin
microbiom
studi
evalu
cat
older
year
age
fed
nutrit
complet
balanc
diet
includ
fortif
vitamin
thirtyon
cat
ice
demonstr
increas
fecal
fat
subnorm
fat
digest
subnorm
serum
cobalamin
increas
serum
methylmalon
acid
without
exocrin
pancreat
insuffici
assess
assay
serum
trypsinlik
immunoreact
serum
cobalamin
determin
competit
bind
assay
fecal
microbiom
roch
sequenc
analysi
qiim
quantit
insight
microbi
ecolog
pca
princip
compon
analysi
opl
orthogon
project
latent
structur
ice
cat
supplement
oral
cobalamin
month
serum
cobalamin
concentr
determin
monthli
supplement
month
cessat
supplement
cat
signific
p
associ
serum
cobalamin
fecal
microbiom
speci
posit
correl
serum
cobalamin
concentr
speci
neg
correl
serum
cobalamin
subnorm
ngl
ice
cat
start
supplement
studi
subsequ
becam
normal
supranorm
within
month
cessat
supplement
serum
cobalamin
subnorm
origin
cat
addit
cat
conclud
serum
cobalamin
concentr
respons
oral
supplement
subsequ
cessat
supplement
significantli
associ
composit
intestin
microflora
reflect
fecal
microbiom
disclosur
studi
describ
abstract
perform
nestlepurina
facil
fund
entir
nestlepurina
david
william
consult
advis
nestlepurina
idexx
laboratori
gastrointestin
laboratori
texa
univers
receiv
royalti
idexx
laboratori
given
continu
educ
lectur
sponsor
nestlepurina
inflammatori
bowel
diseas
ibd
common
caus
chronic
gastrointestin
sign
cat
typic
lymphoplasmacyt
inflamm
found
biopsi
subset
cat
ibd
neutrophil
inflamm
clinic
signific
neutrophil
infiltr
unclear
aim
retrospect
studi
use
fluoresc
situ
hybridis
fish
look
presenc
microorgan
within
intestin
epithelium
cat
diagnos
ibd
ident
microorgan
hypothesi
neutrophil
enter
cat
would
associ
intestin
mucos
invas
microorgan
specif
campylobact
spp
studi
includ
cat
present
small
anim
hospit
langford
veterinari
servic
investig
gastrointestin
diseas
duoden
biopsi
collect
endoscop
thirteen
cat
diagnos
neutrophil
inflamm
studi
group
cat
lymphoplasmacyt
inflamm
control
group
fluoresc
situ
hybridis
fish
target
either
eubacteria
campylobact
jejuni
coli
upsaliensi
use
identifi
count
intramur
bacteria
intestin
biopsi
sampl
neutrophil
detect
simultan
use
fish
probe
neutrophil
elastas
pixel
distanc
differ
bacteri
speci
neutrophil
measur
anim
group
show
presenc
intraepitheli
bacteria
number
bacteria
present
differ
control
studi
group
similarli
campylobact
jejuni
upsaliensi
present
anim
group
number
differ
group
contrast
campylobact
coli
present
significantli
studi
cat
control
cat
p
chisquar
test
studi
group
show
significantli
higher
number
c
coli
tissu
control
group
p
mannwhitney
u
test
colocalis
neutrophil
c
coli
demonstr
c
coli
closer
bacteria
neutrophil
associ
statist
signific
p
mannwhitney
u
test
role
intestin
virom
health
diseas
gain
increas
attent
human
medicin
use
next
gener
sequenc
ng
technolog
allow
identif
divers
distribut
virom
approach
equal
appli
dogsthi
studi
aim
identifi
characteris
virom
present
faec
dog
chronic
enteropathi
ce
compar
virom
healthi
dog
hd
faecal
sampl
evalu
hd
dog
ce
food
antibiot
steroid
respons
use
ng
approach
viral
enrich
protocol
use
seri
centrifug
endonucleas
treatment
bacteri
filtrat
perform
enrich
viral
dna
rna
extract
amplifi
use
sequenceindepend
singleprim
amplif
sispa
protocol
subsequ
sequenc
ng
use
illumina
miseq
platform
agrf
two
bioinformat
pipelin
use
analys
viral
popul
select
high
qualiti
read
remov
dog
bacteri
sequenc
sequenc
inform
compar
refer
databas
identifi
total
viral
contig
dna
viral
sequenc
rna
sequenc
across
dog
sampl
major
viral
hit
group
faecal
sampl
bacteriophag
hd
ce
sever
famili
mainli
caudoviral
order
analys
viral
eukaryot
famili
identifi
across
sampl
two
group
sequenc
similar
known
viru
famili
reovirida
papillomavirida
identifi
group
hd
ce
respect
sequenc
similar
picornavirida
identifi
one
dog
ce
sequenc
similar
adenovirida
parvovirida
coronavirida
identifi
healthi
dog
genom
characteris
phylogenet
analysi
undertaken
virus
genom
segment
rotaviru
reovirida
isol
determin
similarli
sequenc
entir
code
region
kobuviru
picornavirida
isol
determin
preliminari
analys
indic
rotaviru
gene
segment
exhibit
nt
homolog
previous
report
canin
rotavirus
kobuviru
sequenc
exhibit
moder
nt
homolog
previous
describ
genom
cluster
canin
kobuviru
sequenc
avail
genbank
conclus
viral
sequenc
rang
differ
viru
famili
includ
rna
dna
famili
known
pathogen
identifi
characteris
largest
proport
viral
contig
identifi
belong
bacteriophag
disclosur
disclosur
report
endoscopi
wide
use
perform
target
minim
invas
biopsi
histopatholog
gastrointestin
tract
dog
cat
studi
focus
diagnost
contribut
cytolog
sampl
alimentari
tract
aim
studi
compar
imprint
squash
techniqu
obtain
valuabl
cytolog
sampl
endoscop
biopsi
evalu
potenti
interest
cytolog
compar
histolog
reach
definit
diagnosi
eighteen
dog
cat
present
gastrointestin
symptom
underw
endoscopi
alimentari
tract
prospect
includ
five
biopsi
area
interest
collect
regular
histopatholog
analysi
addit
biopsi
area
use
obtain
cytolog
specimen
imprint
squash
techniqu
cytolog
sampl
review
blindli
pathologist
cytolog
sampl
insuffici
qualiti
consid
non
diagnost
exclud
analysi
diagnost
conclus
cytolog
histolog
analys
classifi
defin
categori
inflamm
neoplasia
subcategori
fibrosi
epitheli
hyperplasia
normal
allow
comparison
techniqu
agreement
cytolog
histolog
determin
cohen
kappa
coeffici
case
biopsi
specimen
collect
differ
local
histolog
cytolog
slide
obtain
final
diagnosi
neoplasia
case
inflammatori
diseas
consid
imprint
techniqu
consid
non
diagnost
squash
techniqu
cytolog
sampl
consid
non
diagnost
squash
cytolog
histolog
gave
result
case
n
agreement
techniqu
consid
moder
k
confid
interv
ci
agreement
fair
imprint
cytolog
histolog
n
k
ci
gastric
spiral
organ
gso
observ
case
case
identifi
cytolog
amongst
case
mast
cell
identifi
cytolog
case
histolog
case
mast
cell
found
case
prospect
pilot
studi
demonstr
cytolog
examin
gastrointestin
biopsi
squash
sampl
obtain
endoscopi
alimentari
tract
may
give
relev
inform
help
clinician
initi
treatment
histopatholog
analysi
pend
furthermor
give
addit
inform
presenc
potenti
pathogen
mast
cell
may
identifi
histopatholog
disclosur
disclosur
report
intramucos
escherichia
coli
implic
pathogenesi
granulomat
coliti
boxer
dog
clinic
remiss
hing
upon
erad
commonli
achiev
fluoroquinolon
antimicrobi
resist
uncommon
among
e
coli
isol
dog
gc
impair
success
treatment
publish
data
lack
efficaci
therapi
gc
dog
fluoroquinoloneresist
e
coli
aim
studi
character
antimicrobi
resist
pattern
molecular
characterist
e
coli
isol
dog
gc
addit
evalu
clinic
outcom
dog
treat
antimicrobi
guid
cultur
suscept
result
studi
popul
boxer
french
bulldog
clientown
dog
gc
gc
biopsi
fishconfirm
intramucos
e
coli
submit
bacteri
cultur
antimicrobi
suscept
determin
broth
microdilut
strain
character
phylogroup
overal
genotyp
use
triplex
random
amplifi
polymorph
dna
polymeras
chain
reaction
respect
treatment
clinic
outcom
data
obtain
cultur
yield
e
coli
strain
per
dog
med
dog
resist
fluoroquinolon
identifi
dog
correl
resist
macrophagepenetr
antimicrobi
p
phylogroup
overrepres
among
enrofloxacinresist
strain
dog
e
coli
isol
multipl
time
point
phylogroup
chang
time
clinic
remiss
achiev
dog
fluoroquinolonesensit
e
coli
dog
fluoroquinoloneresist
variabl
respons
treatment
meropenem
median
mgkg
sq
hour
week
resolv
clinic
sign
conclud
antimicrobi
resist
grow
concern
gcassoci
e
coli
appear
genet
divers
clinic
remiss
achiev
face
fluoroquinoloneresist
though
vitro
antimicrobi
suscept
consist
predict
posit
respons
disclosur
disclosur
report
canin
potenti
biomark
inflamm
dog
fecal
concentr
increas
dog
chronic
gastroenteropathi
ce
correl
sever
clinic
endoscop
diseas
neg
outcom
associ
higher
fecal
concentr
ce
dog
respons
differ
form
treatment
fecal
report
inform
import
evalu
util
fecal
biomark
gastrointestin
diseas
aim
studi
evalu
associ
respons
variou
treatment
ie
elimin
diet
antimicrobi
drug
corticosteroidsoth
immunosuppress
fecal
dog
ce
fecal
sampl
collect
dog
diagnos
ce
fecal
measur
specimen
use
establish
inhous
elisa
base
respons
treatment
dog
classifi
antibioticrespons
diarrhea
ard
foodrespons
diarrhea
frd
steroidresponsivetherapyresist
idiopath
inflammatori
bowel
diseas
ibd
statist
analysi
perform
use
nonparametr
multiplegroup
comparison
likelihood
ratio
evalu
associ
group
dog
respons
treatment
receiv
oper
characterist
curv
calcul
sensit
specif
optimum
cutoff
concentr
total
dog
ce
median
age
year
male
femal
includ
studi
final
diagnosi
ard
n
frd
n
ibd
n
respons
treatment
complet
remiss
n
partial
respons
n
respons
n
fecal
concentr
rang
ngg
higher
level
seen
dog
ibd
dog
frd
p
ard
p
dog
respond
treatment
significantli
higher
level
dog
partial
p
complet
p
remiss
respons
treatment
associ
diseas
classif
p
despit
small
number
patient
fecal
level
ngg
time
diagnosi
distinguish
dog
fail
respond
treatment
least
partial
remiss
sensit
specif
conclud
line
previou
find
fecal
may
use
biomark
diseas
sever
dog
ibd
fecal
may
also
util
predict
lack
respons
treatment
dog
ce
util
serial
fecal
concentr
monitor
treatment
respons
dog
ce
warrant
research
disclosur
dr
heilmann
dr
steiner
file
patent
applic
includ
elisa
use
studi
constip
common
present
complaint
dog
cat
differenti
diagnosi
clinic
sign
wellknown
strictur
result
gastrointestin
inflamm
commonli
includ
rare
report
literatur
acut
diarrhea
bone
ingest
lead
anal
rectal
strictur
respons
constip
aim
retrospect
studi
describ
preval
inflammatori
rectal
anal
strictur
small
anim
describ
simpl
effect
treatment
medic
record
dog
cat
present
constip
dyschezia
tenesmu
diagnos
inflammatori
strictur
obtain
databas
gastrointestin
diseas
consult
referr
center
gastroenterolog
review
signal
present
complaint
clinic
find
treatment
protocol
outcom
record
five
dog
cat
includ
studi
cat
purebr
kitten
month
among
persian
fifth
cat
femal
domest
shorthair
three
cat
histori
acut
diarrhea
cat
constip
sinc
adopt
unknown
histori
digit
rectal
examin
anesthesia
reveal
strictur
cat
treat
bougienag
everi
day
highfib
diet
dog
age
rang
year
dog
histori
acut
diarrhea
ingest
bone
prior
day
colonoscopi
biopsi
perform
dog
show
lymphoplasmocyt
infiltr
dog
treat
digit
bougienag
everi
day
disappear
strictur
metronidazol
lubric
lax
corticosteroid
highfib
diet
preval
inflammatori
strictur
dog
base
dog
present
complaint
dog
cat
clinic
sign
relat
strictur
resolv
durat
followup
benign
strictur
secondari
gastrointestin
inflamm
systemat
includ
differenti
diagnosi
constip
strictur
easili
palpat
digit
rectal
examin
alway
perform
clinic
examin
histolog
routin
part
diagnosi
workup
exclud
neoplasia
endoscopyassist
balloon
dilat
concurr
intralesion
inject
triamcinolon
use
dog
report
human
literatur
treatment
describ
simpler
effect
dog
done
home
owner
disclosur
disclosur
report
acut
pancreat
diagnost
challeng
anatom
inaccess
pancrea
vagu
clinic
sign
physic
examin
find
inconsist
laboratori
result
common
yet
nonspecif
clinic
sign
includ
abdomin
pain
anorexia
vomit
diarrhea
ultrasonographi
imag
modal
choic
evalu
pancrea
purpos
studi
compar
clinic
sign
ultrasonograph
find
dog
acut
pancreat
account
differ
clinic
present
depend
region
pancrea
affect
determin
ultrasonographi
hypothesi
would
differ
clinic
present
depend
pancreat
region
involv
record
clientown
dog
diagnos
acut
pancreat
base
histori
clinic
sign
laboratori
test
abdomin
ultrasonographi
retrospect
evalu
base
ultrasonographi
dog
divid
group
group
dog
chang
within
left
limb
pancrea
exclus
group
dog
chang
within
right
limb
pancrea
exclus
group
dog
diffus
pancreat
involv
presenc
abdomin
pain
anorexia
vomit
diarrhea
correl
group
use
chisquar
fischer
exact
test
signific
differ
regard
age
breed
sex
note
group
group
pain
note
anorexia
vomit
diarrhea
dog
group
pain
present
anorexia
vomit
diarrhea
dog
group
pain
note
anorexia
vomit
diarrhea
dog
pain
note
significantli
higher
frequenc
diffus
pancreat
diseas
compar
diseas
restrict
left
right
limb
pancrea
anorexia
significantli
common
right
limb
involv
vomit
diarrhea
significantli
common
diseas
restrict
left
limb
compar
diffus
parenchym
right
limb
involv
despit
overlap
group
find
indic
pain
respons
expect
occur
higher
frequenc
diffus
pancreat
overal
common
clinic
sign
anorexia
preval
dog
pancreat
right
limb
wherea
vomit
diarrhea
evid
dog
left
limb
pancreat
differ
group
possibl
ascrib
gastric
involv
left
side
pancrea
affect
disclosur
disclosur
report
increas
physic
exercis
report
improv
clinic
symptom
chronic
enteropathi
inflammatori
bowel
diseas
human
patient
aim
investig
evalu
impact
intervent
increas
physic
exercis
dog
chronic
enteropathi
twentytwo
dog
exercis
control
group
chronic
enteropathi
respons
elimin
diet
includ
routin
diagnost
workup
haematolog
plasma
biochemistri
profil
urinalysi
faecal
parasitolog
abdomin
radiograph
ultrasound
conduct
dog
elimin
underli
caus
dog
given
oral
prednisolon
mgkgday
day
follow
taper
dosag
week
week
prednisolon
treatment
certifi
canin
rehabilit
therapist
instruct
owner
dog
exercis
group
increas
dog
physic
exercis
exercis
protocol
combin
aerob
resist
exercis
lowto
moderateintens
interv
train
owner
dog
control
group
ask
maintain
dog
routin
lifestyl
modifi
canin
inflammatori
bowel
diseas
activ
score
cibdai
base
paramet
activ
level
appetit
vomit
stool
consist
stool
frequenc
bloat
weight
loss
calcul
pretreat
week
posttreat
dog
cibdai
score
compar
among
timepoint
pretreat
posttreat
assess
group
exercis
control
use
multivari
repeatedmeasur
model
multipl
comparison
dog
show
improv
week
prednisolon
treatment
modifi
cibdai
decreas
exercis
ae
ae
control
ae
ae
group
week
increas
physic
exercis
intervent
modifi
cibdai
exercis
group
decreas
significantli
ae
rel
first
posttreat
assess
p
wherea
index
remain
similar
ae
control
group
modifi
cibdai
differ
significantli
group
week
treatment
p
paramet
modifi
cibdai
significantli
affect
intervent
increas
physic
exercis
largest
differ
found
bodi
weight
p
adjust
r
faecal
frequenc
p
adjust
r
activ
level
p
adjust
r
increas
physic
activ
intervent
posit
effect
clinic
symptom
dog
chronic
enteropathi
disclosur
disclosur
report
corticosteroid
therapi
commonli
requir
veterinari
patient
treatment
inflammatori
immunemedi
neurolog
neoplast
diseas
patient
also
requir
assist
enter
nutrit
via
percutan
endoscop
gastrostomi
peg
tube
retrospect
casecontrol
studi
evalu
complic
associ
peg
tube
use
veterinari
patient
receiv
corticosteroid
referr
teach
hospit
medic
record
dog
cat
peg
tube
place
qmha
januari
march
review
patient
includ
peg
tube
use
least
hour
complet
medic
record
includ
clinic
note
refer
veterinarian
kennel
sheet
commun
record
patient
owner
note
tube
remov
avail
includ
steroid
group
patient
must
receiv
corticosteroid
therapi
mgkgday
least
length
time
peg
tube
use
control
patient
treat
corticosteroid
fortytwo
case
includ
dog
cat
fourteen
patient
dog
cat
includ
steroid
group
patient
dog
cat
includ
control
group
complic
score
term
sever
minor
moder
major
compar
group
use
mannwhitney
utest
valu
p
consid
signific
complic
includ
serou
discharg
n
sanguin
discharg
purul
discharg
stoma
site
inflamm
peg
tube
dislodg
pain
around
stoma
peg
tube
blockag
peg
tube
chew
patient
tip
stoma
median
interquartil
rang
maximum
complic
score
control
steroid
group
respect
maximum
complic
score
significantli
differ
group
u
p
though
patient
receiv
corticosteroid
show
trend
toward
higher
maximum
complic
score
control
group
conclus
owner
dog
cat
receiv
corticosteroid
peg
tube
plan
apprais
possibl
complic
beyond
normal
associ
tube
placement
alon
disclosur
disclosur
report
canin
obes
usual
treat
dietari
energi
restrict
data
limit
regard
nutrit
adequaci
aim
current
studi
compar
intak
essenti
nutrient
nation
research
council
recommend
obes
dog
weight
manag
purposeformul
diet
twentyseven
dog
includ
nonrandom
retrospect
observ
cohort
studi
determin
system
well
without
signific
abnorm
base
upon
physic
examin
clinicopatholog
assess
dog
underw
control
weight
loss
protocol
least
week
achiev
ideal
condit
use
high
protein
high
fiber
weight
loss
diet
median
maximum
minimum
daili
intak
essenti
nutrient
compar
nrc
recommend
allow
ra
adult
dog
median
weight
loss
median
daili
energi
intak
kcalkg
kcalkg
sign
nutrient
defici
observ
dog
base
upon
averag
nutrient
content
diet
daili
intak
major
essenti
nutrient
greater
nrc
ra
per
kg
bodi
weight
except
selenium
cholin
cholin
dog
methioninecystein
dog
essenti
nutrient
remain
nrc
minimum
requir
mr
throughout
trial
daili
intak
essenti
nutrient
meet
nrc
ra
mr
obes
dog
throughout
period
weight
loss
light
absenc
sign
nutrient
defici
signific
borderlin
intak
nutrient
especi
selenium
cholin
known
studi
recommend
disclosur
follow
conflict
interest
appli
ajg
readership
fund
royal
canin
ajg
also
receiv
financi
remuner
gift
provid
educ
materi
speak
confer
consult
work
slh
post
univers
liverpool
also
fund
royal
canin
diet
use
studi
manufactur
royal
canin
ss
vb
employ
royal
canin
endocrin
profil
obes
dog
j
rochel
c
amato
p
nguyen
l
jaillardon
b
siliart
oniri
nant
atlant
colleg
veterinari
medicin
food
scienc
engin
nant
cedex
franc
obes
frequent
condit
dog
associ
mani
endocrin
metabol
disturb
lead
major
organ
dysfunct
therefor
aim
assess
biochem
hormon
profil
larg
cohort
obes
dog
obes
dog
retrospect
includ
studi
base
overweight
ideal
bodi
weight
ibw
endocrin
profil
consist
assess
prolactin
leptin
insulin
like
growth
factor
type
cortisol
acth
stimul
test
insulin
free
thyroxin
ctsh
serum
concentr
obes
dog
femal
spay
male
castrat
differ
breed
rang
year
median
year
year
dog
suffer
gener
versu
abdomin
obes
longterm
obes
year
describ
case
main
observ
clinic
sign
abdomin
distens
fatig
polyphagia
declin
interest
usual
activ
polyuropolydipsia
biochem
profil
unremark
except
dog
hypercholesterolemia
cholesterol
mmoll
high
prolactin
valu
ngml
observ
dog
high
leptin
valu
lgl
high
valu
lgl
ibw
kg
ibw
kg
ibw
kg
high
insulin
valu
lui
ml
without
signific
correl
glucos
concentr
case
dog
high
cortisol
valu
nmolel
acth
stimul
alow
pmoll
high
tsh
valu
ngml
canin
obes
associ
mani
endocrin
disord
includ
hyperprolactinemia
hyperleptinemia
high
valu
hypercortisolemia
andor
hypothyroxinemia
associ
high
ctsh
valu
endocrin
profil
could
interest
diagnosi
prognosi
canin
obes
could
allow
veterinarian
choos
better
treatment
particularli
diet
unsuccess
investig
could
done
assess
prognost
valu
endocrin
profil
diagnosi
canin
obes
control
treatment
effici
disclosur
disclosur
report
better
understand
dog
undergo
healthi
age
would
benefit
owner
veterinarian
alik
juli
longitudin
studi
began
evalu
health
longev
labrador
retriev
male
femal
neuter
mean
age
year
continu
fed
fix
plane
nutrit
ident
hous
standardis
husbandri
veterinari
care
bodi
condit
score
maintain
scale
standard
veterinari
protocol
use
medic
condit
cancer
sever
life
threaten
condit
manag
individu
base
qualiti
life
assess
averag
lifespan
labrador
retriev
estim
year
dog
classifi
accord
lifespan
typic
die
year
age
long
year
except
year
correspond
longer
averag
lifespan
data
analys
use
linear
mix
model
random
effect
slope
intercept
fix
effect
lifespan
group
variabl
juli
dog
classifi
except
still
aliv
typic
n
long
n
gender
age
neuter
associ
surviv
time
risk
death
bodi
weight
chang
show
quadrat
trend
age
bodi
weight
increas
lifespan
group
chang
significantli
differ
signific
chang
bodi
weight
year
except
dog
increas
bodi
weight
longlifespan
dog
lost
weight
versu
kgdogyear
p
age
except
long
group
similar
loss
dualenergi
xray
absorptiometri
scan
reveal
wholebodi
fat
g
increas
lifespan
group
age
chang
significantli
slower
long
lifespan
dog
compar
typic
dog
accumul
fat
time
rate
group
lost
similar
amount
wholebodi
lean
tissu
g
age
p
age
mean
gain
whole
bodi
fat
loss
wholebodi
lean
tissu
slower
mean
chang
fat
lean
ratio
lower
except
longliv
dog
compar
typic
dog
p
typic
age
labrador
show
greater
gain
fat
tissu
greater
loss
lean
tissu
year
age
except
dog
disclosur
eukanuba
diet
use
studi
manufactur
spectrum
brand
whilst
dmm
employ
spectrum
brand
vja
independ
epidemiologist
help
analyz
data
financi
support
spectrum
brand
work
pjw
particip
veterinari
seminar
organis
spectrum
brand
receiv
honorarium
work
introduct
healthi
anim
phosphat
p
combin
calcium
homeostasi
regul
compar
narrow
limit
excess
ingest
p
excret
via
urin
common
knowledg
howev
p
progress
factor
chronic
renal
failur
crf
wherefor
typic
p
restrict
diet
prescrib
affect
patient
pastoor
demonstr
p
excess
significantli
mg
pmj
cap
day
impair
renal
function
even
healthi
cat
diagnos
mainli
reduc
endogen
creatinin
clearanc
dietari
p
origin
meat
protein
sourc
bone
cartilag
miner
supplement
technic
addit
water
bind
palat
ao
textur
enhanc
etc
daili
amount
ingest
complet
diet
european
market
often
exce
recommend
daili
allow
rda
nrc
fediaf
consider
anonymu
studi
done
aim
survey
reproduc
result
pastoor
test
effect
differ
cap
ratio
p
sourc
paramet
renal
function
healthi
adult
cat
anim
materi
method
adult
healthi
cat
appoint
group
everi
trial
period
firstli
balanc
diet
fed
day
includ
day
balanc
trial
one
group
switch
high
p
diet
wherea
remain
balanc
diet
complet
balanc
trial
day
washout
balanc
diet
group
switch
crossov
design
repeat
day
trial
period
design
carri
repeatedli
high
p
diet
differ
compos
concern
cap
ratio
p
sourc
endogen
creatinin
clearanc
glucosuria
microalbuminuria
water
miner
balanc
determin
period
studi
approv
proper
author
anim
welfar
result
discuss
studi
confirm
result
pastoor
p
content
approxim
mgmj
diet
consum
healthi
cat
mainten
may
lead
decreas
creatinin
clearanc
marker
acut
tubular
damag
ie
glucos
microprotein
urin
show
posit
result
sever
trial
p
concentr
diet
alon
suffici
marker
toler
sinc
cap
ratio
p
origin
influenc
effect
therefor
high
p
diet
consid
safe
avoid
also
healthi
cat
literatur
studi
aim
investig
serum
global
proteom
dog
overt
dilat
cardiomyopathi
dcm
correl
protein
express
serum
ascit
fluid
eight
dog
diagnos
dcm
base
echocardiograph
evid
includ
increas
left
ventricular
dimens
diastol
systol
increas
e
point
septal
separ
decreas
fraction
shorten
includ
studi
serum
ascit
fluid
sampl
analyz
proteom
use
labelfre
lcmsm
method
eight
dog
differ
breed
sex
age
serv
control
proteom
analys
reveal
significantli
differ
express
eight
protein
sampl
express
serum
apolipoprotein
ig
heavi
chain
v
superoxid
dismutas
plasminogen
higher
p
express
clusterin
hemoglobin
subunit
apolipoprotein
c
ii
b
glycoprotein
lower
p
dog
dcm
control
dog
addit
apolipoprotein
clusterin
hemoglobin
subunit
ig
heavi
chain
v
plasminogen
downregul
wherea
apolipoprotein
c
ii
superoxid
dismutas
upregul
ascit
fluid
compar
serum
dog
dcm
data
obtain
present
studi
suggest
serum
andor
ascit
fluid
proteom
may
help
explain
pathophysiolog
mechan
involv
progress
dcm
tick
paralysi
import
diseas
dog
cat
australia
induc
toxin
paralysi
tick
ixod
holocyclu
commonli
occur
spring
autumn
eastern
seaboard
respiratori
failur
one
major
clinic
derang
occur
sever
case
tick
paralysi
although
pathogenesi
poorli
characteris
suggest
respiratori
failur
secondari
toxininduc
myocardi
dysfunct
subsequ
develop
cardiogen
pulmonari
oedema
purpos
studi
determin
cardiac
involv
dog
infest
ixod
holocyclu
measur
cardiac
biomark
crosssect
studi
clientown
dog
undertaken
dog
enrol
studi
belong
one
group
dog
tick
paralysi
nomild
respiratori
compromis
group
dog
tick
paralysi
moderatesever
respiratori
compromis
group
b
control
group
dog
neither
tick
paralysi
respiratori
compromis
respiratori
compromis
score
use
commonli
employ
grade
system
anim
follow
paramet
determin
serum
cardiac
troponin
ctni
concentr
plasma
ntermin
probtyp
natriuret
peptid
ntprobnp
concentr
serum
creatinin
concentr
dog
also
determin
mean
ntprobnp
concentr
significantli
lower
dog
tick
paralysi
control
group
statist
differ
detect
dog
without
respiratori
compromis
signific
differ
mean
ctni
concentr
group
howev
high
outlier
ctni
concentr
creatinin
concentr
differ
significantli
group
control
group
highest
mean
creatinin
group
b
lowest
mean
creatinin
signific
differ
group
studi
show
compel
evid
cardiac
insult
measur
cardiac
biomark
cohort
dog
tick
paralysi
howev
evid
support
reduc
preload
dog
addit
result
studi
suggest
small
subset
patient
system
hypoxaemia
might
loss
cardiomyocyt
integr
disclosur
employeesalari
gp
nicolson
r
malik
nj
beijerink
employe
sydney
univers
alh
mcgrath
student
sydney
univers
ra
webster
employe
anim
emerg
servic
carrara
kay
employe
queensland
veterinari
specialist
stafford
height
j
li
employe
northsid
emerg
veterinari
servic
forestvil
grantsresearch
studi
fund
bequest
grant
provid
faculti
veterinari
scienc
univers
sydney
idexx
laboratori
provid
fund
laboratori
test
disclosur
speak
consult
none
relat
present
investmentscommerci
interest
none
relat
present
gift
hospit
travel
support
none
relat
present
none
relat
present
use
ntprobnp
troponin
highsensit
ctni
prescreen
occult
dilat
cardiomyopathi
odcm
doberman
pinscher
dp
previous
report
aim
prospect
collabor
studi
identifi
robust
prescreen
recommend
dp
util
current
gener
commerci
avail
diagnost
test
cohort
asymptomat
dp
evalu
american
doberman
nation
specialti
show
n
median
age
year
rang
evalu
consist
auscult
echocardiographi
echo
ecg
ecg
ntprobnp
cardiopet
plu
r
ctni
dp
classifi
affect
odcm
lvid
protect
entri
criteria
without
vpc
n
dp
classifi
normal
nl
lvidd
lvid
protect
entri
criteria
vpc
ntprobnp
n
ctni
n
n
roc
analysi
compar
odcm
nl
done
ntprobnp
ctni
overal
accuraci
percent
correctli
classifi
consid
individu
test
well
varieti
combin
goal
combin
test
elimin
fals
neg
minim
fals
posit
auc
ntprobnp
ctni
respect
percentag
correctli
classifi
equal
includ
fals
neg
cutoff
pmoll
ngml
posit
heteroor
homozyg
use
respect
cutoff
ntprobnp
ctni
use
combin
auc
correctli
classifi
fals
neg
fals
posit
disclosur
research
programat
support
idexx
lab
run
ntprobnp
studi
sponsor
boehring
ingelheim
idexx
doberman
pinscher
societi
america
renal
diseas
r
langhorn
kloster
lr
jessen
jensen
j
koch
univers
copenhagen
frederiksberg
c
denmark
copenhagen
small
anim
hospit
valbi
denmark
cardiac
troponin
sensit
specif
marker
myocardi
injuri
howev
reliabl
renal
diseas
question
due
possibl
renal
involv
troponin
elimin
purpos
studi
examin
whether
cardiac
troponin
ctni
elev
cat
renal
diseas
concurr
cardiac
diseas
whether
ctni
measur
urin
cat
normal
compromis
renal
function
cat
present
renal
diseas
primari
structur
cardiac
diseas
enrol
renal
cardiac
group
respect
healthi
control
group
similarli
includ
clinic
echocardiograph
examin
perform
blood
urin
sampl
obtain
cat
mannwhitney
u
test
appli
evalu
differ
group
seven
cat
renal
diseas
cat
cardiac
diseas
healthi
cat
includ
serum
ctni
concentr
median
rang
ngml
renal
group
ngml
cardiac
group
ngml
control
group
renal
group
significantli
higher
serum
ctni
concentr
control
group
p
significantli
differ
cardiac
group
p
urin
ctni
measur
cat
renal
group
ngml
cardiac
group
control
ngml
conclud
elev
serum
ctni
cat
renal
diseas
may
occur
without
concurr
cardiac
diseas
moreov
compromis
renal
function
associ
presenc
ctni
urin
disclosur
disclosur
report
sudden
death
sd
commonli
occur
dog
breed
high
predisposit
vpd
vt
occur
asymptomat
doberman
pinscher
dp
dp
chf
report
boxer
arvc
human
patient
atrial
fibril
af
anticoagul
therapi
stroke
prevent
n
cardiac
death
sd
progress
heart
failur
report
account
death
object
studi
evalu
incid
sd
irish
wolfhound
iw
dcm
andor
af
iw
western
europ
n
examin
physic
examin
standard
echocardiographi
electrocardiographi
av
dog
longitudin
follow
owner
instruct
report
date
circumst
death
dcm
andor
af
diagnos
longterm
followup
death
possibl
dog
dcm
dog
lone
af
base
initi
diagnosi
diseas
group
establish
result
sd
occur
group
dcm
af
dog
dcm
af
sd
occur
median
day
median
age
year
dog
dcm
sinu
rhythm
die
sd
median
day
median
age
year
iw
dcm
af
chf
die
sd
median
day
median
age
year
iw
lone
af
sd
occur
median
day
median
age
year
dog
develop
dcm
prior
death
sudden
cardiac
death
sd
cardiac
arrest
common
caus
death
peopl
worldwid
account
death
cardiovascular
diseas
ventricular
tachycardia
vt
fibril
vf
common
caus
sd
caus
includ
pulseless
electr
activ
fatal
arrhythmia
record
iw
studi
vpd
record
one
occas
iw
af
dcm
iw
without
heart
diseas
vpd
seen
male
femal
conclus
sd
occur
iw
lone
af
develop
dcm
chf
dog
dcm
disclosur
disclosur
report
tachycardia
may
induc
dilat
cardiomyopathi
dcm
irish
wolfhound
iw
commonli
affect
dcm
atrial
fibril
af
object
studi
compar
heart
rate
hr
iw
lone
af
hr
age
gender
match
control
iw
cohort
neither
af
dcm
death
iw
dcm
either
congest
heart
failur
chf
af
sinu
rhythm
sr
diseas
group
hr
record
month
medic
therapi
iw
cardiovascular
examin
includ
standard
echocardiographi
electrocardiographi
longterm
followup
death
possibl
dog
dcm
dog
lone
af
base
initi
diagnosi
diseas
group
establish
dog
receiv
singl
combin
treatment
metildigoxin
acei
pimobendan
diltiazem
furosemid
spironolacton
atenolol
sotalol
mean
hr
minut
ecg
monitor
record
printout
evalu
differ
hr
diseas
group
treatment
versu
control
examin
analysi
varianc
post
hoc
multipl
comparison
dunnett
mean
hr
control
dog
bpm
mean
hr
iw
lone
af
bpm
bpm
therapi
mean
hr
dog
dcm
af
bpm
bpm
therapi
mean
hr
dog
dcm
sinu
rhythm
sr
bpm
ae
sd
bpm
therapi
mean
hr
iw
dcm
af
chf
bpm
median
bpm
therapi
conclus
compar
control
dog
untreat
iw
chf
dcmaf
iw
lone
af
statist
signific
p
increas
hr
dog
dcm
sr
medic
therapi
elev
hr
signific
p
iw
chf
dcm
disclosur
disclosur
report
echocardiographi
noninvas
method
increasingli
use
complementari
mean
diagnosi
small
anim
clinic
practic
need
standard
techniqu
ultrasound
oper
measur
differ
echocardiograph
paramet
essenti
proper
examin
aim
work
check
potenti
correl
valu
obtain
right
parastern
longaxi
shortaxi
view
mode
mmode
twenti
persian
cat
submit
complet
physic
examin
clinicopatholog
test
hematocrit
total
solid
hormon
systol
blood
pressur
measur
use
doppler
echocardiographi
seventeen
cat
fulfil
criteria
inclus
includ
studi
twodimension
mode
mmode
echocardiogram
record
systol
diastol
shortaxi
longaxi
view
evalu
left
ventricular
intern
diamet
lvd
interventricular
septum
thick
iv
left
ventricular
free
wall
thick
lvpw
aorta
diamet
left
atrium
diamet
la
pulmonari
arteri
diamet
shorten
fraction
fs
eject
fraction
fe
statist
analysi
includ
pair
ttest
wilcoxon
test
linear
regress
analysi
graphic
analysi
assess
agreement
method
data
acquisit
highli
signific
correl
p
valu
obtain
shortaxi
longaxi
view
paramet
la
diamet
longitudin
cm
transvers
cm
signific
correl
p
paramet
lvd
longitudin
cm
transvers
cm
signific
correl
p
paramet
ivss
longitudin
cm
transvers
cm
lvpw
longitudin
cm
transvers
cm
fs
longitudin
transvers
signific
correl
p
method
remain
paramet
conclus
data
obtain
right
parastern
shortaxi
longaxi
record
use
interchang
evalu
diastol
paramet
normal
adult
cat
disclosur
disclosur
report
real
time
threedimension
transesophag
echocardiographi
establish
imag
modal
intervent
cardiac
procedur
human
shown
yield
comprehens
view
cardiac
valv
congenit
heart
defect
potenti
provid
accur
echocardiograph
mean
evalu
cardiac
chamber
volum
precis
pre
postop
tool
use
combin
convent
transesophag
tee
transthorac
echocardiographi
tte
standard
imag
protocol
pulmon
valv
anatomi
function
evalu
clientown
dog
sever
valvular
pulmon
stenosi
prior
postballoon
valvuloplasti
imag
obtain
phillip
cardiac
ultrasound
system
use
transesophag
mhz
xmatrix
probe
standard
cardiac
mhz
mhz
mhz
sector
array
probe
use
acquir
tte
imag
diagnost
imag
obtain
examin
patient
chang
balloon
size
decis
compar
tee
provid
addit
view
detail
anatomi
pulmon
valv
cusp
commissur
well
thick
mobil
pulmon
valv
cusp
compar
obtain
tee
tte
success
balloon
valvuloplasti
achiev
patient
repeat
artifact
occur
respiratori
excurs
insuffici
probe
contact
complic
relat
observ
provid
enhanc
view
pulmon
valv
aid
procedur
guidanc
evalu
result
postballoon
valvuloplasti
better
understand
anatomi
pulmon
valv
may
improv
procedur
success
immedi
visual
result
postballoon
valvuloplasti
may
reduc
patient
risk
fluoroscopi
time
larger
sampl
research
need
establish
guidelin
predict
success
base
particular
valv
anatomi
conclud
provid
addit
anatom
intraprocedur
inform
well
toler
group
dog
disclosur
disclosur
report
pimobendan
inodil
utilis
extens
treatment
canin
congest
heart
failur
sever
retrospect
studi
evalu
clinic
record
suggest
well
toler
cat
howev
efficaci
speci
remain
illdefin
moreov
recent
pharmacokinet
studi
found
peak
plasma
concentr
drug
around
ten
time
greater
report
dog
thu
highlight
interspeci
differ
pharmacokinet
potenti
pharmacodynam
drug
studi
conduct
evalu
cardiovascular
effect
follow
oral
dose
pimobendan
healthi
cat
placebocontrol
randomis
operatorblind
crossov
studi
conduct
healthi
cat
weight
rang
kg
evalu
effect
dose
pimobendan
high
dose
hd
mg
vetmedin
chewabl
tablet
po
low
dose
ld
mg
vetmedin
chewabl
tablet
po
placebo
pl
water
po
cardiovascular
paramet
time
standard
echocardiographi
mmode
spectral
doppler
oscillometr
blood
pressur
measur
vethdo
perform
repeatedli
hour
follow
dose
measur
paramet
evalu
betweenand
withintreat
effect
time
use
linear
mix
model
reml
estim
account
intercat
variabl
heart
rate
use
proxi
level
anxieti
experienc
cat
adjust
perform
inclus
heart
rate
fix
effect
final
model
effect
treatment
pimobendan
evid
left
ventricular
intern
diamet
systol
lvid
maxim
effect
occur
hour
follow
treatment
hd
ld
predict
mean
reduct
baselin
follow
heart
rate
adjust
time
lvid
mm
reduct
mm
reduct
hd
ld
respect
although
signific
differ
hd
ld
magnitud
effect
given
time
point
lvid
remain
significantli
reduc
baselin
pl
group
longer
hd
minut
hour
follow
dose
ld
group
hour
follow
dose
signific
treatment
effect
aortic
veloc
fraction
shorten
also
present
lesser
degre
result
demonstr
treatment
pimobendan
result
measur
chang
systol
indic
cat
dosedepend
increas
durat
effect
also
observ
studi
requir
characteris
optim
dose
pimobendan
cat
evalu
efficaci
clinic
patient
disclosur
studi
fund
grant
provid
faculti
veterinari
scienc
univers
sydney
yata
receiv
financi
support
luoda
pharma
australian
postgradu
award
scholarship
eric
horatio
maclean
scholarship
whilst
undertak
project
none
author
involv
studi
current
affili
drug
compani
manufactur
product
use
studi
boehring
ingelheim
pimobendan
posit
inotrop
posit
lusitrop
vasodil
effect
licens
use
dog
cardiac
diseas
mani
countri
numer
studi
shown
benefit
use
pimobendan
canin
dilat
cardiomyopathi
chronic
degen
mitral
valv
diseas
whilst
licens
use
cat
recent
studi
report
benefit
use
oral
pimobendan
varieti
cardiac
diseas
includ
dilat
hypertroph
cardiomyopathi
intraven
formul
avail
uk
sinc
januari
use
intraven
pimobendan
cat
clinic
set
previous
describ
aim
studi
describ
use
intraven
pimobendan
cat
natur
occur
heart
failur
report
toler
side
effectsadvers
reaction
hospit
data
base
search
use
intraven
pimobendan
felin
patient
signal
present
sign
investig
diagnosi
dose
time
pimobendan
administr
concurr
medic
shortterm
outcom
advers
reaction
record
boardedcertifi
cardiologist
retrospect
review
case
order
confirm
diagnosi
owner
sign
consent
form
permit
use
licens
drug
eight
cat
includ
studi
median
age
year
rang
six
male
domest
shorthair
weight
rang
kg
present
dyspnoea
three
cat
heart
murmur
gallop
rhythm
differ
heart
condit
diagnos
includ
cat
cardiomyopathi
suspect
endocard
median
dose
intraven
pimobendan
mgkg
rang
concurr
drug
administ
includ
frusemid
dalteparin
terbutalin
dexamethason
amoxicillinclavulan
maropit
midazolam
butorphanol
methadon
glyceryl
trinitr
clopidogrel
aspirin
potassium
glucon
immedi
advers
reactionssid
effect
observ
cat
five
cat
discharg
hospit
hour
post
pimobendan
administr
one
cat
euthanat
one
die
thoracocentesi
one
thromboembol
episod
hour
post
pimobendan
administr
intraven
pimobendan
well
toler
clinic
popul
cat
heart
failur
immedi
advers
reaction
side
effect
observ
intraven
rout
may
consid
altern
method
administr
pimobendan
cat
heart
failur
disclosur
disclosur
report
spironolacton
sp
aldosteron
receptor
antagonist
regist
europ
treatment
congest
heart
failur
chf
caus
valvular
regurgit
dog
combin
standard
therapi
cat
cardiomyopathi
cm
predomin
caus
heart
failur
evalu
safeti
efficaci
sp
cat
cm
doubl
blind
random
placebocontrol
studi
conduct
cat
receiv
either
sp
mgkg
po
daili
placebo
month
addit
benazepril
furosemid
dose
clinician
discret
cat
dsh
ragdol
siames
burmes
cm
variou
type
hypertroph
dilat
unclassifi
arrhythmogen
right
ventricular
enrol
cat
random
either
group
b
accord
presenc
hcm
whether
cat
requir
hospit
due
clinic
need
cat
recruit
group
sp
cat
recruit
group
b
placebo
signific
differ
group
baselin
aortic
diamet
p
larger
sp
group
la
ao
ratio
p
larger
placebo
group
surviv
analysi
show
surviv
rate
month
respect
intent
treat
itt
per
protocol
pp
popul
sp
group
placebo
group
differ
group
signific
log
rank
test
itt
popul
p
pp
popul
p
hazard
ratio
indic
itt
pp
reduct
risk
event
occurr
sp
group
effect
covari
age
weight
bc
systol
blood
pressur
ratio
laao
signific
although
pilot
studi
small
number
cat
data
would
suggest
spironolacton
like
benefici
treatment
cat
congest
heart
failur
secondari
cardiomyopathi
disclosur
studi
joint
fund
ceva
univers
nottingham
author
right
publish
result
studi
irrespect
outcom
object
studi
describ
pulmonari
transit
time
myocardi
perfus
normal
heart
rate
nptt
nmp
respect
evalu
mean
contrast
echocardiographi
dog
stabl
stage
c
acvim
myxomat
mitral
valv
diseas
mmvd
assess
shortterm
effect
pimobendan
paramet
hypothes
nptt
nmp
increas
dog
mmvd
compar
normal
dog
addit
hypothes
treatment
pimobendan
decreas
variabl
dog
mmvd
prospect
enrol
normal
dog
dog
stabl
stage
c
acvim
mmvd
dog
standard
contrast
echocardiograph
examin
begin
studi
time
mmvd
dog
randomli
assign
receiv
either
pimobendan
mgkg
dog
mmvd
reevalu
mean
standard
contrast
echocardiographi
week
oper
blind
dog
treatment
result
show
nptt
significantli
increas
dog
mmvd
p
compar
normal
dog
nptt
significantli
decreas
dog
receiv
pimobendan
p
nmp
significantli
differ
dog
mmvd
compar
healthi
dog
p
significantli
differ
treatment
group
p
conclus
contrast
echocardiographi
valid
complementari
tool
echocardiograph
analysi
dog
mmvd
pimobendan
decreas
nptt
dog
affect
mmvd
myocardi
perfus
differ
dog
mmvd
chang
pimobendan
treatment
disclosur
michel
borgarelli
receiv
research
fund
boheringh
inghelheim
studi
human
be
assess
atrial
function
use
speckl
track
echocardiographi
ste
use
sever
cardiovascular
diseas
date
inform
use
ste
evalu
canin
atrial
function
lack
assess
feasibl
reproduc
ste
assess
left
atrial
la
function
healthi
dog
dog
myxomat
mitral
valv
diseas
mmvd
compar
ste
deriv
indic
paramet
left
atrial
ventricular
function
morpholog
privat
own
dog
includ
clinic
healthi
dog
control
h
dog
mmvd
subdivid
accord
heart
failur
class
cd
enrol
standard
echocardiograph
examin
carri
dog
furthermor
video
clip
acquir
apic
view
ste
analysi
done
use
dedic
softwar
ste
analysi
region
interest
drawn
includ
entir
left
atrial
wall
softwar
provid
straintim
curv
repres
degre
deform
la
wall
entir
cardiac
cycl
similarli
la
area
provid
follow
variabl
evalu
peak
atrial
longitudin
strain
pal
point
maxim
systol
strain
peak
atrial
contract
strain
pac
atrial
contract
phase
contract
strain
index
csi
calcul
variabl
la
area
record
ventricular
systol
la
maximum
area
laamax
cm
atrial
contract
la
minimum
area
laamin
cm
la
fraction
area
chang
fac
calcul
intraand
interobserv
variabl
assess
use
coeffici
variat
cv
variabl
low
variabl
cv
left
atrial
measur
commonli
obtain
cardiologist
assess
sever
left
heart
diseas
tradit
measur
obtain
mmode
imag
howev
sever
studi
examin
measur
left
atrial
dimens
area
imag
studi
demonstr
interobserv
variabl
aortic
valv
measur
effect
time
measur
throughout
cardiac
cycl
howev
studi
examin
interobserv
variabl
left
atrial
measur
imag
factor
affect
variabl
consequ
variabl
ascrib
degre
diseas
sever
patient
imag
right
parastern
shortaxi
view
left
atrium
aorta
provid
cardiologist
cardiolog
resid
imag
depict
left
atria
vari
size
dog
cat
rang
normal
markedli
enlarg
particip
place
arrow
imag
denot
start
finish
point
left
atrial
measur
without
prior
instruct
first
near
interfac
aorta
second
along
caudolater
border
left
atrium
thu
set
imag
analyz
distribut
map
analyz
determin
dispers
start
finish
point
compar
imag
look
associ
sever
estim
median
la
ao
imag
imag
complex
result
variabl
measur
around
origin
la
measur
interfac
aorta
small
scale
increas
heart
size
variabl
distal
measur
point
complex
imag
interobserv
variabl
la
ao
rang
la
ao
variabl
systemat
observ
effect
note
variabl
appear
scale
sever
diseas
imag
complex
although
case
greatest
variabl
sever
enlarg
indistinct
margin
conclus
studi
demonstr
highli
train
individu
vari
consider
measur
left
atria
right
parastern
shortaxi
view
variabl
increas
increas
diseas
sever
imag
complex
instanc
patient
could
classifi
differ
differ
observ
reli
la
ao
threshold
studi
suggest
standard
method
measur
develop
minim
variabl
disclosur
studi
support
veterinari
inform
network
salari
imag
softwar
grow
evid
fibrosi
play
import
role
develop
remodel
heart
failur
cardiac
diseas
cellular
level
fibrot
process
prior
clinic
manifest
symptom
fibrosi
extracellular
matrix
remodel
influenc
cardiac
function
neg
manner
knowledg
biomark
abl
properli
detect
heartspecif
fibrot
process
remodel
peripher
blood
biomark
would
great
import
cardiac
diagnost
risk
stratif
therapi
monitor
preliminari
studi
use
microarray
method
pathway
analysi
pool
sampl
abl
identifi
heart
specif
geneexpress
profil
repres
fibrot
inflammatori
process
peripher
blood
tachypacinginduc
cardiomyopathi
model
dog
result
valid
histopatholog
quantit
real
time
rtpcr
qrtpcr
base
microarray
result
current
studi
aim
select
investig
panel
possibl
cardiac
fibrosi
remodel
specif
gene
blood
whole
blood
left
ventricular
sampl
tachypac
dog
n
healthi
control
n
blood
sampl
canin
clinic
patient
n
differ
cardiomyopathi
collect
rnastabil
solut
rna
integr
confirm
capillari
electrophoresi
rin
exonspan
primer
design
express
select
gene
measur
sybrgreen
base
qrtpcr
normal
differ
housekeep
gene
ddct
method
qualiti
control
made
melt
curv
analysi
size
determin
pcr
product
agarosegel
electrophoresi
data
evalu
descript
statist
student
ttest
mann
whitney
utest
use
select
geneexpress
panel
consist
differ
mrna
repres
main
biolog
process
relat
fibrosi
remodel
impair
contractil
vcan
directli
relat
collagen
turnov
remodel
inflammatori
marker
earli
stress
respons
gene
central
role
fibrosi
ensur
cardiac
specif
found
signific
regul
p
vcan
regul
gene
heart
tissu
sampl
target
also
show
similar
chang
blood
sampl
except
howev
alter
signific
base
select
panel
clinic
case
could
clearli
differenti
healthi
dog
use
geneexpress
pattern
blood
sampl
find
suggest
peripher
blood
may
potenti
reveal
cardiac
specif
fibrosi
dog
disclosur
disclosur
report
within
distal
nephron
enzym
hydroxysteroid
dehydrogenas
protect
mineralocorticoid
receptor
mr
activ
cortisol
allow
interact
aldosteron
human
mutat
caus
appar
mineralocorticoid
excess
characteris
sodium
water
retent
result
hypertens
sodium
water
retent
also
hallmark
canin
congest
heart
failur
chf
could
partli
explain
dysregul
renal
activ
expos
mr
activ
cortisol
aim
studi
investig
activ
renal
canin
chf
measur
concentr
cortisol
metabolit
urin
affect
dog
owner
collect
urin
home
environ
healthi
adult
dog
n
dog
prior
present
noncardiac
chronic
diseas
n
dog
cardiac
diseas
isachc
ib
n
isachcii
iii
n
level
cortisol
f
cortison
e
excret
urin
measur
mass
spectrometri
urinari
cortisol
normalis
creatinin
account
variat
glomerular
filtrat
rate
cortisol
also
measur
plasma
obtain
unhealthi
dog
plasma
cortisol
level
p
urinari
cortisol
creatinin
ratio
p
differ
group
howev
fe
ratio
increas
dog
class
iiiii
heart
failur
p
increas
fe
ratio
presenc
unchang
plasma
cortisol
impli
decreas
renal
activ
enhanc
mr
activ
cortisol
canin
chf
data
suggest
chang
renal
cortisol
metabol
canin
chf
explain
chronic
diseas
urinari
fe
ratio
potenti
biomark
canin
chf
renal
could
offer
therapeut
target
manag
studi
investig
express
bioactiv
canin
chf
ongo
disclosur
support
fiona
ian
russel
seed
corn
grant
univers
edinburgh
human
endomyocardi
biopsi
emb
highli
recommend
case
unexplain
left
ventricular
dysfunct
associ
ventricular
arrhythmia
va
highgrad
atrioventricular
block
avb
despit
frequenc
condit
dog
histopatholog
data
lack
aim
studi
describ
feasibl
emb
dog
investig
possibl
role
viral
myocard
case
unexplain
dilat
cardiomyopathi
dcm
phenotyp
highgrad
avb
supraventricular
arrhythmia
sva
va
twentyf
dog
differ
breed
mf
mean
age
year
mean
bodi
weight
kg
present
third
degre
avb
dcm
va
sva
vasva
underw
percutan
right
emb
gener
anesthesia
throughout
jugular
vein
dog
clinic
record
analyz
dog
least
one
right
ventricular
sampl
rang
collect
histopatholog
immunohistochemistri
dog
least
one
sampl
rang
viral
pcr
collect
histopatholog
sampl
stain
haematoxylin
eosin
masson
trichrom
red
elast
picrociriu
select
case
stain
monoclon
perform
nucleic
acid
obtain
sampl
storag
rna
later
solut
disrupt
tissu
lyser
extract
trizol
test
canin
virus
enter
respiratori
coronaviru
herp
viru
distemp
viru
adenoviru
parvoviru
west
nile
viru
bartonella
spp
seven
dog
aspecif
sign
cardiomyopathi
suggest
arrhythmogen
right
ventricular
cardiomyopathi
arvc
emb
gave
normal
sampl
dog
diagnost
dog
nine
sampl
suggest
myocard
differ
stage
third
degre
avb
dcm
sva
two
dog
result
posit
viru
enter
coronaviru
herp
viru
none
dog
posit
immunoistochem
stain
two
dog
cardiomyopathi
posit
herp
viru
herp
viru
parvoviru
respect
dog
came
kennel
complic
note
dog
one
dog
selflimit
pericardi
effus
studi
show
similarli
human
cardiolog
emb
safe
use
techniqu
allow
recognit
classif
unexplain
myocardi
rhythm
disord
possibl
associ
viral
myocard
studi
need
prove
relationship
virus
myocard
larger
cohort
dog
disclosur
disclosur
report
echocardiograph
evalu
right
ventricl
rv
challeng
studi
lack
quantit
assess
rv
dog
goal
studi
therefor
evalu
rv
morpholog
systol
function
use
differ
transthorac
echocardiograph
te
view
compar
result
magnet
reson
imag
mri
measur
adult
healthi
anesthet
beagl
te
variabl
rv
wall
thick
wt
short
axi
subcost
view
fraction
shorten
fs
rv
fraction
area
chang
fac
differ
apic
view
optim
view
rv
standard
chamber
view
tricuspid
annular
plane
systol
excurs
taps
differ
apic
view
right
ventricular
outflow
tract
diamet
proxim
valvular
level
obtain
long
short
axi
tissu
doppler
imag
tdi
deriv
tricuspid
annulu
systol
wave
isovolum
contract
veloc
ivcvel
isovolum
contract
acceler
time
ivcat
mri
variabl
rv
wt
short
long
axi
eject
fraction
ef
stroke
volum
sv
base
flow
quantif
differ
rv
wt
measur
te
short
axi
mm
subcost
view
mm
mri
mm
differ
found
measur
long
mm
former
mm
latter
short
axi
mm
former
mm
latter
te
howev
short
long
axi
overestim
te
compar
mri
mm
long
axi
mm
short
axi
short
long
axi
obtain
te
lower
mri
valu
mm
te
fs
valu
taps
vari
significantli
use
differ
apic
view
optim
mm
standard
chamber
mm
true
fac
optim
view
standard
chamber
mm
tdi
ms
ivcvel
ms
ivcat
msec
te
correl
found
taps
fac
echocardiograph
variabl
correl
mri
base
sv
ml
fac
mri
base
ef
correl
echocardiograph
variabl
new
approach
assess
rv
function
reveal
problem
similar
earlier
attempt
without
reliabl
standard
comparison
quantit
result
valu
te
paramet
question
furthermor
te
paramet
obtain
differ
view
produc
differ
result
indic
standard
mayb
difficult
respect
increas
risk
variabl
disclosur
disclosur
report
spontan
echo
contrast
sec
smoke
caus
low
blood
veloc
appear
ultrasound
swirl
blood
flow
pattern
associ
increas
risk
thromboembol
small
anim
detect
sec
entir
subject
limit
consensu
veterinari
medicin
regard
echocardiograph
techniqu
best
detect
sec
main
hypothesi
studi
dimension
colour
tissu
doppler
imag
tdi
would
significantli
outperform
colour
grey
scale
best
echocardiograph
techniqu
view
sec
hypothesi
colour
blind
would
influenc
result
echocardiograph
data
obtain
retrospect
small
anim
case
present
univers
glasgow
small
anim
hospit
case
evid
sec
use
ge
vivid
echocardiographi
machin
case
one
video
loop
record
colour
tdi
colour
tdi
replac
differ
colour
gold
sepia
aqua
differ
grey
scale
colour
machin
preset
video
loop
record
case
order
record
video
loop
randomis
video
loop
case
view
standardis
condit
observ
veterinari
cardiologist
resid
intern
student
observ
full
colour
spectrum
vision
fcsv
redgreen
colour
blind
deuteranopia
observ
rank
abil
see
sec
colour
least
abl
visualis
sec
best
abl
visualis
sec
binari
logist
regress
use
minitab
version
use
identifi
factor
associ
whether
tdi
rank
best
potenti
explanatori
variabl
examin
view
colour
blind
observ
case
also
fit
fix
random
effect
account
cluster
within
variabl
tdi
chosen
observ
occas
best
techniqu
diagnos
sec
significantli
frequent
colour
view
togeth
p
signific
differ
colour
blind
observ
fcsv
p
influenc
observ
case
final
model
conclus
colour
tdi
may
assist
easier
diagnosi
spontan
echo
contrast
veterinari
medicin
regardless
colour
visual
spectrum
observ
easier
detect
sec
would
allow
earlier
implement
prevent
measur
disclosur
disclosur
report
foramen
oval
fo
slitlik
passageway
septum
secundum
primum
typic
close
birth
fusion
septa
human
patent
foramen
oval
pfo
persist
adulthood
preval
pfo
small
anim
unknown
interatri
channel
may
serv
bypass
pulmonari
circul
import
caus
paradox
embol
pe
stroke
peopl
primari
aim
studi
evalu
preval
pfo
larg
popul
dog
cat
secondari
aim
gather
data
preval
atrial
septal
defect
asd
potenti
associ
pfo
clinicalpatholog
sign
stroke
thromboembol
b
presenc
rightsid
heart
diseas
heart
dog
cat
underw
full
diagnost
post
mortem
examin
prospect
evalu
pfo
blind
fashion
clinic
histori
caus
death
select
case
patent
close
fo
respect
histolog
examin
interatri
septum
undertaken
clinic
inform
result
post
mortem
examin
evalu
heart
examin
total
heart
cat
dog
examin
cat
dog
median
age
year
year
year
respect
exhibit
probepat
pfo
adult
anim
presum
normal
right
atrial
pressur
preval
pfo
cat
dog
none
anim
asd
one
dog
pfo
also
exhibit
aortic
thrombu
otherwis
evid
pe
popul
dog
cat
close
fo
left
side
interatri
septum
septum
primum
still
partial
probepat
channel
extend
left
atrial
crescent
ridg
ostium
secundum
limbu
close
level
thin
easili
ruptur
membran
conclus
pfo
common
dog
cat
less
preval
human
contrast
asd
appear
rare
either
despit
high
preval
pfo
clinic
complic
seem
rare
major
dog
close
fo
fossa
ovali
weakli
fuse
limbu
may
facilit
blunt
transsept
atrial
catheteris
provid
easier
access
left
atrium
disclosur
jose
novo
mato
toni
glau
perform
consult
work
boehring
ingelheim
vetoquinol
human
medicin
diabet
mellitu
dm
known
lead
cardiovascular
dysfunct
heart
failur
character
earli
diastol
late
systol
dysfunct
diabet
cardiomyopathi
defin
exist
left
ventricular
dysfunct
diabet
without
coronari
arteri
diseas
hypertens
potenti
etiolog
condit
preval
diabet
cardiomyopathi
cat
previous
studi
sought
prospect
identifi
cardiac
diastol
dysfunct
present
would
develop
popul
cat
newli
diagnos
dm
cat
recruit
base
diagnosi
primari
dm
patient
receiv
physic
examin
biochem
hematolog
profil
includ
thyroxin
insulinlik
growth
factor
urinalysi
blood
pressur
measur
thorac
abdomin
radiograph
abdomin
ultrasound
echocardiographi
perform
diagnosi
month
post
diagnosi
echocardiograph
assess
includ
convent
mmode
spectral
tissu
doppler
measur
patient
relev
concomit
system
ill
secondari
dm
exclud
studi
healthi
age
match
control
cat
retrospect
enrol
thirtytwo
diabet
enrol
studi
eighteen
femal
male
mean
age
year
march
cat
receiv
month
echocardiograph
control
ten
control
cat
enrol
c
eight
male
femal
mean
age
year
result
fluoroscop
guid
pacemak
implant
impart
risk
radiat
exposur
ideal
exposur
risk
minim
avoid
previous
report
use
transthorac
tte
transesophag
echocardiographi
guid
pda
occlus
balloon
valvuloplasti
therefor
hypothes
tte
could
use
minim
fluoroscopi
time
pacemak
implant
dog
implant
singl
bipolar
lead
pacemak
vvir
dog
use
either
activ
passiv
fixat
determin
tte
assess
right
ventricular
apic
myocardium
thick
dog
apic
rv
thick
mm
implant
passiv
fixat
lead
dog
anesthet
posit
right
later
recumb
standard
echocardiographi
tabl
left
jugular
vein
exterior
venotomi
perform
dog
perman
pace
lead
advanc
left
jugular
venotomi
direct
cranial
vena
cava
right
atrium
rv
tte
guidanc
echocardiograph
right
parastern
view
optim
visual
pace
lead
use
start
short
axi
imag
right
atrium
end
long
axi
view
rv
optim
imag
ventricular
apex
place
pace
lead
rv
apex
tte
guidanc
accept
measur
captur
threshold
imped
obtain
fluoroscopi
use
confirm
lead
placement
puls
gener
connect
pace
lead
secur
within
right
dorsal
cervic
pocket
incis
close
routin
postimplant
thorac
radiograph
perform
pace
lead
appear
hyperecho
tte
imag
tte
guidanc
provid
imag
qualiti
suffici
clearli
monitor
implant
realtim
realtim
monitor
allow
immedi
correct
pace
lead
malposit
excess
loop
activefix
lead
tte
allow
visual
fixat
helix
implant
myocardium
case
right
parastern
echocardiograph
window
allow
imag
differ
posit
lead
cardiac
chamber
entir
procedur
implant
success
dog
first
case
requir
fluoroscop
guidanc
follow
intraventricular
progress
lead
last
dog
use
fluoroscop
intraop
xray
machin
cine
mode
demonstr
tte
monitor
guid
pacemak
lead
implant
fluoroscopi
requir
confirm
correct
placement
lead
end
procedur
disclosur
disclosur
report
decid
whether
cardiac
murmur
innoc
result
congenit
cardiac
anomali
could
challeng
gold
standard
method
differenti
innoc
murmur
congenit
cardiac
anomali
echocardiogram
perform
skill
oper
present
studi
investig
whether
object
auscultationcriteria
differenti
innoc
patholog
murmur
asymptomat
puppi
month
age
nullhypothesi
systol
murmur
intens
music
charact
innoc
total
puppi
includ
juli
januari
puppi
origin
either
breeder
brought
puppi
clinic
screen
congenit
portosystem
shunt
refer
cardiolog
servic
evalu
murmur
puppi
brought
shuntscreen
puppi
age
day
murmur
audibl
everi
beat
dog
small
terrier
breed
dog
intermitt
audibl
murmur
exclud
remain
puppi
age
day
referr
cardiolog
servic
base
describ
auscult
criteria
murmur
classifi
innoc
dog
patholog
dog
dog
echocardiogram
perform
abnorm
seen
dog
whose
murmur
classifi
innoc
echocardiographi
reveal
one
congenit
cardiac
anomali
dog
whose
murmur
classifi
patholog
congenit
anomali
patent
ductu
arteriosu
pulmon
stenosi
sever
moder
mild
combin
small
ventricular
septal
defect
aortic
stenosi
sever
moder
ventricular
septal
defect
mild
mitral
valv
dysplasia
doublechamb
right
ventricl
moder
isol
combin
mild
aortic
stenosi
small
ventricular
septal
defect
mild
mitral
valv
dysplasia
puppi
isol
mild
mitral
dysplasia
soft
systol
murmur
music
charact
everi
puppi
murmur
shuntscreen
group
also
phonocardiogram
perform
phonocardiogram
innoc
murmur
reveal
earli
systol
murmur
low
amplitud
auscult
turn
sensit
specif
method
differenti
innoc
murmur
patholog
one
phonocardiogram
addit
valu
limit
describ
find
may
use
breed
predispos
aortic
stenosi
boxer
disclosur
disclosur
report
sinc
first
descript
felin
hyperthyroid
sever
epidemiolog
studi
suggest
diet
causal
factor
aim
critic
assess
evid
present
epidemiolog
studi
suggest
foodassoci
factor
etiolog
scientif
literatur
screen
peer
review
public
investig
foodassoci
factor
sinc
first
describ
studi
design
check
classic
epidemiolog
bias
foodassoci
factor
show
increas
risk
assess
compat
bradfordhil
bh
criteria
use
evalu
whether
associ
involv
causal
compon
evid
causal
compon
higher
bh
criteria
met
total
public
investig
foodassoci
factor
identifi
retrospect
three
public
investig
qualit
factor
eg
prefer
food
flavor
quantit
feed
can
food
found
signific
risk
factor
one
studi
found
signific
quantit
risk
factor
public
howev
import
limit
design
control
includ
sick
cat
studi
case
outnumb
control
studi
case
control
differ
age
studi
diet
inform
reflect
diet
fed
time
develop
studi
three
bh
criteria
met
consid
can
diet
feed
increas
risk
develop
avail
literatur
insuffici
evid
conclud
can
diet
foodassoci
factor
etiolog
retrospect
studi
describ
associ
caus
effect
relationship
sensit
bia
host
environ
less
like
identifi
etiolog
factor
preval
case
hypothes
link
foodassoci
factor
bpa
pbde
flavonoid
iodin
content
never
proven
date
lifelong
prospect
studi
requir
investig
foodassoci
factor
etiolog
iodinerestrict
food
recent
introduc
potenti
therapeut
option
felin
hyperthyroid
control
studi
publish
treatment
aim
nonrandomis
control
trial
evalu
effect
iodinerestrict
food
serum
concentr
clinic
clinicopatholog
paramet
clientown
cat
hyperthyroid
indoor
cat
newli
diagnos
hyperthyroid
consist
clinic
sign
serum
concentr
nmoll
without
mild
moder
azotemia
iri
includ
cat
sever
concurr
disord
ie
lymphoma
neoplasia
malabsorpt
sever
azotemia
iri
exclud
cat
alloc
owner
prefer
group
group
receiv
iodinerestrict
food
singl
therapi
control
group
group
b
receiv
transderm
methimazol
pluron
lecithin
organogel
plo
mgml
start
dose
mgcat
q
h
group
clinic
paramet
biochemistri
serum
evalu
baselin
day
treatment
began
twentyf
cat
enrol
studi
includ
group
group
b
statist
differ
present
group
signal
clinic
laboratori
find
includ
concentr
group
cat
complet
studi
caus
interrupt
food
refus
loss
followup
death
unrel
caus
poor
owner
complianc
group
b
cat
complet
studi
caus
interrupt
suspect
methimazol
induc
hepatotox
loss
followup
median
serum
concentr
nmoll
rang
nmoll
group
nmoll
rang
nmoll
group
b
signific
differ
found
serum
concentr
group
group
b
evalu
time
bodyweight
serum
creatinin
significantli
increas
group
b
p
p
respect
nevertheless
urea
significantli
chang
group
ast
alt
alp
significantli
decreas
group
b
p
p
p
respect
result
suggest
iodinerestrict
food
effect
reduc
serum
concentr
hyperthyroid
cat
compar
transderm
methimazol
food
produc
increas
serum
creatinin
appar
less
effect
improv
bodyweight
liver
paramet
disclosur
disclosur
report
object
studi
identifi
whether
pretreat
plasma
ioniz
calcium
ica
concentr
predict
hypocalcemia
follow
parathyroid
remov
heat
ablat
dog
primari
hyperparathyroid
fiftyf
dog
seen
januari
februari
met
inclus
criteria
persist
hypercalcemia
defin
ica
mmoll
due
primari
hyperparathyroid
absenc
preemptiv
calcitriol
therapi
ica
monitor
postop
dog
treat
surgeri
n
ultrasoundguid
percutan
heat
ablat
n
hypercalcemia
resolv
dog
within
hour
procedur
dog
split
pretreat
ica
group
mmoll
mmoll
mmoll
signific
associ
higher
pretreat
hypercalcemia
lower
post
treatment
hypocalcemia
addit
signific
doserespons
relationship
pretreat
calcium
concentr
absolut
declin
calcium
follow
treatment
sixteen
dog
becam
notabl
hypocalcem
ica
mmoll
four
dog
pretreat
ica
mmoll
dog
ica
mmoll
dog
pretreat
ica
mmoll
becam
hypocalcem
ica
mmoll
advers
effect
hypocalcemia
observ
dog
pretreat
ica
mmoll
given
risk
signific
hypocalcemia
follow
parathyroid
remov
dog
pretreat
ica
mmoll
patient
treat
prevent
rapid
declin
develop
clinic
hypocalcemia
disclosur
disclosur
report
diabet
mellitu
estim
affect
pet
dog
uk
case
thought
result
insulin
defici
result
loss
pancreat
beta
cell
similar
human
type
diabet
juvenileonset
diabet
rare
catchpol
et
al
seven
labrador
retriev
puppi
diagnos
diabet
mellitu
week
age
basi
presenc
hyperglycaemia
glucosuria
compat
clinic
sign
includ
polyuria
polydipsia
polyphagia
two
dog
known
relat
full
sibl
remain
case
famili
member
full
half
sibl
one
sire
also
report
affect
though
clinic
detail
avail
pancreat
histopatholog
post
mortem
case
show
islet
hypoplasia
puppi
test
hypoinsulinaemia
identifi
two
puppi
euthanas
soon
diagnosi
lost
follow
surviv
year
age
well
control
diabet
due
earli
age
onset
occurr
within
singl
breed
hypothesis
diabet
case
might
due
mutat
singl
gene
three
candid
gene
select
basi
common
genet
caus
monogen
diabet
human
neonat
young
children
code
region
canin
orthologu
gene
respect
amplifi
sequenc
genom
dna
affect
puppi
unaffect
sibl
control
labrador
variant
identifi
code
sequenc
novel
synonym
code
singl
nucleotid
base
substitut
variant
identifi
affect
dog
howev
variant
consid
unlik
caus
clinic
syndrom
presenc
cosegreg
diseas
within
famili
across
cohort
chang
protein
code
sequenc
conclus
report
case
seri
labrador
puppi
suspect
affect
monogen
diabet
mellitu
result
candid
gene
screen
identifi
caus
mutat
investig
possibl
genet
caus
would
requir
elucid
caus
earli
onset
diabet
breed
disclosur
er
salari
laboratori
cost
paid
use
grant
wellcom
trust
sampl
submit
canin
diabet
regist
rvc
receiv
fund
masterfood
kennel
club
charit
trust
msd
anim
health
eu
grant
lupa
meh
truste
kennel
club
charit
trust
part
discuss
award
fund
canin
diabet
regist
sampl
submit
part
ljd
phd
fund
rvc
clinic
research
fellowship
addit
fund
intervet
pharma
r
current
msd
anim
health
diabet
mellitu
dm
common
felin
endocrinopathi
pathophysiolog
similar
human
type
diabet
occur
due
combin
insulin
resist
bcell
dysfunct
sever
studi
identifi
environment
genet
suscept
factor
cat
environment
factor
obes
physic
inact
link
dm
howev
identif
genet
factor
challeng
date
gene
shown
associ
increas
suscept
dm
overweight
domest
short
hair
dsh
cat
aim
present
studi
perform
genomewid
associ
studi
gwa
identifi
loci
associ
dm
lean
dsh
cat
illumina
infinium
iselect
dna
array
use
interrog
genom
dna
sampl
lean
diabet
dsh
cat
royal
veterinari
colleg
felin
dm
archiv
control
dsh
cat
data
analys
use
plink
whole
genom
data
analysi
toolset
signific
establish
p
snp
minor
allel
frequenc
call
rate
individu
genotyp
rate
exclud
analysi
total
snp
avail
analysi
exclud
cat
low
genotyp
rate
control
dsh
lean
diabet
dsh
cat
evalu
diabet
cat
mean
sd
age
year
male
femal
nondiabet
cat
mean
sd
age
year
femal
male
control
cat
significantli
older
diabet
cat
p
ttest
five
signific
snp
identifi
p
p
p
p
p
first
snp
locat
within
chromosom
other
locat
within
mb
region
toward
end
chromosom
snp
chromosom
locat
kb
upstream
peptidas
similar
involv
incretin
inactiv
within
identifi
region
chromosom
gene
interest
includ
associ
human
like
caus
insulin
resist
first
gwa
dm
cat
number
signific
snp
identifi
locat
proxim
gene
associ
human
other
could
involv
pathophysiolog
relat
dm
investig
candid
gene
warrant
disclosur
snp
chip
gwa
provid
morri
anim
foundat
diabet
mellitu
dm
treatment
document
exert
neg
psychosoci
impact
cat
owner
common
owner
concern
includ
hypoglycaemia
worri
socialand
worklif
impact
desir
control
cat
treatment
home
blood
glucos
monitor
hbgm
suggest
enabl
superior
glycaem
control
could
address
abovement
qualityoflif
qol
issu
convers
hbgm
could
also
exert
neg
psychosoci
effect
disturb
catown
bond
prospect
trial
aim
document
accept
rate
hbgm
among
owner
diabet
cat
reason
declin
hbgm
possibl
impact
glycaem
control
whether
accept
alter
pet
owner
qol
measur
use
valid
psychometr
diabet
pet
qoltool
diaqolpet
baselin
owner
recent
diagnos
cat
receiv
veterinari
glucomet
alphatrak
zoeti
standardis
demonstr
use
cat
diabet
manag
standardis
includ
low
carbohydr
diet
twicedaili
insulin
follow
standardis
doseadjustmentprotocol
accord
initi
weekli
blood
glucos
curv
bgc
carri
hbgm
adopt
hbgmgroup
inhospit
adopt
nonhbgmgroup
mannwhitney
utest
assess
signific
differ
fructosamin
averag
bgcvalu
insulin
dose
diaqolpetscor
month
hbgmand
nonhbgmgroup
fisher
exact
test
use
compar
remiss
rate
averag
valu
given
median
rang
hbgm
introduc
owner
success
adopt
reason
failur
patient
aggress
n
owner
concern
patient
distress
n
lack
avail
assist
n
signific
differ
fructosamin
hbgm
lmoll
nonhbgm
lmoll
p
insulin
dose
hbgm
ukgdos
nonhbgm
u
kgdose
p
averag
bgcvalu
hbgm
mmoll
nonhbgm
mmoll
p
overal
diaqolpetscor
hbgm
nonhbgm
examin
individu
diaqolpetcategori
hbgmcat
owner
report
signific
differ
bond
felt
cat
p
degre
worri
hypoglycaemia
p
restrict
work
p
sociallif
p
compar
nonhbgmgroup
four
hbgmcat
achiev
diabet
remiss
none
nonhbgmgroup
p
hbgm
success
adopt
major
catown
combin
without
demonstr
extra
burden
cat
owner
qol
hbgm
also
appear
compromis
owner
relationship
cat
larger
sampl
size
like
need
assess
whether
hbgm
promot
superior
glycaem
control
remiss
disclosur
research
present
abstract
support
zoeti
clinic
research
conduct
also
support
boehring
ingelheim
nestl
purina
petcar
ruth
gostelow
christoph
scudder
receiv
phd
fund
evettsluff
anim
welfar
trust
stijn
neissen
act
consult
veterinari
inform
network
vin
major
difficulti
manag
diabet
mellitu
dm
inabl
predict
blood
glucos
valu
respons
insulin
dose
link
exist
numer
factor
impact
blood
glucos
diabet
patient
eg
calor
intak
type
food
exercis
insulin
type
dose
stress
artifici
neural
network
ann
statist
learn
algorithm
shown
potenti
aid
predict
process
human
dm
develop
huge
aid
introduct
continu
glucos
monitor
system
cgm
enabl
gener
suffici
datapoint
goal
current
studi
develop
ann
felin
dm
algorithm
develop
matlab
mathwork
uk
use
data
exogen
insulin
dose
serial
blood
glucos
obtain
tradit
blood
glucos
curv
cgm
calor
intak
hour
diabet
cat
cat
maintain
environ
enabl
normal
activ
limit
stress
neural
network
toolbox
tm
mathwork
uk
use
construct
test
type
ann
multilay
perceptron
mlp
radial
basi
function
rbf
ann
train
use
diabet
cat
data
follow
socal
detrend
elimin
outlier
configur
extern
delay
order
increas
accuraci
neural
architectur
set
singl
hidden
layer
maximum
neuron
inclus
satur
neuron
forbidden
accuraci
result
mlp
rbf
model
assess
calcul
mean
squar
normalis
error
threshold
gener
comparison
predict
data
actual
regist
data
recruit
diabet
cat
total
diabet
cat
recruit
studi
male
femal
sd
kg
age
burmes
dsh
breed
blood
glucos
curv
perform
n
cgm
respons
insulin
predict
mlp
rbf
calcul
mean
squar
normal
error
reveal
diabet
cat
mlp
rbf
dynam
blood
glucos
curv
correctli
predict
ann
conclus
studi
first
describ
success
develop
ann
predict
blood
glucos
dynam
insulintr
diabet
cat
evalu
indic
though
annmodelbas
predict
glucos
concentr
may
allow
clinician
futur
optimis
insulin
manag
protocol
may
allow
develop
artifici
pancrea
diabet
cat
disclosur
disclosur
report
glucagonlik
peptid
glp
analogu
induc
signific
weight
loss
human
presum
slow
gastric
empti
increas
satieti
lean
purposebr
cat
shortterm
analogu
treatment
also
induc
weight
loss
evalu
effect
week
exenatid
analogu
approv
treatment
human
type
diabet
placebo
treatment
bodi
composit
adipokin
obes
clientown
cat
cat
random
subcutan
salin
n
exenatid
n
inject
lgkg
h
initi
week
lg
kg
h
follow
week
bodi
weight
bodi
composit
use
dualenergi
xray
absorptiometri
adipokin
level
measur
treatment
cat
obes
bodi
condit
score
mean
bodi
weight
kg
rang
kg
mean
bodi
fat
median
percent
loss
baselin
bodi
weight
rang
exenatid
rang
placebo
exenatid
group
signific
absolut
weight
loss
howev
differ
median
percent
loss
group
signific
chang
total
amount
bodi
fat
differ
group
correspondingli
plasma
leptin
total
adiponectin
unalt
treatment
complic
limit
singl
mild
hypoglycem
episod
case
selflimit
gastrointestin
sign
conclud
appoint
dose
exenatid
well
toler
safe
obes
healthi
cat
larger
studi
popul
may
requir
fulli
elucid
effect
exenatid
obes
cat
disclosur
disclosur
report
felin
diabet
mellitu
dm
recommend
treat
address
underli
diseas
bid
insulin
inject
low
carbohydr
diet
good
glycaem
control
suggest
promot
diabet
remiss
recent
systemat
review
felin
dm
literatur
identifi
studi
glargin
lent
insulin
proportion
overrepres
compar
insulin
type
addit
insulin
studi
suffer
lack
screen
concurr
diseas
homogen
manag
assess
qualiti
life
qol
recent
porcin
lent
insulin
avail
veterinarylicens
product
prospect
trial
evalu
impact
newli
veterinarylicens
humanrecombin
protamin
zinc
insulin
prozinc
tm
boehring
ingelheim
clinic
sign
glycaem
control
qol
diabet
cat
recent
month
diagnos
diabet
cat
treat
caninsulin
msd
bid
least
week
receiv
specif
low
carbohydr
diet
recruit
full
histori
physic
examin
diabet
clinic
score
dc
rang
diabet
sign
mani
diabet
sign
fructosamin
concentr
bloodglucosecurv
bgc
qolassess
diaqolpetscor
perform
month
transit
prozinc
tm
start
dose
unitkg
bid
follow
set
protocol
weekli
bgc
dose
adjust
unit
changeinjectionweek
guid
nadir
cat
exclud
screen
biochemistri
urinalysi
fpli
abdomin
ultrasound
identifi
ketoacidosi
clinic
pancreat
glucocorticoid
progestogen
administr
hyperthyroid
acromegali
condit
impair
treatment
respons
data
assess
normal
report
meanaestandard
deviat
chang
assess
use
pair
ttest
p
without
multipl
comparison
correct
follow
latest
statist
guidelin
sixteen
cat
recruit
male
neuter
femal
neuter
age
month
complet
trial
time
entri
cat
receiv
caninsulin
bid
dc
diaqolpetscor
bgcvalu
mmoll
fructosamin
lmoll
three
month
transit
prozinc
tm
cat
receiv
bid
significantli
lower
mean
dc
p
diaqolpetscor
p
bgcvalu
mmoll
fructosamin
lmoll
also
lower
though
significantli
p
p
respect
three
cat
enter
diabet
remiss
result
show
transit
cat
caninsulin
prozinc
tm
produc
signific
improv
clinic
sign
qol
case
like
need
document
addit
signific
glycaem
impact
transit
final
veterinari
dm
research
repres
first
clinic
trial
includ
valid
quantit
qolassess
outcom
paramet
disclosur
studi
describ
abstract
receiv
financi
support
boehring
ingelheim
clinic
research
produc
also
receiv
support
nestl
purina
petcar
zoeti
ruth
gostelow
christoph
scudder
receiv
phd
fund
evettsluff
anim
welfar
trust
stijn
niessen
consult
veterinari
inform
network
vin
hope
spenc
ik
ramsey
univers
glasgow
small
anim
hospit
bearsden
uk
serial
blood
glucos
measur
current
use
accept
method
assess
diabet
control
howev
extend
curv
expens
technic
challeng
new
day
continu
glucos
monitor
system
cgm
call
dexcom
platinum
incorpor
glucos
oxidasebas
sensor
measur
interstiti
blood
glucos
evalu
compar
result
blood
glucos
measur
contemporan
glucomet
alphatrak
measur
made
least
twice
daili
time
calibr
cgm
variabl
period
hour
previou
calibr
total
measur
eight
dog
glucos
curv
blood
glucos
rang
mmoll
median
mmoll
compar
pair
measur
interstiti
glucos
calcul
pearson
correl
coeffici
r
minimum
measur
obtain
dog
devic
provid
specif
measur
interstiti
glucos
rang
mmoll
valu
rang
includ
studi
subject
devic
easi
use
intuit
user
interfac
provid
wireless
real
time
measur
much
smaller
older
cgm
system
overal
excel
correl
glucomet
cgm
read
r
statist
signific
p
rang
differ
blood
interstiti
glucos
concentr
mmoll
median
mmoll
problem
encount
system
includ
detach
system
dog
skin
well
variabl
correl
glucomet
cgm
read
individu
dog
r
rang
median
conclus
dexcom
cgm
use
assess
interstiti
glucos
concentr
dog
gener
well
correl
blood
glucos
concentr
work
need
larger
number
patient
determin
relationship
correl
time
calibr
determin
dog
seem
poorer
correl
other
disclosur
disclosur
report
sever
continu
glucos
monitor
system
measur
interstiti
glucos
ig
current
avail
howev
requir
multipl
calibr
therefor
multipl
blood
sampl
moreov
sensor
quit
expens
use
day
new
human
flash
glucos
monitor
system
fgm
freestyl
libr
abbott
uk
measur
ig
requir
calibr
rather
inexpens
sensor
use
mani
day
compos
small
sensor
appli
subcutan
scan
reader
obtain
real
time
glucos
valu
aim
studi
assess
accuraci
fgm
diabet
dog
dog
sensor
place
neck
area
fix
adhes
patch
st
th
th
day
applic
ig
measur
compar
peripher
blood
edta
plasma
glucos
pg
concentr
analys
refer
hexochinas
base
method
olympusbeckman
coulter
linear
regress
bland
altman
plot
clark
error
grid
analysi
use
assess
accuraci
ten
clientown
diabet
dog
insulin
treatment
includ
median
age
year
rang
femal
spay
male
neuter
median
bodi
weight
kg
rang
four
hundr
sixti
four
simultan
measur
taken
fgm
ig
refer
method
pg
sampl
hypoglycem
rang
mgdl
euglycem
rang
mgdl
hyperglycem
rang
mgdl
consid
measur
togeth
posit
signific
correl
ig
pg
concentr
r
found
meanaestandard
deviat
differ
refer
method
mgdl
hypoglycem
rang
mgdl
euglycem
rang
mgdl
hyperglycem
rang
ig
valu
differ
mgdl
refer
method
mgdl
hypoglycem
euglycem
hyperglycem
rang
respect
underestimationoverestim
ig
compar
pg
observ
hypoglycem
euglycem
hyperglycem
measur
respect
glucos
valu
measur
fgm
fall
zone
zone
ab
error
grid
analysi
respect
applic
sensor
easi
appar
painless
mild
local
erythema
sensor
remov
found
dog
fgm
simpl
promis
glucos
monitor
system
seem
accur
clinic
use
diabet
dog
disclosur
disclosur
report
cornerston
treatment
diabet
cat
insulin
among
issu
insuffici
durat
insulin
action
may
lead
poor
metabol
control
persist
clinic
sign
aim
improv
current
therapeut
option
present
studi
evalu
pharmacodynam
paramet
onset
action
time
glucos
nadir
durat
action
protamin
zinc
insulin
prozinc
boehring
ingelheim
insulin
degludec
tresiba
novo
nordisk
healthi
cat
addit
accuraci
differ
sensor
sofand
enlitesensor
continu
glucos
monitor
system
cgm
medtron
determin
particular
attent
low
glycem
rang
sinc
reliabl
cgm
case
hypoglycemia
crucial
three
differ
dose
iukg
insulin
sensor
test
healthi
purpos
bred
cat
random
crossov
trial
sensor
place
neck
area
day
pair
glucos
measur
obtain
everi
hour
valid
portabl
blood
glucos
meter
alphatrak
abbot
set
standard
accuraci
assess
use
iso
criteria
addit
determin
onset
insulin
action
time
glucos
nadir
durat
action
glucos
concentr
measur
minut
minut
insulin
administr
everi
hour
hour
median
rang
onset
action
hour
prozinc
hour
tresiba
median
rang
time
glucos
nadir
durat
action
hour
hour
prozinc
hour
hour
tresiba
respect
regard
pair
glucos
measur
sensor
type
zone
b
consensu
error
grid
glucos
concentr
mmoll
sofsensor
measur
enlitesensor
measur
within
mmoll
standard
glucos
concentr
mmoll
sofsensor
measur
enlitesensor
measur
within
standard
conclus
healthi
cat
inject
prozinc
tresiba
show
similar
onset
action
later
glucos
nadir
longer
durat
action
seen
cat
treat
tresiba
compar
treat
prozinc
sensor
reveal
good
clinic
accuraci
perform
similarli
low
glycem
rang
disclosur
disclosur
report
canin
adren
cortex
consist
concentr
zone
zona
glomerulosa
zg
zona
fasciculata
zf
zona
reticulari
zr
produc
mineralocorticoid
glucocorticoid
androgen
respect
human
critic
step
product
either
aldosteron
cortisol
zgspecif
aldosteron
synthas
zfspecif
cytochrom
fact
human
dog
adrenocort
end
product
ie
aldosteron
cortisol
led
assumpt
canin
steroidogenesi
ident
human
howev
dog
zonal
express
steroidogen
enzym
studi
previous
moreov
dog
express
unclear
one
code
gene
sequenc
publish
ncbi
databas
adjac
larg
nonsequenc
gap
present
hypothes
canin
adren
possess
one
gene
similar
sheep
pig
zg
zf
tissu
isol
separ
use
laserguid
microdissect
adren
healthi
dog
zonespecif
tissu
confirm
specif
marker
mrna
rel
express
angiotensin
ii
receptor
significantli
higher
p
p
p
respect
zg
compar
zf
rtqpcr
analysi
mrna
rel
express
steroidogen
enzym
demonstr
significantli
higher
fold
chang
steroidogen
acut
regulatori
protein
star
cytochrom
side
chain
cleavag
p
p
p
respect
zf
compar
zg
zfspecif
presenc
also
demonstr
immunohistochemistri
signific
differ
p
mrna
rel
express
mention
databas
found
southern
blot
analysi
show
nonsequenc
gap
contain
anoth
gene
conclud
one
function
enzym
canin
adren
zonespecif
product
aldosteron
cortisol
probabl
due
zonespecif
express
presenc
zf
crucial
cortisol
synthesi
lack
zg
conduct
steroidogenesi
mineralocorticoid
product
first
report
provid
insight
one
import
physiolog
mechan
canin
adren
cortex
zonedepend
steroidogenesi
disclosur
disclosur
report
pathogenesi
cortisolsecret
adrenocort
tumor
at
becom
clear
recent
mutat
gna
gene
provid
explan
acthindepend
hormon
activ
at
autonom
growth
remain
greatli
undisclos
approach
elucid
prolif
capac
at
learn
current
understand
adren
growth
biolog
sonic
hedgehog
shh
signal
pathway
play
essenti
role
develop
adren
gland
regul
adrenocort
cell
prolifer
member
shh
signal
pathway
present
progenitor
steroidogen
cell
normal
adren
gland
dysregul
shh
signal
implic
adren
cancer
human
hypothes
shh
signal
also
enhanc
canin
at
predominantli
carcinoma
examin
rel
express
shh
pathway
compon
shh
smo
rtqpcr
analysi
cortisolsecret
adenoma
n
carcinoma
n
normal
canin
adren
n
rel
express
member
shh
pathway
detect
at
normal
adren
tissu
signific
p
lower
mrna
express
detect
carcinoma
compar
normal
tissu
amongst
gene
signific
differ
found
sinc
mainli
repressor
gene
activ
shh
pathway
regul
carcinoma
could
point
enhanc
shh
signal
adrenocort
carcinoma
could
theoret
respons
expans
growth
conclus
dysregul
shh
pathway
might
involv
pathogenesi
canin
cortisolsecret
carcinoma
modul
shh
express
might
provid
new
target
therapi
adrenocort
carcinoma
need
explor
futur
disclosur
disclosur
report
felin
hypersomatotrop
acromegali
suggest
underdiagnos
endocrinopathi
among
diabet
cat
treatment
option
includ
manag
secondari
diabet
mellitu
alon
medic
pituitari
inhibit
radiotherapi
rt
hypophysectomi
hpx
tool
diagnos
diseas
monitor
treatment
effect
limit
insulinlik
growth
current
easili
access
blood
test
serum
previous
shown
insensit
assess
rt
effect
develop
addit
serolog
diagnost
tool
measur
alongsid
serum
therefor
desir
pilot
studi
previous
valid
ntermin
type
iii
procollagen
propeptid
piiinp
elisa
use
cat
found
peripher
biomark
collagen
turnov
significantli
elev
small
number
hypersomatotrop
diabet
hsdm
cat
studi
therefor
aim
evalu
use
serum
piiinp
differenti
hsdm
dm
evalu
piiinp
marker
treatment
success
piiinp
concentr
measur
cat
uncompl
diabet
mellitu
dm
ngml
radioimmunoassay
exogen
insulin
requir
confirm
hsdm
ngml
pituitari
mass
comput
tomographi
use
previous
valid
elisa
addit
piiinp
measur
preand
posttreat
month
sampl
hsdm
cat
respond
favour
decreas
insulin
requir
radiotherapi
rt
n
hypophysectomi
hp
n
achiev
diabet
remiss
time
sampl
serum
piiinp
concentr
significantli
higher
hsdm
cat
median
ngml
rang
compar
dm
cat
median
ngml
p
mann
whitney
utest
receiveroperatorcurveanalysi
reveal
ngml
cutoff
differenti
dm
hsdm
cat
sensit
specif
auc
confid
interv
rt
piiinp
increas
significantli
median
prert
ngml
postrt
ngml
p
wilcoxon
sign
ranktest
despit
absenc
signific
chang
concentr
median
prert
ngml
postrt
ngml
p
wilcoxon
sign
ranktest
follow
hpx
serum
piiinp
concentr
chang
significantli
median
prehpx
ngml
posthpx
ngml
p
wilcoxon
sign
ranktest
despit
signific
serum
decreas
median
prehpx
ngml
posthpx
ngml
p
wilcoxon
sign
ranktest
conclus
serum
piiinp
concentr
confirm
use
addit
paramet
differenti
hsdm
dm
cat
howev
current
data
suggest
piiinp
reliabl
marker
treatment
success
follow
rt
hpx
disclosur
disclosur
report
decreas
frequenc
function
peripher
regulatori
cell
treg
document
peopl
immunemedi
haemolyt
anaemia
imha
suggest
defect
peripher
toler
may
play
role
pathogenesi
diseas
aim
current
studi
test
hypothesi
frequenc
peripher
treg
decreas
dog
primari
imha
accompani
increas
helper
th
cell
cytotox
tc
cell
b
cell
residu
edtaanticoagul
blood
sampl
obtain
dog
primari
imha
n
dog
inflammatori
diseas
n
healthi
dog
n
primari
imha
diagnos
dog
regen
anaemia
pack
cell
volum
pcv
either
persist
agglutin
erythrocyt
salin
dilut
detect
spherocytosi
fresh
blood
smear
studi
approv
institut
ethic
welfar
committe
erythrocyt
lysi
peripher
blood
mononuclear
cell
stain
fluorophoreconjug
antibodi
specif
extracellular
intracellular
antigen
multicolour
flow
cytometri
undertaken
determin
proport
lymphocyt
b
cell
hi
th
cell
hi
tc
cell
hi
treg
hi
kruskalw
test
use
compar
proport
group
correl
proport
treg
pcv
serum
total
bilirubin
concentr
tbil
dog
imha
present
assess
use
spearman
rho
coeffici
median
proport
cell
express
interquartil
rang
iqr
dog
imha
iqr
dog
inflammatori
diseas
iqr
healthi
dog
differ
group
p
differ
proport
cell
p
p
group
proport
b
cell
p
proport
hi
treg
posit
correl
tbil
dog
imha
spearman
rho
p
pcv
rho
p
though
limit
size
result
pilot
studi
suggest
frequenc
treg
decreas
dog
imha
proport
th
tc
b
cell
also
compar
control
dog
work
requir
determin
whether
function
treg
alter
whether
defect
peripher
toler
contribut
develop
diseas
disclosur
disclosur
report
xenotransfus
canin
blood
cat
may
lifesav
procedur
treat
acut
anaem
syndrom
compat
felin
blood
obtain
publish
evid
limit
number
case
date
indic
cat
appear
naturallyoccur
antibodi
canin
red
blood
cell
antigen
fact
compat
test
first
transfus
demonstr
evid
agglutin
haemolysi
canin
erythrocyt
felin
serum
sever
acut
advers
reaction
report
cat
receiv
singl
transfus
canin
blood
sever
acut
reaction
report
far
howev
exclud
decid
perform
pilot
studi
evalu
presenc
natur
occur
antibodi
canin
red
blood
cell
antigen
cat
viceversa
surplu
materi
diagnost
sampl
blood
edta
blood
serum
sampl
cat
dog
use
perform
testtub
major
minor
crossmatch
test
room
temperatur
rt
blood
type
obtain
inform
consent
owner
hemolysi
macroand
microagglutin
investig
test
tube
consid
marker
posit
match
blood
cat
test
blood
differ
dog
total
major
minor
crossmatch
one
perform
differ
temperatur
incub
thirtyeight
overal
major
crossmatch
prove
posit
rt
respect
minor
crossmatch
posit
test
perform
cat
test
total
neg
rt
major
minor
crossmatch
procedur
perform
toward
singl
dog
ten
cat
experienc
posit
major
minor
crossmatch
rt
toward
differ
dog
five
cat
posit
major
crossmatch
least
toward
differ
differ
dog
seven
cat
obtain
posit
major
crossmatch
rt
andor
toward
dog
cat
test
complet
neg
rt
one
differ
major
crossmatch
perform
conclus
natur
occur
antibodi
canin
red
blood
cell
antigen
appear
frequent
detect
cat
well
felin
red
blood
cell
antigen
dog
xenotrasfus
canin
blood
cat
perform
select
compat
donor
mean
least
neg
major
crossmatch
test
result
disclosur
disclosur
report
antithymocyt
serum
at
potent
immunosuppress
agent
commonli
use
periop
human
patient
increas
graft
survivaland
decreas
reject
transplant
tissu
at
report
part
immunosuppress
protocol
treat
immunemedi
diseas
includ
aplast
anemiaand
myelodysplast
syndrom
md
rabbit
antidog
thymocyt
serum
radt
use
veterinari
medicin
periop
immunosuppress
canin
renal
transplant
howev
report
regard
use
radt
treatment
dog
immunemedi
disord
medic
record
dog
diagnos
imha
dog
itp
dog
md
review
median
age
year
month
year
dog
fail
respond
tradit
immunosuppress
therapi
receiv
radt
none
dog
experienc
advers
reaction
lymphocyt
count
use
monitor
respons
therapi
dog
except
signific
decreas
lymphocyt
count
decreas
initi
lymphocyt
count
aim
previou
studi
radt
dog
discharg
howev
dog
chang
lymphocyt
count
experienc
relaps
imha
week
euthan
case
achiev
clinic
remiss
immunosuppress
taper
discontinu
radt
appear
safe
immunosuppress
agent
interest
refractori
immun
mediat
diseas
disclosur
disclosur
report
cat
upper
respiratori
tract
aspergillosi
urta
invas
diseas
common
speci
invas
mycos
associ
immunodefici
characteris
humor
immun
respons
felin
urta
serv
identifi
whether
select
immunodefici
underli
suscept
determin
util
classspecif
antibodi
detect
earli
diagnosi
shown
serum
antiaspergillu
igg
high
sensit
specif
diagnosi
aim
studi
determin
whether
serum
antiaspergillu
iga
detect
cat
urta
evalu
sensit
specif
iga
detect
diagnosi
sera
collect
group
cat
group
confirm
urta
n
group
upper
respiratori
diseas
without
aspergillosi
n
group
healthi
cat
n
cat
nonfung
nonrespiratori
ill
n
indirect
elisa
detect
antiaspergillu
iga
develop
interassay
intraassay
coeffici
variat
respect
serum
iga
detect
group
cat
respect
use
optim
elisa
cutoff
valu
diagnosi
elisa
unitsml
determin
receiveroper
curv
analysi
assay
sensit
group
cat
specif
highest
group
use
control
compar
group
group
combin
found
evid
role
primari
iga
defici
pathogenesi
felin
urta
serum
antiaspergillu
iga
detect
moder
sensit
moder
specif
diagnosi
urta
disclosur
conflict
interest
studi
partial
fund
australian
companion
anim
health
foundat
grant
noninvas
topic
infus
therapi
wide
use
canin
sinonas
aspergillosi
sna
timeconsum
associ
prolong
recoveri
increas
cost
therefor
main
goal
present
studi
compar
efficaci
simplifi
infus
protocol
infus
protocol
consist
endoscop
debrid
follow
minut
enilconazol
infus
bifonazol
cream
depot
affect
frontal
sinu
endoscop
place
cathet
protocol
debrid
enilconazol
infus
shorten
minut
dog
remain
dorsal
recumb
head
flex
whole
procedur
adjunct
oral
itraconazol
therapi
prescrib
protocol
effect
debrid
fungal
plaqu
consid
essenti
therapeut
step
unfortun
alway
possibl
achiev
perfect
debrid
sinonas
caviti
due
incomplet
access
whole
sinus
area
endoscop
howev
effect
never
assess
therefor
second
aim
studi
evalu
effect
debrid
success
rate
first
treatment
fisher
exact
test
use
assess
differ
success
rate
protocol
function
full
debrid
twentyeight
dog
sna
treat
dog
median
rang
durat
minut
compar
minut
first
treatment
success
rate
differ
protocol
protocol
overal
success
rate
procedur
contrast
major
dog
dog
receiv
recov
quickli
discharg
day
complet
debrid
assess
endoscop
dog
treat
debrid
judg
complet
dog
signific
effect
first
treatment
success
rate
p
debrid
complet
dog
dog
dog
cure
first
procedur
compar
dog
dog
dog
incomplet
debrid
conclud
simplifi
infus
protocol
quick
safe
easi
effect
offer
favour
altern
infus
protocol
treatment
canin
sna
complet
debrid
undoubt
import
step
treatment
success
infus
protocol
disclosur
disclosur
report
gastroesophag
ge
symptom
commonli
report
dog
brachycephal
upper
airway
obstruct
syndrom
bs
sinc
ge
symptom
frequent
occur
situat
increas
inspiratori
effort
excit
respiratori
distress
dynam
disord
ge
junction
gej
probabl
involv
due
transient
increas
neg
intrathorac
pressur
howev
accord
previou
studi
dynam
abnorm
gej
observ
gastroscopi
hypothes
anaesthesia
endotrach
intub
gastroscopi
lead
underestim
gej
abnorm
aim
studi
improv
detect
dynam
gej
abnorm
gastroscopi
use
obstruct
manoeuv
mimick
reproduc
upper
airway
obstruct
variabl
sever
twentysix
dog
present
bs
prospect
includ
respiratori
digest
symptom
well
endoscop
abnorm
score
initi
diagnosi
control
month
surgeri
endoscopi
gej
assess
score
base
esophag
gej
atoni
ge
reflux
cranial
displac
gej
consecut
situat
absenc
obstruct
dog
intub
presenc
natur
obstruct
dog
extub
obnat
complet
manual
obstruct
endotrach
tube
spontan
breath
obcompl
spearman
rank
test
use
assess
correl
differ
clinic
endoscop
score
take
endoscop
procedur
togeth
sever
respiratori
symptom
correl
significantli
sever
respiratori
endoscop
abnorm
p
r
sever
digest
symptom
p
r
diagnosi
dog
present
digest
symptom
endoscop
gej
abnorm
observ
dog
obnat
obcompl
respect
gej
atoni
ge
reflux
cranial
displac
gej
slide
hiatal
hernia
present
dog
dog
obnat
dog
obcompl
respect
signific
correl
found
digest
endoscop
gej
score
obcompl
r
p
well
obnat
r
p
conclud
dog
bs
gej
abnorm
dynam
relat
degre
upper
airway
obstruct
use
obstruct
manoeuvr
gastroscopi
improv
detect
gej
abnorm
disclosur
disclosur
report
tracheobronchi
foreign
bodi
common
caus
respiratori
diseas
children
rare
veterinari
medicin
particularli
cat
report
tracheobronchi
foreign
bodi
scarc
studi
aim
describ
clinic
present
diagnost
find
treatment
modal
confirm
case
tracheobronchi
foreign
bodi
cat
hypothes
bronchoscopi
highli
effect
extract
cat
case
confirm
tracheobronchi
foreign
bodi
cat
admit
referr
center
franc
may
novemb
includ
file
retrospect
analyz
age
sex
breed
clinic
sign
delay
onset
sign
present
diagnost
procedur
method
extract
locat
natur
foreign
bodi
twelv
cat
includ
male
femal
mean
age
present
year
old
year
ae
cough
main
chiefcomplaint
present
cat
cat
present
consult
first
week
begin
respiratori
sign
cat
exhibit
clinic
sign
week
chest
radiograph
done
cat
bronchoscopi
perform
cat
confirm
presenc
foreign
bodi
materi
allow
extract
anim
cat
bronchoscop
extract
unsuccess
pulmonari
lobectomi
requir
foreign
bodi
locat
trachea
cat
bronchial
tree
remain
cat
right
caudal
bronchu
left
caudal
bronchu
main
left
bronchu
veget
foreign
bodi
grain
seed
foxtail
awn
miner
bone
fragment
teeth
small
stone
undetermin
origin
miner
foreign
bodi
extract
trachea
whilst
major
veget
one
remov
bronchial
tree
case
seri
bronchial
foreign
bodi
frequent
tracheal
foreign
bodi
cat
find
differ
previou
data
report
trachea
preferenti
locat
felin
respiratori
foreign
bodi
veget
foreign
bodi
common
due
natur
shape
may
prone
lodg
bronchial
tree
miner
foreign
bodi
remain
trachea
accord
result
bronchoscopi
highli
effect
identif
extract
tracheobronchi
foreign
bodi
cat
disclosur
disclosur
report
mycophenol
mofetil
prodrug
mycophenol
acid
mpa
select
noncompetit
inhibitor
dehydrogenas
express
mani
cell
type
mpa
abil
induc
lymphocyt
cytotox
reduc
monocyt
recruit
suppress
dendrit
cell
matur
use
target
treat
immun
mediat
inflammatori
diseas
use
extens
human
medicin
transplant
recipi
recent
veterinari
medicin
dog
variou
immun
mediat
diseas
howev
use
cat
limit
part
mpa
primarili
metabol
glucuronid
cat
inher
decreas
abil
glucuronid
mani
drug
propos
cat
may
glucuronid
mpa
slowli
human
dog
conduct
seri
vitro
studi
explor
hypothesi
use
liver
microsom
cat
individu
pool
dog
pool
human
pool
liver
sampl
incub
water
bath
mpa
udpglucuron
acid
udpglucos
udpglucos
studi
sinc
mpa
glucosid
minor
metabolit
human
may
major
metabolit
speci
hplcm
use
determin
concentr
mpaglucuronid
phenol
acyl
mpaglucosid
phenol
form
incub
cat
form
much
less
mpa
phenol
glucuronid
nmole
minmg
dog
nmolesminmg
human
nmole
minmg
cat
form
similar
amount
mpa
acyl
glucuronid
nmolesminmg
human
nmolesminmg
less
dog
nmolesminmg
contrast
cat
nmolesmin
mg
form
mpa
phenol
glucosid
human
nmolesminmg
less
dog
nmolesminmg
pathway
metabol
sum
speci
cat
nmolesminmg
metabol
mpa
much
less
effici
dog
nmolesminmg
human
nmolesminmg
variabl
metabolit
format
individu
cat
high
rang
fold
mpa
glucosid
fold
mpa
phenol
glucuronid
fold
mpa
acyl
glucuronid
preliminari
result
confirm
cat
glucuronid
mpa
less
rapidli
dog
human
howev
cat
dog
found
glucosid
mpa
effici
human
addit
individu
cat
variabl
abil
glucuronid
glucosid
mpa
preliminari
vitro
data
compar
vivo
studi
mpa
pharmacokinet
elucid
proper
dose
mpa
cat
disclosur
disclosur
report
cystocentesi
gold
standard
sampl
method
urin
microbiolog
dog
void
sampl
associ
higher
risk
contamin
howev
accuraci
veterinari
cutoff
valu
current
recommend
detect
clinic
signific
bacteriuria
void
urin
poorli
investig
aim
studi
evalu
accuraci
veterinari
human
criteria
diagnosi
urinari
tract
infect
uti
dog
use
void
urin
sampl
dog
suspect
uti
prospect
enrol
pair
urin
sampl
collect
cystocentesi
void
respect
store
c
cultur
within
hour
bacteri
count
void
urin
interpret
use
veterinari
coloni
form
unit
cfu
per
ml
human
cfuml
plu
presenc
clinic
sign
criteria
diagnos
uti
compar
obtain
urin
collect
cystocentesi
gold
standard
signific
bacteriuria
cystocentesi
sampl
defin
cfuml
sixtyf
dog
includ
studi
appli
veterinari
criteria
diagnos
uti
void
sampl
diagnost
accuraci
sensit
specif
posit
predict
valu
ppv
neg
predict
valu
npv
appli
human
criteria
accuraci
fell
sensit
specif
ppv
npv
result
indic
dog
suspect
uti
accur
diagnosi
obtain
use
void
urin
appli
current
veterinari
cutoff
valu
sampl
store
refriger
temperatur
cultur
shortli
collect
disclosur
studi
support
financi
uccar
research
centr
univers
copenhagen
minor
extern
foundat
antimicrobi
resist
amr
major
public
health
concern
like
first
caus
mortal
human
medicin
canin
bacteri
urinari
infect
frequent
condit
might
implic
interspeci
transmiss
resist
mechan
studi
aim
retrospect
describ
evolut
amr
uropathogen
period
veterinari
teach
hospit
posit
urinari
cultur
obtain
cystocentesi
cfu
ml
dog
treat
nation
veterinari
school
toulous
envt
review
annual
preval
amr
sever
enterobacteriacea
staphylococcu
spp
enterococcu
spp
streptococcu
spp
record
variou
veterinari
human
antimicrobi
frequenc
extend
spectrum
betalactamaseproduc
enterobacteriacea
esbl
multidrug
resist
mdr
bacteria
note
logist
regress
perform
analyz
evolut
amr
pvalu
consid
signific
studi
period
isol
stabl
annual
distribut
identifi
consid
enterobacteriacea
amr
sever
antimicrobi
significantli
evolv
time
despit
possibl
increas
antimicrobi
gener
decreas
amr
observ
preval
esbl
mdr
bacteria
remain
stabl
mean
preval
respect
trend
amr
enterobacteriacea
studi
period
envt
accord
worrisom
gener
tendenc
could
consist
ration
antimicrobi
use
howev
persist
elev
preval
esbl
mdr
bacteria
possibl
increas
amr
last
studi
year
warrant
investig
surveil
disclosur
disclosur
report
klebsiella
pneumonia
import
pathogen
caus
urinari
tract
infect
uti
antibioticresist
virul
bacteri
clone
high
interhost
transmiss
may
play
import
role
spread
antimicrobi
resist
studi
aim
character
antimicrobi
resist
virul
clinic
klebsiella
isol
anim
human
uti
determin
lineag
companion
anim
klebsiella
pneumonia
resist
thirdgener
cephalosporin
thirtyf
companion
anim
clinic
klebsiella
spp
obtain
januari
human
clinic
strain
isol
includ
antimicrobi
suscept
test
perform
use
disk
diffus
clsi
breakpoint
appli
extendedspectrum
blactamas
esbl
plasmidmedi
ampc
gene
detect
pcr
whenev
resist
detect
furthermor
klebsiella
character
multilocu
sequenc
type
regard
virul
pcr
detect
fimh
adhesin
fimbria
mrkd
adhesin
fimbria
entb
enterobactin
ybt
yersiniabactin
rpma
regul
mucoid
phenotypea
gene
conduct
companion
anim
human
strain
respect
k
pneumonia
main
speci
isol
companion
anim
n
human
n
klebsiella
oxytoca
also
identifi
resist
cefotaxim
ceftazidim
present
n
n
companion
anim
human
strain
respect
overal
k
pneumonia
found
ctxm
n
cmi
n
dha
n
produc
companion
anim
k
oxytoca
dha
produc
companion
anim
resist
klebsiella
frequent
n
coresist
fluoroquinol
trimethoprimsulphamethoxazol
render
multidrug
resist
moreov
companion
anim
resist
strain
also
resistantintermedi
amoxicillinclavulan
n
overal
companion
anim
klebsiella
resist
amoxicillinclavulan
n
fluoroquinolon
n
trimethoprimsulphamethoxazol
n
high
companion
anim
k
pneumonia
resist
belong
n
n
n
n
lineag
concern
virul
k
pneumonia
posit
fimh
mrkd
entb
yersiniabactin
present
n
n
companion
anim
human
k
pneumonia
respect
k
oxytoca
n
posit
entb
ybt
test
strain
neg
rpma
detect
k
pneumonia
lineag
highli
import
human
companion
anim
uti
rais
great
concern
regard
role
reservoir
moreov
fact
also
found
share
resist
gene
common
virul
factor
human
extend
risk
transfer
disclosur
conflict
interest
first
author
current
receiv
phd
grant
fund
portugues
foundat
scienc
technolog
felin
lower
urinari
tract
diseas
flutd
refer
heterogen
group
disord
similar
clinic
sign
diet
design
manag
flutd
promot
struvit
stone
dissolut
address
key
risk
factor
overweight
low
water
intak
stress
goal
studi
compar
struvit
dissolut
potenti
diet
market
flutd
standard
vitro
condit
six
adult
healthi
cat
fed
success
dri
diet
royal
canin
sobiopeptid
b
hill
cdurinarystress
day
urin
collect
last
day
urin
collect
diet
pool
distribut
bottl
contain
mean
urin
volum
produc
daili
per
cat
urin
ph
struvit
rel
supersatur
rss
measur
pool
two
felin
struvit
urolith
homogen
shape
weight
immers
separ
urin
bottl
diet
put
stove
twentyfour
hour
later
urin
filter
collect
stone
dri
weigh
everi
day
stone
place
new
bottl
correspond
urin
first
complet
stone
dissolut
diet
effect
urin
ph
volum
rss
analys
non
parametr
wilcoxon
pair
rank
test
diet
effect
combin
period
effect
period
day
dissolut
complet
factori
design
analys
struvit
stone
weight
evolut
period
diet
mix
model
diet
period
diet
x
period
fix
effect
fdr
method
appli
compar
diet
period
diet
induc
higher
mean
urin
volum
versu
mlkgday
lower
rss
diet
b
versu
p
urin
ph
diet
significantli
differ
p
day
struvit
stone
immers
urin
diet
total
dissolv
versu
dissolut
stone
urin
diet
b
consid
period
day
struvit
weight
diminut
significantli
higher
struvit
stone
immers
urin
diet
diet
b
diet
effect
p
interact
diet
period
effect
reveal
differ
dissolut
rate
diet
signific
soon
first
day
period
p
increas
period
p
diet
induc
lower
struvit
rss
greater
urin
dilut
allow
faster
struvit
stone
dissolut
disclosur
author
coauthor
work
royal
canin
compani
commerci
one
diet
evalu
serum
cystatin
c
scysc
urinari
cystatin
c
ucysc
potenti
marker
detect
felin
chronic
kidney
diseas
ckd
aim
twofold
firstli
evalu
cysc
marker
ckd
compar
scysc
ucysc
ckd
healthi
cat
correl
scysc
scr
glomerular
filtrat
rate
gfr
calcul
sensit
specif
detect
decreas
gfr
secondli
compar
assay
perform
turbidimetr
assay
petia
previous
valid
nephelometr
assay
penia
fortynin
ckd
iri
stage
healthi
cat
includ
gfr
measur
plasma
exogen
creatinin
pect
endo
penict
exoiohexol
pexict
clearanc
test
ckd
healthi
cat
base
pexict
scysc
evalu
distinguish
normal
borderlin
low
gfr
sensit
specif
detect
pexict
mlminkg
calcul
valid
petia
perform
scysc
result
penia
petia
correl
gfr
statist
analysi
perform
use
gener
linear
model
serum
cysc
ucysc
significantli
higher
p
ckd
cat
howev
ucysc
detect
ckd
cat
r
valu
gfr
scr
scysc
respect
sensit
specif
scysc
scr
serum
cysc
could
distinguish
healthi
ckd
cat
normal
borderlin
low
gfr
contrast
scr
penia
appear
superior
petia
conclus
scysc
reliabl
marker
gfr
cat
ucysc
could
detect
ckd
cat
disclosur
work
support
receiv
institut
promot
innov
scienc
technolog
flander
iwt
bursari
lfe
ghi
soblechero
fj
duqu
p
ruiz
r
barrera
univers
extremadura
c
acer
spain
serum
cystatin
c
sci
c
marker
glomerular
filtrat
rate
advantag
serum
creatinin
human
medicin
author
observ
sci
c
influenc
methylprednisolon
prednison
administr
aim
follow
cours
maker
renal
function
acut
diseas
patient
receiv
glucocorticoid
medic
follow
dog
whit
steroid
respons
mening
studi
carri
patient
divid
group
control
group
clinic
healthi
dog
group
b
dog
treat
prednison
due
steroid
respons
mening
treat
mgkg
prednison
day
follow
mgkg
prednison
anoth
day
dog
known
preexist
renal
diseas
previou
glucocorticoid
medic
group
c
establish
test
effect
endogen
steroid
dog
hyperadrenocortic
evalu
serum
cy
c
measur
turbidimetr
latex
creatinin
jaff
reaction
spinreac
determin
time
diagnosi
group
b
day
mening
dog
statist
signific
increas
scysc
observ
group
b
dose
mgkg
prednison
ae
mgl
p
dose
mgkg
prednison
ae
mgl
p
respect
dog
treatment
ae
mgl
compar
control
group
ae
mgl
howev
serum
concentr
observ
hyperadrenocortic
mgl
similar
one
find
healthi
anim
group
creatinin
concentr
increas
either
prednison
treatment
case
hiperadrenocortic
conclus
present
studi
agre
describ
human
medicin
confirm
effect
glucocorticoid
sci
c
concentr
dog
administr
high
dose
prednison
associ
sci
c
increas
hand
endogen
cortisol
increas
hyperadrenocortic
dog
seen
modif
sci
c
disclosur
disclosur
report
chronic
kidney
diseas
ckd
produc
progress
reduct
number
function
nephron
directli
affect
homeostasi
solut
excret
urin
includ
phosphoru
hyperphosphatemia
consid
factor
directli
relat
increas
mortal
human
cat
dog
order
provid
data
control
clinic
studi
examin
effect
hyperphosphatemia
progress
surviv
natur
occur
canin
ckd
follow
studi
conduct
present
studi
dog
follow
veterinari
teach
hospit
univers
extremadura
spain
use
studi
distribut
follow
group
group
healthi
adult
dog
group
ii
adult
dog
ckd
second
group
subclasif
attend
differ
factor
phosphatemia
iia
dog
phosphatemia
mgdl
iib
dog
phosphatemia
mgdl
leishmaniasi
iic
dog
ckd
due
leishmaniasi
iid
dog
ckd
due
leishmaniasi
iri
classif
dog
dog
dog
dog
result
surviv
follow
statist
lower
surviv
found
group
iia
iib
p
also
iri
grade
iri
grade
p
iri
iri
p
iri
iri
p
signific
differ
posit
neg
leishmaniasi
conclus
plasma
phosphat
concentr
dog
increas
chronic
kidney
diseas
develop
invers
relationship
surviv
dog
phosphoru
concentr
mgdl
progress
iri
scale
observ
disclosur
disclosur
report
studi
analyz
extent
upc
dog
influenc
pyuria
yield
conflict
result
moreov
data
effect
proteinuria
plasma
acut
phase
protein
dog
dog
upc
prospect
measur
upc
avail
result
plasma
biochemistri
includ
measur
creactiv
protein
crp
day
analyz
use
mannwhitneyutest
sampl
without
sediment
analysi
n
exclud
result
urin
sampl
analysi
hematuria
erythrocyteshpf
pyuria
leucocyteshpf
bacteriuria
present
sampl
respect
upc
sampl
hematuria
significantli
p
higher
median
th
th
percentil
compar
sampl
without
hematuria
dog
pyuria
upc
significantli
p
higher
compar
sampl
without
pyuria
sampl
pyuria
upc
contrast
data
report
previous
pyuric
urin
sampl
upc
vet
clin
path
bacteriuria
influenc
upc
p
sampl
dog
neg
protein
dipstick
result
upc
respect
sampl
low
urin
specif
graviti
alkalin
ph
total
sampl
correspond
plasma
data
albumin
refer
interv
ri
gdl
crp
ri
mgl
avail
crp
significantli
p
higher
dog
upc
mgl
compar
dog
upc
mgl
albumin
significantli
p
lower
gdl
dog
upc
compar
dog
upc
gdl
natur
occur
pyuria
profound
effect
upc
result
previous
report
proteinuria
associ
chang
acut
phase
protein
hypoalbuminemia
increas
crp
whether
consequ
caus
proteinuria
need
investig
furthermor
anim
low
urin
specif
graviti
may
clinic
relev
proteinuria
even
light
neg
dipstick
result
therefor
measur
upc
recommend
exclud
renal
protein
loss
hypoand
isosthenur
dog
disclosur
disclosur
report
high
blood
pressur
caus
increas
vascular
endotheli
growth
factor
vegf
secret
felin
hypertens
commonli
associ
chronic
kidney
diseas
ckd
amlodipin
first
choic
antihypertens
treatment
cat
could
neg
effect
kidney
increas
glomerular
pressur
affer
arteriolar
dilat
aim
studi
valid
method
quantif
vegf
felin
serum
sampl
assess
associ
urinari
vegf
serum
vegf
svegf
biochem
clinic
variabl
hypertens
cat
investig
chang
urinari
vegf
amlodipin
treatment
randomis
doubl
blind
placebo
control
parallel
group
studi
n
conduct
phase
determin
efficaci
safeti
amlodipin
cat
natur
occur
hypertens
placebo
group
crossedov
amlodipin
day
canin
vegf
elisa
previous
valid
felin
urin
use
measur
urin
serum
vegf
urin
vegf
concentr
normalis
urinari
creatinin
urinari
vegf
creatinin
ratio
uvc
univari
linear
regress
model
follow
backward
multivari
linear
regress
model
perform
identifi
independ
predictor
svegf
uvc
linear
mix
measur
model
use
compar
effect
placebo
amlodipin
uvc
day
investig
potenti
chang
uvc
longterm
amlodipin
treatment
day
intraassay
interassay
cv
svegf
measur
n
n
respect
dilut
parallel
indic
mean
recoveri
ae
n
urea
urin
protein
creatinin
upc
independ
neg
posit
predictor
svegf
respect
plasma
creatinin
independ
neg
predictor
uvc
upc
sodium
independ
posit
predictor
associ
found
svegf
uvc
signific
chang
uvc
differ
group
found
day
amlodipin
placebo
treatment
mean
uvc
screen
lgg
day
amlodipin
treatment
p
within
healthi
cat
refer
rang
lgg
lack
correl
urinari
serum
vegf
suggest
uvc
reflect
renal
vegf
product
possibl
biomark
renal
stress
uvc
significantli
chang
amlodipin
treatment
suggest
amlodipin
may
caus
renal
stress
use
cat
hypertens
concurr
ckd
disclosur
studi
sponsor
orion
inc
ceva
anim
health
use
residu
sampl
collect
anim
involv
clinic
trial
run
orion
inc
jonathan
elliott
provid
consult
advic
follow
compani
bayer
anim
health
ceva
anim
health
orion
inc
elanco
anim
health
zoeti
ltd
boehring
ingelheim
vetoquinol
ltd
waltham
centr
pet
nutrit
idexx
ltd
group
receipt
research
fund
follow
compani
novarti
anim
health
royal
canin
ltd
zoeti
ceva
anim
health
orion
inc
jonathan
elliott
serv
follow
advisori
board
intern
renal
interest
societi
european
emesi
council
diffus
larg
bcell
lymphoma
dlbcl
frequent
subtyp
nonhodgkin
lymphoma
dog
human
common
morpholog
variant
recogn
world
health
organ
classif
centroblast
immunoblast
anaplast
classif
recent
adapt
canin
lymphoma
howev
studi
clearli
correl
prognosi
morpholog
variant
canin
dlbcl
object
retrospect
studi
correl
morpholog
variant
dlbcl
prognosi
dog
treat
standard
chemotherapi
protocol
medic
record
dog
cytolog
diagnosi
dlbcl
retrospect
review
singl
board
clinic
pathologist
centroblast
dlbclcp
immunoblast
morphotyp
dlbclib
defin
previous
describ
anaplast
variant
rare
dog
case
meet
inclus
criteria
diagnos
studi
period
fourth
borderlin
morpholog
variant
identifi
distinguish
studi
clinic
consider
immunoblast
rich
centroblast
dlbclirc
character
presenc
higher
number
immunoblast
compar
dlbclcp
complet
initi
followup
clinic
inform
applic
standard
chemotherapi
protocol
part
main
inclus
criteria
statist
analysi
perform
use
kaplanmei
analysi
fourtynin
dog
includ
thirtyfour
dlbclcp
dlbclib
dlbclirc
median
first
remiss
durat
dlbclcp
dlbclib
dlbclirc
respect
day
p
median
overal
surviv
time
dlbclcp
dlbclib
dlbclirc
respect
day
p
signific
shorter
time
obtain
complet
remiss
p
signific
longer
durat
first
remiss
p
dog
dlbclcp
comparison
dlbclib
observ
dlbclirc
includ
dlbclib
group
interestingli
case
dlbclirc
variant
observ
peripher
lymph
node
wherea
dlbclib
variant
observ
spleen
moreov
recurr
dlbclcp
dlbclirc
display
progress
toward
dlbclib
variant
conclus
studi
show
first
time
signific
prognost
differ
morpholog
variant
canin
dlbcl
suggest
prognost
impact
immunoblast
featur
discuss
human
disclosur
resid
program
david
sayag
support
part
zoeti
canin
lymphoma
heterogen
group
diseas
evid
exist
describ
differ
behaviour
bcell
tcell
phenotyp
diseas
studi
aim
describ
respons
treatment
surviv
canin
bcell
multicentr
lymphoma
cbcml
case
treat
royal
veterinari
colleg
signal
clinic
find
stage
treatment
respons
surviv
time
record
retrospect
sixtythre
case
cbcml
identifi
fortynin
percent
present
stage
stage
stage
sixtytwo
percent
substag
b
substag
fortyfour
percent
receiv
chop
induct
protocol
cop
coap
rest
receiv
variou
induct
protocol
ninetyf
percent
dog
respond
induct
treatment
median
first
remiss
durat
frd
day
thirtyseven
dog
receiv
rescu
protocol
respons
rate
median
overal
surviv
time
os
day
followup
day
studi
show
cop
protocol
follow
doxorubicin
rescu
therapi
gave
signific
differ
os
compar
chop
induct
alon
chop
follow
rescu
protocol
p
os
significantli
increas
increas
frd
p
absenc
aberr
immunophenotyp
p
complet
respons
therapi
p
use
rescu
protocol
p
frd
significantli
increas
use
chop
induct
protocol
compar
cop
protocol
p
complet
respons
therapi
p
age
bodyweight
sexneut
statu
stage
substag
cell
size
effect
frd
os
seven
dog
prolong
os
excess
year
dog
remain
aliv
dog
prolong
os
group
like
anaem
present
pcv
p
experienc
greater
frd
p
like
treat
rescu
protocol
p
dog
signific
differ
signal
clinic
present
stage
substag
treatment
receiv
found
group
dog
other
group
dog
chop
induct
therapi
gave
surviv
benefit
cheaper
less
intens
cop
protocol
provid
doxorubicin
rescu
therapi
later
employ
proport
dog
receiv
chop
induct
versu
cop
significantli
differ
dog
prolong
surviv
without
use
rescu
protocol
complet
respons
treatment
aberr
immunophenotyp
first
remiss
durat
shown
prognost
relev
disclosur
disclosur
report
lymphoma
common
malign
haemopoiet
tumour
dog
gene
express
profil
gep
canin
lymphoma
highlight
import
signal
pathway
includ
bcell
activ
bcell
receptor
nfkb
signal
nextgener
sequenc
offer
benefit
microarray
technolog
gep
identif
novel
transcript
sequenc
variant
aim
studi
examin
gene
express
variant
call
canin
lymphoma
use
rnaseq
lymph
node
sampl
collect
canin
multicentr
lymphoma
patient
part
clinic
investig
diagnosi
confirm
cytolog
histolog
cell
lineag
establish
pcr
antigen
receptor
rearrang
parr
flow
cytometri
cdna
prepar
extract
rna
sequenc
perform
illumina
nextseq
sequenc
gener
bp
pairedend
read
sampl
bcell
tumour
stage
v
stage
iv
stage
iii
stage
ii
cell
tumour
stage
iii
stage
ii
iv
v
million
read
mean
per
sampl
obtain
map
canin
genom
band
tcell
sampl
cluster
separ
princip
compon
analysi
indic
distinct
gene
express
pattern
gene
upregul
q
valu
bcell
lymphoma
mani
involv
bcr
signal
primari
immunodefici
haematopoiet
cell
lineag
pathway
innat
immun
inflammatori
respons
gene
upregul
q
valu
cell
lymphoma
affect
tcr
signal
also
natur
killer
mediat
cytotox
jakstat
signal
haemopoiet
cell
lineag
cancer
pathway
compar
refer
genom
million
sequenc
variant
detect
across
sampl
previous
describ
use
sift
sort
intoler
toler
algorithm
predict
deleteri
protein
function
function
analysi
affect
gene
indic
mani
involv
bcr
signal
cancerrel
pathway
affect
almost
case
although
proport
frequent
b
cell
lymphoma
other
exclus
b
cell
case
gene
affect
larg
number
case
tend
common
variant
present
case
wherea
gene
variant
uniqu
singl
case
although
remain
confirm
detect
variant
repres
true
mutat
rather
polymorph
rnaseq
canin
lymphoma
sampl
gener
interest
pilot
data
need
expand
sampl
valid
result
disclosur
manikhandan
mudaliar
work
glasgow
polyom
commerci
compani
within
glasgow
univers
carri
genom
polyom
assay
next
gen
sequenc
done
glasgow
polyom
partli
use
ecvim
grant
felin
larg
granular
lymphocyt
lgl
lymphoma
uncommonli
describ
literatur
caus
mainli
tcell
lymphocyt
date
standard
protocol
yet
establish
long
term
prognosi
poor
recent
studi
krick
et
al
describ
median
surviv
time
day
rang
cat
lgl
lymphoma
receiv
mainli
copbas
protocol
case
adjuv
surgeri
orthovoltag
radiat
therapi
surprisingli
studi
longest
surviv
time
achiev
cat
non
treat
group
median
surviv
time
day
rang
receiv
prednison
singl
agent
cyclophosphamid
consid
data
advantag
treat
one
alchyl
agent
tcell
lymphoma
dog
brodski
et
al
aim
studi
assess
sequenti
use
differ
alchyl
agent
benefit
cat
lgl
lymphoma
owner
cat
cytolog
hystopatolog
diagnosi
lgl
lymphoma
present
san
marco
veterinari
clinic
juli
till
decemb
offer
treatment
sequenti
alchyl
agent
prednison
saa
p
protocol
palli
care
prednison
saa
p
protocol
consist
prednison
mgkg
h
chlorambucil
mgcat
cat
kg
h
cat
kg
despit
treatment
progress
diseas
stabl
diseas
plu
clinic
sign
refer
lgl
lymphoma
present
chlorambucil
substitut
cyclophosphamid
mgcat
day
final
cat
stop
respond
cyclophosphamid
drug
substitut
lomustin
mgm
week
studi
period
cat
diagnos
lgl
lymphoma
owner
request
cat
euthanas
time
diagnosi
cat
sent
home
treatment
lost
followup
cat
receiv
prednison
alon
cat
receiv
saa
p
protocol
median
surviv
time
cat
treat
prednison
alon
day
rang
day
ci
day
cat
treat
saa
p
protocol
day
rang
day
ci
surviv
kaplanmei
curv
treatment
group
significantli
differ
log
rank
test
p
surviv
time
cat
lgl
lymphoma
treat
saa
p
protocol
significantli
longer
cat
receiv
prednison
seem
longer
histor
report
data
cat
receiv
copbas
protocol
disclosur
disclosur
report
mast
cell
tumor
often
accompani
eosinophil
inflamm
known
produc
eosinophil
chemotact
factor
howev
littl
known
frequenc
eventu
prognost
signific
blood
eosinophilia
mct
bear
dog
thu
aim
studi
determin
frequenc
absolut
rel
peripher
blood
eosinophilia
well
eosinopenia
evalu
potenti
influenc
progress
free
interv
pfi
overal
surviv
time
ost
tumor
specif
surviv
tss
dog
mast
cell
tumor
diagnos
includ
retrospect
studi
data
collect
medic
record
follow
phone
convers
patient
owner
refer
veterinarian
medic
record
review
rule
underli
clinic
condit
mct
could
caus
eosinophilia
tumor
diagnosi
made
either
fine
needl
aspir
andor
tumor
biopsi
patient
alloc
eosinophil
group
eosinophil
concentr
rel
percentag
respect
eosinophil
concentr
patient
categor
eosinopen
group
compar
pearson
chisquar
test
pfi
ost
tss
curv
gener
kaplanmei
product
limit
method
log
rank
test
use
compar
curv
onehundr
dog
includ
studi
absolut
eosinophilia
detect
patient
rel
eosinophilia
present
median
concentr
eosinophil
rang
median
rel
percentag
rang
eosinopenia
found
dog
posit
associ
rel
eosinophilia
low
grade
tumor
detect
patnaik
p
kiupel
p
grade
system
posit
linear
correl
notic
absolut
eosinophilia
ost
p
posit
correl
confirm
rel
eosinophilia
pf
p
ost
p
tss
p
accordingli
neg
linear
fit
found
eosinopenia
pfi
p
ost
p
tss
p
data
indic
peripher
blood
eosinophilia
might
serv
easili
avail
addit
prognost
tool
mast
cell
tumor
bear
dog
disclosur
disclosur
report
limit
literatur
avail
prognost
factor
canin
renal
carcinoma
human
histolog
differenti
tumor
type
strongli
associ
outcom
dog
one
public
far
report
associ
express
document
sever
canin
neoplasia
prognost
valu
canin
mammari
carcinoma
renal
carcinoma
express
demonstr
signific
known
aim
studi
evalu
clinic
histopatholog
featur
canin
renal
carcinoma
includ
express
correl
outcom
hypothesi
advanc
diseas
higher
histolog
grade
increas
express
would
associ
shorter
surviv
retrospect
multiinstitut
studi
within
veterinari
institut
includ
histolog
confirm
case
canin
renal
carcinoma
undergo
nephrectomi
avail
follow
histolog
featur
immunostain
score
review
independ
pathologist
avail
signal
clinic
present
stage
adjuv
therapi
surviv
time
record
statist
analysi
perform
sixtytwo
case
includ
male
femal
ratio
median
age
year
crossbre
dog
n
labrador
retriev
n
overrepres
present
dog
metastasi
overal
median
surviv
time
mst
day
day
dog
without
metastasi
live
longer
mst
versu
day
p
twentyseven
dog
receiv
adjuv
therapi
postnephrectomi
without
impact
mst
treatment
day
treatment
day
p
fifti
sampl
avail
histopatholog
review
immunostain
shorter
surviv
time
seen
solid
histolog
type
compar
other
solid
day
papillari
day
tubular
day
p
histolog
degre
differenti
associ
mst
well
day
moder
day
undifferenti
day
p
vascular
invas
associ
shorter
surviv
mst
day
versu
day
absent
p
mark
invas
associ
shorter
mst
day
versu
mild
day
moder
day
p
patient
low
express
longer
mst
day
high
day
p
mitot
index
clear
cell
type
nuclear
morpholog
fuhrman
nuclear
grade
presenc
pseudocapsul
necrosi
haemorrhag
type
inflamm
significantli
associ
mst
histopatholog
find
degre
differenti
invas
vascular
invas
solid
histolog
type
express
metastasi
present
diagnosi
strongli
associ
surviv
canin
renal
carcinoma
use
prognost
factor
disclosur
disclosur
report
detect
leishmania
infantumspecif
antibodi
extens
exploit
specif
diagnosi
monitor
treatment
canin
leishmaniosi
high
level
l
infantumspecif
antibodi
commonli
observ
dog
moder
sever
diseas
controversi
result
describ
regard
use
kinet
l
infantum
specif
antibodi
treatment
monitor
major
studi
report
antibodi
often
decreas
slowli
remain
detect
long
period
time
older
studi
consid
serolog
use
treatment
monitor
consensu
statement
measur
antibodi
level
meaningless
month
treatment
aim
studi
evalu
l
infantumspecif
antibodi
time
diagnosi
treatment
followup
visit
correl
dog
clinic
statu
nineteen
dog
diagnos
day
followedup
treatment
day
treatment
protocol
combin
meglumin
antimoni
h
sc
month
allopurinol
h
po
year
physic
examin
baselin
laboratori
test
cbc
biochemistri
profil
serum
electrophoresi
urinalysi
urinari
proteincreatinin
ratio
perform
visit
leishmania
infantumspecif
antibodi
assess
end
point
sera
dilut
elisa
method
major
dog
n
classifi
leishvet
stage
ii
moder
diseas
time
diagnosi
three
dog
classifi
leishvet
stage
iii
sever
diseas
n
iv
sever
diseas
n
result
show
high
variabl
level
specif
antibodi
time
diagnosi
meanaesd
elisa
unit
eu
interestingli
rapid
signific
reduct
p
observ
day
treatment
mean
aesd
eu
continu
signific
decreas
specif
antibodi
also
determin
day
mean
ae
sd
eu
mean
aesd
eu
dog
improv
clinic
treatment
except
one
dog
clinic
relaps
month
posttreat
specif
antibodi
level
slightli
increas
conclus
studi
report
first
time
rapid
reduct
l
infantum
specif
antibodi
day
treatment
end
point
sera
dilut
elisa
method
associ
clinic
improv
import
also
highlight
mark
decreas
antibodi
level
also
note
month
year
treatment
disclosur
disclosur
report
broad
rang
clinic
manifest
immun
respons
describ
canin
leishmaniosi
canin
l
infantum
infect
manifest
chronic
subclin
infect
selflimit
diseas
nonselflimit
ill
protect
tcellmedi
immun
respons
character
product
interferongamma
tnfalpha
believ
present
resist
subclin
dog
respons
seem
diminish
absent
sick
dog
howev
poorli
standard
assay
evalu
respons
dog
addit
cellular
mediat
immun
mainli
investig
subclin
vaccin
dog
limit
inform
avail
sick
dog
differ
degre
diseas
sever
aim
studi
investig
l
infantumspecif
cellular
immun
dog
clinic
leishmaniosi
time
diagnosi
twentysix
dog
diagnos
base
physic
examin
routin
laboratori
test
cbc
biochemistri
profil
serum
electrophoresi
urinalysi
urinari
proteincreatinin
ratio
l
infantumspecif
antibodi
level
measur
quantit
elisa
heparin
whole
blood
stimul
l
infantum
solubl
antigen
lsa
mitogen
concavalin
cona
incub
day
unstimul
whole
blood
dog
use
control
supernat
collect
ifngamma
concentr
measur
commerci
sandwich
elisa
major
dog
n
classifi
leishvet
stage
ii
moder
diseas
rest
dog
classifi
stage
n
stage
iii
n
stage
iv
n
twelv
dog
stage
n
stage
iia
n
stage
iii
n
produc
ifngamma
stimul
lsa
mean
ae
sd
pg
ml
cona
meanaesd
ae
pgml
contrast
dog
stage
iia
n
stage
iib
n
stage
iii
n
stage
iv
n
produc
detect
ifngamma
stimul
lsa
dog
produc
ifngamma
stimul
cona
mean
ae
sd
pgml
one
dog
unrespons
cona
differ
ifngamma
concentr
found
ifngamma
produc
nonproduc
dog
blood
stimul
cona
p
interestingli
ifngamma
produc
sick
dog
present
lower
antibodi
level
meanaesd
elisa
unit
eu
compar
ifngamma
nonproduc
sick
dog
mean
ae
sd
eu
differ
statist
signific
p
result
studi
suggest
sick
dog
exagger
humor
respons
sever
diseas
lack
l
infantum
specif
ifngamma
product
stimul
blood
disclosur
disclosur
report
canin
anaplasma
plati
infect
capi
result
thrombocytopenia
consid
subclin
diseas
unit
state
diseas
first
identifi
europ
diseas
seem
sever
suggest
circul
strain
pathogen
although
coinfect
vectorborn
pathogen
vbp
may
also
contribut
express
clinic
sign
howev
avail
pcrbase
investig
impact
coinfect
natur
infect
dog
limit
compromis
assess
clinic
signific
field
condit
aim
present
studi
describ
epidemiolog
clinic
featur
capi
field
condit
area
endem
sever
canin
vbp
studi
conduct
veterinari
clinic
across
itali
spain
portug
sick
anim
includ
fit
least
clinic
andor
biolog
criteria
compat
ehrlichi
diseas
serolog
test
snap
snap
leish
test
diagnost
pcr
ehrlichia
cani
anaplasma
plati
anaplasma
phagocytophilum
babesiatheileria
spp
hepatozoon
cani
leishmania
infantum
detect
perform
identifi
etiolog
agent
capi
consid
basi
suggest
sign
associ
posit
pcrbase
assay
anaplasma
plati
among
dog
includ
pcr
posit
plati
annual
incid
risk
capi
probabl
diagnos
capi
face
clinic
andor
biolog
sign
suggest
ehrlichi
diseas
evalu
nine
dog
monoinfect
dog
coinfect
ecani
linfantum
babesia
sp
hcani
dog
test
perform
anorexia
weight
loss
common
reason
visit
lymphadenomegali
hyperthermia
cutan
sign
frequent
find
wherea
musculoskelet
disord
petechiaeecchymosi
splenomegali
dehydr
ocular
lesion
epistaxi
less
common
haematolog
abnorm
includ
thrombocytopenia
anaemia
leucopoenia
leucocytosi
riskanalysi
conduct
monoand
coinfect
dog
nt
highlight
signific
differ
except
anorexia
significantli
frequent
monoinfect
dog
studi
illustr
magnitud
capi
mediterranean
basin
support
exist
virul
strain
area
coinfect
common
weak
impact
clinic
express
result
emphas
also
import
test
dog
multipl
vbp
due
difficulti
assign
specif
symptom
haematolog
abnorm
specif
vectorborn
infect
endem
area
disclosur
disclosur
report
leptospirosi
worldwid
zoonot
diseas
high
mortal
rate
human
dog
clinicopatholog
chang
may
reflect
renal
diseas
hepat
diseas
caus
often
vomit
polyuriapolydipsia
diarrhea
therefor
sever
electrolyt
anion
gap
ag
abnorm
could
expect
aim
cohort
studi
investig
serum
electrolyt
ag
dog
natur
occur
leptospirosi
assess
prognost
valu
electron
databas
san
marco
veterinari
clinic
poa
systemplu
search
dog
diagnosi
leptospirosi
group
n
inclus
criteria
group
consist
clinicopatholog
sign
posit
microscop
agglutin
test
vaccin
dog
nonvaccin
dog
increas
convalesc
titer
andor
posit
pcr
urin
andor
blood
leptospirosi
paramet
studi
serum
electolyt
sodium
chlorid
potassium
ag
ag
albuminadjust
ag
albadjust
ag
x
alb
two
control
popul
randomli
healthi
dog
group
n
sick
dog
without
leptospirosi
group
n
dog
creat
match
group
age
month
sex
includ
sexual
statu
breed
statist
differ
group
evalu
kruskalw
test
posttest
analysi
perform
wilcoxonmannwhitney
mortal
rel
risk
mrr
day
postadmiss
group
group
evalu
roc
curv
use
identifi
best
prognost
analyt
signific
level
statist
test
set
p
serum
sodium
chlorid
concentr
significantli
decreas
group
compar
group
p
comparison
serum
potassium
concentr
significantli
decreas
group
compar
group
p
differ
present
group
p
serum
ag
ag
albadjust
significantli
increas
group
compar
group
p
comparison
significantli
increas
mortal
rate
group
n
compar
group
n
mrr
ci
variabl
studi
serum
potassium
auc
p
chlorid
auc
p
ag
auc
p
ag
albadjust
auc
p
prognost
serum
electrolyt
ag
ag
albadjust
significantli
differ
dog
leptospirosi
compar
healthi
sick
dog
without
leptospirosi
except
serum
potassium
similar
sick
dog
without
leptospirosi
variabl
studi
ag
albadjust
result
best
paramet
predict
death
dog
leptospirosi
disclosur
disclosur
report
enterococci
caus
urinari
tract
infect
uti
companion
anim
may
carri
import
resist
gene
bifunct
enzym
furthermor
virul
factor
seldomli
report
veterinari
medicin
thu
studi
aim
character
uropathogen
enterococci
antimicrobi
resist
virul
gene
clonal
highlevel
gentamicin
resist
hlgr
enterococcu
faecali
antimicrobi
suscept
test
clinic
uropathogen
enterococci
isol
dog
cat
uti
isol
perform
disc
diffus
method
clsi
clinic
breakpoint
appli
strain
show
hlgr
screen
aac
ieaph
ia
aph
gene
pcr
e
faecali
harbour
hlgr
gene
type
multilocussequenc
fiftynin
strain
character
pcr
presenc
gel
e
gelatinas
ace
collagen
bind
antigen
aggreg
substanc
efa
endocard
virul
gene
e
faecali
frequent
isol
n
follow
enterococcu
faecium
n
overal
antimicrobi
suscept
result
n
resist
penicillinampicillin
n
resist
fluoroquinolon
enrofloxacin
ciprofloxacin
n
resist
nitrofurantoin
n
resist
chloramphenicol
n
resist
tetracyclin
hlgr
detect
n
enterococci
name
e
faecali
two
e
faecium
hlgr
e
faecali
aac
ieaph
ia
carrier
one
e
faecium
posit
aac
ieaph
ia
wherea
posit
aph
interestingli
ampicillinresist
detect
e
faecium
isol
furthermor
hlgr
e
faecium
also
ampicillinresist
hlgr
e
faecali
found
belong
major
lineag
circul
hospit
commun
set
portug
consid
enterococci
n
n
n
n
posit
gel
e
ace
efa
virul
gene
respect
uropathogen
e
faecium
posit
ace
gene
thu
e
faecali
higher
virul
gene
frequenc
studi
detect
import
human
hlgr
e
faecali
belong
clonal
complex
e
faecali
among
uropathogen
companion
anim
presenc
major
clonal
lineag
companion
anim
highlight
role
communityassoci
host
possibl
reservoir
put
human
pathogen
enterococci
disclosur
conflict
interest
c
atia
marqu
current
receiv
phd
grant
fund
portugues
foundat
scienc
technolog
haemotrop
mycoplasma
haemoplasma
caus
haemolyt
anaemia
mani
speci
includ
peopl
three
felin
haemoplasma
identifi
mycoplasma
haemof
mhf
candidatu
mycoplasma
haemominutum
cmhm
candidatu
mycoplasma
turicensi
cmt
mhf
consid
pathogen
whilst
cmhm
cmt
usual
caus
anaemia
cat
concurr
diseas
immunosuppress
aim
studi
estim
preval
felin
haemoplasma
serbia
identifi
potenti
risk
factor
infect
surplu
edta
blood
sampl
cat
belgrad
region
use
cat
follow
variabl
record
age
health
statu
gender
outdoor
access
presenc
ectoparasit
haematolog
result
sampl
store
transport
univers
bristol
haemoplasma
quantit
pcr
test
serolog
petchek
idexx
perform
felv
n
fiv
n
infect
statist
analysi
perform
use
spss
univari
associ
variabl
haemoplasma
statu
first
evalu
v
categor
variabl
ttestmannwhitney
u
test
continu
variabl
follow
multivari
analysi
two
sampl
neg
intern
control
rdna
exclud
studi
remain
cat
infect
one
haemoplasma
speci
singli
infect
mhf
cmhm
cmt
dualli
infect
mhfcmhm
mhfcmt
cmhmcmt
tripl
infect
overal
preval
mhf
cmhm
cmt
respect
cat
felv
infect
whilst
fiv
infect
multivari
analysi
identifi
signific
associ
haemoplasma
infect
anaemia
anaemicnonanaem
odd
ratio
ci
p
male
gender
malefemal
ci
p
outdoor
access
yesno
ci
p
nonpedigre
breed
nonpedigreepedigre
ci
p
fiv
posit
statu
posit
neg
ci
p
overal
preval
felin
haemoplasma
serbia
similar
report
european
countri
cmhm
preval
haemoplasma
speci
current
studi
similar
european
studi
rang
previou
studi
report
cmt
infect
least
preval
felin
haemoplasma
speci
current
studi
preval
cmt
greater
mhf
similarli
previou
studi
presenc
anaemia
male
gender
outdoor
access
nonpedigre
statu
fiv
infect
significantli
associ
haemoplasma
infect
disclosur
disclosur
report
canin
parvoviru
type
frequent
digest
pathogen
dog
respons
high
mortal
rate
puppi
control
infect
disinfect
isol
patient
limit
effici
rais
question
contagion
sourc
aim
studi
evalu
epidemiolog
role
dam
viral
circul
reproduct
period
total
bitch
mean
ae
standard
deviat
year
old
one
kennel
enrol
studi
annual
vaccin
nobivac
dhppilepto
vaccin
msd
beaucouz
e
franc
dam
follow
mate
whelp
dam
follow
whelp
wean
puppi
lactat
dam
n
follow
sinc
week
age
fecal
excret
evalu
real
time
pcr
rectal
swab
everi
day
gestat
dam
everi
day
lactat
dam
puppi
data
analyz
logist
regress
mix
linear
model
total
sampl
collect
pregnanc
bitch
excret
least
one
sampl
quantif
threshold
copiesg
fece
lactat
bitch
found
posit
least
time
mean
went
quantif
threshold
least
lactat
excret
viral
load
significantli
higher
g
fece
p
g
fece
p
g
fece
p
compar
earli
lactat
copiesg
fece
despit
threshold
clinic
parvovirosi
g
fece
none
bitch
express
symptom
case
dam
excret
puppi
viral
load
excret
puppi
correl
excret
dam
proport
puppi
excret
viral
load
clinic
threshold
increas
per
litter
overal
mortal
studi
demonstr
appropri
vaccin
adult
femal
dog
may
excret
gestat
lactat
due
high
quantiti
excret
femal
probabl
repres
major
sourc
contamin
puppi
viral
excret
bitch
lactat
next
breed
period
male
would
interest
follow
better
understand
role
adult
circul
felin
panleukopenia
viru
fpv
respons
one
sever
infecti
diseas
cat
studi
address
factor
prognost
import
earlier
investig
span
year
leukopenia
thrombocytopenia
hypoalbuminemia
hypokalemia
found
associ
poor
outcom
aim
identifi
outcom
predictor
shelter
outbreak
panleukopenia
limit
analysi
fresh
case
treat
follow
recoveri
death
institut
clinic
record
affect
cat
review
inform
collect
diagnosi
hospit
data
includ
anamnest
histori
physic
examin
complet
blood
count
biochem
profil
blood
ga
analysi
treatment
includ
type
antibiot
antivir
antiemet
analges
crystalloid
colloid
hemoderiv
administ
outcom
predictor
analyz
use
logist
regress
mixeddesign
analysi
varianc
studi
includ
cat
diagnos
panleukopenia
base
clinic
find
posit
fecal
elisa
month
old
femal
clinic
sign
diagnosi
includ
lethargi
vomit
diarrhea
admiss
median
rang
leukocyt
count
platelet
hypoalbuminemia
hypokalemia
treatment
includ
administr
amoxicillinclavulan
interferonx
intraven
glucos
solut
overal
cat
surviv
letharg
cat
like
die
ci
p
leukocyt
count
diagnosi
associ
outcom
day
hospit
particular
cat
aliv
day
succumb
later
leukocyt
count
wherea
survivor
p
survivor
like
receiv
amoxicillinclavulan
p
less
like
intraven
glucos
solut
p
thrombocytopenia
hypoalbuminemia
hypokalemia
administr
interferonx
associ
outcom
result
suggest
infect
cat
lower
leukocyt
count
later
hospit
like
die
despit
treatment
studi
differ
previou
data
lower
leukocyt
count
admiss
predict
outcom
possibl
due
inclus
cat
earli
fpv
diagnosi
administr
intraven
glucos
associ
poor
outcom
perhap
increas
risk
sepsi
also
cat
critic
condit
like
receiv
intraven
glucos
benefici
role
amoxicillinclavulan
sick
cat
might
due
broadspectrum
bactericid
activ
interferonx
show
conspicu
effect
disclosur
disclosur
report
accord
prior
studi
cat
southern
germani
protect
antibodi
felin
panleukopenia
viru
thu
like
suscept
felin
panleukopenia
infect
unknown
healthi
adult
cat
differ
antibodi
titer
react
felin
panleukopenia
vaccin
field
therefor
aim
studi
measur
antibodi
titer
healthi
adult
cat
within
day
felin
panleukopenia
vaccin
one
hundr
twelv
healthi
adult
cat
vaccin
rcp
vaccin
vaccin
day
day
antibodi
panleukopenia
viru
determin
hemagglutin
inhibit
cat
antibodi
prior
vaccin
detect
cat
vaccin
regularli
nearli
one
third
cat
show
antibodi
increas
vaccin
cat
antibodi
titer
decreas
despit
vaccin
within
day
howev
cat
like
protect
preexist
antibodi
titer
cat
antibodi
detect
neither
prior
vaccin
larg
number
adult
cat
protect
antibodi
therefor
risk
felin
panleukopenia
viru
infect
hand
mani
cat
show
high
antibodi
titer
develop
antibodi
due
vaccin
therefor
evalu
individu
antibodi
statu
cat
vaccin
cat
antibodi
low
titer
recommend
disclosur
independ
studi
financ
merial
influenc
result
studi
merial
coauthorship
plan
merial
felin
coronavirus
fcov
occur
pathotyp
enigmat
even
controversi
relationship
low
virul
nonvirul
felin
enter
coronaviru
fecv
highli
lethal
felin
infecti
periton
viru
fipv
recent
sequenc
differ
within
spike
gene
region
encod
put
fusion
peptid
describ
propos
correl
mutat
form
fecv
ie
fipv
lead
clinic
present
felin
infecti
periton
fip
present
develop
valid
allel
discrimin
realtim
pcr
type
test
identifi
mutat
separ
describ
diagnost
sensit
specif
report
set
european
clinic
sampl
acquir
either
fip
confirm
cat
healthi
cat
previous
test
fcov
posit
archiv
sampl
fcov
posit
sampl
includ
valid
sampl
pass
qualiti
control
viru
level
limit
detect
pcr
assay
remain
sampl
type
correctli
accuraci
one
fip
character
sampl
type
fecv
diagnost
sensit
healthi
cat
type
fecv
diagnost
specif
confirm
spike
gene
mutat
uniqu
european
cat
fip
addit
valid
studi
us
japanes
sampl
conduct
us
clinic
studi
includ
case
fip
suspici
case
nonfip
compat
diseas
fipv
realpcr
biotyp
assay
abl
accur
differenti
fip
nonfip
fecv
etiolog
p
biotyp
cat
confirm
nonfip
diseas
fipv
confirm
high
diagnost
specif
molecular
test
disclosur
aim
studi
compar
diagnost
accuraci
fip
convent
clinicopatholog
test
routin
hematolog
serum
protein
electrophoresi
acid
glycoprotein
agpmeasur
analysi
effus
molecular
test
routin
pcr
pcr
follow
sequenc
spike
gene
blood
effus
tissu
specimen
collect
cat
symptom
imput
fip
vivo
examin
consist
clinicopatholog
test
complet
blood
count
serum
protein
electrophoresi
agp
measur
cytolog
biochem
examin
well
evalu
sysmex
dtnc
effus
present
molecular
test
screen
pcr
direct
toward
utr
region
pcr
direct
toward
gene
follow
sequenc
amplif
product
order
detect
aminoacid
substitut
consid
diagnost
fip
molecular
techniqu
appli
tissu
sampl
collect
necropsi
also
allow
divid
cat
fip
group
cat
non
fip
group
cat
base
histolog
immunohistochemistri
diagnost
accuraci
sensit
specif
neg
posit
predict
valu
test
calcul
best
test
tissu
immunohistochemistri
sen
spec
screen
pcr
suffer
low
sensit
low
specif
sen
spec
gene
sequenc
posit
reveal
mutat
nucleotid
show
low
sensit
sen
spec
effus
best
test
result
screen
pcr
cytolog
sen
spec
comparison
dtnc
measur
sen
spec
gene
sequenc
spec
blood
sampl
agp
measur
demonstr
best
diagnost
accuraci
sen
spec
serum
protein
electrophoresi
show
surprisingli
low
sensit
sen
screen
pcr
sen
spec
gene
sequenc
sen
spec
prove
low
accuraci
demonstr
neg
result
molecular
test
allow
exclud
fip
chang
hw
egberink
hf
halpin
r
spiro
dj
rottier
pjm
spike
protein
fusion
peptid
felin
coronaviru
virul
emerg
infect
di
diagnosi
felin
infecti
periton
fip
still
challeng
especi
cat
without
bodi
caviti
effus
uveiti
cat
fip
commonli
present
without
effus
make
definit
confirm
fip
difficult
aim
studi
evalu
diagnost
util
immunocytochem
icc
assay
use
aqueou
humor
cat
suspect
fip
sampl
cat
immunohistochem
confirm
fip
cat
suspect
fip
due
similar
clinic
laboratori
chang
definit
diagnos
anoth
diseas
examin
aqueou
humor
collect
postmortem
cat
euthan
due
diagnos
diseas
icc
analysi
carri
use
antifelin
coronaviru
mous
monoclon
avidinbiotin
complex
method
sensit
specif
neg
posit
predict
valu
determin
confid
interv
ci
calcul
aqueou
humor
sampl
fip
control
reveal
posit
icc
result
fals
posit
icc
result
obtain
cat
suffer
lymphoma
pulmonari
adenocarcinoma
diagnost
sensit
icc
assay
aqueou
humor
ci
diagnost
specif
ci
neg
predict
valu
ci
posit
predict
valu
ci
unfortun
fals
posit
result
occur
specif
consid
import
paramet
fatal
diseas
like
fip
posit
icc
result
aqueou
humor
interpret
cautious
confirm
suspicion
fip
disclosur
disclosur
report
alanin
aminotransferas
alt
level
plasma
commonli
use
indic
hepatocellular
injuri
dog
howev
dog
advanc
liver
diseas
present
alt
level
within
refer
rang
recent
studi
shown
potenti
circul
microrna
biomark
liver
injuri
hepatocytederiv
identifi
liver
specif
superior
sensit
alt
level
mice
human
aim
present
studi
investig
potenti
circul
serv
diagnost
serum
biomark
hepatocellular
injuri
dog
hereto
liver
biopsi
labrador
retriev
collect
liver
histolog
includ
grade
hepat
stage
fibrosi
review
boardcertifi
veterinari
pathologist
tsgamvdi
concurr
serum
sampl
collect
analyz
alt
level
level
dog
includ
one
follow
group
normal
liver
normal
alt
level
control
group
liver
patholog
normal
alt
level
liver
patholog
high
alt
level
compar
statist
group
perform
use
mannwhitney
u
test
associ
alt
level
grade
stage
hepat
copper
concentr
analyz
use
spearman
rank
correl
coeffici
logist
regress
model
use
assess
accuraci
alt
detect
presenc
hepatocellular
injuri
total
dog
normal
liver
histolog
normal
alt
level
thirtyeight
dog
liver
patholog
whereof
dog
increas
alt
level
high
alt
group
median
level
rang
time
higher
compar
control
group
p
even
dog
liver
patholog
normal
alt
level
median
level
rang
time
higher
compar
control
group
p
univari
logist
regress
show
alt
level
signific
predictor
abnorm
liver
histolog
p
serum
level
posit
correl
alt
level
histolog
grade
stage
fibrosi
r
r
r
respect
p
studi
highlight
potenti
earli
sensit
biomark
liver
injuri
dog
sensit
alt
level
earli
diagnosi
hepatocellular
injuri
open
opportun
institut
treatment
subclin
stage
diseas
possibl
favor
outcom
disclosur
studi
financi
support
ecvim
clinic
studi
fund
author
declar
conflict
interest
evalu
liver
fibrosi
major
import
manag
chronic
liver
diseas
predict
prognosi
although
liver
biopsi
gold
standard
evalu
fibrosi
noninvas
test
enabl
clinician
stage
monitor
varieti
liver
diseas
human
medicin
transform
growth
factor
b
tgfb
hyaluron
acid
ha
biomark
hepat
fibrogenesi
reflect
activ
fibrogen
fibrinolyt
process
use
valid
dog
aim
studi
evalu
measur
tgfb
ha
assess
sensibl
specif
monitor
dog
differ
level
hepat
fibrosi
eighti
three
adult
dog
prospect
enrol
base
persist
elev
alt
exclus
focal
hepat
lesion
ultrasound
examin
dog
underw
liver
biopsi
serum
blood
collect
lf
stage
accord
histopatholog
wsava
criteria
amount
collagen
measur
morphometr
analysi
quantit
variabl
express
meanaesd
bean
plot
describ
relationship
variabl
bivari
analysi
ha
alt
pal
lf
perform
spearman
correl
parametr
test
student
test
carri
assess
relationship
tgfb
lf
diagnost
cutoff
determin
accord
maximum
youden
index
sensit
se
specif
spe
preliminari
result
dog
show
individu
ha
ngml
densiti
collagen
serum
concentr
ha
significantli
pvalu
higher
group
whose
fibrosi
densiti
tgfb
sensit
marker
specif
diagnos
dog
collagen
quit
low
preliminari
result
show
potenti
interest
ha
biomark
detect
liver
fibrosi
dog
interest
tgfb
could
demonstr
ha
combin
good
sensit
fair
specif
complet
result
studi
help
refin
cutoff
valu
improv
diagnost
perform
ah
evalu
interest
tgfb
combin
sever
marker
would
help
elabor
sensit
specif
diagnost
test
liver
fibrosi
disclosur
speaker
declar
potenti
conflict
interest
compani
echosen
echosen
cover
part
biolog
measur
expens
clinic
trial
associ
abstract
primari
hepat
common
disord
dog
treatment
primari
hepat
typic
symptomat
importantli
predict
prognosi
point
diagnosi
remain
challeng
contrast
human
medicin
type
hepat
defin
incit
caus
caus
chronic
hepat
identifi
dog
major
case
idiopath
system
inflamm
well
recognis
human
liver
diseas
system
inflammatori
respons
syndrom
sir
clinic
express
action
complex
intrins
mediat
acut
phase
reaction
presenc
sir
link
poor
outcom
variou
liver
diseas
preval
predict
valu
sir
dog
primari
hepat
examin
dog
liver
diseas
surpris
given
accumul
evid
sir
link
develop
hepat
encephalopathi
dog
liver
diseas
although
pathogenesi
complet
understood
indic
ammonia
inflammatori
cytokin
play
crucial
role
develop
import
caus
morbid
mortal
patient
liver
diseas
hypothesi
studi
examin
preval
sever
sir
n
dog
histolog
confirm
primari
hepatopathi
eighti
dog
primari
hepatopathi
confirm
histopatholog
includ
studi
sir
score
calcul
respir
rate
breath
per
minut
heart
rate
beat
per
minut
total
white
blood
cell
count
rectal
temperatur
sir
score
present
valu
patient
date
arriv
hospit
date
death
record
therefor
surviv
time
day
could
determin
sir
score
appli
surviv
time
record
median
surviv
sir
day
sir
median
surviv
day
p
valu
log
rank
test
studi
demonstr
sir
common
featur
dog
primari
hepat
valuabl
predict
clinic
outcom
disclosur
disclosur
report
aim
studi
determin
preval
congenit
portosystem
shunt
cpss
deerhound
focuss
uk
usa
determin
mani
deerhound
breeder
routin
test
puppi
cpss
congenit
portosystem
shunt
cpss
overrepres
certain
breed
irish
wolfhound
maltes
yorkshir
terrier
anecdot
evid
suggest
also
increas
preval
deerhound
confirm
howev
studi
questionnairebas
distribut
onlin
deerhound
breeder
worldwid
particularli
usa
uk
addit
distribut
post
uk
questionnair
pass
ethic
review
depart
veterinari
medicin
univers
cambridg
fiftysix
breeder
worldwid
return
questionnair
uk
usa
countri
uk
respons
rate
includ
postal
onlin
respons
preval
shunt
found
puppi
preval
uk
usa
respect
worldwid
breeder
found
test
routin
cpss
puppi
proport
uk
usa
respect
preval
cpss
uk
usa
deerhound
found
studi
higher
found
mixedbre
dog
separ
studi
suggest
genet
compon
diseas
deerhound
lower
proport
breeder
routin
test
cpss
usa
compar
uk
preval
cpss
also
lower
usa
find
may
relat
would
advis
breeder
routin
test
puppi
cpss
sale
avoid
breed
affect
anim
disclosur
st
catharin
colleg
cambridg
contribut
cost
studi
deerhound
club
uk
scottish
deerhound
club
america
gave
support
help
distribut
advertis
studi
measur
neuroendocrin
marker
offer
diagnost
prognost
therapeut
inform
obtain
clinic
examin
ntprobnp
potenti
biomark
hypertens
target
organ
damag
tod
circul
concentr
biomark
increas
human
hypertens
patient
tod
poor
respons
antihypertens
treatment
cat
hypertens
tod
significantli
higher
ntprobnp
concentr
nonhypertens
cat
aim
studi
investig
util
ntprobnp
biomark
hypertens
tod
efficaci
antihypertens
treatment
plasma
sampl
hypertens
cat
seen
first
opinion
practic
retrospect
identifi
hypertens
diagnos
base
systol
blood
pressur
sbp
mmhg
evid
hypertens
retinopathi
todgroup
n
mmhg
consecut
visit
week
apart
without
evid
retin
patholog
notodgroup
n
cat
achiev
sbp
control
defin
mmhg
mg
amlodipin
daili
sampl
avail
hypertens
visit
first
visit
target
sbp
achiev
addit
healthi
cat
year
old
n
normotens
cat
diagnos
ckd
plasma
creatinin
lmoll
conjunct
usg
n
identifi
ntprobnp
concentr
measur
extern
laboratori
necessari
variabl
logtransform
meet
normal
distribut
binari
logist
regress
use
investig
ntprobnp
predictor
hypertens
use
healthi
ckd
cat
compar
group
tod
use
notod
compar
group
comparison
group
respons
treatment
perform
use
mannwhitney
u
wilcoxon
rank
sum
test
respect
higher
ntprobnp
concentr
significantli
increas
probabl
cat
hypertens
odd
ratio
log
ntprobnp
confid
interv
p
could
reliabl
predict
tod
p
ntprobnp
concentr
howev
significantli
higher
cat
tod
cat
tod
data
suggest
increas
plasma
ntprobnp
concentr
predict
hypertens
statu
cat
cat
without
tod
significantli
lower
ntprobnp
concentr
diagnosi
hypertens
cat
tod
ntprobnp
concentr
decreas
effect
antihypertens
treatment
studi
requir
determin
whether
ntprobnp
remain
elev
cat
poorli
control
blood
pressur
disclosur
esther
bijsman
phd
fund
zoeti
hypovitaminosi
previous
shown
preval
amongst
dog
protein
lose
enteropathi
ple
outcom
gener
poor
canin
ple
lack
studi
identifi
underli
risk
factor
hypothesi
studi
low
vitamin
serum
concentr
could
risk
factor
bad
outcom
patient
medic
record
dog
seen
royal
veterinari
colleg
review
identifi
dog
diagnosi
ple
confirm
histopatholog
dog
includ
studi
serum
sampl
frozen
within
minut
sampl
kept
degre
c
analysi
clinic
activ
score
ccecai
record
time
diagnosi
fortythre
dog
includ
studi
followup
refer
veterinarian
made
determin
outcom
patient
patient
divid
group
patient
deceas
due
ple
poor
outcom
group
n
patient
aliv
deceas
due
anoth
diseas
good
outcom
group
n
treatment
patient
alloc
group
one
group
consist
patient
prescrib
diet
group
receiv
diet
immunosuppress
agent
sampl
sent
dri
ice
michigan
state
univers
diagnost
center
popul
anim
health
ionis
calcium
ica
measur
use
ion
specif
electrod
oh
measur
use
commerci
avail
radioimmunoassay
valid
use
veterinari
medicin
comparison
outcom
group
age
ccecai
treatment
serum
oh
ica
perform
use
mannwhitney
u
test
chi
logist
regress
analysi
perform
determin
possibl
risk
factor
poor
outcom
result
ccecai
score
age
ica
concentr
group
significantli
differ
significantli
greater
number
dog
treat
food
alon
group
good
outcom
poor
outcom
group
p
furthermor
median
serum
oh
concentr
significantli
lower
patient
poor
outcom
nmoll
rang
nmoll
compar
patient
good
outcom
nmoll
rang
nmoll
p
use
logist
regress
oh
serum
concentr
statist
signific
factor
poor
outcom
p
increas
oh
serum
concentr
reduc
odd
poor
outcom
odd
ratio
ci
studi
requir
investig
vitamin
potenti
adjuv
therapeut
agent
ple
patient
disclosur
disclosur
report
campylobact
jejuni
cj
c
upsaliensi
cu
c
helveticu
ch
commonli
isol
dog
cat
faec
associ
clinic
sign
discord
lack
cj
recogn
human
pathogen
cu
consid
emerg
pathogen
ch
consid
pathogen
despit
high
level
genet
similar
recent
greater
wax
moth
galleria
mellonella
describ
anim
model
diseas
invertebr
high
degre
function
structur
homolog
mammalian
innat
immun
system
studi
aim
evalu
pathogen
potenti
cj
cu
ch
use
galleria
mellonella
larva
model
twelv
isol
cj
cu
ch
dog
cat
use
inocul
larva
inocula
prepar
suspend
isol
phosphatebuff
salin
pb
dilut
made
dilut
test
duplic
set
larva
larva
inject
haemocoel
via
last
left
proleg
use
insulin
syring
control
consist
pb
inocul
larva
uninocul
larva
surviv
larva
h
microaerob
atmospher
monitor
day
postinject
one
subset
isol
grown
muellerhinton
broth
use
prepar
secretori
product
anoth
grown
bloodagar
suspend
pb
heat
inactiv
minut
test
wholecel
lysat
heatstabl
insolubl
solubl
compon
overal
median
surviv
larva
cj
iqr
cu
iqr
ch
iqr
pb
iqr
uninocul
larva
iqr
dosedepend
associ
evid
speci
larval
surviv
similar
low
bacteri
dose
pb
larval
surviv
present
consist
pattern
speci
medium
high
bacteri
load
cj
higher
faster
larval
death
rate
cu
ch
p
differ
observ
cu
ch
p
signific
differ
speci
assay
secretori
product
inactiv
cell
solubleinsolubl
cellular
compon
observ
within
invertebr
diseas
model
support
vari
pathogen
potenti
speci
studi
appear
relat
patho
biolog
speci
rather
cellular
compon
metabol
product
invertebr
anim
model
promis
compar
pathogen
studi
disclosur
disclosur
report
acut
stress
medium
high
durat
highintens
exercis
report
associ
increas
serum
creactiv
protein
crp
concentr
import
acutephas
reactant
dog
howev
effect
exercis
fecal
concentr
biomark
intestin
inflamm
previous
evalu
dog
goal
studi
determin
moder
intens
short
durat
exercis
caus
increas
crp
andor
concentr
dog
potenti
lead
misinterpret
result
adult
militari
work
dog
german
belgian
shepherd
dog
male
mean
age
year
includ
studi
fecal
qualiti
fecal
serum
crp
concentr
evalu
standard
exercis
minut
bikejor
speed
kmh
fecal
qualiti
evalu
base
scale
liquid
dri
hard
fece
fecal
crp
concentr
assay
previous
valid
elisa
test
data
analyz
anova
test
repeat
measur
sa
softwar
result
present
median
rang
serum
crp
concentr
increas
significantli
exercis
median
excercis
mgl
mgl
p
also
fecal
concentr
significantli
higher
exercis
compar
baselin
concentr
ngg
versu
ngg
p
signific
effect
exercis
fecal
score
observ
exercis
p
studi
demonstr
moderateintens
shortdur
effort
perform
healthi
armi
dog
caus
signific
increas
fecal
serum
crp
concentr
compar
baselin
valu
within
respect
refer
interv
therefor
moder
exercis
present
confound
variabl
interpret
fecal
serum
crp
concentr
healthi
dog
disclosur
studi
perform
thank
financi
support
royal
canin
imag
integr
part
workup
canin
gastrointestin
gi
diseas
radiographi
ultrasonographi
noninvas
modal
evalu
bowel
mani
find
lack
desir
sensit
specif
endoscopi
directli
visual
gi
mucosa
limit
length
endoscop
need
gener
anesthesia
advanc
train
expens
equip
ambulatori
lightbas
imag
ali
new
imag
modal
util
highresolut
camera
microprocessor
led
illumin
noninvas
visual
gastrointestin
mucosa
ali
perform
oral
administr
fulli
autom
devic
size
pill
propel
peristalsi
aim
studi
analyz
imag
qualiti
gi
transit
time
seri
client
own
dog
undergo
ali
dog
foodrestrict
hour
hour
capsul
administr
capsul
retriev
imag
download
analyz
video
clip
frame
durat
obtain
stomach
proxim
middl
distal
small
intestin
proxim
colon
assess
imag
qualiti
internist
rate
imag
scale
poor
excel
base
clariti
resolut
imag
obscur
mucosa
fluid
bubbl
debri
score
region
compar
use
gener
estim
equat
analysi
gastric
small
intestin
transit
time
calcul
base
visual
passag
capsul
stomach
duodenum
ileum
colon
clinic
analysi
entir
video
perform
one
author
ali
success
perform
patient
advers
effect
averag
studi
durat
hour
mean
imag
acquisit
count
gastric
small
intestin
transit
time
minut
minut
respect
median
rang
imag
qualiti
score
stomach
si
colon
respect
imag
qualiti
score
significantli
higher
stomach
si
colon
p
visual
lesion
consist
gi
ulcer
dog
inflammatori
bowel
diseas
dog
biliou
vomit
syndrom
dog
one
dog
receiv
chronic
nsaid
normal
studi
ambulatori
lightbas
imag
result
good
excel
imag
qualiti
throughout
gi
tract
bowel
prepar
consid
enhanc
visual
colon
ali
safe
easi
perform
ambulatori
dog
therefor
consid
workup
canin
gi
diseas
disclosur
canin
pancreat
common
exocrin
pancreat
disord
prognosi
canin
pancreat
variabl
logist
regress
construct
sever
score
system
avail
four
hundr
thirti
nine
dog
diagnos
pancreat
acut
onset
compat
clinic
sign
posit
snap
cpl
tm
test
andor
associ
abdomin
ultrasonograph
abnorm
januari
decemb
present
nation
taiwan
univers
veterinari
hospit
ntuvh
one
hundr
three
dog
hospit
complet
medic
therapi
outcom
select
analysi
dog
divid
surviv
n
nonsurviv
n
group
fortyseven
paramet
includ
signal
clinic
sign
physic
examin
clinicopatholog
examin
complic
concurr
diseas
analyz
compar
group
logist
regress
analys
perform
studi
variabl
p
consid
analys
mortal
studi
age
heart
rate
respiratori
rate
white
blood
cell
count
albumin
bun
creatinin
potassium
presenc
system
inflammatori
respons
syndrom
sir
presenc
oliguria
anuria
select
construct
score
continu
variabl
outsid
refer
interv
separ
quartil
yield
quartilespecif
odd
ratio
or
surviv
base
integ
valu
score
system
develop
incorpor
weight
factor
assign
quartil
predict
total
score
calcul
dog
sum
weight
factor
total
score
dog
rang
sever
score
studi
achiev
area
receiv
oper
characterist
auroc
optim
cutoff
point
discrimin
outcom
sensit
specif
respect
mortal
score
wherea
score
signific
differ
p
group
seper
cutoff
point
sever
score
system
studi
provid
reliabl
clinic
applic
method
predict
clinic
outcom
dog
pancreat
disclosur
disclosur
report
glucocorticoid
gc
known
antiinflammatori
immunmodulatori
properti
therefor
often
use
therapi
canin
inflammatori
bowel
diseas
ibd
recent
shown
endogen
gc
also
produc
intestin
epithelium
men
mice
influenc
gastrointestin
immun
system
case
inflammatori
neoplast
condit
thu
aim
project
prove
gc
produc
metabol
canin
intestin
epithelium
five
healthi
beagl
dog
includ
prospect
studi
dog
clinic
examin
given
clinic
score
use
canin
ibd
activ
index
cibdai
score
system
also
gastrointestin
endoscopi
perform
mucos
biopsi
specimen
duodenum
examin
histolog
board
certifi
pathologist
use
wsava
grade
biopsi
incub
endoscop
mucos
biopsi
tissu
cultur
medium
hlabel
progesteron
absenc
stimul
perform
mean
age
includ
dog
year
mean
weight
kg
beagl
dog
mean
clinic
score
mean
wsava
score
hour
supernat
harvest
radioact
progesteron
metabolit
form
detect
use
high
perform
liquid
chromatographi
plu
liquid
scintil
count
dog
hprogesteron
metabol
variou
steroid
speci
nevertheless
local
product
cortisol
could
proven
summari
could
shown
precursor
gc
metabol
healthi
canin
intestin
mucos
tissu
disclosur
disclosur
report
studi
relationship
pancreat
cardiac
injuri
dog
cat
previous
valid
cardiac
troponin
ctni
vet
j
assay
sensit
specif
detect
cardiac
injuri
domest
anim
found
variou
noncardiac
diseas
dog
cat
associ
cardiac
injuri
detect
serum
cardiac
troponin
includ
case
pancreat
also
valid
dggrlipas
assay
costeffect
sensit
specif
detect
pancreat
dog
cat
vet
clin
path
herein
test
hypothesi
pancreat
associ
cardiac
injuri
ctni
measur
advia
centaur
tniultra
assay
dggrlipas
randox
colourimetr
assay
retrospect
analys
data
dog
cat
admit
ucd
veterinari
hospit
ctn
lipas
measur
upper
limit
refer
rang
lipas
dog
ul
consid
indic
mild
pancreat
moder
mark
upper
limit
refer
rang
lipas
cat
refer
rang
ctni
ugl
dog
cat
consid
indic
mild
cardiac
injuri
moder
mark
dog
cat
lipas
ctni
measur
dog
normal
troponin
normal
lipas
normal
lipas
normal
ctni
dog
pancreat
indic
increas
lipas
pancreat
mild
moder
mark
dog
increas
ctni
mild
moder
mark
cardiac
injuri
dog
pancreat
absent
mild
moder
mark
cat
normal
ctn
normal
lipas
cat
pancreat
sever
lipas
ctni
correl
r
dog
cat
conclud
pancreat
cardiac
injuri
indic
highsensit
highspecif
assay
randoxdggrlipas
centaurctni
respect
uncommon
veterinari
hospit
case
confirm
extend
previou
work
pancreat
dog
cat
typic
associ
cardiac
injuri
sever
pancreat
cardiac
injuri
correl
dog
cat
pancreat
cardiac
injuri
moder
mark
disclosur
disclosur
report
intracellular
colon
may
serv
protect
nich
helicobact
spporgan
evad
effect
treatment
contribut
recolon
confoc
endomicroscopi
cem
endoscop
modal
allow
vivo
gastrointestin
imag
high
resolut
aid
realtim
identif
helicobact
pylori
intracellular
mucos
associ
bacteri
dog
nonhelicobact
pylorihelicobact
nhph
describ
intracellularli
object
studi
determin
util
cem
identifi
nhph
dog
compar
diagnost
modal
assess
abil
identifi
intracellular
organ
fourteen
clinic
healthi
dog
underw
standard
gastroduodenoscopi
follow
cem
use
topic
acriflavin
imag
obtain
use
cem
minimum
site
within
stomach
endoscop
pinch
biopsi
obtain
histopatholog
polymeras
chain
reaction
pcr
fluoresc
situ
hybridis
fish
methodolog
compar
sensit
detect
presenc
distribut
nhph
abil
identifi
intracellular
organ
cem
provid
high
qualiti
imag
allow
vivo
identif
ofnhph
dog
fish
postprocedur
analysi
standard
histopatholog
identifi
nhph
nhph
identifi
within
superfici
gastric
mucu
gastric
pit
distribut
throughout
stomach
diffus
multifoc
cem
find
correl
fish
pcr
howev
fish
enabl
identif
intracellular
nhph
present
dog
cem
provid
vivo
histolog
imag
capabl
identifi
nhph
gastroscopi
unabl
identifi
intracellular
organ
use
current
fluorophor
protocol
nhph
canin
stomach
commonli
identifi
intracellularli
disclosur
dr
sharman
share
optiscan
imag
pti
ltd
chronic
enteropathi
ce
exocrin
pancreat
insuffici
epi
caus
hypocobalaminemia
cat
current
supplement
protocol
cobalamin
cat
call
repeat
parenter
inject
human
sever
studi
report
equal
efficaci
oral
administr
cobalamin
also
evid
oral
supplement
effect
dog
hypocobalaminemia
recent
also
report
oral
cobalamin
substitut
restor
normocobalaminemia
healthi
elderli
cat
purpos
retrospect
case
seri
evalu
whether
oral
cobalamin
supplement
restor
normocobalaminemia
hypocobalaminem
cat
chronic
enteropathi
computer
databas
search
cat
treat
evidensia
specialist
anim
hospit
helsingborg
sweden
perform
inclus
criteria
cat
symptom
ce
initi
serum
cobalamin
concentr
pmoll
refer
interv
pmoll
daili
oral
treatment
cyanocobalamin
mgtablet
tabletcat
daili
followup
serum
cobalamin
concentr
measur
day
initi
daili
oral
cobalamin
supplement
thirteen
cat
age
year
median
differ
breed
met
inclus
criteria
present
complaint
includ
vomit
anorexia
diarrhea
weight
loss
lethargi
increas
pancrea
specif
lipas
spec
fpl
serum
concentr
report
cat
increas
serum
alanin
transaminas
activ
felin
serum
trypsin
like
immunoreact
ftli
determin
cat
reveal
result
within
refer
interv
cat
abdomin
ultrasound
chang
relat
gastrointestin
tract
mildmoder
thicken
small
intestin
wall
thicken
musculari
layer
poor
definit
intestin
wall
layer
andor
enlarg
mesenteri
lymph
node
histopatholog
perform
cat
reveal
small
intestin
inflamm
cat
small
intestin
lymphoma
one
serum
cobalamin
increas
cat
treatment
concentr
differ
rang
pmoll
mean
pmoll
mean
ae
standard
deviat
serum
cobalamin
concentr
pmoll
pmoll
supplement
differ
statist
signific
p
pair
ttest
result
suggest
oral
cobalamin
supplement
effect
normal
serum
cobalamin
concentr
cat
variou
enteropathi
prospect
studi
warrant
compar
cellular
cobalamin
statu
cat
treat
parenter
oral
cobalamin
supplement
disclosur
disclosur
report
pulmonari
thromboembol
pte
observ
dog
idiopathicinflammatorybowel
diseas
ibd
particularli
proteinlos
enteropathi
ple
hypercoagul
attribut
antithrombin
loss
although
pathogenesi
like
complex
human
venou
thromboembol
te
wellrecognis
complic
crohn
diseas
ulcer
coliti
pathogenesi
te
still
complet
understood
derang
procoagul
anticoagul
factor
demonstr
includ
increas
circul
procoagul
microparticl
mp
aim
pilot
studi
evalu
mpprocoagul
activ
plasma
dog
ibd
ple
use
function
elisa
assay
zymuphenmpact
aniara
hypothesis
dog
ple
subset
dog
ibd
without
ple
would
increas
level
circul
mp
studi
group
consist
dog
ibd
includ
ple
diagnosi
base
compat
clinic
histopatholog
exclus
caus
chronic
gastrointestin
diseas
ple
defin
ibd
plu
hypoproteinaemia
serum
total
protein
gl
hypoalbuminaemia
serum
albumin
gl
pte
diagnos
one
dog
ple
suspect
second
control
group
compris
healthi
dog
undergo
blood
sampl
reason
unrel
studi
includ
blood
donor
screen
n
health
assess
n
dog
consid
healthi
base
owner
evalu
physic
examin
haematolog
serum
biochemistri
median
mp
procoagul
activ
dog
ibd
nm
rang
compar
nm
rang
control
group
median
mp
activ
ple
dog
nm
rang
compar
nm
rang
nonpl
ibd
dog
use
kruskalw
test
nonparametr
data
dunn
multipl
comparison
test
group
statist
differ
interestingli
mpprocoagul
activ
valu
dog
document
pte
nm
dog
high
clinic
suspicion
pte
mpprocoagul
activ
nm
highest
mpprocoagul
activ
detect
healthi
control
dog
rais
concern
preanalyt
sampl
error
remov
measur
impact
statist
analysi
remain
nonsignific
mpprocoagul
activ
nm
consid
clinic
relev
human
employ
similar
cutoff
control
ibd
ple
group
would
defin
increas
level
circul
mp
studi
requir
fulli
evalu
clinic
relev
diagnost
potenti
mp
evalu
disclosur
disclosur
report
intestin
microbiota
increasingli
link
pathogenesi
chronic
enteropathi
ce
dog
imbal
duoden
fecal
microbi
commun
associ
mucos
inflamm
rel
littl
known
alter
mucos
bacteria
seen
ce
involv
ileum
colon
aim
present
studi
use
fluoresc
situ
hybrid
fish
techniqu
investig
composit
spatial
organ
mucos
microbiota
endoscop
biopsi
obtain
dog
ce
control
tissu
section
ileum
colon
dog
inflammatori
bowel
diseas
ibd
dog
granulomat
coliti
gc
dog
intestin
neoplasia
control
studi
fish
target
rrna
gene
total
bacteria
groupspecif
organ
individu
bacteri
speci
shown
relev
human
ibd
number
mucos
bacteria
analyz
use
gener
linear
model
colon
ileum
tissu
spearman
rank
correl
coeffici
use
test
correl
mucos
microbiota
inflammatori
cibdai
score
histopatholog
indic
ileal
colon
mucosa
healthi
dog
dog
ce
predominantli
colon
bacteria
local
free
adher
mucu
compart
dog
ce
harbor
p
mucos
bacteria
belong
clostridiumcoccoideseubacterium
rectal
group
bacteroid
enterobacteriacea
escherichia
coli
versu
control
within
ce
group
ibd
dog
increas
p
enterobacteriacea
e
coli
bacteria
attach
onto
surfac
epithelia
invad
within
intestin
mucosa
bacteri
invas
e
coli
present
ileal
colon
mucosa
dog
gc
p
dog
intestin
neoplasia
increas
p
adher
total
bacteria
enterobacteriacea
e
coli
invas
enterobacteriacea
e
coli
bacteroid
bacteria
biopsi
specimen
versu
group
increas
number
total
bacteria
adher
colon
mucosa
associ
clinic
diseas
sever
cibdai
score
ibd
dog
p
result
indic
histopatholog
lesion
canin
ce
associ
differ
popul
ileal
colon
mucos
microbiota
spatial
segmentspecif
structur
differenti
respons
select
bacteri
group
intestin
inflamm
may
pivot
regard
function
consequ
alter
pathogenesi
canin
ce
disclosur
disclosur
report
abdomin
girth
use
indic
human
adipos
measur
made
tape
measur
given
concern
precis
accuraci
repeat
measur
tape
measur
design
inbuilt
mechan
improv
consist
although
bodi
condit
score
common
method
assess
adipos
dog
zoometr
system
also
develop
requir
use
tape
measur
howev
precis
accuraci
zoometr
measur
known
aim
studi
determin
precis
accuraci
differ
type
tape
measur
varieti
dimension
measur
varieti
length
head
forelimb
hindlimb
circumferenti
neck
thorax
abdomen
made
use
differ
tape
measur
design
improv
precis
standard
tape
myotap
tm
gulick
ii
tm
assess
intraoper
variabl
measur
taken
consecut
day
healthi
dog
assess
interoper
variabl
oper
independ
took
measur
group
dog
variou
breed
size
intraoper
comparison
precis
good
overal
coeffici
variat
cv
measur
interoper
comparison
precis
variabl
although
reason
averag
mean
cv
vari
depend
upon
tape
measur
type
p
greatest
standard
tape
measur
least
gulich
ii
tm
could
highli
variabl
measur
individu
dog
maximum
cv
head
measur
standard
tape
measur
signific
differ
also
exist
absolut
result
circumferenti
measur
taken
differ
tape
measur
type
neck
p
thorax
p
abdomen
p
final
signific
oper
differ
also
evid
measur
head
p
hindlimb
p
other
forelimb
p
neck
p
thorax
p
abdomen
p
summari
although
precis
individu
oper
make
zoometr
measur
good
signific
interoper
tape
type
differ
exist
result
implic
system
use
rang
zoometr
measur
assess
adipos
order
ensur
precis
accuraci
recommend
oper
take
measur
type
tape
disclosur
studi
conduct
support
research
grant
ajg
readership
fund
royal
canin
ajg
also
receiv
financi
remuner
gift
provid
educ
materi
speak
confer
consult
work
slh
post
univers
liverpool
also
fund
royal
canin
bodi
condit
score
bc
method
commonli
use
diagnosi
nutrit
statu
small
anim
howev
method
subject
due
sensori
evalu
therefor
improv
precis
bc
diagnosi
expect
previou
studi
shown
bc
model
creat
improv
precis
bc
diagnosi
howev
palpat
site
identifi
palpat
site
must
site
thick
subcutan
fat
abl
captur
measur
anim
obes
statu
therefor
object
studi
find
remark
bodi
site
chang
obes
statu
use
ultrason
diagnost
equip
nine
dog
vari
percent
bodi
fat
use
studi
percent
bodi
fat
measur
bodi
fat
analyz
dog
kao
imag
analysi
palpat
site
evalu
use
echo
xario
toshiba
attach
linear
probe
measur
point
oclock
posit
rib
distanc
skin
surfac
rib
measur
echogram
distanc
l
scapula
ilium
measur
offset
differ
physiqu
dog
breed
dl
use
compar
rel
valu
quantiti
fat
measur
point
bc
dog
use
studi
bc
bc
dog
bc
bc
statist
signific
correl
found
bc
dl
valu
dl
valu
increas
order
bc
suggest
thick
subcutan
fat
chest
thicker
head
side
tail
side
also
l
valu
back
abdomen
highest
valu
found
posit
tendenc
remark
bc
differ
dl
valu
recogn
dog
bc
conclus
posit
suitabl
palpat
point
chest
bodi
condit
score
bc
method
commonli
use
diagnosi
nutrit
statu
small
anim
bc
recogn
one
screen
method
nutrit
diagnosi
american
anim
hospit
associ
howev
method
subject
due
sensori
evalu
therefor
made
bc
model
increas
precis
bc
diagnosi
shown
efficaci
bc
model
howev
prototyp
model
report
tend
higher
bc
target
bc
therefor
improv
bc
model
studi
sixti
seven
dog
vari
bc
use
studi
bodi
fat
percentag
measur
use
bodi
fat
analyz
dog
kao
healthlab
bc
model
improv
use
sever
rubber
sheet
rel
hard
stack
rubber
sheet
bc
measur
duromet
satotec
tokyo
japan
bc
diagnosi
dog
perform
pet
owner
use
bc
model
bc
repres
hard
bc
model
hard
decreas
linearli
lowest
bc
valu
expect
high
correl
recogn
bc
bodi
fat
percentag
result
suggest
efficaci
bc
model
howev
bodi
fat
percentag
dog
diagnos
bc
higher
bodi
fat
percentag
report
previou
paper
dog
bodi
fat
percentag
diagnos
bc
need
studi
futur
make
clear
differ
bodi
fat
percentag
data
date
previou
research
complet
bc
model
help
provid
precis
nutrit
diagnosi
dog
human
metabol
syndrom
ms
wellrecognis
extens
studi
entiti
compris
obes
hypertens
dyslipidaemia
glucos
intoler
associ
increas
risk
cardiovascular
diseas
diabet
recent
human
ms
criteria
adapt
dog
defin
condit
obesityrel
metabol
dysfunct
ormd
observ
ormd
associ
increas
circul
insulin
decreas
adiponectin
concentr
suggest
dog
human
link
obes
ormd
associ
diseas
although
pathogenet
mechan
health
signific
dog
remain
unknown
main
aim
present
studi
compar
plasma
proteom
obes
dog
without
ormd
investig
mechan
associ
canin
ormd
possibl
signific
health
statu
eight
obes
dog
refer
weight
manag
royal
canin
weight
manag
clinic
univers
liverpool
particip
studi
clinic
assess
includ
physic
examin
bodi
condit
score
blood
pressur
measur
routin
clinicopatholog
analysi
surplu
plasma
use
proteom
analysi
sampl
first
treat
proteomin
thedeplet
highabund
protein
subsequ
analys
dige
methodolog
dog
studi
dog
ormd
dog
imag
analysi
statist
analysi
allow
identif
spot
differenti
express
concentr
dog
without
ormd
among
spot
overexpress
downexpress
dog
ormd
dog
present
ormd
although
result
present
studi
preliminari
still
identif
spot
perform
observ
datarev
dog
ormd
present
alter
plasma
proteom
could
respons
develop
ormdrel
patholog
disclosur
studi
fund
waltham
ajg
readership
fund
royal
canin
ajg
also
receiv
financi
remuner
gift
provid
educ
materi
speak
confer
consult
work
slh
post
univers
liverpool
also
fund
royal
canin
vb
employe
royal
canin
pjm
employe
waltham
aim
studi
assess
diagnost
valu
discrimin
potenti
normal
heart
size
microcardia
cardiomegali
method
calcul
cardiothorac
ratio
ctr
use
area
measur
compar
vertebr
heart
scale
method
vh
use
refer
cardiac
size
dog
one
hundrednin
dog
xray
accept
studi
patient
belong
small
medium
size
breed
male
femal
age
year
analog
xray
scan
transfer
comput
vh
ctr
calcul
patient
commerci
softwar
data
collect
process
statyst
analysi
softwar
patient
distribut
group
respiratori
phase
heart
size
low
correl
vh
ctr
r
statist
signific
p
good
correl
obtain
vh
ctr
microcardia
normal
heart
size
cardiomegali
group
p
furthermor
ctr
dog
microcardia
normal
cardiac
size
well
ctr
dog
normal
cardiac
size
cardiomegali
significantli
statist
differ
p
respect
p
obtain
among
group
distribut
respiratori
phase
vh
statist
signific
differ
obtain
normal
cardiac
size
cardiomegali
inspiratori
phase
group
p
xray
taken
inspiratori
phase
cutoff
sensit
specif
diagnos
cardiomegali
ctr
consid
valid
method
abl
discrimin
patient
microcardia
cardiomegali
normal
heart
size
moreov
found
ctr
cutoff
mesur
inspiratori
phase
good
predictor
cardiomegali
key
word
cardiac
cardiothorac
ratio
dog
xray
canin
cardiac
conduct
system
modifi
anatom
function
adapt
matern
heart
gestat
howev
clear
chang
persist
modifi
parturit
therefor
aim
studi
describ
canin
electrocardiograph
featur
cours
normal
puerperium
twenti
healthi
purebr
yearold
weigh
kg
bitch
includ
studi
anim
whelp
healthi
puppi
term
wean
day
parturit
day
dog
electrochardiograph
evalu
day
mean
electr
axi
mea
degre
p
wave
amplitud
pa
mv
durat
pd
ms
pr
interv
pr
ms
qr
complex
amplitud
qrsa
mv
durat
qrsd
ms
qt
interv
qt
ms
st
segment
st
mv
calcul
mm
veloc
rr
interv
immedi
preced
complex
record
qt
interv
correct
qtc
van
de
water
formula
qtc
later
lead
ii
record
mmsec
analyz
heart
rate
hr
bpm
cardiac
rhythm
cr
normal
sinu
rhythm
sinu
arrythmia
valu
hr
mea
pa
pd
pr
qrsa
qrsd
qt
rr
qtc
analyz
anova
repeat
measur
follow
tukey
test
cardiac
rhythm
analyz
chi
squar
test
spss
spss
inc
chicago
il
usa
p
consid
signific
studi
period
hr
p
qtc
p
progress
decreas
rr
p
pa
increas
p
qr
complex
amplitud
diminish
second
week
parturit
increas
follow
week
p
mean
electr
axi
shift
right
period
p
day
bitch
present
normal
sinu
rhythm
contrast
day
bitch
present
sinu
arrhythmia
p
day
onward
bitch
show
sinu
arrhythmia
p
wave
durat
pr
qrsd
qt
st
remain
unchang
puerperium
conclud
electrophysiolog
adapt
chang
canin
gestat
revert
normal
puerperium
present
studi
contribut
understand
canin
cardiac
physiolog
reproduct
stage
disclosur
disclosur
report
echocardiograph
assess
pregnant
queen
pg
blanco
r
rodr
carranza
rube
r
vercellini
pr
batista
ortora
c
gobello
nation
univers
la
plata
la
plata
argentina
cardiovascular
adapt
gestat
guarante
appropri
develop
fetus
matern
cardiovascular
maladapt
highli
correl
advers
pregnanc
outcom
hemodynam
chang
occur
canin
pregnanc
describ
scarc
inform
concern
matern
cardiac
variat
felin
gestat
thu
aim
studi
describ
cardiac
morpholog
systol
function
variat
normal
felin
pregnanc
eighteen
pregnant
queen
echocardiograph
evalu
toshiba
nemio
xg
japan
mhz
transduc
everi
day
day
defin
day
mate
parturit
left
ventricular
dimens
measur
short
axi
view
mmode
trace
shorten
fraction
calcul
lvdd
lvd
lvdd
x
assess
systol
function
stroke
volum
ml
calcul
product
veloc
time
integr
measur
pulsedwav
doppler
crosssect
area
aorta
cardiac
output
lmin
calcul
product
stroke
volum
heart
rate
bpm
deriv
electrocardiograph
monitor
uterin
arteri
resist
index
ri
obtain
doppler
ultrasound
paramet
analyz
repeat
measur
anova
queen
deliv
healthi
kitten
term
throughout
studi
period
interventricular
septum
diastol
p
systol
p
left
ventricular
diamet
diastol
p
augment
gestat
shorten
fraction
p
cardiac
output
p
matern
heart
rate
p
also
increas
parturit
convers
uterin
arteri
resist
index
decreas
period
p
conclud
cardiac
structur
function
vari
normal
pregnanc
queen
cardiac
eccentr
hypertrophi
systol
function
cardiac
output
increas
appear
consequ
hemodynam
modif
occur
pregnanc
assess
matern
cardiovascular
function
may
prove
use
screen
tool
detect
pregnanc
complic
felin
reproduct
disclosur
disclosur
report
tricuspid
annular
plane
systol
excurs
taps
echocardiograph
measur
allow
assess
right
ventricular
systol
function
describ
refer
valu
taps
normal
adult
dog
refer
influenc
age
taps
dog
influenc
report
human
thu
goal
studi
determin
reproduc
measur
taps
normal
dog
determin
relationship
taps
age
healthi
beagl
dog
taps
measur
mmode
record
later
aspect
tricuspid
valv
annulu
obtain
left
parastern
apic
view
taps
valu
averag
measur
consecut
beat
sinu
rhythm
measur
record
differ
person
cv
mm
f
differ
grade
experi
canin
echocardiographi
studi
patient
complet
doppler
studi
use
envisor
chd
philip
ultrasound
system
twentythre
healthi
beagl
use
studi
approv
ethic
committe
veterinari
medicin
servic
la
palma
de
gran
canaria
univers
spain
carri
accord
current
european
legisl
anim
protect
dog
divid
differ
group
accord
age
group
includ
dog
year
group
includ
dog
year
group
includ
eight
dog
older
year
analyz
differ
group
use
nonparametr
kruskal
walli
wilcoxon
score
rank
sum
test
differ
respect
sex
dog
group
present
higher
taps
valu
group
cm
versu
cm
versu
cm
p
statist
intraobserv
interobserv
agreement
use
intraclass
correl
coeffici
p
studi
show
taps
measur
easili
obtain
standard
echocardiographi
system
adequ
interobserv
agreement
studi
show
higher
valu
taps
normal
young
dog
respect
older
dog
result
similar
result
obtain
human
could
reflect
less
effect
right
ventricl
age
valu
present
taken
caution
due
rel
small
number
patient
includ
may
also
necessari
valid
result
futur
studi
second
independ
sampl
dog
race
disclosur
disclosur
report
tetralog
fallot
tof
congenit
heart
diseas
character
abnorm
ie
pulmon
stenosi
ventricular
septal
defect
vsd
aortic
overrid
secondari
right
ventricular
hypertrophi
caus
anterior
deviat
abnorm
septat
conal
septum
embryon
period
studi
report
hemodynam
consequ
clinic
outcom
tof
small
anim
object
retrospect
studi
therefor
document
epidemiolog
clinic
echodoppl
find
surviv
canin
felin
popul
tof
case
record
anim
diagnos
tof
combin
use
echocardiographi
doppler
examin
review
tetralog
fallot
identifi
anim
dog
cat
commonli
repres
breed
terrier
dog
domest
shorthair
cat
includ
anim
clinic
affect
time
diagnosi
pulmon
stenosi
character
variabl
systol
dopplerderiv
pressur
gradient
dog
median
rang
mmhg
cat
mmhg
associ
hypoplasia
pulmonari
trunk
one
third
case
vsd
larg
median
vsd
aorta
ratio
dog
cat
median
age
death
cardiac
caus
month
without
signific
differ
dog
cat
p
result
suggest
cat
dog
tofrel
death
occur
predominantli
young
adult
anim
major
hemodynam
consequ
time
diagnosi
disclosur
disclosur
report
aim
studi
assess
whether
radiograph
echocardiograph
cardiovascular
variabl
differ
across
age
band
healthi
cat
cohort
clinic
healthi
cat
categor
group
adolescentadult
year
n
middleag
year
n
geriatr
year
n
cat
underw
full
physic
examin
complet
blood
count
routin
biochem
profil
baselin
serum
total
thyroxin
concentr
auscult
noninvas
blood
pressur
measur
thorac
radiographi
electrocardiographi
echocardiographi
cat
hypertens
hyperthyroid
cardiac
renal
diseas
exclud
studi
bodi
weight
bodi
condit
score
systol
blood
pressur
heart
rate
echocardiograph
indic
similar
across
group
mean
ae
standard
deviat
sd
vertebr
heart
scale
vh
valu
obtain
geriatr
group
ae
significantli
greater
obtain
adolescentadult
group
ae
p
mean
ratio
distanc
cardiac
base
dorsal
sternum
thorac
caviti
height
point
cardiac
base
significantli
less
middleag
ae
geriatr
ae
group
adolescentadult
group
ae
p
mean
angl
cardiac
long
axi
bodi
axi
significantli
smaller
middleag
ae
geriatr
cat
ae
adolescentadult
cat
ae
p
mean
angl
cardiac
long
axi
sternum
middleag
ae
geriatr
cat
ae
significantli
smaller
adolescentadult
cat
ae
p
p
respect
addit
degre
undul
thorac
aorta
correl
posit
age
r
p
find
suggest
differ
horizont
align
heart
thoracicaorta
undul
vh
healthi
geriatr
cat
rel
observ
younger
cat
consid
agerel
disclosur
disclosur
report
aim
studi
investig
presenc
pulmonari
hypertens
ph
young
cat
affect
singl
mix
lungworm
infect
twentythre
cat
infect
lungworm
examin
veterinari
teach
hospit
teramo
itali
anim
underw
complet
physic
examin
radiograph
analysi
thorax
minimum
databas
ie
cbc
serum
biochemistri
serolog
fiv
antibodi
felv
antigen
obtain
patient
nine
cat
exclud
concomit
diseas
cat
includ
studi
microscop
identif
parasit
confirm
molecular
test
cat
receiv
anthelmint
treatment
singl
infect
aelurostrongylu
abstrusu
diagnos
cat
cat
troglostrongylu
brevior
infect
either
alon
combin
abstrusu
transthorac
echocardiographi
perform
use
ultrasound
unit
mhz
phase
array
transduc
structur
abnorm
tricuspid
valv
sign
pulmonari
stenosi
detect
mmode
echocardiographi
show
cardiac
involv
cat
one
cat
infect
abstrusu
brevior
show
mild
systol
tricuspid
regurgit
jet
color
doppler
msec
anoth
abstrususinfect
cat
mild
tr
msec
mean
pap
mmhg
resolv
within
week
therapi
one
cat
diagnos
troglostrongylosi
show
mark
rightsid
cardiac
enlarg
mm
larg
systol
tricuspid
regurgit
jet
tr
peak
veloc
ms
record
continuouswav
doppler
via
color
doppler
echocardiographi
minimum
pressur
differ
right
ventricl
right
atrium
estim
mmhg
pap
least
mmhg
echocardiograph
doppler
evid
mild
ph
persist
examin
perform
month
diagnosi
ph
rare
cat
despit
case
revers
ph
known
cat
aelurostrongylosi
studi
first
case
irrevers
ph
infect
cat
affect
brevior
present
find
support
high
pathogen
troglostrongylosi
especi
young
patient
cat
lungworm
infect
possibl
cardiovascular
complic
must
taken
account
infect
alway
consid
differenti
diagnosi
cat
cardiorespiratori
sign
disclosur
disclosur
report
although
uncommonli
assess
veterinari
cardiolog
right
ventricular
rv
function
shown
import
prognost
determin
mani
congenit
acquir
heart
diseas
human
patient
group
alreadi
demonstr
color
tissu
doppler
imag
provid
noninvas
evalu
systol
diastol
rv
function
awak
dog
adequ
repeat
reproduc
b
howev
noninvas
ultrasound
imag
variabl
reflect
rv
function
need
investig
particularli
correl
pulmonari
arteri
pressur
pap
valu
left
ventricular
lv
function
aim
prospect
studi
therefor
assess
sever
indic
systol
diastol
rv
function
use
convent
echocardiographi
speckl
track
echocardiographi
ste
healthi
awak
dog
differ
breed
document
systol
pap
spap
lv
function
lv
eject
fraction
global
lv
systol
strain
assess
use
simpson
deriv
method
disk
ste
respect
imag
rv
test
variabl
includ
tricuspid
annular
plane
systol
excurs
taps
right
fraction
area
chang
rfac
ste
longitudin
systol
strain
rv
free
wall
rvfw
whole
rv
ie
global
rv
strain
ste
longitudin
systol
strain
rate
sr
diastol
earli
late
sr
ratio
addit
mmode
ventricular
measur
includ
enddiastol
rv
lv
diamet
ratio
rvdd
lvdd
endsystol
rvfw
lvfw
ratio
correl
imag
variabl
calcul
use
spearman
correl
coeffici
mean
age
bodi
weight
ae
sd
rang
studi
popul
year
kg
respect
correl
found
rv
morpholog
variabl
ie
rvdd
lvdd
rvfw
lvfw
ratio
indic
systol
diastol
rv
function
global
rv
strain
meanaesd
rvfw
strain
posit
correl
p
rfac
r
r
respect
neg
correl
p
spap
mmhg
r
r
respect
spap
also
neg
correl
taps
bodi
weight
ratio
systol
sr
r
respect
p
correl
indic
lv
function
ste
indic
rv
function
correl
either
ste
rv
indic
systol
function
diastol
earli
late
sr
ratio
conclus
ste
provid
rapid
noninvas
evalu
rv
function
may
use
clinic
investig
canin
cardiolog
dopplerderiv
dpdt
dpdt
mitral
regurgit
consid
index
assess
systol
diastolicfunct
respect
less
load
depend
eject
phase
index
studi
aim
determin
correl
dopplerderiveddpdt
systol
diastol
echocardiograph
index
use
identifi
dog
without
remodel
without
congest
heart
failur
chf
evalu
chronic
mitral
valv
diseas
cmvd
sever
fiftyseven
dog
cmvd
stage
cd
includ
prospect
observ
crosssect
clinic
studi
distribut
group
regard
presenc
remodel
chf
evaluatedpdt
dpdt
distribut
accord
tdidiastol
pattern
tocompar
dpdt
group
cd
mmhg
p
p
dpdt
significantli
lower
compar
mmhg
p
p
mmhg
p
p
p
groupcd
also
lower
dpdt
compar
p
dog
chf
compar
without
chf
present
lower
dpdt
mmhg
p
p
mmhg
p
p
p
dpdt
p
regardingdiastol
function
dpdt
lower
restrict
pattern
group
compar
without
diastol
dysfunct
delayedrelax
pseudonorm
pattern
p
dpdt
mmhg
posttest
chanc
dog
cmvd
havechf
twice
chanc
dpdt
mmhg
theposttest
chanc
chf
time
higher
conclus
dopplerderiv
dpdt
anddpdt
may
contribut
respect
systol
diastol
assess
ofdog
cmvd
disclosur
disclosur
report
pulmon
stenosi
ps
one
common
congenit
heart
defect
seen
veterinarycardiolog
practic
pulmonari
balloon
valvuloplasti
pbv
consid
treatment
choic
dog
withsever
stenosi
whether
dog
moder
stenosi
benefit
pbv
remain
unclear
variabl
degre
hypertrophi
valv
morpholog
amount
tricuspid
insuffici
presenc
absenc
clinic
sign
aregener
use
recommend
made
pet
owner
studi
report
effect
valv
type
pbv
outcom
dog
treat
differ
academ
special
cardiolog
practic
baselin
echocardiograph
imag
evalu
institut
valv
morpholog
classifi
either
type
n
mmhg
rang
type
b
n
mmhg
rang
n
mmhg
rang
ye
n
mmhg
rang
presenc
pulmonari
annular
hypoplasia
diamet
compar
aortic
annulu
twenti
four
hour
follow
pbv
type
mmhg
rang
type
b
mmhg
rang
valv
signific
reduct
gradient
compar
baselin
p
reduct
remain
signific
day
mmhg
rang
b
mmhg
rang
p
dog
annular
hypoplasia
mmhg
rang
without
annular
hypoplasia
mmhg
rang
signific
reduct
gradient
hour
post
pbv
remain
signific
day
annular
hypoplasia
mmhg
rang
without
annular
hypoplasia
mmhg
rang
p
compar
baselin
consid
valv
type
signific
differ
percent
reduct
gradient
type
versu
type
b
valv
rang
b
rang
p
rang
b
rang
p
recheck
evalu
time
point
addit
signific
differ
gradient
reduct
look
whether
annular
hypoplasia
hour
ye
rang
rang
p
day
ye
rang
rang
p
conclus
classif
dog
ps
accord
valv
type
annulu
morpholog
help
predict
respons
pbv
disclosur
disclosur
report
hypertroph
cardiomyopathi
hcm
common
felin
inherit
cardiac
diseas
major
caus
morbid
mortal
osservatorio
italiano
hcm
felina
form
network
clinician
geneticist
breeder
monitor
studi
hcm
italian
cat
sinc
april
adult
cat
belong
variou
breed
includ
main
coon
siberian
norwegian
forest
cat
ragdol
sphynx
british
sh
birman
other
prospect
enrol
recheck
evalu
perform
cat
cat
underw
clinic
examin
echocardiographi
blood
collect
genet
test
appropri
storag
italian
felin
biobank
diseas
statu
defin
echocardiographi
accord
establish
guidelin
left
ventricular
diastol
wall
thick
mm
hcm
neg
mm
hcm
equivoc
mm
hcm
posit
preval
hcm
popul
cat
equivoc
diagnos
confer
cat
preval
differ
breed
preval
hcm
italian
felin
popul
lower
compar
report
investig
evalu
data
entir
popul
demonstr
left
ventricular
enddiastol
wall
thick
aortic
diamet
show
weak
posit
correl
bodi
weight
p
r
variabl
suggest
weightdepend
limit
wall
thick
consid
cat
current
practic
dog
lower
preval
hcm
italian
cat
breed
compar
examin
elsewher
might
explain
differ
criteria
determin
presenc
absenc
diseas
differ
age
subject
examin
select
bia
breeder
present
cat
consid
normal
disclosur
disclosur
report
chronic
mitral
valv
diseas
far
common
cardiovascular
diseas
dog
diseas
caus
myxomat
degener
mitral
valv
leaflet
approxim
case
accompani
degener
tricuspid
valv
also
describ
previou
studi
approxim
affect
dog
also
evid
associ
pulmonari
arteri
hypertens
preval
diseas
higher
small
breed
dog
although
larg
breed
also
affect
occur
frequent
male
femal
present
studi
aim
character
diseas
popul
dog
portug
retrospect
review
medic
record
dog
present
hospit
veterin
ario
porto
echocardiograph
diagnosi
canin
chronic
mitral
valv
diseas
period
year
record
case
identifi
male
femal
dog
mix
breed
differ
breed
dog
repres
poodl
far
repres
breed
n
follow
english
cocker
spaniel
yorkshir
terrier
boxer
epagneul
breton
dalmatian
pekinges
labrador
retriev
portugues
podengo
breed
repres
popul
regard
weight
dog
n
weight
kg
mean
bodi
weight
kg
rang
kg
mean
age
diagnosi
year
old
also
observ
dog
n
concomit
degener
tricuspid
valv
n
pulmonari
arteri
hypertens
ph
categor
dog
accord
sever
ph
mild
ph
doppler
echocardiographi
deriv
systol
pulmonari
arteri
pressur
spap
mmhg
moder
ph
spap
mmhg
sever
ph
spap
mmhg
found
n
dog
mild
ph
n
moder
ph
n
sever
ph
describ
previou
studi
diseas
affect
mainli
male
small
breed
dog
breed
distribut
reflect
canin
popul
countri
includ
includ
popular
larg
breed
dog
portug
boxer
labrador
presenc
concomit
tricuspid
valv
diseas
ph
higher
preval
studi
previous
describ
disclosur
disclosur
report
peopl
anemia
frequent
patient
heart
failur
hf
associ
poor
outcom
like
pathogen
factor
includ
iron
defici
chronic
kidney
diseas
ckd
cytokin
product
although
factor
may
contribut
littl
known
preval
anemia
dog
cardiovascular
diseas
aim
retrospect
studi
defin
preval
anemia
hct
dog
mitral
valv
diseas
mvd
investig
associ
risk
factor
age
weight
azotemia
hf
irisacvim
class
medic
record
dog
present
cardiolog
servic
divet
univers
milan
januari
march
retrospect
evalu
dog
mvd
complet
physic
thorac
echocardiograph
examin
serum
biochem
panel
includ
serum
creatinin
scr
includ
studi
dog
heart
system
diseas
except
ckd
neoplasm
exclud
statist
analysi
perform
use
jmp
sa
institut
p
valu
consid
signific
two
hundr
nineti
dog
femal
year
age
kg
bodi
weight
fulfil
inclus
criteria
male
femal
neuter
repres
breed
mongrel
miniatur
poodl
york
shire
terrier
cavali
king
charl
dog
c
acvim
class
dog
normoazotem
scr
mgdl
stage
iri
iri
iri
preval
anemia
dog
mvd
show
mild
hct
moder
hct
anemia
sixteen
dog
c
acvim
class
normoazotem
anem
dog
show
signific
higher
scr
normoazotem
dog
show
signific
higher
hb
hct
rbc
overal
popul
anem
group
overal
popul
dog
differ
iri
class
show
statist
differ
hb
hct
rbc
hb
significantli
lower
decompens
hf
dog
conclus
although
relationship
anemia
azotemiackd
document
studi
import
emphas
anem
dog
normoazotem
anemia
exclus
find
cardioren
syndrom
consid
possibl
complic
dog
mvd
alon
disclosur
disclosur
report
object
studi
evalu
left
atrial
la
function
left
atrial
total
fraction
area
chang
lafactot
left
atrial
eject
fraction
laef
dog
affect
chronic
mitral
valv
diseas
cmvd
natur
acquir
without
congest
heart
failur
chf
hypothesi
lafactot
laef
decreas
sever
cmvd
eighti
dog
includ
prospect
observ
crosssect
clinic
studi
group
accord
cmvd
sever
base
echocardiograph
evalu
clinic
sign
dog
equal
distribut
group
c
accord
american
colleg
veterinari
intern
medicin
stage
system
indic
la
function
calcul
follow
equat
lafactot
lamaximum
area
laminimum
area
lamaximum
area
measur
apic
view
laef
x
lamaximum
volum
laminimum
volum
lamaximum
volum
biplan
arealength
method
left
apic
view
lafactot
show
lower
valu
p
group
c
compar
group
group
c
lower
laef
group
p
left
atrial
function
assess
lafactot
laef
reduc
dog
cmvd
chf
compar
healthi
asymptomat
cmvd
group
disclosur
disclosur
report
recurr
episod
heart
andor
kidney
failur
consid
one
caus
lead
worsen
heartren
function
human
patient
aim
prospect
studi
assess
influenc
heartkidney
worsen
elect
paramet
heartkidney
function
dog
affect
mitral
valv
diseas
mvd
juli
may
dog
affect
mvd
acvim
class
without
comorbid
includ
studi
group
control
group
constitut
healthi
dog
match
case
age
older
year
gender
dog
underw
physic
examin
thorax
radiographi
ecg
echocardiographi
system
blood
pressur
assess
complet
blood
count
serum
biochem
analysi
includ
assess
serum
creatinin
scr
serum
urea
nitrogen
urea
glycaemia
gli
urin
analysi
urin
proteincreatinin
ratio
upc
dog
reevalu
everi
octob
statist
analysi
perform
use
ibm
spss
statist
p
valu
signific
twentyon
dog
affect
mvd
case
includ
healthi
dog
control
randomli
select
among
elig
popul
case
experienc
least
one
episod
congest
heart
failur
chf
none
patient
develop
chronic
kidney
diseas
ckd
case
develop
ckd
remain
acvim
class
dog
control
group
develop
ckd
mvd
correl
worsen
renal
function
wrf
scr
elev
mgdl
baselin
furosemid
administr
upc
level
radiograph
paramet
heart
enlarg
echocardiograph
paramet
investig
statist
signific
differ
iri
class
group
accord
wrf
echocardiograph
paramet
left
atrium
aortic
root
laao
accord
furosemid
amount
observ
result
expect
none
case
includ
experienc
renal
damag
wrf
iri
class
chang
upc
chang
concomit
episod
chf
persist
normal
renal
condit
regardless
chf
event
therapi
administr
unexpect
conclus
experienc
chf
seem
directli
affect
renal
function
author
opinion
use
wrf
better
singl
scr
urea
level
may
use
long
term
manag
age
patient
affect
mvd
howev
small
number
case
includ
studi
repres
great
limit
consid
work
pilot
studi
disclosur
disclosur
report
hypertroph
cardiomyopathi
hcm
primari
myocardi
diseas
character
inappropri
thicken
myocardium
absenc
caus
hypertrophi
includ
hypertens
hyperthyroid
aortic
stenosi
acromegali
also
common
heart
diseas
cat
hcm
present
wide
varieti
clinic
sing
depend
sever
locat
hypertrophi
cat
affect
hcm
mean
age
year
old
time
diagnosi
howev
diseas
affect
cat
young
month
although
later
age
unusu
hcm
heterogen
diseas
term
phenotyp
degre
hypertrophi
clinic
outcom
hallmark
histopatholog
hallmark
lesion
hcm
myocyt
disarray
small
coronari
arteriosclerosi
interstiti
fibrosi
replac
order
confirm
hcm
echocardiographi
made
primari
hypertrophi
diagnosi
made
base
presenc
ventricular
hypertrophi
symmetr
asymmetr
absenc
system
disord
purpos
studi
assess
preval
hcm
felin
popul
order
achiev
goal
echocardiogram
made
cat
older
year
clinic
asymptomat
without
cardiac
murmur
echocardiogram
made
accord
guidelin
acvim
publish
diagnosi
ventricular
hypertrophi
made
right
parastern
window
use
b
mode
measur
diamet
lvfw
iv
diastol
cat
mm
wall
thick
measur
bun
crea
blood
pressur
cat
within
normal
limit
later
paramet
consid
hcm
posit
total
number
cat
studi
cat
male
femal
popul
defin
breed
persian
main
coon
norwegian
wood
siames
chartreaux
murmour
detect
cat
detect
cat
different
degre
murmour
detect
cat
hypertrophi
detect
cat
cat
diagnos
hcm
cat
exclud
either
lack
valu
high
valu
blood
pressur
level
crea
studi
popul
hcm
epidemiolog
phenotyp
distribut
highli
variabl
averag
age
diagnosi
hcm
studi
year
disclosur
disclosur
report
mildli
increas
concentr
crp
associ
cardiovascular
diseas
human
dog
known
whether
increas
concentr
crp
associ
myxomat
mitral
valv
diseas
mmvd
dog
rather
sequel
congest
heart
failur
chf
aim
studi
investig
whether
serum
concentr
crp
determin
use
novel
autom
caninespecif
highsensit
crp
assay
gentian
hscrp
associ
sever
mmvd
certain
clinic
variabl
dog
studi
includ
clientown
dog
differ
sever
mmvd
diseas
sever
determin
medic
histori
physic
examin
echocardiographi
respons
diuret
therapi
dog
alloc
group
base
acvim
consensu
statement
guidelin
group
n
group
n
group
n
group
c
n
data
analys
use
descript
statist
multipl
regress
analysi
dog
chf
group
c
significantli
higher
serum
crp
concentr
mgl
median
quartil
quartil
compar
dog
group
mgl
p
mgl
p
mgl
p
measur
diseas
sever
includ
left
atrial
aortic
root
ratio
left
ventricular
enddiastol
diamet
normal
bodi
weight
posit
correl
serum
crp
concentr
conclus
slightli
higher
serum
crp
concentr
found
dog
chf
wherea
sever
asymptomat
mmvd
show
limit
associ
serum
crp
concentr
disclosur
disclosur
report
medetomidin
agonist
wide
employ
sedat
dog
use
discourag
cardiac
patient
even
suffer
myxomat
mitral
valv
diseas
mmvd
howev
one
investig
previous
conduct
wide
rangeregard
class
diseas
mmvd
patient
report
gener
safeti
protocol
present
studi
focus
class
mmvd
aim
provid
detail
inform
cardiovascular
effect
medetomidin
patient
analysi
clinic
instrument
paramet
suggest
diseas
sever
congest
heart
failur
dog
weigh
kg
need
soft
clinic
procedur
show
systol
apic
heart
murmur
screen
select
studi
laao
sed
protocol
consist
iv
inject
lgkg
medetomidin
antagon
clinic
procedur
im
inject
recommend
dose
atipamezol
clinic
paramet
echocardiograph
variabl
thorac
radiograph
oscillometr
blood
pressur
measur
collect
baselin
minut
medetomidin
administr
hour
atipamezol
inject
dog
screen
definit
enrol
signif
decreas
right
parastern
regurgit
jet
area
rparjlaa
peak
veloc
mitral
regurgit
shorten
fraction
observ
along
increas
lvid
p
left
parastern
arjlaa
decreas
without
reach
statist
signific
show
high
correl
rparjlaa
r
interestingli
laao
chang
mildli
never
reach
valu
echocardiograph
variabl
show
particular
trend
systol
blood
pressur
show
valu
upper
physiolog
limit
lower
valu
increas
initi
valu
without
signific
thorac
radiograph
evoc
heart
enlarg
without
pulmonari
venou
congest
pulmonari
oedema
respiratori
rate
chang
degre
sedat
optim
clinic
procedur
case
sedat
lgkg
medetomidin
safe
dog
suffer
mmvd
stage
laao
decreas
observ
peak
veloc
colordoppl
appear
mitral
regurgit
could
due
reduct
myocardi
contractil
systol
blood
pressur
lower
sympathet
activ
via
baroreceptor
stimul
disclosur
disclosur
report
retrospect
studi
includ
total
clientown
dog
undergo
transarteri
occlus
pda
mrey
flipper
detach
embol
coil
n
amplatz
canin
duct
occlud
acdo
n
amplatz
vascular
plug
n
devic
size
select
base
pda
dimens
assess
transesophag
echocardiographi
tee
case
transthorac
echocardiographi
tte
case
angiographi
perform
procedur
assess
success
occlus
confirm
complet
occlus
dog
trivial
residu
flow
dog
follow
day
transthorac
colordoppl
echocardiographi
reveal
complet
ductal
closur
achiev
dog
procedur
hemodynam
success
evidenc
reduct
index
left
ventricular
intern
diamet
diastol
lvidd
p
fraction
shorten
fs
p
left
atrial
aortic
ratio
la
ao
p
within
hour
procedur
four
month
surgeri
index
lvidd
significantli
reduc
p
la
ao
remain
constant
secondari
complic
includ
pulmonari
arteri
embol
acdo
late
rotat
amplatz
vascular
plug
result
increas
flow
pda
dog
rotat
devic
requir
subsequ
surgic
ligat
pda
time
dog
report
aliv
dog
lost
follow
one
dog
remain
congest
heart
failur
therapi
pda
occlus
conclud
pda
occlus
use
acdo
dog
kg
transarteri
coil
embol
dog
kg
high
rate
immedi
complet
occlus
pda
occlus
use
devic
prove
safe
effect
therapeut
method
pda
dog
disclosur
disclosur
report
echocardiograph
evalu
right
pulmonari
arteri
distens
index
rpad
index
recent
describ
valuabl
method
earli
detect
sever
evalu
pulmonari
arteri
hypertens
dog
rpad
index
calcul
percentag
chang
diamet
right
pulmonari
arteri
rpa
systol
diastol
obtain
mmode
echocardiographi
right
parastern
long
axi
view
aim
studi
compar
rpad
index
obtain
differ
echocardiograph
view
dog
studi
design
prospect
multicent
observ
studi
fortyf
clientown
dog
differ
breed
includ
dog
heart
diseas
healthi
dog
two
differ
right
parastern
view
long
axi
rpla
short
axi
rpsa
use
measur
rpad
index
rpla
view
method
rpsa
view
method
short
axi
long
axi
imag
respect
optim
right
pulmonari
arteri
rpad
index
calcul
mmode
percentag
chang
diamet
right
pulmonari
arteri
systol
diamet
diastol
diamet
systol
diamet
measur
done
offlin
averag
consecut
cardiac
cycl
singl
investig
blind
dog
diagnosi
pearson
blandaltman
test
use
assess
correl
agreement
method
respect
intraand
interobserv
measur
variabl
quantifi
averag
coeffici
variat
cv
level
signific
set
p
mmode
evalu
rpad
index
satisfactorili
obtain
method
dog
pearson
test
show
strong
posit
linear
correl
valu
rpad
index
obtain
method
r
p
blandaltman
test
show
good
agreement
method
estim
rpad
index
bia
sd
limit
agreement
mean
differ
method
confid
interv
intraand
interobserv
measur
variabl
clinic
accept
cv
studi
show
good
agreement
short
axi
long
axi
mmode
evalu
rpa
method
use
interchang
evalu
rpad
index
studi
need
evalu
rpad
index
larger
popul
healthi
dog
diagnost
prognost
role
echocardiograph
paramet
dog
differ
type
pulmonari
hypertens
disclosur
disclosur
report
retrospect
studi
march
octob
includ
clientown
great
pyrene
diagnos
hypoadrenocortic
medic
record
dog
diagnosi
natur
occur
hypoadrenocortic
review
emphasi
great
pyrene
record
preval
hypoadrenocortic
studi
popul
well
preval
per
breed
calcul
data
collect
includ
breed
clinic
sign
laboratori
find
age
diagnosi
treatment
caus
death
one
hundr
dog
diagnos
natur
occur
hypoadrenocortic
repres
overal
canin
popul
studi
thirtyf
breed
repres
preval
per
breed
vari
high
preval
observ
west
highland
white
terrier
great
dane
standard
poodl
saintbernard
jack
russel
terrier
gp
present
period
time
n
diagnos
hypoadrenocortic
median
age
diagnosi
year
rang
dog
hypoadrenocortic
year
gp
main
reason
present
addisonian
gp
lethargi
n
anorexia
n
clinic
find
includ
hypotens
n
poor
bodi
condit
n
heart
murmur
n
major
n
serum
electrolyt
abnorm
na
k
ratio
rang
major
laboratori
find
includ
azotemia
n
anemia
n
absenc
stress
leukogram
n
major
n
receiv
fludrocortison
prednison
need
one
gp
euthan
time
diagnosi
great
pyrene
diagnos
hypoadrenocort
overrepres
studi
popul
preval
hypoadrenocortic
gp
popul
therefor
inherit
suscept
suspect
reason
present
clinic
sign
nonspecif
similar
report
breed
human
medicin
haemoglobin
form
glycosyl
haemoglobin
use
standard
measur
averag
glycaem
control
month
measur
dog
previous
demonstr
howev
high
pressur
liquid
chromatographi
techniqu
technic
difficult
routin
use
method
longer
avail
object
studi
assess
use
latex
immunoagglutin
inhibit
use
monoclon
antibodi
measur
dog
use
siemen
dca
vantag
repeat
assess
measur
sampl
time
within
minut
effect
storag
edta
anticoagul
sampl
examin
measur
sampl
store
everi
day
day
storag
assess
freez
sampl
measur
week
machin
use
compar
valu
group
dog
diabet
mellitu
group
n
hyperadrenocortic
group
n
nondiabeticcushingoid
hospitalis
patient
group
n
differ
group
examin
signific
use
kruskalw
analysi
varianc
refer
rang
previous
calcul
mmolmol
valu
mmolmol
seen
diabet
anim
use
high
pressur
liquid
chromatographi
median
coeffici
variat
repeat
studi
found
rang
possibl
store
sampl
day
median
cv
rang
least
week
median
cv
rang
median
concentr
group
mmolmol
group
mmolmol
group
mmolmol
group
significantli
differ
group
use
kruskalw
analysi
varianc
conclus
latex
immunoagglutin
method
repeat
measur
dog
addit
canin
edta
anticoagul
sampl
stabl
day
frozen
could
store
least
week
without
signific
sampl
deterior
assay
provid
expect
result
dog
without
abnorm
glycaem
control
disclosur
siemen
dca
vantag
provid
loan
siemen
well
cartridg
use
machin
run
sampl
studi
wehner
r
anderson
rees
k
hartmann
clinic
small
anim
medicin
munich
germani
institut
veterinari
anatomi
histolog
embryolog
munich
germani
measur
total
thyroxin
often
first
diagnost
step
work
thyroid
diseas
dog
cat
blood
sampl
routin
sent
refer
laboratori
caus
delay
test
might
impact
result
aim
studi
valid
enzym
fluoresc
assay
elfa
inhous
method
measur
dog
cat
measur
sera
dog
cat
method
enzym
immunoassay
eia
enzym
fluoresc
assay
elfa
eia
serv
standard
method
elfa
result
compar
elfa
perform
minivida
autom
analys
biom
erieux
craponn
franc
accord
manufactor
instruct
coeffici
variat
cv
elfa
dog
sera
eia
respect
cv
elfa
cat
sera
eia
respect
overal
bia
elfa
dog
howev
lower
rang
maxim
bia
elfa
cat
correl
method
linear
cat
use
bland
altman
plot
limit
agreement
dog
cat
cohen
kappa
reveal
slight
agreement
method
dog
good
good
agreement
cat
elfa
fast
method
high
precis
recommend
measur
cat
recommend
dog
disclosur
disclosur
report
dysfunct
central
nervou
system
cn
frequent
caus
neurolog
disord
dog
studi
aim
find
cn
diseas
could
associ
select
group
common
microbi
viral
pathogen
dog
cn
diseas
characterist
profil
regard
paramet
creactiv
protein
crp
iga
report
potenti
use
unspecif
marker
cn
diseas
analys
cerebrospin
fluid
sampl
obtain
dog
vari
neurolog
sign
june
novemb
realtim
pcr
employ
probe
toxoplasma
gondii
neospora
caninum
anaplasma
phagocytophilum
canin
distemp
viru
iggantibodi
tickborn
enceph
viru
tbe
assay
iga
titr
measur
use
elisa
crp
concentr
determin
immunoturbidimetr
assay
dog
median
age
year
rang
compris
breed
frequent
involv
chihuahua
labrador
retriev
bernes
mountain
dog
boxer
gender
distribut
femal
spay
bitch
male
neuter
male
nonidentifi
none
case
pcrposit
toxoplasma
gondii
canin
distemp
viru
one
dog
posit
anaplasma
phagocytophilum
anoth
neospora
caninum
antibodi
tbe
viru
within
borderlin
rang
dog
dog
could
divid
age
group
young
dog
year
median
year
older
dog
year
median
year
igahigh
mgdl
case
repres
young
older
dog
respect
crphigh
mgl
case
almost
half
equal
young
older
dog
respect
compar
older
dog
young
dog
higher
level
crp
p
iga
p
within
igahigh
cohort
crphigh
crplow
case
distribut
almost
equal
versu
young
dog
disproportion
versu
older
dog
igalowcrplow
case
young
dog
older
dog
present
data
suggest
canin
cn
disord
larg
character
high
iga
particularli
young
dog
inflammatori
type
crphigh
almost
equal
group
although
signific
remain
yet
determin
pathogen
like
anaplasma
phagocytophilum
neospora
caninum
could
detect
case
canin
cn
disord
disclosur
author
breu
guthardt
j
employ
laboklin
gmbh
co
kg
germani
uller
e
ownermanag
laboklin
gmbh
co
kg
internet
potenti
sourc
medic
inform
pet
owner
therefor
could
play
indirect
import
role
veterinari
practic
survey
assess
onlin
search
behaviour
french
pet
owner
pet
health
influenc
veterinari
consult
april
french
pet
owner
come
veterinari
teach
hospit
medic
surgic
consult
survey
owner
fulfil
questionnair
voluntari
basi
survey
contain
question
deal
topic
onlin
search
behaviour
owner
pet
health
percept
inform
found
onlin
internet
influenc
consult
veterinariancli
owner
use
internet
obtain
inform
pet
health
among
use
rare
occasion
mainli
look
inform
diseas
symptom
breed
nutrit
advic
owner
tri
verifi
accuraci
inform
found
often
question
veterinarian
owner
think
onlin
inform
alway
trustworthi
research
randomli
made
websit
found
search
engin
major
pet
owner
nt
awar
health
certif
label
websit
internet
enabl
certain
pet
owner
feel
eas
pet
health
care
ask
question
veterinarian
feel
involv
medic
choic
owner
consid
internet
posit
impact
relationship
veterinarian
relief
common
emot
respons
onlin
research
medic
inform
howev
owner
feel
overwhelm
amount
inform
found
confus
frighten
seriou
graphic
natur
inform
found
onlin
studi
emphas
frequent
measur
use
internet
french
pet
owner
pet
health
seem
consid
inform
found
net
critic
mind
unexpectedli
appear
internet
could
alli
veterinarian
promot
exchang
client
veterinarian
improv
complianc
care
project
disclosur
disclosur
report
sinonas
aspergillosi
wellknown
describ
fungal
infect
sinonas
caviti
dog
topic
treatment
either
enilconazol
itraconazol
infus
administ
surgic
endoscop
effect
use
clotrimazol
cream
describ
surgic
set
itraconazol
infus
sissen
et
al
aim
work
report
effect
use
topic
clotrimazol
cream
treatment
sinonas
aspergillosi
dog
inclus
criteria
full
medic
record
radiolog
endoscop
imag
record
clotrimazol
discharg
instil
endoscop
control
day
procedur
clotrimazol
cream
appli
cathet
place
direct
endoscop
vision
fungal
plaqu
remov
nine
dog
includ
three
dog
mix
breed
dog
dog
golden
retriev
one
dog
german
shepherd
one
old
english
sheepdog
one
bull
terrier
one
cane
corso
six
dog
male
one
neuter
femal
one
intact
mean
age
year
main
clinic
sign
mucopurul
discharg
pain
sinonas
palpat
nasal
planum
alter
epistaxi
nasal
discharg
bilater
dog
mean
durat
clinic
sign
month
main
radiolog
find
turbin
lysi
frontal
sinu
empyema
frontal
bone
thicken
frontal
bone
lysi
rhinoscopi
disclos
lysi
remodel
nasal
turbin
easi
access
frontal
sinu
septum
lysi
bilater
sinonas
aspergillosi
monolater
nasal
aspergillosi
monolater
sinonas
aspergillosi
contralater
nasal
aspergillosi
monolater
frontal
aspergillosi
main
durat
nasal
cream
discharg
day
dog
underw
endoscop
control
day
procedur
seven
dog
diseas
free
dog
persist
fungal
plaqu
underw
second
treatment
success
rate
success
rate
studi
compar
studi
larger
smaller
case
seri
endoscop
remov
fungal
plaqu
time
consum
topic
administr
either
enilconazol
itraconazol
requir
addit
hour
cathet
placement
clotrimazol
cream
applic
last
minut
caviti
dog
report
use
clotrimazol
cream
treatment
sinonas
aspergillosi
need
evalu
larger
case
seri
disclosur
disclosur
report
studi
exist
euthanasia
small
anim
practic
howev
act
belong
veterinari
procedur
less
frequent
depend
kind
practic
may
deepli
impact
owner
veterinarian
intend
studi
practic
ethic
psycholog
aspect
euthanasia
dog
cat
among
french
veterinari
practition
octob
februari
onlin
questionnair
small
anim
euthanasia
address
practic
aspect
euthanasia
commun
owner
ethic
problem
owner
veterinarian
percept
email
via
profession
associ
network
result
analyz
use
commerci
softwar
sphinx
iq
excel
french
veterinarian
practic
small
anim
medicin
complet
questionnair
repres
popul
euthanasia
occur
rare
home
veterinarian
propos
owner
time
alon
pet
stay
euthanasia
perform
commonli
intraven
inject
mainli
sedationanesthesia
nineti
nine
percent
veterinarian
consid
commun
includ
descript
event
sequenc
dispos
bodi
import
estim
minimum
commun
time
requir
vari
minut
follow
euthanasia
often
thank
owner
veterinarian
refus
euthanasia
consid
unjustifi
suggest
euthanasia
reject
reason
suggest
includ
intract
pain
nonaccept
complic
financi
consider
anim
consid
danger
veterinarian
think
owner
experi
sens
guilt
euthanasia
perceiv
euthanasia
commonli
relief
anim
suffer
part
veterinari
practic
less
frequent
defeat
almost
veterinarian
experienc
emot
challeng
euthanasia
estim
practic
euthanasia
influenc
percept
death
practic
psycholog
aspect
euthanasia
discuss
team
veterinarian
gender
influenc
euthanasia
manag
mostli
concern
commun
practic
aspect
euthanasia
definit
ordinari
veterinari
act
neither
owner
veterinarian
therefor
act
must
perform
much
care
commun
possibl
disclosur
disclosur
report
canin
pancytopenia
associ
rang
intramarrow
extramarrow
caus
includ
though
limit
infecti
agent
drug
toxin
neoplasm
current
limit
inform
regard
clinicopatholog
featur
underli
caus
prognosi
pancytopen
dog
object
retrospect
studi
better
defin
spectrum
diseas
associ
canin
pancytopenia
establish
possibl
clinicopatholog
discrimin
common
caus
investig
sever
pancytopenia
underli
diseas
associ
clinic
outcom
death
surviv
medic
record
dog
comprehens
diagnost
investig
admit
veterinari
teach
hospit
retrospect
review
pancytopenia
defin
hematocrit
hct
dog
month
age
white
blood
cell
count
wbc
platelet
count
plt
control
group
dog
without
evid
blood
cytopenia
also
establish
total
pancytopen
dog
studi
bone
marrow
aspir
cytolog
examin
case
aplasia
hematopoiet
lineag
observ
dog
common
diagnos
includ
monocyt
ehrlichiosi
cme
n
leishmaniosi
canl
n
parvovir
enter
pe
n
concurr
cme
canl
n
mix
breed
dog
like
develop
pancytopenia
compar
purebr
pancytopen
dog
tend
younger
control
condit
depend
logist
regress
model
p
p
respect
among
common
diseas
associ
pancytopenia
mean
wbc
count
significantli
lower
dog
cme
pe
compar
dog
canl
one
way
anova
bonferroni
test
multipl
comparison
p
p
respect
plt
count
significantli
lower
cme
compar
canl
p
pe
p
total
protein
concentr
significantli
lower
dog
pe
compar
cme
p
canl
p
use
univari
logist
regress
analysi
model
associ
establish
underli
diseas
final
outcom
howev
higher
hct
least
one
percentag
unit
wbc
least
plt
least
valu
tend
significantli
increas
odd
surviv
p
p
p
respect
present
studi
cme
canl
pe
major
caus
canin
pancytopenia
potenti
use
diagnost
indic
includ
sever
leucopenia
cme
pe
thrombocytopenia
cme
hypoproteinemia
pe
disclosur
disclosur
report
laryng
mass
lm
usual
produc
air
flow
limit
inspir
expir
transient
subseg
breath
phase
felin
bronchial
diseas
fbd
predominantli
expiratori
flow
restrict
barometr
wholebodi
plethysmographi
bwbp
noninvas
pulmonari
function
test
pft
allow
dynam
studi
breath
pattern
wide
use
evalu
lower
airway
respons
object
preliminari
studi
evalu
signific
differ
respiratori
rate
rr
bwbp
detect
upper
lower
airway
diseas
site
airway
obstruct
result
increas
pressur
chang
associ
breath
nevertheless
result
suggest
signific
differ
tv
p
ti
p
pef
p
eep
p
penh
p
pau
p
lm
fbd
cat
signific
differ
bwbp
paramet
found
upper
airway
obstruct
previous
evalu
cat
use
pft
mckieman
lin
author
knowledg
first
studi
design
compar
upper
lower
airway
obstruct
use
bwbp
attend
result
evid
bwbp
help
character
mechan
dysfunct
airway
cat
lm
obstruct
howev
must
keep
mind
limit
studi
low
number
anim
individu
variabl
breath
pattern
chanc
bronchoreact
test
disclosur
disclosur
report
median
lifespan
domest
dog
estim
year
littl
known
risk
factor
mortal
age
dog
mortal
studi
dog
carri
among
diseas
dog
renal
heart
diseas
cancer
postop
death
determin
characterist
associ
mortal
priori
healthi
age
dog
prospect
cohort
studi
conduct
guid
dog
follow
systemat
geriatr
examin
ge
either
allcaus
death
cutoff
date
juli
th
surviv
analys
kaplanmei
estim
logrank
test
multivari
cox
proport
hazard
model
use
assess
associ
time
death
median
age
ge
year
dog
neuter
femal
major
dog
golden
retriev
n
labrador
retriev
n
among
dog
obes
present
skin
nodul
use
bu
transport
total
dog
die
followup
lead
median
surviv
time
ge
year
adjust
demograph
biochem
variabl
age
sex
total
protein
cholesterol
alp
increas
alanin
amionotransferas
level
uil
adjust
hazard
ratio
ahr
present
skin
nodul
ahr
labrador
ahr
independ
associ
shorter
time
death
p
public
transport
tend
associ
mortal
ahr
p
highlight
import
environ
mortal
neither
sex
biochem
paramet
significantli
associ
mortal
alanin
amionotransferas
level
presenc
skin
nodul
seem
predictor
mortal
senior
guid
dog
mostli
labrador
golden
mix
breed
labradorgolden
impact
environ
particular
urban
environ
mortal
need
investig
studi
breed
pet
also
necessari
gener
result
disclosur
sara
hoummadi
receiv
grant
mp
labo
phd
work
dog
age
marc
blondot
work
pari
guid
dog
school
laryng
dysfunct
commonli
associ
aspir
pneumonia
howev
role
lower
airway
diseas
investig
laryngoscop
bronchoscop
find
dog
examin
author
evalu
presenc
absenc
laryng
abnorm
dog
present
evalu
inspiratori
difficulti
pant
exclud
analysi
clinic
diagnos
inflammatori
airway
diseas
airway
collaps
airway
infect
eosinophil
bronchopneumopathi
combin
disord
obtain
bronchoscopi
bronchoalveolar
lavag
fluid
analysi
detect
rate
laryng
abnorm
compar
among
diseas
group
use
chi
squar
analysi
fisher
exact
test
signific
set
p
total
dog
evalu
vari
age
month
year
median
year
weight
rang
kg
median
kg
dog
kg
dog
kg
dog
kg
dog
kg
dog
kg
laryng
hyperemia
swell
found
dog
detect
rate
differ
among
diseas
process
laryng
function
consid
suspect
case
prompt
administr
doxapram
normal
function
dog
laryng
paresi
paralysi
report
total
dog
substanti
number
dog
chronic
cough
display
evid
abnorm
laryng
structur
function
suggest
complet
laryngoscop
examin
perform
dog
evalu
cough
disclosur
member
felin
advisori
board
speaker
honoraria
intern
nation
region
continu
educ
meet
bronchiectasi
poorli
character
diseas
dog
identifi
airway
dilat
radiograph
comput
tomographi
bronchoscopi
histopatholog
littl
known
underli
diseas
process
associ
bronchiectasi
dog
medic
record
dog
present
uc
davi
search
identif
bronchiectasi
underli
diseas
process
clinic
diagnos
obtain
review
histori
physic
examin
respiratori
endoscopi
bronchoalveolar
lavag
fluid
analysi
microbiolog
histor
report
result
imag
bronchoscopi
fluid
analysi
scrutini
patholog
clinic
diagnos
comprehens
evalu
identifi
like
underli
diseas
process
associ
bronchiectasi
bronchiectasi
diagnos
dog
bronchoscopi
perform
dog
rang
age
year
median
year
dog
month
dog
year
dog
year
age
dog
year
age
dog
breed
affect
includ
labrador
retriev
cocker
spaniel
golden
retriev
standard
poodl
durat
cough
rang
day
year
median
month
underli
diseas
process
includ
pneumonia
dog
inflammatori
airway
diseas
dog
eosinophil
bronchopneumopathi
dog
twentythre
dog
posit
bacteri
cultur
isol
streptococcu
n
enter
speci
n
commonli
studi
found
bronchiectasi
often
occur
older
larg
breed
dog
infecti
inflammatori
pneumonia
disclosur
johnson
felin
advisori
board
speaker
honoraria
chronic
respiratori
diseas
often
character
chronic
cough
common
dog
purpos
studi
determin
etiolog
chronic
respiratori
diseas
dog
present
persist
chronic
cough
retrospect
studi
clientown
dog
sign
persist
chronic
lower
respiratori
diseas
underw
bronchoscopi
togeth
either
endotrach
wash
etw
bronchoalveolar
lavag
bal
perform
dog
evalu
mean
full
clinic
examin
hematolog
serum
biochemistri
analys
survey
thorac
radiograph
echocardiographi
ecg
indic
bronchoscopi
cytolog
analysi
aerob
cultur
etw
bal
fluid
etw
perform
dog
bal
perform
dog
posit
aerob
bacteri
cultur
identifi
submit
etwbal
fluid
sampl
commonli
isol
bacteria
includ
mycoplasma
sp
bordetella
bronchiseptica
pseudomona
aeruginosa
definit
diagnosi
made
case
chronic
bronchiti
common
diagnosi
median
age
year
follow
airway
tracheal
collaps
bronchomalacia
median
age
year
primari
bacteri
infect
median
age
year
less
common
etiolog
identifi
includ
neoplasia
median
age
year
parasit
infect
median
age
year
eosinophil
bronchopneumopathi
median
age
year
rare
etiolog
identifi
includ
primari
pulmonari
hypertens
primari
ciliari
dyskinesia
excitementinduc
cough
obes
myxodemat
mitral
valv
diseas
found
concurr
dog
studi
conclud
use
structur
combin
survey
thorac
radiographi
bronchoscopi
etw
bal
cytolog
cultur
diagnosi
could
made
major
dog
chronic
respiratori
diseas
disclosur
disclosur
report
canin
steril
steroidrespons
lymphaden
cssrl
uncommon
caus
lymphadenomegali
diagnosi
one
exclus
extens
investig
exclud
infecti
inflammatori
neoplast
aetiolog
resolut
clinic
sign
occur
corticosteroid
retrospect
studi
aim
defin
characterist
progress
treatment
regimen
case
recruit
uk
referr
centr
diagnost
investig
case
exclud
potenti
caus
lymphadenomegali
thirtysix
dog
diagnos
cssrl
lymph
node
cytolog
andor
histopatholog
eighteen
breed
repres
spaniel
english
springer
spaniel
ess
account
case
along
cocker
spaniel
cavali
king
charl
spaniel
border
colli
clinic
present
vari
dog
clinic
sign
pyrexia
lethargi
anorexia
common
sign
includ
cough
tachypnoea
dyspnoea
dysphagia
vomit
diarrhoea
neck
spinal
pain
abdomin
pain
joint
effus
dermatolog
sign
median
referr
time
day
ess
cocker
border
colli
day
twentytwo
anim
pyrex
present
mean
rang
thirtyon
anim
present
peripher
lymphadenomegali
anim
display
intern
lymph
node
enlarg
cytolog
perform
case
neutrophil
lymphaden
follow
granulomat
pyogranulomat
reactiv
hyperplasia
histopatholog
perform
case
document
neutrophil
pyogranulomat
granulomat
lymphaden
lymph
node
cultur
stain
gram
pa
zn
perform
anim
respect
neg
prednisolon
administ
case
dose
rang
mgkg
daili
anim
initi
therapi
mgkg
q
hour
mean
treatment
length
week
dog
relaps
throughout
studi
period
ess
cocker
ckc
border
colli
lurcher
beagl
ess
relaps
within
month
diagnosi
median
relaps
time
week
studi
document
dog
cssrl
uk
suggest
overrepresent
spaniel
breed
particularli
ess
femal
young
dog
typic
affect
cytolog
histopatholog
examin
confirm
steril
lymphaden
anim
show
mark
rapid
clinic
improv
corticosteroid
disclosur
disclosur
report
brachycephal
dog
uniqu
upper
respiratori
anatomi
abnorm
breath
pattern
similar
human
obstruct
sleep
apnea
syndrom
osa
oxid
stress
bodi
repres
imbal
product
reactiv
oxid
speci
abil
antioxid
defens
mechan
detoxifi
reactiv
intermedi
oxid
stress
involv
pathogenesi
mani
diseas
includ
hemolyt
anemia
atherosclerosi
tissu
reperfus
injuri
also
carcinogen
potenti
sever
studi
clearli
shown
associ
obstruct
sleep
apnea
syndrom
human
oxid
stress
detail
underli
pathomechan
remain
unclear
due
consider
brachycephal
dog
anim
model
human
osa
studi
design
evalu
oxid
stress
paraoxonas
activ
total
antioxid
statu
tac
brachycephal
dog
brachycephal
airway
obstruct
syndrom
bao
surgeri
compar
control
dog
studi
conduct
dog
bao
control
dog
twenti
bao
dog
evalu
month
surgic
correct
mean
valu
tac
differ
studi
group
follow
control
dog
tac
bao
dog
tac
bao
dog
postsurgeri
statist
signific
differ
tac
level
observ
dog
bao
control
dog
p
statist
signific
differ
observ
tac
level
surgeri
hand
differ
observ
tac
level
bao
dog
accord
type
brachycephal
breed
grade
respiratori
digest
sign
presenc
evert
ventricular
laryng
result
studi
show
statist
signific
differ
tac
valu
control
dog
bao
confirm
oxid
stress
previous
describ
human
even
human
patient
osa
partial
revers
increas
oxid
stress
use
nasal
continu
posit
airway
pressur
treatment
dog
bao
differ
observ
month
surgic
treatment
bao
surgic
treatment
use
reduc
tac
level
probabl
bao
induc
evid
inflammatori
process
dog
human
patient
osa
disclosur
disclosur
report
canin
idiopath
pulmonari
fibrosi
cipf
progress
interstiti
lung
diseas
mainli
affect
west
highland
white
terrier
whwt
cipf
cours
vari
greatli
among
dog
rapid
deterior
slowli
progress
form
surviv
time
onset
clinic
sign
rang
month
sever
year
human
ipf
increas
chemokin
ccmotif
ligand
concentr
bronchoalveolar
lavag
fluid
balf
indic
poor
outcom
serum
concentr
correl
clinic
paramet
lung
function
dog
serum
balf
concentr
shown
elev
whwt
cipf
compar
healthi
whwt
aim
present
studi
investig
whether
serum
concentr
measur
whwt
cipf
diagnosi
use
indic
prognosi
correl
lung
function
paramet
concentr
determin
elisa
canin
quantikin
elisa
kit
r
system
serum
whwt
suspect
cipf
median
age
year
rang
followup
avail
median
followup
time
month
rang
serum
sampl
extend
may
januari
cipf
diagnosi
confirm
thorac
high
resolut
comput
tomographi
lung
histopatholog
examin
whwt
respect
kaplanmei
analysi
conduct
investig
differ
surviv
time
accord
serum
concentr
diagnosi
spearman
analysi
use
assess
correl
serum
concentr
lung
function
paramet
name
distanc
walk
walk
test
arteri
partial
pressur
oxygen
po
among
cipf
whwt
includ
die
euthan
cipfrel
reason
die
euthan
noncipfrel
reason
still
aliv
end
studi
median
surviv
whwt
cipfrel
death
euthanasia
rang
month
diagnosi
serum
concentr
pgml
significantli
associ
shorter
surviv
time
whwt
affect
cipf
p
weak
neg
correl
found
serum
concentr
r
p
n
correl
observ
arteri
po
valu
n
conclus
serum
concentr
provid
prognost
inform
whwt
suffer
cipf
marker
weakli
correl
clinic
lung
function
paramet
avail
present
studi
disclosur
disclosur
report
canin
idiopath
pulmonari
fibrosi
cipf
progress
interstiti
lung
diseas
mainli
affect
west
highland
white
terrier
whwt
studi
intend
describ
thorac
highresolut
comput
tomographi
thrct
find
obtain
cipf
dog
gener
anesthesia
ga
use
glossari
fleischner
societi
compar
imag
obtain
ga
thrct
ga
obtain
sedat
thrct
thrct
imag
whwt
cipf
control
whwt
retrospect
review
observ
consensu
specif
thrct
featur
assess
grade
lung
lobe
absenc
mild
moder
sever
global
score
calcul
test
threshold
use
statist
analysi
ground
glass
opac
ggo
observ
cipf
whwt
control
p
control
ggo
mild
localis
mainli
cranial
lobe
cipf
whwt
ggo
mild
moder
sever
dog
respect
without
lobe
predilect
consolid
observ
cipf
whwt
control
p
mild
moder
mosaic
pattern
suggest
air
trap
notic
cipf
whwt
control
p
mild
moder
sever
whwt
respect
without
lobe
predilect
nodul
present
cipf
whwt
control
reticul
subpleur
band
parenchym
band
notic
cipf
whwt
respect
honeycomb
emphysema
pleural
effus
pleural
thicken
never
observ
bronchial
wall
thicken
mild
bronchiectasi
present
cipf
whwt
respect
control
p
p
overal
thrct
qualiti
good
examin
compar
thrct
ga
p
presenc
motion
artefact
higher
thrct
p
frequent
grade
mild
p
thrct
allow
identif
mosaic
pattern
addit
cipf
whwt
consolid
could
identifi
other
differ
identif
gradat
featur
thrct
ga
thrct
conclus
ggo
consolid
mosaic
pattern
bronchial
wall
thicken
main
thrct
featur
cipf
whwt
honeycomb
major
featur
ipf
human
never
observ
suggest
differ
pathophysiolog
entiti
thrct
imag
accord
thrct
ga
use
cipf
diagnosi
disclosur
disclosur
report
literatur
mesenteri
lymphaden
lad
mesenteri
lymph
node
abscess
lab
small
anim
scarc
case
file
search
dog
diagnosi
mesenteri
ladlab
base
cytolog
andor
histopatholog
case
identifi
exclud
due
incomplet
data
remain
dog
mix
breed
n
small
munsterland
n
one
breed
nine
dog
male
femal
median
age
month
rang
diagnosi
base
fine
needl
aspir
fna
n
histopatholog
n
n
signific
find
dog
histori
includ
gastrointestin
sign
n
puppi
whose
mother
mastiti
bite
woundsabscess
skin
n
pulmon
stenosi
n
orthopaed
diseas
n
common
present
complaint
lethargi
n
hyperthermia
n
diarrhoea
n
vomitingnausea
n
inappetenceanorexia
n
backabdomin
pain
n
lame
n
diagnost
test
perform
includ
haematologyserum
biochemistri
n
thorac
n
abdomin
n
radiograph
abdomin
ultrasound
n
ctmri
n
fna
organ
n
urinalysi
n
cultur
n
coagul
profil
n
orthopaed
radiograph
n
cpl
n
blood
cultur
n
csfjoint
tap
n
dog
retrospect
divid
group
n
dog
diseas
ladlab
idiopath
group
b
n
dog
diseas
diagnos
simultan
includ
neoplasia
carcinoma
n
lymphoma
n
leiomysarcoma
n
histiocyt
neoplasia
n
prostat
carcinoma
n
gastroenter
n
presum
pancreat
n
purul
monoarthr
n
purul
hepat
spleniti
n
fungal
infect
distant
site
n
mycobacteriosi
n
eleven
dog
receiv
surgic
treatment
antibiot
dog
conserv
medic
manag
consist
support
treatment
antibiot
dog
discharg
aliv
dog
group
hospit
longer
mean
day
sd
dog
group
b
mean
day
sd
p
median
followup
time
day
day
differ
pretreat
antibiot
antiinflammatori
group
ttest
kruskallw
test
show
dog
group
borderlin
significantli
younger
p
significantli
higher
respiratori
rate
p
rectal
temperatur
p
monocyt
count
p
crp
concentr
p
dog
group
b
small
munsterland
odd
ratio
breed
suffer
ladlab
conclus
idiopath
mesenteri
ladlab
seen
young
dog
hyperthermia
gastrointestin
sign
diagnosi
purul
ladlab
fna
exclud
presenc
anoth
underli
pathogenesi
disclosur
disclosur
report
dog
includ
show
respiratori
sign
day
consist
cird
noninfecti
respiratori
condit
could
exclud
nasal
pharyng
swab
taken
dog
cird
test
respiratori
pathogen
includ
canin
parainfluenza
viru
cpiv
canin
adenoviru
cav
canin
distemp
viru
cdv
canin
herp
viru
chv
canin
respiratori
coronaviru
crcov
canin
influenza
viru
civ
bordetella
bronchiseptica
b
bronchiseptica
polymeras
chain
reaction
result
clinic
laboratori
data
correl
underli
pathogen
use
fisher
exact
test
chisquar
test
cpiv
detect
crcov
b
bronchiseptica
dog
patient
show
infect
one
pathogen
signific
differ
age
gender
distribut
group
howev
dog
infect
cpiv
like
origin
shelter
p
clinic
data
compar
signific
differ
paramet
depress
fever
cough
nasal
discharg
dyspnoea
abnorm
lung
sound
furthermor
signific
differ
regard
abnorm
erythrocyt
platelet
leukocyt
differenti
count
group
studi
show
dog
cird
clinic
laboratori
paramet
indic
underli
pathogen
furthermor
diseas
sever
seem
depend
infecti
organ
involv
disclosur
disclosur
report
breed
relat
predisposit
bacteri
bronchopneumonia
bp
report
irish
wolfhound
iwh
underli
factor
unknown
howev
immun
deficit
ciliari
dysfunct
aspir
suggest
predispos
factor
purpos
prospect
studi
evalu
lymphocyt
subpopul
iwh
one
previou
bp
compar
result
elderli
iwh
without
previou
bacteri
respiratori
infect
addit
healthi
dog
breed
includ
control
previou
bp
confirm
iwh
median
age
year
interquartil
rang
year
healthi
iwh
n
year
dog
breed
n
year
histori
find
suggest
previou
bp
edta
blood
sampl
collect
dog
healthi
stain
fluoresc
mous
anti
dog
mhc
class
ii
antibodi
abd
serotec
flow
cytometri
analysi
perform
bd
facsaria
ii
cell
sorter
facsdiva
softwar
statist
comparison
group
effect
age
studi
use
analysi
covari
ancova
model
number
leucocyt
differ
significantli
group
total
number
lymphocyt
number
major
lymphocyt
subpopul
bcell
tcell
significantli
lower
healthi
iwh
iwh
previou
bp
compar
dog
breed
lymphocyt
p
p
bcell
p
p
tcell
p
p
tcell
p
p
respect
percentag
number
mhc
class
ii
nonb
lymphocyt
significantli
higher
iwh
group
dog
breed
p
comparison
lymphocyt
number
subpopul
differ
significantli
healthi
iwh
compar
iwh
previou
bp
agerel
declin
total
number
lymphocyt
p
tcell
p
tcell
p
mhc
class
ii
non
bcell
p
notic
group
iwh
previou
bp
preliminari
result
indic
iwh
may
significantli
lower
number
lymphocyt
bcell
well
tcell
dog
breed
studi
need
determin
whether
alter
repres
breed
relat
phenomenon
connect
predisposit
bp
agerel
declin
lymphocyt
total
tcell
tcell
number
detect
iwh
previou
bp
human
age
relat
chang
tcell
associ
increas
suscept
infect
disclosur
disclosur
report
felin
chronic
kidney
diseas
ckd
common
featur
age
cat
angiotensinconvert
enzym
inhibitor
acei
recommend
treat
hypertens
associ
ckd
limit
targetorgan
damag
especi
glomerular
hypertens
addit
intern
renal
interest
societi
iri
guidelin
recommend
prescript
acei
patient
ckd
proteinuria
knowledg
studi
demonstr
effect
long
term
administr
acei
client
own
popul
cat
suffer
ckd
glomerular
filtrat
rate
gfr
aim
studi
evalu
effect
acei
imidapril
prilium
v
etoquinol
sa
gfr
cat
suffer
natur
occur
chronic
kidney
diseas
ckd
month
sixtysix
cat
present
clinic
biolog
sign
ckd
enrol
european
investig
follow
till
month
random
blind
studi
thirtytwo
cat
provid
suitabl
data
gfr
analysi
anim
receiv
imidapril
dosag
mgkgday
receiv
placebo
anim
avail
gfr
valu
data
exclud
well
anim
iohexol
clearanc
could
determin
follow
censor
month
due
small
sampl
size
statist
comparison
cat
sampl
minut
intraven
administr
mg
iohexol
gfr
base
determin
iohexol
clearanc
calcul
phoenix
winnonlin
softwar
statist
analys
perform
sasstat
softwar
gfr
avail
time
point
given
anim
treatment
group
compar
gfr
determin
point
use
ancova
analysi
covari
gfr
determin
covari
gfr
mlkgmin
imidapril
placebo
group
respect
signific
statist
differ
versu
mlkgmin
imidapril
placebo
group
respect
p
observ
favor
higher
gfr
imidapril
treat
anim
higher
gfr
also
observ
imidapril
group
significantli
differ
placebo
group
daili
long
term
imidapril
treatment
compar
placebo
may
effect
treatment
slow
progress
renal
failur
cat
natur
occur
chronic
kidney
diseas
disclosur
author
employe
vetoquinol
concern
potenti
cytotox
drug
could
harm
expos
worker
special
oncolog
ecvimca
publish
guidelin
order
prevent
risk
howev
data
exist
evalu
real
risk
occupationn
exposur
concern
aim
studi
biomark
use
vincristin
cyclophosphamid
surfac
sampl
collect
consult
room
ward
dedic
chemotherapi
sampl
collect
wet
filter
paper
cm
surfac
object
comput
instanc
sampl
analys
liquid
chromatographi
mass
spectrometr
methodth
limit
quantif
ng
cm
gobject
vincristin
cm
gobject
cyclophosphamid
sampl
consult
room
collect
treat
dog
vincristin
clean
sampl
dedic
ward
collect
clean
stay
treat
dog
aerasobject
test
consult
room
dedic
ward
vincristin
ward
cyclophosphamid
treatment
dog
consult
room
trace
vincristin
detect
floor
laboratori
bench
top
cm
moreov
surfac
auscult
tabl
extern
side
glove
contamin
prepar
administr
vincristin
respect
ngobjet
clean
sampl
consult
room
posit
trace
vincristin
detect
floor
object
wall
otoscop
cm
clean
sampl
ward
posit
trace
vincristin
detect
floor
object
box
wastebin
bowl
ngobjet
clean
anim
treatment
cyclophosphamid
detect
area
test
ngobjet
despit
protect
guidelin
avoid
spread
cytotox
drug
environement
exposur
demonstr
howev
contamin
limit
show
handl
procedur
cytotox
drug
well
control
mostelev
contamin
level
vincristin
notic
extern
side
glove
depsit
use
appropri
materi
worker
pay
particular
attent
glove
withdraw
limit
exposur
small
amount
vincristin
found
inapropri
place
computeur
mous
even
residu
thought
peopl
work
regular
basi
room
activ
chemotherapi
decid
adapt
clinic
practic
evalu
occup
exposur
cytotox
drug
import
step
prevent
incid
heigt
awar
nurs
staff
appli
good
clinic
practic
disclosur
disclosur
report
tumorassoci
inflammatori
respons
effect
enhanc
mammari
tumorigenesi
help
incipi
neoplasia
acquir
hallmark
capabl
human
dog
tcell
migrat
tumor
site
follow
activ
may
essenti
requir
promot
effect
tumor
human
breast
cancer
signal
pathway
ckit
describ
possibl
involv
differenti
migrat
surviv
matur
tcell
inflammatori
cell
tumor
site
order
clarifi
subject
canin
mammari
tumor
cmt
malign
neoplasm
studi
use
immunohistochemistri
compar
intratumor
tlymphocyt
ckit
express
togeth
vegf
microvessel
densiti
mvd
clinicopatholog
characterist
tumor
aggress
cell
high
ckit
immunoexpress
reveal
posit
statist
signific
correl
vegf
r
p
r
p
ckit
respect
r
p
r
p
ckit
respect
statist
signific
associ
p
posit
correl
r
p
tlymphocyt
ckit
also
observ
tumor
high
ckit
express
show
higher
count
tcell
mvd
high
tumor
significantli
elev
p
similar
associ
observ
high
ckitvegf
tumor
p
studi
high
high
ckitvegf
high
tumor
statist
significantli
associ
elev
grade
malign
p
ckitvegf
presenc
neoplast
intravascular
emboli
p
p
ckitvegf
presenc
lymph
node
metastasi
p
ckit
vegf
tumor
high
p
high
ckitvegf
p
high
p
express
associ
shorter
os
time
interestingli
group
tumor
high
ckitvegf
retain
signific
multivari
analysi
aris
independ
predictor
os
result
studi
suggest
tlymphocyt
may
share
common
signal
pathway
ckit
vegf
cmt
progress
may
contribut
increas
angiogenesi
aggress
shorter
os
tumor
disclosur
disclosur
report
lgl
lymphoma
comparison
made
cat
diseas
form
felin
lymphoma
therefor
object
studi
assess
differ
preval
signal
breed
sex
age
physic
exam
find
bodi
weight
bodi
condit
score
bodi
temperatur
heart
rate
respiratori
rate
systol
blood
pressur
felv
fiv
statu
cat
lgl
lymphoma
group
type
felin
lymphoma
group
electron
databas
san
marco
veterinari
clinic
search
cat
cytolog
histopatholog
diagnosi
lymphoma
differ
group
assess
ttest
mann
whitney
pearsonchi
squar
pearson
chi
squar
yate
correct
fisher
exact
test
studi
period
sick
cat
seen
clinic
diagnos
lymphoma
group
n
group
n
preval
type
felin
lymphoma
compar
sick
cat
chang
time
rang
per
year
p
overal
preval
ci
lymphoma
lgl
preval
compar
type
lymphoma
chang
time
rang
per
year
p
overal
preval
ci
among
variabl
studi
sex
group
femal
male
group
femal
male
p
age
group
month
group
month
p
significantli
differ
group
sixteen
cat
lgl
lymphoma
test
felvfiv
statu
result
felvand
one
fiv
seventyfour
cat
type
lymphoma
test
felvfiv
statu
result
felv
fiv
five
cat
felvfiv
preval
felv
infect
significantli
lower
p
group
compar
group
differ
preval
fiv
infect
group
lymphoma
lgl
affect
femal
older
cat
compar
type
felin
lymphoma
opposit
type
lymphoma
accord
previou
litteratur
inform
felv
statu
play
role
pathogenesi
felin
lgl
lymphoma
disclosur
disclosur
report
activ
regulatori
cell
treg
known
close
associ
express
transcript
factor
regulatori
cell
distinct
group
lymphocyt
immunosuppress
properti
normal
cell
work
prevent
harm
autoimmun
respons
howev
also
interfer
benefici
immun
respons
antitumor
immun
human
breast
cancer
cell
play
crucial
role
tumor
progress
canin
mammari
tumor
cmt
studi
topic
welldocu
studi
includ
malign
cmt
studi
immunohistochemistri
intratumor
express
togeth
vascular
endotheli
growth
factor
vegf
microvessel
densiti
mvd
antibodi
sever
clinicopatholog
characterist
abund
cell
statist
associ
presenc
tumor
necrosi
p
nuclear
grade
p
poor
differenti
tumor
p
high
mitot
grade
p
high
histolog
grade
malign
p
presenc
neoplast
intravascular
emboli
p
presenc
lymph
node
metastasi
p
intratumor
level
correl
level
vegf
r
p
intratumor
mvd
r
p
addit
tumor
abund
cell
associ
shorter
overal
surviv
os
time
p
result
suggest
treg
cell
play
role
cmt
progress
may
contribut
increas
angiogenesi
aggress
tumor
associ
intratumor
express
shorter
os
anim
suggest
util
treg
cell
activ
prognost
marker
disclosur
disclosur
report
cypru
island
state
eastern
mediterranean
basin
epidemiolog
studi
yet
perform
infecti
agent
cat
cypru
aim
studi
determin
preval
sever
infecti
agent
includ
vectorborn
infect
cat
cypru
surplu
edtablood
serum
sampl
recruit
cypriot
cat
signal
lifestyl
characterist
record
dna
extract
realtim
quantit
polymeras
chain
reaction
qpcr
assay
use
detect
haemplasma
mycoplasma
haemof
candidatu
mycoplasma
haemominutum
candidatu
mycoplasma
turicensi
leishmania
sppand
bartonella
hensela
convent
pcr
assay
use
detect
ehrlichiaanaplasma
spp
sampl
yield
posit
result
leishmania
spp
ehrlichiaanaplasma
spp
underw
characteris
sequenc
elisa
perform
detect
l
infantum
antibodi
felin
leukaemia
viru
felv
antigen
felin
immunodefici
viru
fiv
antibodi
statist
analysi
perform
use
spss
assess
associ
variabl
infecti
agent
sampl
extract
exclud
due
failur
one
intern
control
pcr
remain
sampl
posit
pcr
haemoplasma
includ
haemof
ca
haemominutum
ca
turicensi
nineteen
posit
b
hensela
one
cat
pcr
posit
ehrlichiaanaplasma
spp
sequenc
reveal
ident
anaplasma
plati
leishmania
spp
dna
detect
cat
sequenc
reveal
l
infantum
case
l
infantum
serolog
posit
cat
test
one
cat
posit
leishmania
pcr
serolog
cat
underw
retrovir
serolog
felv
fiv
posit
statist
analysi
identifi
sever
signific
associ
p
includ
follow
haemoplasma
infect
outdoor
access
feralshelt
cat
origin
felv
fiv
infect
anaemia
feralshelt
cat
origin
studi
document
first
time
presenc
haemoplasma
l
infantum
b
hensela
plati
felv
fiv
felin
popul
cypru
preval
haemoplasma
fiv
b
hensela
infect
among
highest
report
cat
mediterranean
countri
leishmania
spp
similar
second
report
plati
infect
cat
mediterranean
countri
disclosur
disclosur
report
bartonella
speci
spp
zoonot
pathogen
infect
cat
common
preval
cat
southern
germani
still
unknown
aim
studi
determin
preval
bartonella
spp
dna
blood
cat
southern
germani
evalu
associ
bartonella
bacteremia
hous
condit
felin
immunodefici
viru
fiv
felin
leukemia
viru
felv
statu
includ
progress
regress
abort
felv
infect
blood
sampl
cat
present
differ
veterinari
clinic
southern
germani
variou
reason
test
bartonella
spp
dna
use
previous
publish
convent
polymeras
chain
reaction
pcr
target
fragment
rrna
intergen
spacer
region
statist
analysi
fisher
exact
test
use
preval
rate
bartonella
spp
bacteremia
ci
b
hensela
amplifi
cat
one
cat
posit
b
clarridgeia
dna
infect
cat
clinic
healthi
half
cat
thrombocytopenia
potenti
caus
bartonella
spp
infect
significantli
higher
risk
infect
bartonella
spp
live
mainli
outdoor
fivor
felvinfect
preval
bartonella
spp
bacteremia
low
southern
german
cat
still
risk
human
bartonella
infect
associ
cat
ownership
clinic
chang
bartonella
sppinfect
cat
relat
diseas
howev
thrombocytopenia
common
studi
requir
defin
potenti
clinic
relev
disclosur
disclosur
report
antemortem
diagnosi
felin
infecti
periton
fip
still
challeng
aim
studi
evalu
sensit
specif
combin
revers
transcript
nest
polymeras
chain
reaction
rtnpcr
sequenc
approach
detect
mutat
differ
nucleotid
posit
within
spike
gene
previous
shown
correl
fip
phenotyp
studi
popul
consist
cat
confirm
fip
defin
control
group
cat
fip
consid
import
differenti
diagnosi
definit
diagnos
diseas
blood
andor
effus
sampl
examin
felin
coronaviru
fcov
rna
rtnpcr
posit
nucleotid
posit
sequenc
nucleotid
transit
sensit
specif
neg
posit
predict
valu
determin
confid
interv
ci
calcul
rtnpcr
detect
fcov
cat
blood
n
andor
effus
n
fip
one
mutat
interest
found
pcrposit
blood
sampl
pcrposit
effus
sampl
diagnost
specif
combin
rtnpcr
sequenc
approach
blood
ci
effus
ci
diagnost
sensit
ci
blood
ci
effus
posit
test
result
therefor
confirm
suspicion
fip
neg
result
howev
use
rule
fip
especi
blood
avail
therefor
effus
present
diagnosi
fip
still
remain
challeng
disclosur
dr
elisabeth
mueller
manag
director
laboklin
gmbh
cokg
dr
karola
weider
employ
laboklin
gmbh
cokg
laboratori
offer
combin
rtnpcr
sequenc
approach
commerci
basi
perform
test
studi
felin
infecti
periton
fip
viral
diseas
caus
virul
strain
felin
coronaviru
fipv
diseas
appear
clinic
form
dri
effus
lead
fatal
outcom
diagnosi
base
histopatholog
lesion
necropsi
recent
discoveri
mutat
associ
fipv
strain
spike
gene
main
goal
detail
distribut
gene
mutat
differ
biolog
sampl
cat
suffer
fip
retrospect
observ
studi
cat
show
clinic
sign
compat
fip
ten
cat
pure
breed
male
femal
median
age
month
present
clinic
present
patholog
find
virolog
data
review
accord
clinic
sign
cat
classifi
dri
form
wet
form
fip
main
clinic
sign
includ
dehydr
hyperthermia
icteru
abnorm
abdomin
palpat
neurolog
ocular
disord
possibl
blood
fecal
materi
effus
fine
needl
aspir
fna
relev
organ
combin
recov
cat
felin
coronaviru
fcov
first
research
rtpcr
part
gene
sequenc
determin
eventu
presenc
mutat
among
dri
case
fcov
detect
blood
sampl
fecal
sampl
fna
among
wet
case
blood
sampl
fecal
sampl
effus
sampl
posit
presenc
fcov
mutat
never
found
fecal
sampl
found
effus
sampl
fna
mutat
detect
fecal
sampl
fna
effus
sampl
cat
mutat
neither
gene
identifi
despit
confirm
fip
necropsi
gene
mutat
frequent
observ
gene
despit
case
mutat
identifi
moreov
presenc
strain
harbour
mutat
fece
never
describ
could
suggest
possibl
diffus
fipv
among
felin
popul
conclus
viral
diagnosi
fip
base
rtpcr
sequenc
effus
fna
sampl
essenti
rtpcr
result
blood
sampl
care
interpret
high
risk
miss
fipv
final
search
mutat
gene
recommend
disclosur
disclosur
report
methicillin
resist
staphylococcu
aureu
mrsa
recent
becom
great
concern
pet
anim
diseas
zoonot
infect
mrsa
strain
transfer
pet
anim
human
could
occur
aim
present
studi
determin
occurr
mrsa
household
dog
januari
june
clinic
sampl
collect
dog
patient
veterinari
teach
hospit
depart
veterinari
scienc
messina
itali
affect
sever
diseas
variou
origin
sampl
process
bacteriolog
convent
method
isol
identif
strain
test
phenotyp
suscept
oxacillin
subject
pcr
protocol
detect
meca
gene
strain
carri
gene
consid
methicillin
resist
mr
lastli
mr
methicillin
sensit
mss
strain
kirbybau
disk
diffus
suscept
test
perform
highlight
resist
profil
use
molecul
belong
main
class
antimicrobi
use
veterinari
practic
strain
resist
least
one
molecul
class
antibiot
consid
multidrugresist
mdr
statist
analysi
result
made
use
ztest
primer
softwar
forti
staphylococcu
spp
strain
isol
belong
speci
frequent
isol
microorgan
staphylococcu
aureu
isol
staphylococcu
pseudintermediu
isol
follow
staphylococcu
epidermidi
isol
staphylococcu
cohnii
staphylococcu
warneri
isol
singl
isol
obtain
speci
staphylococcu
chromogen
staphylococcu
haemolyticu
staphylococcu
lentu
staphylococcu
lugdunensi
staphylococcu
saprophyticu
staphylococcu
simulan
staphylococcu
sciuri
thirteen
strain
staphylococcu
spp
phenotyp
resist
oxacillin
staphylococcu
aureu
pyoderma
exud
pleural
effus
posit
meca
gene
strain
staphylococcu
spp
mdr
result
show
presenc
mrsa
multidrugresist
staphylococc
strain
household
dog
lack
correspond
antimicrobi
suscept
test
molecular
method
found
present
studi
disclosur
disclosur
report
fourth
haemoplasma
call
candidatu
haematoparvunlik
cmhp
latter
identifi
cat
publish
studi
chile
carri
cat
preval
pcr
mhf
cmhmthe
aim
studi
perform
molecular
detect
haemoplasma
cat
valdivia
southern
chile
blood
sampl
taken
cat
use
haemoplasma
dna
detect
quantit
real
time
pcr
qpcr
universidad
austral
de
chile
qpcr
protocol
base
detect
felin
dna
target
housekeep
gene
mycoplasma
spp
rrna
gene
univers
primer
forward
revers
sybr
green
method
melt
temperatur
tm
analysi
allow
identifi
infect
mycoplasma
speci
mhf
cmhm
cmt
posibl
identifi
haemoplasma
speci
co
infect
cat
second
qpcr
speci
specif
protocol
appli
sampl
second
qpcr
protocol
base
rrna
gene
specif
primer
detect
mhf
cmhm
cmt
cmhp
sampl
posit
gene
prove
presenc
cat
dna
cat
posit
haemoplasma
correspond
cmhm
tm
mhf
tm
cmt
tm
co
infect
associ
cmhmmhf
cmhmcmt
cmhmcmhp
cmhmmhf
cmhp
detect
co
infect
anim
result
agre
found
previou
report
chile
europ
eua
brazil
cmhm
preval
speci
co
infect
less
frequent
valdivia
cat
infect
differ
haemoplasma
speci
cmt
cmhp
report
first
time
chilefound
uach
project
disclosur
disclosur
report
clinic
manifest
canin
viscer
leishmaniasi
canl
nonspecif
includ
progress
weight
loss
anemia
lymphadenomegali
hepatosplenomegali
dermatolog
renal
ocular
alter
cardiac
lesion
result
clinic
sign
scarc
describ
dog
vl
presenc
parasit
cardiac
tissu
involv
report
accordingli
present
studi
aim
evalu
histopatholog
abnorm
cardiac
tissu
dog
natur
infect
leishmania
infantum
chagasi
total
dog
evalu
dog
symptomat
one
present
clinic
sign
cardiac
involv
complianc
feder
law
owner
sign
consent
dog
submit
euthanasia
comprehens
postmortem
evalu
sampl
right
atrium
free
wall
ra
right
ventricl
free
wall
rv
interventricular
septum
iv
left
ventricl
free
wall
lv
collect
evalu
tissu
sampl
fix
formalin
embed
paraffin
section
mm
stain
hematoxylin
eosin
antileishmania
immunohistochemistri
also
perform
studi
approv
ethic
committe
anim
experiment
anim
welfar
protocol
number
histopatholog
chang
observ
least
one
evalu
cardiac
region
dog
frequent
cardiac
injuri
inflammatori
reaction
character
presenc
mononuclear
cell
infiltr
differ
degre
evalu
region
ra
one
highest
incid
histopatholog
chang
observ
anim
follow
rv
lv
siv
affect
dog
respect
immunohistochemistri
reveal
amastigot
cardiac
tissu
dog
posit
correl
found
cardiac
lesion
presenc
amastigot
myocardium
p
disclosur
disclosur
report
canin
leishmaniosi
life
threaten
zoonot
diseas
combin
meglumin
antimoni
allopurinol
consid
effect
therapi
canin
leishmaniosi
constitut
first
line
protocol
diseas
allopurinol
parasitostat
drug
use
longterm
maintain
low
parasit
load
avoid
clinic
relaps
tradit
allopurinol
consid
safe
drug
dog
howev
report
indic
xanthinuria
xanthin
urolithiasi
produc
prolong
therapi
allopurinol
dog
aim
prospect
studi
evalu
preval
urinari
advers
effect
allopurinol
treatment
mgkgbidpo
dog
leishmaniosi
diagnosi
made
compat
clinicopatholog
abnormalitit
leishmaniosi
high
leishmania
infantumspecif
antibodi
level
assess
quantit
elisa
leishmaniosi
diagnos
close
followup
day
treatment
includ
physic
examin
baselin
laboratori
test
cbc
biochemistri
profil
serum
electrophoresi
urinalysi
urinari
proteincreatinin
ratio
abdomin
ultrasound
perform
preliminari
result
dog
includ
dog
present
urinari
abnorm
base
biochemistri
profil
urinalysi
abdomin
ultrasound
time
diagnosi
four
present
xanthinuria
n
n
n
two
dog
present
renal
miner
treatment
two
dog
present
bladder
urolithiasi
sinc
treatment
xanthinuria
present
initi
dog
develop
renal
miner
bladder
urolithiasi
dog
renal
miner
urolithiasi
treat
restrict
protein
diet
far
develop
renal
diseas
present
studi
describ
earli
xanthinuria
renal
miner
urolithiasi
advers
effect
due
chronic
allopurinol
treatment
dog
leishmaniosi
neither
miner
analysi
renal
biopsi
perform
confirm
origin
lesion
urinari
abnorm
present
allopurinol
treatment
institut
thorough
monitor
dog
treat
leishmaniosi
combin
urinalysi
abdomin
ultrasound
perform
evalu
urinari
advers
effect
help
clinic
manag
advers
effect
disclosur
disclosur
report
giardia
duodenali
one
import
gastrointestin
parasit
dog
cat
zoonot
potenti
germani
preval
dog
cat
reach
respect
genotyp
genet
assemblag
parasit
infect
human
assemblag
b
mammal
includ
small
anim
contrast
parasit
assemblag
c
specif
dog
assemblag
f
cat
object
studi
analys
preval
potenti
epidemiolog
risk
factor
symptom
g
duodenali
infect
dog
cat
detect
g
duodenali
fece
dog
cat
analys
elisa
techniqu
dna
extract
real
time
pcr
well
multilocu
sequenc
type
perform
follow
gene
loci
triosephosph
isomeras
glutam
dehydrogenas
betagiardingen
ssu
rrna
questionnair
possibl
epidemiolog
risk
factor
evalu
statist
analys
perform
use
spss
odd
ratio
kolmogorowsmirnow
test
spearman
correl
fecal
sampl
dog
cat
collect
time
period
month
elisa
test
posit
dog
cat
giardia
posit
dog
posit
cat
gastrointestin
sign
genotyp
success
dog
sampl
assign
assemblag
follow
assemblag
n
ac
n
ad
n
b
n
bd
n
c
n
cd
n
n
one
posit
cat
sampl
could
genotyp
atyp
identifi
assemblag
signific
correl
giardia
infect
age
clinic
sign
deworm
statu
stay
abroad
found
monocent
studi
preval
rate
dog
cat
detect
good
accord
previou
studi
studi
highlight
high
rate
asymptomat
g
duodenali
infect
anim
potenti
zoonot
assemblag
detect
transmiss
giardia
small
anim
human
vice
versa
exclud
especi
young
deworm
anim
higher
preval
disclosur
disclosur
report
canin
parvovir
enter
remain
common
caus
morbid
mortal
young
dog
goal
studi
document
larg
cohort
affect
dog
analyz
sever
factor
possibl
predictor
fatal
outcom
medic
record
retrospect
search
dog
parvovir
enter
diagnos
posit
fecal
antigen
test
fecal
pcr
dog
includ
medic
record
complet
popul
compar
refer
popul
hospit
time
period
chi
squar
test
sever
factor
analyz
possibl
predictor
death
logist
regress
one
hundr
fourti
seven
case
includ
seventi
percent
dog
non
vaccin
puppi
age
month
intact
femal
rottweil
american
staffordshir
terrier
french
beauc
shepherd
dog
overrepres
clinic
sign
vomit
diarrhea
dehydr
present
dog
respect
hyperthermia
anemia
leucopenia
observ
dog
respect
major
affect
dog
hospit
day
mortal
rate
dog
hypoglycemia
admiss
observ
dog
blood
glucos
measur
risk
factor
associ
death
p
studi
predisposit
rottweil
american
staffordshir
terrier
french
beauc
shepherd
dog
observ
hypoglycemia
admiss
predictor
fatal
outcom
disclosur
disclosur
report
canin
parvoviru
cpv
infect
dog
remain
widespread
around
world
still
repres
major
health
threat
puppi
vaccin
manufactur
includ
compon
core
vaccin
packag
recommend
inject
week
interv
week
age
despit
broad
vaccin
coverag
number
report
suggest
lack
efficaci
vaccin
dog
report
implic
vaccin
belong
major
manufactur
case
usual
consid
link
interfer
matern
antibodi
matab
abl
persist
beyond
week
age
led
expert
group
recommend
third
vaccin
around
week
age
persist
matab
actual
repres
major
issu
immun
puppi
parvovirosi
inde
matab
titr
higher
haemaglutin
inhibit
hi
test
still
inhibit
vaccin
uptak
wherea
titr
prevent
field
viru
infect
contrast
hi
titr
higher
usual
consid
protect
diseas
viru
excret
immun
gap
therefor
critic
period
puppi
outcom
vaccin
order
evalu
impact
residu
mda
efficaci
standard
primari
vaccin
protocol
perform
vaccin
field
trial
serolog
followup
puppi
week
age
present
veterinari
practic
receiv
inject
week
interv
serolog
perform
elisa
vaccin
averag
matern
antibodi
titr
strongli
correl
age
puppi
primari
vaccin
remain
vaccin
inhibit
level
week
age
averag
titr
increas
significantli
inject
primari
vaccin
group
group
inject
primari
vaccin
individu
variabl
remain
signific
vaccin
uptak
invers
strongli
correl
prevaccin
matab
titr
vaccin
puppi
nt
seroconvert
despit
vaccin
compli
recommend
schedul
vaccin
start
dog
week
complet
week
averag
initi
matab
titr
compar
gener
popul
conclus
trial
support
recommend
addit
inject
primari
vaccin
week
especi
area
high
parvoviru
preval
pressur
high
level
matab
like
transfer
puppi
disclosur
author
employe
merial
dog
pcr
posit
aim
studi
evalu
use
determin
serum
level
creactiv
protein
crp
dog
natur
infect
bacterium
phagocytophilum
possibl
indic
clinic
phase
diseas
pcr
andor
ifa
posit
dog
clinic
present
andor
thrombocytopenia
includ
studi
base
result
dog
divid
group
pcr
posit
dog
ifa
posit
subdivid
accord
titer
level
pcr
neg
dog
posit
control
group
pcr
ifa
neg
dog
clinic
sign
andor
thrombocytopenia
neg
control
group
clinic
healthi
pcr
ifa
neg
dog
serum
level
crp
determin
use
lifeassay
canin
crp
lifeassay
lund
sveden
elev
concentr
crp
mgl
determin
pcr
posit
ifa
posit
dog
ifa
titer
coincid
presenc
clinic
sign
commonli
gener
clinic
sign
elev
bodi
temperatur
gastrointestin
problem
andor
mild
sever
thrombocytopenia
assess
crp
concentr
correl
certain
clinic
alter
thrombocytopenia
suggest
crp
concentr
elev
acut
phase
diseas
correl
aforement
chang
therefor
serv
addit
diagnost
paramet
crp
concentr
ifa
posit
dog
regardless
ifa
titer
level
present
clinic
sign
thrombocytopenia
higher
detect
level
mgl
dog
without
clinic
sign
laboratori
alter
may
speak
favor
reinfect
reactiv
persist
infect
least
case
caus
inflamm
found
specif
treatment
would
therefor
reason
case
especi
case
rise
crp
concentr
disclosur
disclosur
report
gallbladd
agenesi
rare
caus
elev
liver
enzym
dog
studi
evalu
featur
dog
male
castrat
femal
spay
suspect
gallbladd
agenesi
ultrasonographi
five
differ
breed
includ
chihuahua
n
toy
poodl
german
shepherd
jack
russel
terrier
shiba
dog
median
age
year
ten
dog
asymptomat
dog
show
decreas
appetit
vomit
ascit
seizur
diarrhea
dog
show
elev
liver
enzym
high
alanin
aminotransferas
level
median
ul
ul
dog
high
gammaglutamyl
transpeptidas
level
median
ul
ul
gallbladd
agenesi
confirm
use
laparoscopi
dog
laparotomi
liver
biopsi
sampl
obtain
dog
addit
comput
tomographi
cholangiographi
perform
dog
use
multidetector
comput
tomographi
mdct
scanner
follow
intraven
administr
contrast
medium
meglumin
iotrox
obtain
imag
analyz
workstat
reveal
absent
gallbladd
dog
vestigi
gallbladd
common
bile
duct
dilat
dog
dog
laparotomi
laparoscopi
use
visual
gallbladd
liver
abnorm
includ
malform
lobe
surfac
irregular
acquir
portal
system
collater
visual
confirm
dog
also
exhibit
hypoplasia
portal
vein
histolog
examin
conclus
anim
gallbladd
agenesi
asymptomat
studi
indic
good
longterm
prognosi
howev
symptom
associ
portal
hypertens
must
monitor
anim
primari
portal
vein
hypoplasia
disclosur
disclosur
report
assess
systol
arteri
blood
pressur
sap
import
tool
small
anim
intern
medicin
practic
especi
diseas
clinic
condit
caus
hypertens
hypotens
doppler
method
noninvas
sever
advantag
compar
oscillometr
method
studi
effect
bodi
posit
sap
consciou
dog
hypothesi
anim
posit
measur
alter
sap
valu
studi
design
prospect
random
regard
order
posit
measur
one
hundr
twenti
clientown
consciou
healthi
sick
adult
dog
weigh
kg
includ
sap
record
doppler
ultrasonographi
follow
american
colleg
veterinari
intern
medicin
consensu
statement
anim
posit
sternal
recumb
right
later
recumb
dog
lay
owner
lap
order
bodi
posit
raffl
time
measur
five
consecut
measur
bodi
posit
perform
alway
left
forelimb
averag
calcul
sap
valu
higher
sternal
recumb
mmhg
p
p
compar
obtain
owner
lap
mmhg
p
similar
right
later
recumb
mmhg
p
result
suggest
sap
measur
obtain
owner
lap
right
later
recumb
use
clinic
routin
sap
measur
obtain
sternal
recumb
avoid
measur
may
overestim
disclosur
disclosur
report
canin
patient
may
present
blood
pressur
bp
assess
clinic
diseas
associ
system
hypertens
ht
suspect
confirm
popul
may
encompass
patient
normal
bp
true
ht
situat
ht
clinician
aim
identifi
anim
ht
reliabl
minim
fals
posit
prospect
studi
investig
repeat
duplic
withinvisit
systol
bp
assess
consecut
canin
patient
present
bp
assess
small
anim
clinic
duplic
sbp
record
dog
control
group
healthi
dog
duplic
sbp
obtain
control
dog
result
duplic
measur
analysi
doppler
method
use
duplic
assess
oscillometr
method
use
duplic
assess
cuff
sizeloc
consist
within
dog
sbp
mmhg
consid
normal
nml
sbp
mmhg
consid
abnorm
abn
median
rang
elaps
time
duplic
read
minut
obtain
within
minut
correl
elaps
time
chang
sbp
p
equal
lower
median
decreas
dog
mmhg
n
nml
dog
abn
pant
score
compar
group
dog
nml
score
p
dog
stop
pant
tend
decreas
p
withinvisit
repeat
bp
diagnosi
good
dog
nml
appar
fals
posit
diagnos
ht
occur
dog
abn
mmhg
repeat
dog
pant
may
associ
increas
measur
sbp
method
duplic
withinday
measur
may
help
identifi
fals
posit
ht
diagnos
dog
initi
sbp
measur
mmhg
disclosur
disclosur
report
hypovitaminosi
previous
shown
preval
amongst
dog
protein
lose
enteropathi
ple
outcom
gener
poor
canin
ple
lack
studi
identifi
underli
risk
factor
hypothesi
studi
low
vitamin
serum
concentr
could
risk
factor
bad
outcom
patient
medic
record
dog
seen
royal
veterinari
colleg
review
identifi
dog
diagnosi
ple
confirm
histopatholog
dog
includ
studi
serum
sampl
frozen
within
minut
sampl
kept
degre
c
analysi
clinic
activ
score
ccecai
record
time
diagnosi
fortythre
dog
includ
studi
followup
refer
veterinarian
made
determin
outcom
patient
patient
divid
two
group
patient
deceas
due
ple
poor
outcom
group
n
patient
aliv
deceas
due
anoth
diseas
good
outcom
group
n
treatment
patient
alloc
two
group
one
group
consist
patient
prescrib
diet
group
receiv
diet
immunosuppress
agent
sampl
sent
dri
ice
michigan
state
univers
diagnost
center
popul
anim
health
ionis
calcium
ica
measur
use
ion
specif
electrod
oh
measur
use
commerci
avail
radioimmunoassay
valid
use
veterinari
medicin
comparison
outcom
group
age
ccecai
treatment
serum
oh
ica
perform
use
mannwhitney
u
test
chi
logist
regress
analysi
perform
determin
possibl
risk
factor
poor
outcom
result
ccecai
score
age
ica
concentr
two
group
significantli
differ
significantli
greater
number
dog
treat
food
alon
group
good
outcom
poor
outcom
group
p
furthermor
median
serum
oh
concentr
significantli
lower
patient
poor
outcom
nmoll
rang
nmoll
compar
patient
good
outcom
nmoll
rang
nmoll
p
use
logist
regress
oh
serum
concentr
statist
signific
factor
poor
outcom
p
increas
oh
serum
concentr
reduc
odd
poor
outcom
odd
ratio
ci
studi
requir
investig
vitamin
potenti
adjuv
therapeut
agent
ple
patient
disclosur
disclosur
report
campylobact
jejuni
cj
c
upsaliensi
cu
c
helveticu
ch
commonli
isol
dog
cat
faec
associ
clinic
sign
discord
lack
cj
recogn
human
pathogen
cu
consid
emerg
pathogen
ch
consid
pathogen
despit
high
level
genet
similar
recent
greater
wax
moth
galleria
mellonella
describ
anim
model
diseas
invertebr
high
degre
function
structur
homolog
mammalian
innat
immun
system
studi
aim
evalu
pathogen
potenti
cj
cu
ch
use
galleria
mellonella
larva
model
twelv
isol
cj
cu
ch
dog
cat
use
inocul
larva
inocula
prepar
suspend
isol
phosphatebuff
salin
pb
three
dilut
made
dilut
test
duplic
set
larva
larva
inject
haemocoel
via
last
left
proleg
use
insulin
syring
control
consist
pb
inocul
larva
uninocul
larva
surviv
larva
h
microaerob
atmospher
monitor
day
postinject
one
subset
isol
grown
muellerhinton
broth
use
prepar
secretori
product
anoth
grown
bloodagar
suspend
pb
heat
inactiv
minut
test
wholecel
lysat
heatstabl
insolubl
solubl
compon
overal
median
surviv
larva
cj
iqr
cu
iqr
ch
iqr
pb
iqr
uninocul
larva
iqr
dosedepend
associ
evid
speci
larval
surviv
similar
low
bacteri
dose
pb
larval
surviv
present
consist
pattern
speci
medium
high
bacteri
load
cj
higher
faster
larval
death
rate
cu
ch
p
differ
observ
cu
ch
p
signific
differ
speci
assay
secretori
product
inactiv
cell
solubleinsolubl
cellular
compon
observ
within
invertebr
diseas
model
support
vari
pathogen
potenti
speci
studi
appear
relat
patho
biolog
speci
rather
cellular
compon
metabol
product
invertebr
anim
model
promis
compar
pathogen
studi
disclosur
disclosur
report
grellet
duboi
feugier
c
girardet
magnan
v
andr
eo
g
trombini
ca
boehring
j
suchodolski
j
steiner
royal
canin
aimargu
franc
veterinari
depart
french
armi
health
servic
suipp
franc
gastrointestin
laboratori
texa
univers
colleg
station
tx
usa
acut
stress
medium
high
durat
highintens
exercis
report
associ
increas
serum
creactiv
protein
crp
concentr
import
acutephas
reactant
dog
howev
effect
exercis
fecal
concentr
biomark
intestin
inflamm
previous
evalu
dog
goal
studi
determin
moder
intens
short
durat
exercis
caus
increas
crp
andor
concentr
dog
potenti
lead
misinterpret
result
thirtyseven
adult
militari
work
dog
german
belgian
shepherd
dog
male
mean
age
year
includ
studi
fecal
qualiti
fecal
serum
crp
concentr
evalu
standard
exercis
minut
bikejor
speed
kmh
fecal
qualiti
evalu
base
scale
liquid
dri
hard
fece
fecal
crp
concentr
assay
previous
valid
elisa
test
data
analyz
anova
test
repeat
measur
sa
softwar
result
present
median
rang
serum
crp
concentr
increas
significantli
exercis
median
excercis
mgl
mgl
p
also
fecal
concentr
significantli
higher
exercis
compar
baselin
concentr
ngg
vs
ngg
p
signific
effect
exercis
fecal
score
observ
exercis
p
studi
demonstr
moderateintens
shortdur
effort
perform
healthi
armi
dog
caus
signific
increas
fecal
serum
crp
concentr
compar
baselin
valu
within
respect
refer
interv
therefor
moder
exercis
present
confound
variabl
interpret
fecal
serum
crp
concentr
healthi
dog
disclosur
studi
perform
thank
financi
support
royal
canin
imag
integr
part
workup
canin
gastrointestin
gi
diseas
radiographi
ultrasonographi
noninvas
modal
evalu
bowel
mani
find
lack
desir
sensit
specif
endoscopi
directli
visual
gi
mucosa
limit
length
endoscop
need
gener
anesthesia
advanc
train
expens
equip
ambulatori
lightbas
imag
ali
new
imag
modal
util
highresolut
camera
microprocessor
led
illumin
noninvas
visual
gastrointestin
mucosa
ali
perform
oral
administr
fulli
autom
devic
size
pill
propel
peristalsi
aim
studi
analyz
imag
qualiti
gi
transit
time
seri
five
client
own
dog
undergo
ali
dog
foodrestrict
hour
hour
capsul
administr
capsul
retriev
imag
download
analyz
video
clip
frame
durat
obtain
stomach
proxim
middl
distal
small
intestin
proxim
colon
assess
imag
qualiti
internist
rate
imag
scale
poor
excel
base
clariti
resolut
imag
obscur
mucosa
fluid
bubbl
debri
score
region
compar
use
gener
estim
equat
analysi
gastric
small
intestin
transit
time
calcul
base
visual
passag
capsul
stomach
duodenum
ileum
colon
clinic
analysi
entir
video
perform
one
author
ali
success
perform
patient
advers
effect
averag
studi
durat
ae
hour
mean
imag
acquisit
count
ae
gastric
small
intestin
transit
time
ae
minut
ae
minut
respect
median
rang
imag
qualiti
score
stomach
si
colon
respect
imag
qualiti
score
significantli
higher
stomach
si
colon
p
visual
lesion
consist
gi
ulcer
dog
inflammatori
bowel
diseas
dog
biliou
vomit
syndrom
dog
one
dog
receiv
chronic
nsaid
normal
studi
ambulatori
lightbas
imag
result
good
excel
imag
qualiti
throughout
gi
tract
bowel
prepar
consid
enhanc
visual
colon
ali
safe
easi
perform
ambulatori
dog
therefor
consid
workup
canin
gi
diseas
disclosur
dr
hardi
solomon
employ
infin
medic
establish
sever
score
system
outcom
predict
dog
pancreat
pc
liu
fr
wu
yj
lee
bl
su
graduat
institut
veterinari
medicin
nation
taiwan
univers
taipei
taiwan
nation
taiwan
univers
veterinari
hospit
nation
taiwan
univers
taipei
taiwan
institut
veterinari
clinic
scienc
nation
taiwan
univers
taipei
taiwan
canin
pancreat
common
exocrin
pancreat
disord
prognosi
canin
pancreat
variabl
logist
regress
construct
sever
score
system
avail
four
hundr
thirti
nine
dog
diagnos
pancreat
acut
onset
compat
clinic
sign
posit
snap
cpl
trademark
test
andor
associ
abdomin
ultrasonograph
abnorm
januari
decemb
present
nation
taiwan
univers
veterinari
hospit
ntuvh
one
hundr
three
dog
hospit
complet
medic
therapi
outcom
select
analysi
dog
divid
surviv
n
nonsurviv
n
group
fortyseven
paramet
includ
signal
clinic
sign
physic
examin
clinicopatholog
examin
complic
concurr
diseas
analyz
compar
two
group
logist
regress
analys
perform
studi
variabl
p
consid
analys
mortal
studi
age
heart
rate
respiratori
rate
white
blood
cell
count
albumin
bun
creatinin
potassium
presenc
system
inflammatori
respons
syndrom
sir
presenc
oliguria
anuria
select
construct
score
continu
variabl
outsid
refer
interv
separ
quartil
yield
quartilespecif
odd
ratio
or
surviv
base
integ
valu
score
system
develop
incorpor
weight
factor
assign
quartil
predict
total
score
calcul
dog
sum
weight
factor
total
score
dog
rang
sever
score
studi
achiev
area
receiv
oper
characterist
auroc
optim
cutoff
point
discrimin
outcom
sensit
specif
respect
mortal
score
wherea
score
signific
differ
p
two
group
seper
cutoff
point
sever
score
system
studi
provid
reliabl
clinic
applic
method
predict
clinic
outcom
dog
pancreat
disclosur
disclosur
report
glucocorticoid
gc
known
antiinflammatori
immunmodulatori
properti
therefor
often
use
therapi
canin
inflammatori
bowel
diseas
ibd
recent
shown
endogen
gc
also
produc
intestin
epithelium
men
mice
influenc
gastrointestin
immun
system
case
inflammatori
neoplast
condit
thu
aim
project
prove
gc
produc
metabol
canin
intestin
epithelium
five
healthi
beagl
dog
includ
prospect
studi
dog
clinic
examin
given
clinic
score
use
canin
ibd
activ
index
cibdai
score
system
also
gastrointestin
endoscopi
perform
mucos
biopsi
specimen
duodenum
examin
histolog
board
certifi
pathologist
use
wsava
grade
biopsi
incub
endoscop
mucos
biopsi
tissu
cultur
medium
hlabel
progesteron
absenc
stimul
perform
mean
age
includ
dog
year
mean
weight
kg
beagl
dog
mean
clinic
score
mean
wsava
score
hour
supernat
harvest
radioact
progesteron
metabolit
form
detect
use
high
perform
liquid
chromatographi
plu
liquid
scintil
count
dog
hprogesteron
metabol
variou
steroid
speci
nevertheless
local
product
cortisol
could
proven
summari
could
shown
precursor
gc
metabol
healthi
canin
intestin
mucos
tissu
disclosur
disclosur
report
studi
relationship
pancreat
cardiac
injuri
dog
cat
previous
valid
cardiac
troponin
ctni
vet
j
assay
sensit
specif
detect
cardiac
injuri
domest
anim
found
variou
noncardiac
diseas
dog
cat
associ
cardiac
injuri
detect
serum
cardiac
troponin
includ
case
pancreat
also
valid
dggrlipas
assay
costeffect
sensit
specif
detect
pancreat
dog
cat
vet
clin
path
herein
test
hypothesi
pancreat
associ
cardiac
injuri
ctni
measur
advia
centaur
tniultra
assay
dggrlipas
randox
colourimetr
assay
retrospect
analys
data
dog
cat
admit
ucd
veterinari
hospit
ctn
lipas
measur
upper
limit
refer
rang
lipas
dog
ul
consid
indic
mild
pancreat
moder
mark
upper
limit
refer
rang
lipas
cat
refer
rang
ctni
ugl
dog
cat
consid
indic
mild
cardiac
injuri
moder
mark
dog
cat
lipas
ctni
measur
seventyeight
dog
normal
troponin
normal
lipas
normal
lipas
normal
ctni
dog
pancreat
indic
increas
lipas
pancreat
mild
moder
mark
sixtyseven
dog
increas
ctni
mild
moder
mark
cardiac
injuri
dog
pancreat
absent
mild
moder
mark
cat
normal
ctn
normal
lipas
cat
pancreat
sever
lipas
ctni
correl
r
dog
cat
conclud
pancreat
cardiac
injuri
indic
highsensit
highspecif
assay
randoxdggrlipas
centaurctni
respect
uncommon
veterinari
hospit
case
confirm
extend
previou
work
pancreat
dog
cat
typic
associ
cardiac
injuri
sever
pancreat
cardiac
injuri
correl
dog
cat
pancreat
cardiac
injuri
moder
mark
disclosur
disclosur
report
intracellular
colon
may
serv
protect
nich
helicobact
spporgan
evad
effect
treatment
contribut
recolon
confoc
endomicroscopi
cem
endoscop
modal
allow
vivo
gastrointestin
imag
high
resolut
aid
realtim
identif
helicobact
pylori
intracellular
mucos
associ
bacteri
dog
nonhelicobact
pylorihelicobact
nhph
describ
intracellularli
object
studi
determin
util
cem
identifi
nhph
dog
compar
diagnost
modal
assess
abil
identifi
intracellular
organ
fourteen
clinic
healthi
dog
underw
standard
gastroduodenoscopi
follow
cem
use
topic
acriflavin
imag
obtain
use
cem
minimum
five
site
within
stomach
endoscop
pinch
biopsi
obtain
histopatholog
polymeras
chain
reaction
pcr
fluoresc
situ
hybridis
fish
methodolog
compar
sensit
detect
presenc
distribut
nhph
abil
identifi
intracellular
organ
cem
provid
high
qualiti
imag
allow
vivo
identif
ofnhph
dog
fish
postprocedur
analysi
standard
histopatholog
identifi
nhph
nhph
identifi
within
superfici
gastric
mucu
gastric
pit
distribut
throughout
stomach
diffus
multifoc
cem
find
correl
fish
pcr
howev
fish
enabl
identif
intracellular
nhph
present
dog
cem
provid
vivo
histolog
imag
capabl
identifi
nhph
gastroscopi
unabl
identifi
intracellular
organ
use
current
fluorophor
protocol
nhph
canin
stomach
commonli
identifi
intracellularli
disclosur
dr
sharman
share
optiscan
imag
pti
ltd
chronic
enteropathi
ce
exocrin
pancreat
insuffici
epi
caus
hypocobalaminemia
cat
current
supplement
protocol
cobalamin
cat
call
repeat
parenter
inject
human
sever
studi
report
equal
efficaci
oral
administr
cobalamin
also
evid
oral
supplement
effect
dog
hypocobalaminemia
recent
also
report
oral
cobalamin
substitut
restor
normocobalaminemia
healthi
elderli
cat
purpos
retrospect
case
seri
evalu
whether
oral
cobalamin
supplement
restor
normocobalaminemia
hypocobalaminem
cat
chronic
enteropathi
computer
databas
search
cat
treat
evidensia
specialist
anim
hospit
helsingborg
sweden
perform
inclus
criteria
cat
symptom
ce
initi
serum
cobalamin
concentr
pmoll
refer
interv
pmoll
daili
oral
treatment
cyanocobalamin
mgtablet
tabletcat
daili
followup
serum
cobalamin
concentr
measur
day
initi
daili
oral
cobalamin
supplement
thirteen
cat
age
year
median
differ
breed
met
inclus
criteria
present
complaint
includ
vomit
anorexia
diarrhea
weight
loss
lethargi
increas
pancrea
specif
lipas
spec
fpl
serum
concentr
report
cat
increas
serum
alanin
transaminas
activ
felin
serum
trypsin
like
immunoreact
ftli
determin
cat
reveal
result
within
refer
interv
cat
abdomin
ultrasound
chang
relat
gastrointestin
tract
mildmoder
thicken
small
intestin
wall
thicken
musculari
layer
poor
definit
intestin
wall
layer
andor
enlarg
mesenteri
lymph
node
histopatholog
perform
cat
reveal
small
intestin
inflamm
five
cat
small
intestin
lymphoma
one
serum
cobalamin
increas
cat
treatment
concentr
differ
rang
pmoll
mean
pmoll
mean
aestandard
deviat
serum
cobalamin
concentr
pmoll
pmoll
supplement
differ
statist
signific
p
pair
ttest
result
suggest
oral
cobalamin
supplement
effect
normal
serum
cobalamin
concentr
cat
variou
enteropathi
prospect
studi
warrant
compar
cellular
cobalamin
statu
cat
treat
parenter
oral
cobalamin
supplement
disclosur
disclosur
report
pulmonari
thromboembol
pte
observ
dog
idiopathicinflammatorybowel
diseas
ibd
particularli
proteinlos
enteropathi
ple
hypercoagul
attribut
antithrombin
loss
although
pathogenesi
like
complex
human
venou
thromboembol
te
wellrecognis
complic
crohn
diseas
ulcer
coliti
pathogenesi
te
still
complet
understood
derang
procoagul
anticoagul
factor
demonstr
includ
increas
circul
procoagul
microparticl
mp
aim
pilot
studi
evalu
mpprocoagul
activ
plasma
dog
ibd
ple
use
function
elisa
assay
zymuphenmpact
aniara
hypothesis
dog
ple
subset
dog
ibd
without
ple
would
increas
level
circul
mp
studi
group
consist
dog
ibd
includ
ple
diagnosi
base
compat
clinic
histopatholog
exclus
caus
chronic
gastrointestin
diseas
ple
defin
ibd
plu
hypoproteinaemia
serum
total
protein
gl
hypoalbuminaemia
serum
albumin
gl
pte
diagnos
one
dog
ple
suspect
second
control
group
compris
healthi
dog
undergo
blood
sampl
reason
unrel
studi
includ
blood
donor
screen
n
health
assess
n
dog
consid
healthi
base
owner
evalu
physic
examin
haematolog
serum
biochemistri
median
mp
procoagul
activ
dog
ibd
nm
rang
compar
nm
rang
control
group
median
mp
activ
ple
dog
nm
rang
compar
nm
rang
nonpl
ibd
dog
use
kruskalw
test
nonparametr
data
dunn
multipl
comparison
test
group
statist
differ
interestingli
mpprocoagul
activ
valu
dog
document
pte
nm
dog
high
clinic
suspicion
pte
mpprocoagul
activ
nm
highest
mpprocoagul
activ
detect
healthi
control
dog
rais
concern
preanalyt
sampl
error
remov
measur
impact
statist
analysi
remain
nonsignific
mpprocoagul
activ
nm
consid
clinic
relev
human
employ
similar
cutoff
control
ibd
ple
group
would
defin
increas
level
circul
mp
studi
requir
fulli
evalu
clinic
relev
diagnost
potenti
mp
evalu
disclosur
disclosur
report
intestin
microbiota
increasingli
link
pathogenesi
chronic
enteropathi
ce
dog
imbal
duoden
fecal
microbi
commun
associ
mucos
inflamm
rel
littl
known
alter
mucos
bacteria
seen
ce
involv
ileum
colon
aim
present
studi
use
fluoresc
situ
hybrid
fish
techniqu
investig
composit
spatial
organ
mucos
microbiota
endoscop
biopsi
obtain
dog
ce
control
tissu
section
ileum
colon
dog
inflammatori
bowel
diseas
ibd
dog
granulomat
coliti
gc
dog
intestin
neoplasia
control
studi
fish
target
rrna
gene
total
bacteria
groupspecif
organ
individu
bacteri
speci
shown
relev
human
ibd
number
mucos
bacteria
analyz
use
gener
linear
model
colon
ileum
tissu
spearman
rank
correl
coeffici
use
test
correl
mucos
microbiota
inflammatori
cibdai
score
histopatholog
indic
ileal
colon
mucosa
healthi
dog
dog
ce
predominantli
colon
bacteria
local
free
adher
mucu
compart
dog
ce
harbor
p
mucos
bacteria
belong
clostridiumcoccoideseubacterium
rectal
group
bacteroid
enterobacteriacea
escherichia
coli
versu
control
within
ce
group
ibd
dog
increas
p
enterobacteriacea
e
coli
bacteria
attach
onto
surfac
epithelia
invad
within
intestin
mucosa
bacteri
invas
e
coli
present
ileal
colon
mucosa
dog
gc
p
dog
intestin
neoplasia
increas
p
adher
total
bacteria
enterobacteriacea
e
coli
invas
enterobacteriacea
e
coli
bacteroid
bacteria
biopsi
specimen
versu
group
increas
number
total
bacteria
adher
colon
mucosa
associ
clinic
diseas
sever
cibdai
score
ibd
dog
p
result
indic
histopatholog
lesion
canin
ce
associ
differ
popul
ileal
colon
mucos
microbiota
spatial
segmentspecif
structur
differenti
respons
select
bacteri
group
intestin
inflamm
may
pivot
regard
function
consequ
alter
pathogenesi
canin
ce
disclosur
disclosur
report
abdomin
girth
use
indic
human
adipos
measur
made
tape
measur
given
concern
precis
accuraci
repeat
measur
tape
measur
design
inbuilt
mechan
improv
consist
although
bodi
condit
score
common
method
assess
adipos
dog
zoometr
system
also
develop
requir
use
tape
measur
howev
precis
accuraci
zoometr
measur
known
aim
studi
determin
precis
accuraci
differ
type
tape
measur
varieti
dimension
measur
varieti
length
head
forelimb
hindlimb
circumferenti
neck
thorax
abdomen
made
use
three
differ
tape
measur
two
design
improv
precis
standard
tape
myotap
tm
gulick
ii
tm
assess
intraoper
variabl
measur
taken
consecut
day
healthi
dog
assess
interoper
variabl
oper
independ
took
measur
group
dog
variou
breed
size
intraoper
comparison
precis
good
overal
coeffici
variat
cv
measur
interoper
comparison
precis
variabl
although
reason
averag
mean
cv
vari
depend
upon
tape
measur
type
p
greatest
standard
tape
measur
least
gulich
ii
tm
could
highli
variabl
measur
individu
dog
maximum
cv
head
measur
standard
tape
measur
signific
differ
also
exist
absolut
result
circumferenti
measur
taken
differ
tape
measur
type
neck
p
thorax
p
abdomen
p
final
signific
oper
differ
also
evid
measur
head
p
hindlimb
p
other
forelimb
p
neck
p
thorax
p
abdomen
p
summari
although
precis
individu
oper
make
zoometr
measur
good
signific
interoper
tape
type
differ
exist
result
implic
system
use
rang
zoometr
measur
assess
adipos
order
ensur
precis
accuraci
recommend
oper
take
measur
type
tape
disclosur
studi
conduct
support
research
grant
ajg
readership
fund
royal
canin
ajg
also
receiv
financi
remuner
gift
provid
educ
materi
speak
confer
consult
work
slh
post
univers
liverpool
also
fund
royal
canin
koizumi
noda
c
shimokawa
kusumi
kobayashi
watari
k
otsuji
teikyo
univers
scienc
tokyo
japan
grace
anim
hospit
tokyo
japan
nihon
univers
fujisawa
japan
bodi
condit
score
bc
method
commonli
use
diagnosi
nutrit
statu
small
anim
howev
method
subject
due
sensori
evalu
therefor
improv
precis
bc
diagnosi
expect
previou
studi
shown
bc
model
creat
improv
precis
bc
diagnosi
howev
palpat
site
identifi
palpat
site
must
site
thick
subcutan
fat
abl
captur
measur
anim
obes
statu
therefor
object
studi
find
remark
bodi
site
chang
obes
statu
use
ultrason
diagnost
equip
nine
dog
vari
percent
bodi
fat
use
studi
percent
bodi
fat
measur
bodi
fat
analyz
dog
kao
imag
analysi
palpat
site
evalu
use
echo
xario
toshiba
attach
linear
probe
measur
point
oclock
posit
rib
distanc
skin
surfac
rib
measur
echogram
distanc
l
scapula
ilium
measur
offset
differ
physiqu
dog
breed
dl
use
compar
rel
valu
quantiti
fat
measur
point
bc
dog
use
studi
bc
bc
dog
bc
bc
statist
signific
correl
found
bc
dl
valu
dl
valu
increas
order
bc
suggest
thick
subcutan
fat
chest
thicker
head
side
tail
side
also
l
valu
back
abdomen
highest
valu
found
posit
tendenc
remark
bc
differ
dl
valu
recogn
dog
bc
conclus
posit
suitabl
palpat
point
chest
k
otsuji
suzuki
n
furukawa
n
kobayashi
koizumi
kusumi
kobayashi
efficaci
bodi
condit
score
bc
model
bc
diagnosi
wsava
proceed
disclosur
disclosur
report
bodi
condit
score
bc
method
commonli
use
diagnosi
nutrit
statu
small
anim
bc
recogn
one
screen
method
nutrit
diagnosi
american
anim
hospit
associ
howev
method
subject
due
sensori
evalu
therefor
made
bc
model
increas
precis
bc
diagnosi
shown
efficaci
bc
model
howev
prototyp
model
report
tend
higher
bc
target
bc
therefor
improv
bc
model
studi
sixti
seven
dog
vari
bc
use
studi
bodi
fat
percentag
measur
use
bodi
fat
analyz
dog
kao
healthlab
bc
model
improv
use
sever
rubber
sheet
rel
hard
stack
rubber
sheet
bc
measur
duromet
satotec
tokyo
japan
bc
diagnosi
dog
perform
pet
owner
use
bc
model
bc
repres
hard
bc
model
hard
decreas
linearli
lowest
bc
valu
expect
high
correl
recogn
bc
bodi
fat
percentag
result
suggest
efficaci
bc
model
howev
bodi
fat
percentag
dog
diagnos
bc
higher
bodi
fat
percentag
report
previou
paper
dog
bodi
fat
percentag
diagnos
bc
need
studi
futur
make
clear
differ
bodi
fat
percentag
data
date
previou
research
complet
bc
model
help
provid
precis
nutrit
diagnosi
dog
human
metabol
syndrom
ms
wellrecognis
extens
studi
entiti
compris
obes
hypertens
dyslipidaemia
glucos
intoler
associ
increas
risk
cardiovascular
diseas
diabet
recent
human
ms
criteria
adapt
dog
defin
condit
obesityrel
metabol
dysfunct
ormd
observ
ormd
associ
increas
circul
insulin
decreas
adiponectin
concentr
suggest
dog
human
link
obes
ormd
associ
diseas
although
pathogenet
mechan
health
signific
dog
remain
unknown
main
aim
present
studi
compar
plasma
proteom
obes
dog
without
ormd
investig
mechan
associ
canin
ormd
possibl
signific
health
statu
eight
obes
dog
refer
weight
manag
royal
canin
weight
manag
clinic
univers
liverpool
particip
studi
clinic
assess
includ
physic
examin
bodi
condit
score
blood
pressur
measur
routin
clinicopatholog
analysi
surplu
plasma
use
proteom
analysi
sampl
first
treat
proteomin
thedeplet
highabund
protein
subsequ
analys
dige
methodolog
eight
dog
studi
dog
ormd
dog
imag
analysi
statist
analysi
allow
identif
spot
differenti
express
concentr
dog
without
ormd
among
spot
overexpress
downexpress
dog
ormd
dog
present
ormd
although
result
present
studi
preliminari
still
identif
spot
perform
observ
datarev
dog
ormd
present
alter
plasma
proteom
could
respons
develop
ormdrel
patholog
disclosur
studi
fund
waltham
ajg
readership
fund
royal
canin
ajg
also
receiv
financi
remuner
gift
provid
educ
materi
speak
confer
consult
work
slh
post
univers
liverpool
also
fund
royal
canin
vb
employe
royal
canin
pjm
employe
waltham
aim
studi
assess
diagnost
valu
discrimin
potenti
normal
heart
size
microcardia
cardiomegali
method
calcul
cardiothorac
ratio
ctr
use
area
measur
compar
vertebr
heart
scale
method
vh
use
refer
cardiac
size
dog
one
hundrednin
dog
xray
accept
studi
patient
belong
small
medium
size
breed
fourtyseven
male
sixtytwo
femal
age
year
analog
xray
scan
transfer
comput
vh
ctr
calcul
patient
commerci
softwar
data
collect
process
statyst
analysi
softwar
patient
distribut
group
respiratori
phase
heart
size
low
correl
vh
ctr
r
statist
signific
p
good
correl
obtain
vh
ctr
microcardia
normal
heart
size
cardiomegali
group
p
furthermor
ctr
dog
microcardia
normal
cardiac
size
well
ctr
dog
normal
cardiac
size
cardiomegali
significantli
statist
differ
p
respect
p
obtain
among
group
distribut
respiratori
phase
vh
statist
signific
differ
obtain
normal
cardiac
size
cardiomegali
inspiratori
phase
group
p
xray
taken
inspiratori
phase
cutoff
sensit
specif
diagnos
cardiomegali
ctr
consid
valid
method
abl
discrimin
patient
microcardia
cardiomegali
normal
heart
size
moreov
found
ctr
cutoff
mesur
inspiratori
phase
good
predictor
cardiomegali
key
word
cardiac
cardiothorac
ratio
dog
xray
disclosur
disclosur
report
canin
cardiac
conduct
system
modifi
anatom
function
adapt
matern
heart
gestat
howev
clear
chang
persist
modifi
parturit
therefor
aim
studi
describ
canin
electrocardiograph
featur
cours
normal
puerperium
twenti
healthi
purebr
ae
yearold
weigh
kg
ae
bitch
includ
studi
anim
whelp
healthi
puppi
term
wean
day
parturit
day
dog
electrochardiograph
evalu
day
mean
electr
axi
mea
degre
p
wave
amplitud
pa
mv
durat
pd
ms
pr
interv
pr
ms
qr
complex
amplitud
qrsa
mv
durat
qrsd
ms
qt
interv
qt
ms
st
segment
st
mv
calcul
mm
veloc
rr
interv
immedi
preced
complex
record
qt
interv
correct
qtc
van
de
water
formula
qtc
later
lead
ii
record
mm
analyz
heart
rate
hr
bpm
cardiac
rhythm
cr
normal
sinu
rhythm
sinu
arrythmia
valu
hr
mea
pa
pd
pr
qrsa
qrsd
qt
rr
qtc
analyz
anova
repeat
measur
follow
tukey
test
cardiac
rhythm
analyz
chi
squar
test
spss
spss
inc
chicago
il
usa
p
consid
signific
studi
period
hr
p
qtc
p
progress
decreas
rr
p
pa
increas
p
qr
complex
amplitud
diminish
second
week
parturit
increas
follow
week
p
mean
electr
axi
shift
right
period
p
day
bitch
present
normal
sinu
rhythm
contrast
day
bitch
present
sinu
arrhythmia
p
day
onward
bitch
show
sinu
arrhythmia
p
wave
durat
pr
qrsd
qt
st
remain
unchang
puerperium
conclud
electrophysiolog
adapt
chang
canin
gestat
revert
normal
puerperium
present
studi
contribut
understand
canin
cardiac
physiolog
reproduct
stage
disclosur
disclosur
report
echocardiograph
assess
pregnant
queen
pg
blanco
r
rodr
carranza
rube
r
vercellini
pr
batista
ortora
c
gobello
nation
univers
la
plata
la
plata
argentina
cardiovascular
adapt
gestat
guarante
appropri
develop
fetus
matern
cardiovascular
maladapt
highli
correl
advers
pregnanc
outcom
hemodynam
chang
occur
canin
pregnanc
describ
scarc
inform
concern
matern
cardiac
variat
felin
gestat
thu
aim
studi
describ
cardiac
morpholog
systol
function
variat
normal
felin
pregnanc
eighteen
pregnant
queen
echocardiograph
evalu
toshiba
nemio
xg
japan
mhz
transduc
everi
day
day
defin
day
mate
parturit
left
ventricular
dimens
measur
short
axi
view
mmode
trace
shorten
fraction
calcul
lvdd
lvd
lvdd
assess
systol
function
stroke
volum
ml
calcul
product
veloc
time
integr
measur
pulsedwav
doppler
crosssect
area
aorta
cardiac
output
lminut
calcul
product
stroke
volum
heart
rate
bpm
deriv
electrocardiograph
monitor
uterin
arteri
resist
index
ri
obtain
doppler
ultrasound
paramet
analyz
repeat
measur
anova
queen
deliv
healthi
kitten
term
throughout
studi
period
interventricular
septum
diastol
p
systol
p
left
ventricular
diamet
diastol
p
augment
gestat
shorten
fraction
p
cardiac
output
p
matern
heart
rate
p
also
increas
parturit
convers
uterin
arteri
resist
index
decreas
period
p
conclud
cardiac
structur
function
vari
normal
pregnanc
queen
cardiac
eccentr
hypertrophi
systol
function
cardiac
output
increas
appear
consequ
hemodynam
modif
occur
pregnanc
assess
matern
cardiovascular
function
may
prove
use
screen
tool
detect
pregnanc
complic
felin
reproduct
disclosur
disclosur
report
tricuspid
annular
plane
systol
excurs
taps
echocardiograph
measur
allow
assess
right
ventricular
systol
function
describ
refer
valu
taps
normal
adult
dog
refer
influenc
age
taps
dog
influenc
report
human
thu
goal
studi
determin
reproduc
measur
taps
normal
dog
determin
relationship
taps
age
healthi
beagl
dog
taps
measur
mmode
record
later
aspect
tricuspid
valv
annulu
obtain
left
parastern
apic
view
taps
valu
averag
measur
consecut
beat
sinu
rhythm
measur
record
two
differ
person
cv
mm
f
differ
grade
experi
canin
echocardiographi
studi
patient
complet
twodimension
doppler
studi
use
envisor
chd
philip
ultrasound
system
twentythre
healthi
beagl
use
studi
approv
ethic
committe
veterinari
medicin
servic
la
palma
de
gran
canaria
univers
spain
carri
accord
current
european
legisl
anim
protect
dog
divid
three
differ
group
accord
age
group
includ
twelv
dog
year
group
includ
three
dog
year
group
includ
eight
dog
older
year
analyz
differ
group
use
nonparametr
kruskal
walli
wilcoxon
score
rank
sum
test
differ
respect
sex
dog
group
present
higher
taps
valu
group
ae
cm
vs
ae
cm
vs
ae
cm
p
statist
intraobserv
interobserv
agreement
use
intraclass
correl
coeffici
p
studi
show
taps
measur
easili
obtain
standard
echocardiographi
system
adequ
interobserv
agreement
studi
show
higher
valu
taps
normal
young
dog
respect
older
dog
result
similar
result
obtain
human
could
reflect
less
effect
right
ventricl
age
valu
present
taken
caution
due
rel
small
number
patient
includ
may
also
necessari
valid
result
futur
studi
second
independ
sampl
dog
race
disclosur
disclosur
report
tetralog
fallot
tof
congenit
heart
diseas
character
abnorm
ie
pulmon
stenosi
ventricular
septal
defect
vsd
aortic
overrid
secondari
right
ventricular
hypertrophi
caus
anterior
deviat
abnorm
septat
conal
septum
embryon
period
studi
report
hemodynam
consequ
clinic
outcom
tof
small
anim
object
retrospect
studi
therefor
document
epidemiolog
clinic
echodoppl
find
surviv
canin
felin
popul
tof
case
record
anim
diagnos
tof
combin
use
echocardiographi
doppler
examin
review
tetralog
fallot
identifi
anim
dog
cat
commonli
repres
breed
terrier
dog
domest
shorthair
cat
includ
anim
clinic
affect
time
diagnosi
pulmon
stenosi
character
variabl
systol
dopplerderiv
pressur
gradient
dog
median
rang
mmhg
cat
mmhg
associ
hypoplasia
pulmonari
trunk
one
third
case
vsd
larg
median
vsd
aorta
ratio
dog
cat
median
age
death
cardiac
caus
month
without
signific
differ
dog
cat
p
result
suggest
cat
dog
tofrel
death
occur
predominantli
young
adult
anim
major
hemodynam
consequ
time
diagnosi
disclosur
disclosur
report
aim
studi
assess
whether
radiograph
echocardiograph
cardiovascular
variabl
differ
across
age
band
healthi
cat
cohort
clinic
healthi
cat
categor
three
group
adolescentadult
year
n
middleag
year
n
geriatr
year
n
cat
underw
full
physic
examin
complet
blood
count
routin
biochem
profil
baselin
serum
total
thyroxin
concentr
auscult
noninvas
blood
pressur
measur
thorac
radiographi
electrocardiographi
echocardiographi
cat
hypertens
hyperthyroid
cardiac
renal
diseas
exclud
studi
bodi
weight
bodi
condit
score
systol
blood
pressur
heart
rate
echocardiograph
indic
similar
across
three
group
mean
aestandard
deviat
sd
vertebr
heart
scale
vh
valu
obtain
geriatr
group
ae
significantli
greater
obtain
adolescentadult
group
ae
p
mean
ratio
distanc
cardiac
base
dorsal
sternum
thorac
caviti
height
point
cardiac
base
significantli
less
middleag
ae
geriatr
ae
group
adolescentadult
group
ae
p
mean
angl
cardiac
long
axi
bodi
axi
significantli
smaller
middleag
ae
geriatr
cat
ae
adolescentadult
cat
ae
p
mean
angl
cardiac
long
axi
sternum
middleag
ae
geriatr
cat
ae
significantli
smaller
adolescentadult
cat
ae
p
p
respect
addit
degre
undul
thorac
aorta
correl
posit
age
r
p
find
suggest
differ
horizont
align
heart
thoracicaorta
undul
vh
healthi
geriatr
cat
rel
observ
younger
cat
consid
agerel
disclosur
disclosur
report
aim
studi
investig
presenc
pulmonari
hypertens
ph
young
cat
affect
singl
mix
lungworm
infect
twentythre
cat
infect
lungworm
examin
veterinari
teach
hospit
teramo
itali
anim
underw
complet
physic
examin
twoor
threeview
radiograph
analysi
thorax
minimum
databas
ie
cbc
serum
biochemistri
serolog
fiv
antibodi
felv
antigen
obtain
patient
nine
cat
exclud
concomit
diseas
cat
includ
studi
microscop
identif
parasit
confirm
molecular
test
cat
receiv
anthelmint
treatment
singl
infect
aelurostrongylu
abstrusu
diagnos
eleven
cat
three
cat
troglostrongylu
brevior
infect
either
alon
combin
abstrusu
transthorac
echocardiographi
perform
use
ultrasound
unit
mhz
phase
array
transduc
structur
abnorm
tricuspid
valv
sign
pulmonari
stenosi
detect
twodimension
mmode
echocardiographi
show
cardiac
involv
three
cat
one
cat
infect
abstrusu
brevior
show
mild
systol
tricuspid
regurgit
jet
color
doppler
ms
anoth
abstrususinfect
cat
mild
tr
ms
mean
pap
mmhg
resolv
within
week
therapi
one
cat
diagnos
troglostrongylosi
show
mark
rightsid
cardiac
enlarg
mm
larg
systol
tricuspid
regurgit
jet
tr
peak
veloc
ms
record
continuouswav
doppler
via
color
doppler
echocardiographi
minimum
pressur
differ
right
ventricl
right
atrium
estim
mmhg
pap
least
mmhg
echocardiograph
doppler
evid
mild
ph
persist
examin
perform
month
diagnosi
ph
rare
cat
despit
case
revers
ph
known
cat
aelurostrongylosi
studi
first
case
irrevers
ph
infect
cat
affect
brevior
present
find
support
high
pathogen
troglostrongylosi
especi
young
patient
cat
lungworm
infect
possibl
cardiovascular
complic
must
taken
account
infect
alway
consid
differenti
diagnosi
cat
cardiorespiratori
sign
disclosur
disclosur
report
ventricular
function
convent
echocardiographi
speckl
track
imag
although
uncommonli
assess
veterinari
cardiolog
right
ventricular
rv
function
shown
import
prognost
determin
mani
congenit
acquir
heart
diseas
human
patient
group
alreadi
demonstr
twodimension
color
tissu
doppler
imag
provid
noninvas
evalu
systol
diastol
rv
function
awak
dog
adequ
repeat
reproduc
b
howev
noninvas
ultrasound
imag
variabl
reflect
rv
function
need
investig
particularli
correl
pulmonari
arteri
pressur
pap
valu
left
ventricular
lv
function
aim
prospect
studi
therefor
assess
sever
indic
systol
diastol
rv
function
use
convent
echocardiographi
speckl
track
echocardiographi
ste
healthi
awak
dog
differ
breed
document
systol
pap
spap
lv
function
lv
eject
fraction
global
lv
systol
strain
assess
use
simpson
deriv
method
disk
ste
respect
imag
rv
test
variabl
includ
tricuspid
annular
plane
systol
excurs
taps
right
fraction
area
chang
rfac
ste
longitudin
systol
strain
rv
free
wall
rvfw
whole
rv
ie
global
rv
strain
ste
longitudin
systol
strain
rate
sr
diastol
earli
late
sr
ratio
addit
mmode
ventricular
measur
includ
enddiastol
rv
lv
diamet
ratio
rvdd
lvdd
endsystol
rvfw
lvfw
ratio
correl
imag
variabl
calcul
use
spearman
correl
coeffici
mean
age
bodi
weight
aesd
rang
studi
popul
year
kg
respect
correl
found
rv
morpholog
variabl
ie
rvdd
lvdd
rvfw
lvfw
ratio
indic
systol
diastol
rv
function
global
rv
strain
mean
ae
sd
ae
rvfw
strain
ae
posit
correl
p
rfac
ae
r
r
respect
neg
correl
p
spap
ae
mmhg
r
r
respect
spap
also
neg
correl
taps
bodi
weight
ratio
systol
sr
r
respect
p
correl
indic
lv
function
ste
indic
rv
function
correl
either
ste
rv
indic
systol
function
diastol
earli
late
sr
ratio
conclus
ste
provid
rapid
noninvas
evalu
rv
function
may
use
clinic
investig
canin
cardiolog
dopplerderiv
dpdt
dpdt
mitralregurgit
consid
index
assess
systol
diastolicfunct
respect
less
load
depend
eject
phaseindex
studi
aim
determin
correl
dopplerderiveddpdt
systol
diastol
echocardiograph
index
theycan
use
identifi
dog
without
remodel
withoutcongest
heart
failur
chf
evalu
chronic
mitral
valvediseas
cmvd
sever
fiftyseven
dog
cmvd
stage
cd
wereinclud
prospect
observ
crosssect
clinic
studi
anddistribut
group
regard
presenc
remodel
chf
evaluatedpdt
dpdt
distribut
accord
tdidiastol
pattern
tocompar
group
cd
mmhg
p
p
dpdt
significantli
lower
compar
mmhg
p
p
mmhg
p
p
p
groupcd
also
lower
compar
mmhg
ae
mmhg
ae
p
dog
chf
compar
without
chf
present
lower
dpdt
mmhg
p
p
mmhg
p
p
p
mmhg
ae
mmhg
ae
p
regardingdiastol
function
lower
restrict
pattern
group
mmhg
ae
compar
without
diastol
dysfunct
mmhg
ae
delayedrelax
mmhg
ae
pseudonorm
pattern
mmhg
ae
p
dpdt
mmhg
posttest
chanc
dog
cmvd
havechf
twice
chanc
mmhg
theposttest
chanc
chf
eight
time
higher
conclus
dopplerderiv
dpdt
may
contribut
respect
systol
diastol
assess
ofdog
cmvd
disclosur
disclosur
report
pulmon
stenosi
ps
one
common
congenit
heart
defect
seen
veterinarycardiolog
practic
pulmonari
balloon
valvuloplasti
pbv
consid
treatment
choic
dog
withsever
stenosi
whether
dog
moder
stenosi
benefit
pbv
remain
unclear
variabl
degre
hypertrophi
valv
morpholog
amount
tricuspid
insuffici
presenc
absenc
clinic
sign
aregener
use
recommend
made
pet
owner
studi
report
effect
valv
type
pbv
outcom
dog
treat
three
differ
academ
special
cardiolog
practic
baselin
echocardiograph
imag
evalu
institut
valv
morpholog
classifi
either
type
n
mmhg
rang
type
b
n
mmhg
rang
n
mmhg
rang
ye
n
mmhg
rang
presenc
pulmonari
annular
hypoplasia
diamet
compar
aortic
annulu
twentyfour
hour
follow
pbv
type
mmhg
rang
type
b
mmhg
rang
valv
signific
reduct
gradient
compar
baselin
p
reduct
remain
signific
day
mmhg
rang
b
mmhg
rang
p
dog
annular
hypoplasia
mmhg
without
annular
hypoplasia
mmhg
rang
signific
reduct
gradient
hour
post
pbv
remain
signific
day
annular
hypoplasia
mmhg
rang
without
annular
hypoplasia
mmhg
rang
p
compar
baselin
consid
valv
type
signific
differ
percent
reduct
gradient
type
versu
type
b
valv
rang
b
rang
p
rang
b
rang
p
recheck
evalu
time
point
addit
signific
differ
gradient
reduct
look
whether
annular
hypoplasia
hour
ye
rang
rang
p
day
ye
rang
rang
p
conclus
classif
dog
ps
accord
valv
type
annulu
morpholog
help
predict
respons
pbv
disclosur
disclosur
report
hypertroph
cardiomyopathi
hcm
common
felin
inherit
cardiac
diseas
major
caus
morbid
mortal
osservatorio
italiano
hcm
felina
form
network
clinician
geneticist
breeder
monitor
studi
hcm
italian
cat
sinc
april
adult
cat
belong
variou
breed
includ
main
coon
siberian
norwegian
forest
cat
ragdol
sphynx
british
sh
birman
other
prospect
enrol
recheck
evalu
perform
cat
cat
underw
clinic
examin
echocardiographi
blood
collect
genet
test
appropri
storag
italian
felin
biobank
diseas
statu
defin
echocardiographi
accord
establish
guidelin
left
ventricular
diastol
wall
thick
mm
hcm
neg
mm
hcm
equivoc
mm
hcm
posit
preval
hcm
popul
cat
equivoc
diagnos
confer
cat
preval
differ
breed
preval
hcm
italian
felin
popul
lower
compar
report
investig
evalu
data
entir
popul
demonstr
left
ventricular
enddiastol
wall
thick
aortic
diamet
show
weak
posit
correl
bodi
weight
p
r
variabl
suggest
weightdepend
limit
wall
thick
consid
cat
current
practic
dog
lower
preval
hcm
italian
cat
breed
compar
examin
elsewher
might
explain
differ
criteria
determin
presenc
absenc
diseas
differ
age
subject
examin
select
bia
breeder
present
cat
consid
normal
disclosur
disclosur
report
chronic
mitral
valv
diseas
far
common
cardiovascular
diseas
dog
diseas
caus
myxomat
degener
mitral
valv
leaflet
approxim
case
accompani
degener
tricuspid
valv
also
describ
previou
studi
approxim
affect
dog
also
evid
associ
pulmonari
arteri
hypertens
preval
diseas
higher
small
breed
dog
kg
although
larg
breed
also
affect
occur
frequent
male
femal
present
studi
aim
character
diseas
popul
dog
portug
retrospect
review
medic
record
dog
present
hospit
veterin
ario
porto
echocardiograph
diagnosi
canin
chronic
mitral
valv
diseas
period
year
record
case
identifi
male
femal
dog
mix
breed
differ
breed
dog
repres
poodl
far
repres
breed
n
follow
english
cocker
spaniel
yorkshir
terrier
boxer
epagneul
breton
dalmatian
pekinges
labrador
retriev
portugues
podengo
breed
repres
popul
regard
weight
dog
n
weight
kg
mean
bodi
weight
kg
rang
kg
mean
age
diagnosi
year
old
also
observ
dog
n
concomit
degener
tricuspid
valv
n
pulmonari
arteri
hypertens
ph
categor
dog
accord
sever
ph
mild
ph
doppler
echocardiographi
deriv
systol
pulmonari
arteri
pressur
spap
mmhg
moder
ph
spap
mmhg
sever
ph
spap
mmhg
found
n
dog
mild
ph
n
moder
ph
n
sever
ph
describ
previou
studi
diseas
affect
mainli
male
small
breed
dog
breed
distribut
reflect
canin
popul
countri
includ
includ
popular
larg
breed
dog
portug
boxer
labrador
presenc
concomit
tricuspid
valv
diseas
ph
higher
preval
studi
previous
describ
disclosur
disclosur
report
peopl
anemia
frequent
patient
heart
failur
hf
associ
poor
outcom
like
pathogen
factor
includ
iron
defici
chronic
kidney
diseas
ckd
cytokin
product
although
factor
may
contribut
littl
known
preval
anemia
dog
cardiovascular
diseas
aim
retrospect
studi
defin
preval
anemia
hct
dog
mitral
valv
diseas
mvd
investig
associ
risk
factor
age
weight
azotemia
hf
irisacvim
class
medic
record
dog
present
cardiolog
servic
divet
univers
milan
januari
retrospect
evalu
dog
mvd
complet
physic
thorac
echocardiograph
examin
serum
biochem
panel
includ
serum
creatinin
scr
includ
studi
dog
heart
system
diseas
except
ckd
neoplasm
exclud
statist
analysi
perform
use
jmp
sa
institut
p
valu
consid
signific
two
hundr
nineti
dog
femal
ae
year
age
ae
kg
bodi
weight
fulfil
inclus
criteria
male
femal
neuter
repres
breed
mongrel
miniatur
poodl
york
shire
terrier
cavali
king
charl
dog
c
acvim
class
dog
normoazotem
scr
mgdl
stage
iri
iri
iri
preval
anemia
dog
mvd
show
mild
hct
moder
hct
anemia
sixteen
dog
c
acvim
class
thirtyfour
normoazotem
anem
dog
show
signific
higher
scr
normoazotem
dog
show
signific
higher
hb
hct
rbc
overal
popul
anem
group
overal
popul
dog
differ
iri
class
show
statist
differ
hb
hct
rbc
hb
significantli
lower
decompens
hf
dog
conclus
although
relationship
anemia
azotemiackd
document
studi
import
emphas
anem
dog
normoazotem
anemia
exclus
find
cardioren
syndrom
consid
possibl
complic
dog
mvd
alon
disclosur
disclosur
report
object
studi
evalu
left
atrial
la
function
left
atrial
total
fraction
area
chang
lafactot
left
atrial
eject
fraction
laef
dog
affect
chronic
mitral
valv
diseas
cmvd
natur
acquir
without
congest
heart
failur
chf
hypothesi
lafactot
laef
decreas
sever
cmvd
eighti
dog
includ
prospect
observ
crosssect
clinic
studi
group
accord
cmvd
sever
base
echocardiograph
evalu
clinic
sign
dog
equal
distribut
group
c
accord
american
colleg
veterinari
intern
medicin
stage
system
indic
la
function
calcul
follow
equat
lafactot
lamaximum
area
area
lamaximum
area
measur
apic
four
view
laef
lamaximum
volum
laminimum
volum
lamaximum
volum
biplan
arealength
method
left
apic
four
twochamb
view
lafactot
show
lower
valu
p
group
c
compar
group
group
c
lower
laef
group
p
left
atrial
function
assess
lafactot
laef
reduc
dog
cmvd
chf
compar
healthi
asymptomat
cmvd
group
disclosur
disclosur
report
recurr
episod
heart
andor
kidney
failur
consid
one
caus
lead
worsen
heartren
function
human
patient
aim
prospect
studi
assess
influenc
heartkidney
worsen
elect
paramet
heartkidney
function
dog
affect
mitral
valv
diseas
mvd
juli
may
dog
affect
mvd
acvim
class
without
comorbid
includ
studi
group
control
group
constitut
healthi
dog
match
case
age
older
year
gender
dog
underw
physic
examin
thorax
radiographi
ecg
echocardiographi
system
blood
pressur
assess
complet
blood
count
serum
biochem
analysi
includ
assess
serum
creatinin
scr
serum
urea
nitrogen
urea
glycaemia
gli
urin
analysi
urin
proteincreatinin
ratio
upc
dog
reevalu
everi
octob
statist
analysi
perform
use
ibm
spss
statist
p
valu
signific
twentyon
dog
affect
mvd
case
includ
healthi
dog
control
randomli
select
among
elig
popul
case
experienc
least
one
episod
congest
heart
failur
chf
none
patient
develop
chronic
kidney
diseas
ckd
case
develop
ckd
remain
acvim
class
dog
control
group
develop
ckd
mvd
correl
worsen
renal
function
wrf
scr
elev
mgdl
baselin
furosemid
administr
upc
level
radiograph
paramet
heart
enlarg
echocardiograph
paramet
investig
statist
signific
differ
iri
class
group
accord
wrf
echocardiograph
paramet
left
atrium
aortic
root
laao
accord
furosemid
amount
observ
result
expect
none
case
includ
experienc
renal
damag
wrf
iri
class
chang
upc
chang
concomit
episod
chf
persist
normal
renal
condit
regardless
chf
event
therapi
administr
unexpect
conclus
experienc
chf
seem
directli
affect
renal
function
author
opinion
use
wrf
better
singl
scr
urea
level
may
use
long
term
manag
age
patient
affect
mvd
howev
small
number
case
includ
studi
repres
great
limit
consid
work
pilot
studi
disclosur
disclosur
report
hypertroph
cardiomyopathi
hcm
primari
myocardi
diseas
character
inappropri
thicken
myocardium
absenc
caus
hypertrophi
includ
hypertens
hyperthyroid
aortic
stenosi
acromegali
also
common
heart
diseas
cat
hcm
present
wide
varieti
clinic
sing
depend
sever
locat
hypertrophi
cat
affect
hcm
mean
age
year
old
time
diagnosi
howev
diseas
affect
cat
young
month
although
later
age
unusu
hcm
heterogen
diseas
term
phenotyp
degre
hypertrophi
clinic
outcom
hallmark
histopatholog
hallmark
lesion
hcm
myocyt
disarray
small
coronari
arteriosclerosi
interstiti
fibrosi
replac
order
confirm
hcm
echocardiographi
made
primari
hypertrophi
diagnosi
made
base
presenc
ventricular
hypertrophi
symmetr
asymmetr
absenc
system
disord
purpos
studi
assess
preval
hcm
felin
popul
order
achiev
goal
echocardiogram
made
cat
older
year
clinic
asymptomat
without
cardiac
murmur
echocardiogram
made
accord
guidelin
acvim
publish
diagnosi
ventricular
hypertrophi
made
right
parastern
window
use
b
mode
measur
diamet
lvfw
iv
diastol
cat
mm
wall
thick
measur
bun
crea
blood
pressur
cat
within
normal
limit
later
paramet
consid
hcm
posit
total
number
cat
studi
cat
male
femal
popul
defin
breed
persian
main
coon
norwegian
wood
siames
chartreaux
murmour
detect
cat
detect
cat
different
degre
murmour
detect
cat
hypertrophi
detect
cat
cat
diagnos
hcm
cat
exclud
either
lack
valu
high
valu
blood
pressur
level
crea
studi
popul
hcm
epidemiolog
phenotyp
distribut
highli
variabl
averag
age
diagnosi
hcm
studi
year
disclosur
disclosur
report
mildli
increas
concentr
crp
associ
cardiovascular
diseas
human
dog
known
whether
increas
concentr
crp
associ
myxomat
mitral
valv
diseas
mmvd
dog
rather
sequel
congest
heart
failur
chf
aim
studi
investig
whether
serum
concentr
crp
determin
use
novel
autom
caninespecif
highsensit
crp
assay
gentian
hscrp
associ
sever
mmvd
certain
clinic
variabl
dog
studi
includ
clientown
dog
differ
sever
mmvd
diseas
sever
determin
medic
histori
physic
examin
echocardiographi
respons
diuret
therapi
dog
alloc
group
base
acvim
consensu
statement
guidelin
conclus
slightli
higher
serum
crp
concentr
found
dog
chf
wherea
sever
asymptomat
mmvd
show
limit
associ
serum
crp
concentr
disclosur
disclosur
report
medetomidin
agonist
wide
employ
sedat
dog
use
discourag
cardiac
patient
even
suffer
myxomat
mitral
valv
diseas
mmvd
howev
one
investig
previous
conduct
wide
rangeregard
class
diseaseof
mmvd
patient
report
gener
safeti
protocol
present
studi
focus
class
mmvd
aim
provid
detail
inform
cardiovascular
effect
medetomidin
patient
analysi
clinic
instrument
paramet
suggest
diseas
sever
congest
heart
failur
dog
weigh
kg
need
soft
clinic
procedur
show
systol
apic
heart
murmur
screen
select
studi
laao
sed
protocol
consist
iv
inject
lgkg
medetomidin
antagon
clinic
procedur
im
inject
recommend
dose
atipamezol
clinic
paramet
echocardiograph
variabl
thorac
radiograph
oscillometr
blood
pressur
measur
collect
baselin
minut
medetomidin
administr
hour
atipamezol
inject
dog
screen
definit
enrol
signif
decreas
right
parastern
regurgit
jet
area
rparjlaa
peak
veloc
mitral
regurgit
shorten
fraction
observ
along
increas
lvid
p
left
parastern
arjlaa
decreas
without
reach
statist
signific
show
high
correl
rparjlaa
r
interestingli
laao
chang
mildli
never
reach
valu
echocardiograph
variabl
show
particular
trend
systol
blood
pressur
show
valu
upper
physiolog
limit
lower
valu
increas
initi
valu
without
signific
thorac
radiograph
evoc
heart
enlarg
without
pulmonari
venou
congest
pulmonari
oedema
respiratori
rate
chang
degre
sedat
optim
clinic
procedur
case
sedat
lgkg
medetomidin
safe
dog
suffer
mmvd
stage
laao
decreas
observ
peak
veloc
colordoppl
appear
mitral
regurgit
could
due
reduct
myocardi
contractil
systol
blood
pressur
lower
sympathet
activ
via
baroreceptor
stimul
disclosur
disclosur
report
retrospect
studi
includ
total
clientown
dog
undergo
transarteri
occlus
pda
mrey
flipper
detach
embol
coil
n
amplatz
canin
duct
occlud
acdo
n
amplatz
vascular
plug
n
devic
size
select
base
pda
dimens
assess
transesophag
echocardiographi
tee
case
transthorac
echocardiographi
tte
case
angiographi
perform
procedur
assess
success
occlus
confirm
complet
occlus
dog
trivial
residu
flow
dog
follow
day
transthorac
colordoppl
echocardiographi
reveal
complet
ductal
closur
achiev
dog
procedur
hemodynam
success
evidenc
reduct
index
left
ventricular
intern
diamet
diastol
lvidd
p
fraction
shorten
fs
p
left
atrial
aortic
ratio
la
ao
p
within
hour
procedur
four
month
surgeri
index
lvidd
significantli
reduc
p
la
ao
remain
constant
secondari
complic
includ
pulmonari
arteri
embol
acdo
late
rotat
amplatz
vascular
plug
result
increas
flow
pda
dog
rotat
devic
requir
subsequ
surgic
ligat
pda
time
dog
report
aliv
dog
lost
follow
one
dog
remain
congest
heart
failur
therapi
pda
occlus
conclud
pda
occlus
use
acdo
dog
kg
transarteri
coil
embol
dog
kg
high
rate
immedi
complet
occlus
pda
occlus
use
devic
prove
safe
effect
therapeut
method
pda
dog
disclosur
disclosur
report
echocardiograph
evalu
right
pulmonari
arteri
distens
index
rpad
index
recent
describ
valuabl
method
earli
detect
sever
evalu
pulmonari
arteri
hypertens
dog
rpad
index
calcul
percentag
chang
diamet
right
pulmonari
arteri
rpa
systol
diastol
obtain
mmode
echocardiographi
right
parastern
long
axi
view
aim
studi
compar
rpad
index
obtain
two
differ
echocardiograph
view
dog
studi
design
prospect
multicent
observ
studi
fortyf
clientown
dog
differ
breed
includ
dog
heart
diseas
healthi
dog
two
differ
right
parastern
view
long
axi
rpla
short
axi
rpsa
use
measur
rpad
index
rpla
view
method
rpsa
view
method
short
axi
long
axi
imag
respect
optim
right
pulmonari
arteri
rpad
index
calcul
mmode
percentag
chang
diamet
right
pulmonari
arteri
systol
diamet
diastol
diamet
systol
diamet
measur
done
offlin
averag
consecut
cardiac
cycl
singl
investig
blind
dog
diagnosi
pearson
blandaltman
test
use
assess
correl
agreement
method
respect
intraand
interobserv
measur
variabl
quantifi
averag
coeffici
variat
cv
level
signific
set
p
mmode
evalu
rpad
index
satisfactorili
obtain
method
dog
pearson
test
show
strong
posit
linear
correl
valu
rpad
index
obtain
method
r
p
blandaltman
test
show
good
agreement
method
estim
rpad
index
bia
sd
limit
agreement
mean
differ
two
method
confid
interv
intraand
interobserv
measur
variabl
clinic
accept
cv
studi
show
good
agreement
short
axi
long
axi
mmode
evalu
rpa
method
use
interchang
evalu
rpad
index
studi
need
evalu
rpad
index
larger
popul
healthi
dog
diagnost
prognost
role
echocardiograph
paramet
dog
differ
type
pulmonari
hypertens
disclosur
disclosur
report
natur
occur
hypoadrenocortic
addison
diseas
uncommon
ill
preval
gener
canin
popul
estim
certain
breed
appear
increas
risk
develop
hypoadrenocortic
includ
beard
colli
standard
poodl
portugues
water
dog
nova
scotia
duck
toll
retriev
report
preval
respect
object
evalu
preval
clinic
featur
natur
occur
hypoadrenocortic
great
pyrene
gp
present
centr
hospitali
universitair
v
et
erinair
chuv
univers
montreal
retrospect
studi
march
octob
includ
clientown
great
pyrene
diagnos
hypoadrenocortic
medic
record
dog
diagnosi
natur
occur
hypoadrenocortic
review
emphasi
great
pyrene
record
preval
hypoadrenocortic
studi
popul
well
preval
per
breed
calcul
data
collect
includ
breed
clinic
sign
laboratori
find
age
diagnosi
treatment
caus
death
one
hundr
dog
diagnos
natur
occur
hypoadrenocortic
repres
overal
canin
popul
studi
thirtyf
breed
repres
preval
per
breed
vari
high
preval
observ
west
highland
white
terrier
great
dane
standard
poodl
saintbernard
jack
russel
terrier
gp
present
period
time
n
diagnos
hypoadrenocortic
median
age
diagnosi
year
rang
dog
hypoadrenocortic
year
gp
main
reason
present
addisonian
gp
lethargi
n
anorexia
n
clinic
find
includ
hypotens
n
poor
bodi
condit
n
heart
murmur
n
major
n
serum
electrolyt
abnorm
na
k
ratio
rang
major
laboratori
find
includ
azotemia
n
anemia
n
absenc
stress
leukogram
n
major
n
receiv
fludrocortison
prednison
need
one
gp
euthan
time
diagnosi
great
pyrene
diagnos
hypoadrenocort
overrepres
studi
popul
preval
hypoadrenocortic
gp
popul
therefor
inherit
suscept
suspect
reason
present
clinic
sign
nonspecif
similar
report
breed
human
medicin
haemoglobin
form
glycosyl
haemoglobin
use
standard
measur
averag
glycaem
control
month
measur
dog
previous
demonstr
howev
high
pressur
liquid
chromatographi
techniqu
technic
difficult
routin
use
method
longer
avail
object
studi
assess
use
latex
immunoagglutin
inhibit
use
monoclon
antibodi
measur
dog
use
siemen
dca
vantag
repeat
assess
measur
sampl
time
within
minut
effect
storag
edta
anticoagul
sampl
examin
measur
sampl
store
everi
day
day
storag
assess
freez
sampl
measur
week
machin
use
compar
valu
group
dog
diabet
mellitu
group
n
hyperadrenocortic
group
n
nondiabeticcushingoid
hospitalis
patient
group
n
differ
group
examin
signific
use
kruskalw
analysi
varianc
refer
rang
previous
calcul
mmolmol
valu
mmolmol
seen
diabet
anim
use
high
pressur
liquid
chromatographi
median
coeffici
variat
repeat
studi
found
rang
possibl
store
sampl
day
median
cv
rang
least
week
median
cv
rang
median
concentr
group
mmolmol
group
mmolmol
group
mmolmol
group
significantli
differ
two
group
use
kruskalw
analysi
varianc
conclus
latex
immunoagglutin
method
repeat
measur
dog
addit
canin
edta
anticoagul
sampl
stabl
day
frozen
could
store
least
week
without
signific
sampl
deterior
assay
provid
expect
result
dog
without
abnorm
glycaem
control
disclosur
siemen
dca
vantag
provid
loan
siemen
well
cartridg
use
machin
run
sampl
studi
wehner
r
anderson
rees
k
hartmann
clinic
small
anim
medicin
munich
germani
institut
veterinari
anatomi
histolog
embryolog
munich
germani
measur
total
thyroxin
often
first
diagnost
step
work
thyroid
diseas
dog
cat
blood
sampl
routin
sent
refer
laboratori
caus
delay
test
might
impact
result
aim
studi
valid
enzym
fluoresc
assay
elfa
inhous
method
measur
dog
cat
measur
sera
dog
cat
two
method
enzym
immunoassay
eia
enzym
fluoresc
assay
elfa
eia
serv
standard
method
elfa
result
compar
elfa
perform
minivida
autom
analys
biom
erieux
craponn
franc
accord
manufactor
instruct
coeffici
variat
cv
elfa
dog
sera
eia
respect
cv
elfa
cat
sera
eia
respect
overal
bia
elfa
dog
howev
lower
rang
maxim
bia
elfa
cat
correl
method
linear
cat
use
bland
altman
plot
limit
agreement
dog
cat
cohen
kappa
reveal
slight
agreement
method
dog
good
good
agreement
cat
elfa
fast
method
high
precis
recommend
measur
cat
recommend
dog
disclosur
disclosur
report
dysfunct
central
nervou
system
cn
frequent
caus
neurolog
disord
dog
studi
aim
find
cn
diseas
could
associ
select
group
common
microbi
viral
pathogen
dog
cn
diseas
characterist
profil
regard
two
paramet
creactiv
protein
crp
iga
report
potenti
use
unspecif
marker
cn
diseas
analys
cerebrospin
fluid
sampl
obtain
dog
vari
neurolog
sign
june
novemb
realtim
pcr
employ
probe
toxoplasma
gondii
neospora
caninum
anaplasma
phagocytophilum
canin
distemp
viru
iggantibodi
tickborn
enceph
viru
tbe
assay
iga
titr
measur
use
elisa
crp
concentr
determin
immunoturbidimetr
assay
dog
median
age
year
rang
compris
breed
frequent
involv
chihuahua
labrador
retriev
bernes
mountain
dog
boxer
gender
distribut
femal
spay
bitch
male
neuter
male
nonidentifi
none
case
pcrposit
toxoplasma
gondii
canin
distemp
viru
one
dog
posit
anaplasma
phagocytophilum
anoth
neospora
caninum
antibodi
tbe
viru
within
borderlin
rang
dog
dog
could
divid
two
age
group
young
dog
year
median
year
older
dog
year
median
year
igahigh
mgdl
case
repres
young
older
dog
respect
crphigh
mgl
case
almost
half
equal
young
older
dog
respect
compar
older
dog
young
dog
higher
level
crp
p
iga
p
within
igahigh
cohort
crphigh
crplow
case
distribut
almost
equal
versu
young
dog
disproportion
versu
older
dog
igalowcrplow
case
young
dog
older
dog
present
data
suggest
canin
cn
disord
larg
character
high
iga
particularli
young
dog
inflammatori
type
crphigh
almost
equal
group
internet
potenti
sourc
medic
inform
pet
owner
therefor
could
play
indirect
import
role
veterinari
practic
survey
assess
onlin
search
behaviour
french
pet
owner
pet
health
influenc
veterinari
consult
april
french
pet
owner
come
veterinari
teach
hospit
medic
surgic
consult
survey
owner
fulfil
questionnair
voluntari
basi
survey
contain
question
deal
three
topic
onlin
search
behaviour
owner
pet
health
percept
inform
found
onlin
internet
influenc
consult
veterinariancli
owner
use
internet
obtain
inform
pet
health
among
use
rare
occasion
mainli
look
inform
diseas
symptom
breed
nutrit
advic
owner
tri
verifi
accuraci
inform
found
often
question
veterinarian
owner
think
onlin
inform
alway
trustworthi
research
randomli
made
websit
found
search
engin
major
pet
owner
nt
awar
health
certif
label
websit
internet
enabl
certain
pet
owner
feel
eas
pet
health
care
ask
question
veterinarian
feel
involv
medic
choic
owner
consid
internet
posit
impact
relationship
veterinarian
relief
common
emot
respons
onlin
research
medic
inform
howev
owner
feel
overwhelm
amount
inform
found
confus
frighten
seriou
graphic
natur
inform
found
onlin
studi
emphas
frequent
measur
use
internet
french
pet
owner
pet
health
seem
consid
inform
found
net
critic
mind
unexpectedli
appear
internet
could
alli
veterinarian
promot
exchang
client
veterinarian
improv
complianc
care
project
disclosur
disclosur
report
sinonas
aspergillosi
wellknown
describ
fungal
infect
sinonas
caviti
dog
topic
treatment
either
enilconazol
itraconazol
infus
administ
surgic
endoscop
effect
use
clotrimazol
cream
describ
surgic
set
itraconazol
infus
sissen
et
al
aim
work
report
effect
use
topic
clotrimazol
cream
treatment
sinonas
aspergillosi
dog
inclus
criteria
full
medic
record
radiolog
endoscop
imag
record
clotrimazol
discharg
instil
endoscop
control
day
procedur
clotrimazol
cream
appli
cathet
place
direct
endoscop
vision
fungal
plaqu
remov
nine
dog
includ
three
dog
mix
breed
dog
two
dog
golden
retriev
one
dog
german
shepherd
one
old
english
sheepdog
one
bull
terrier
one
cane
corso
six
dog
male
one
neuter
three
femal
one
intact
mean
age
year
main
clinic
sign
mucopurul
discharg
pain
sinonas
palpat
nasal
planum
alter
epistaxi
nasal
discharg
bilater
dog
mean
durat
clinic
sign
month
main
radiolog
find
turbin
lysi
frontal
sinu
empyema
frontal
bone
thicken
frontal
bone
lysi
rhinoscopi
disclos
lysi
remodel
nasal
turbin
easi
access
frontal
sinu
septum
lysi
bilater
sinonas
aspergillosi
monolater
nasal
aspergillosi
monolater
sinonas
aspergillosi
contralater
nasal
aspergillosi
monolater
frontal
aspergillosi
main
durat
nasal
cream
discharg
day
dog
underw
endoscop
control
day
procedur
seven
dog
diseas
free
two
dog
persist
fungal
plaqu
underw
second
treatment
success
rate
success
rate
studi
compar
studi
larger
smaller
case
seri
endoscop
remov
fungal
plaqu
time
consum
topic
administr
either
enilconazol
itraconazol
requir
addit
hour
cathet
placement
clotrimazol
cream
applic
last
minut
caviti
dog
report
use
clotrimazol
cream
treatment
sinonas
aspergillosi
need
evalu
larger
case
seri
disclosur
disclosur
report
studi
exist
euthanasia
small
anim
practic
howev
act
belong
veterinari
procedur
less
frequent
depend
kind
practic
may
deepli
impact
owner
veterinarian
intend
studi
practic
ethic
psycholog
aspect
euthanasia
dog
cat
among
french
veterinari
practition
octob
februari
onlin
questionnair
small
anim
euthanasia
address
practic
aspect
euthanasia
commun
owner
ethic
problem
owner
veterinarian
percept
email
via
profession
associ
network
result
analyz
use
commerci
softwar
sphinx
iq
excel
french
veterinarian
practic
small
anim
medicin
complet
questionnair
repres
popul
euthanasia
occur
rare
home
veterinarian
propos
owner
time
alon
pet
stay
euthanasia
perform
commonli
intraven
inject
mainli
sedationanesthesia
nineti
nine
percent
veterinarian
consid
commun
includ
descript
event
sequenc
dispos
bodi
import
estim
minimum
commun
time
requir
vari
minut
follow
euthanasia
often
thank
owner
veterinarian
refus
euthanasia
consid
unjustifi
suggest
euthanasia
reject
reason
suggest
includ
intract
pain
nonaccept
complic
financi
consider
anim
consid
danger
veterinarian
think
owner
experi
sens
guilt
euthanasia
perceiv
euthanasia
commonli
relief
anim
suffer
part
veterinari
practic
less
frequent
defeat
almost
veterinarian
experienc
emot
challeng
euthanasia
estim
practic
euthanasia
influenc
percept
death
practic
psycholog
aspect
euthanasia
discuss
team
veterinarian
gender
influenc
euthanasia
manag
mostli
concern
commun
practic
aspect
euthanasia
definit
ordinari
veterinari
act
neither
owner
veterinarian
therefor
act
must
perform
much
care
commun
possibl
disclosur
disclosur
report
canin
pancytopenia
associ
rang
intramarrow
extramarrow
caus
includ
though
limit
infecti
agent
drug
toxin
neoplasm
current
limit
inform
regard
clinicopatholog
featur
underli
caus
prognosi
pancytopen
dog
object
retrospect
studi
better
defin
spectrum
diseas
associ
canin
pancytopenia
establish
possibl
clinicopatholog
discrimin
common
caus
investig
sever
pancytopenia
underli
diseas
associ
clinic
outcom
death
surviv
medic
record
dog
comprehens
diagnost
investig
admit
veterinari
teach
hospit
retrospect
review
pancytopenia
defin
hematocrit
hct
dog
month
age
white
blood
cell
count
wbc
platelet
count
plt
control
group
dog
without
evid
blood
cytopenia
also
establish
total
pancytopen
dog
studi
bone
marrow
aspir
cytolog
examin
case
aplasia
hematopoiet
lineag
observ
dog
common
diagnos
includ
monocyt
ehrlichiosi
cme
n
leishmaniosi
canl
n
parvovir
enter
pe
n
concurr
cme
canl
n
mix
breed
dog
like
develop
pancytopenia
compar
purebr
pancytopen
dog
tend
younger
control
condit
depend
logist
regress
model
p
p
respect
among
common
diseas
associ
pancytopenia
mean
wbc
count
significantli
lower
dog
cme
pe
compar
dog
canl
one
way
anova
bonferroni
test
multipl
comparison
p
p
respect
plt
count
significantli
lower
cme
compar
canl
p
pe
p
total
protein
concentr
significantli
lower
dog
pe
compar
cme
p
canl
p
use
univari
logist
regress
analysi
model
associ
establish
underli
diseas
final
outcom
howev
higher
hct
least
one
percentag
unit
wbc
least
plt
least
valu
tend
significantli
increas
odd
surviv
p
p
p
respect
present
studi
cme
canl
pe
major
caus
canin
pancytopenia
potenti
use
diagnost
indic
includ
sever
leucopenia
cme
pe
thrombocytopenia
cme
hypoproteinemia
pe
disclosur
disclosur
report
bwbp
detect
upper
lower
airway
diseas
site
airway
obstruct
result
increas
pressur
chang
associ
breath
nevertheless
result
suggest
signific
differ
tv
p
ti
p
pef
p
eep
p
penh
p
pau
p
lm
fbd
cat
signific
differ
bwbp
paramet
found
upper
airway
obstruct
previous
evalu
cat
use
pft
mckieman
lin
author
knowledg
first
studi
design
compar
upper
lower
airway
obstruct
use
bwbp
attend
result
evid
bwbp
help
character
mechan
dysfunct
airway
cat
lm
obstruct
howev
must
keep
mind
limit
studi
low
number
anim
individu
variabl
breath
pattern
chanc
bronchoreact
test
disclosur
disclosur
report
median
lifespan
domest
dog
estim
year
littl
known
risk
factor
mortal
age
dog
mortal
studi
dog
carri
among
diseas
dog
renal
heart
diseas
cancer
postop
death
determin
characterist
associ
mortal
priori
healthi
age
dog
prospect
cohort
studi
conduct
guid
dog
follow
systemat
geriatr
examin
ge
either
allcaus
death
cutoff
date
juli
surviv
analys
kaplanmei
estim
logrank
test
multivari
cox
proport
hazard
model
use
assess
associ
time
death
median
age
ge
year
dog
neuter
femal
major
dog
golden
retriev
n
labrador
retriev
n
among
dog
obes
present
skin
nodul
use
bu
transport
total
dog
die
followup
lead
median
surviv
time
ge
year
adjust
demograph
biochem
variabl
age
sex
total
protein
cholesterol
alp
increas
alanin
amionotransferas
level
uil
adjust
hazard
ratio
ahr
present
skin
nodul
ahr
labrador
ahr
independ
associ
shorter
time
death
p
public
transport
tend
associ
mortal
ahr
p
highlight
import
environ
mortal
neither
sex
biochem
paramet
significantli
associ
mortal
alanin
amionotransferas
level
presenc
skin
nodul
seem
predictor
mortal
senior
guid
dog
mostli
labrador
golden
mix
breed
labradorgolden
impact
environ
particular
urban
environ
mortal
need
investig
studi
breed
pet
also
necessari
gener
result
disclosur
sara
hoummadi
receiv
grant
mp
labo
phd
work
dog
age
marc
blondot
work
pari
guid
dog
school
laryng
dysfunct
commonli
associ
aspir
pneumonia
howev
role
lower
airway
diseas
investig
laryngoscop
bronchoscop
find
dog
examin
author
evalu
presenc
absenc
laryng
abnorm
dog
present
evalu
inspiratori
difficulti
pant
exclud
analysi
clinic
diagnos
inflammatori
airway
diseas
airway
collaps
airway
infect
eosinophil
bronchopneumopathi
combin
disord
obtain
bronchoscopi
bronchoalveolar
lavag
fluid
analysi
detect
rate
laryng
abnorm
compar
among
diseas
group
use
chi
squar
analysi
fisher
exact
test
signific
set
p
total
dog
evalu
vari
age
month
year
median
year
weight
rang
kg
median
kg
dog
kg
dog
kg
dog
kg
dog
kg
dog
kg
laryng
hyperemia
swell
found
dog
detect
rate
differ
among
diseas
process
laryng
function
consid
suspect
case
prompt
administr
doxapram
normal
function
dog
laryng
paresi
paralysi
report
total
dog
substanti
number
dog
chronic
cough
display
evid
abnorm
laryng
structur
function
suggest
complet
laryngoscop
examin
perform
dog
evalu
cough
disclosur
member
felin
advisori
board
speaker
honoraria
intern
nation
region
continu
educ
meet
bronchiectasi
poorli
character
diseas
dog
identifi
airway
dilat
radiograph
comput
tomographi
bronchoscopi
histopatholog
littl
known
underli
diseas
process
associ
bronchiectasi
dog
medic
record
dog
present
uc
davi
search
identif
bronchiectasi
underli
diseas
process
clinic
diagnos
obtain
review
histori
physic
examin
respiratori
endoscopi
bronchoalveolar
lavag
fluid
analysi
microbiolog
histor
report
result
imag
bronchoscopi
fluid
analysi
scrutini
patholog
clinic
diagnos
comprehens
evalu
identifi
like
underli
diseas
process
associ
bronchiectasi
bronchiectasi
diagnos
dog
bronchoscopi
perform
dog
rang
age
year
median
year
dog
month
dog
year
dog
year
age
dog
year
age
dog
breed
affect
includ
labrador
retriev
cocker
spaniel
golden
retriev
standard
poodl
durat
cough
rang
day
year
median
month
underli
diseas
process
includ
pneumonia
dog
inflammatori
airway
diseas
dog
eosinophil
bronchopneumopathi
dog
twentythre
dog
posit
bacteri
cultur
isol
streptococcu
n
enter
speci
n
commonli
studi
found
bronchiectasi
often
occur
older
larg
breed
dog
infecti
inflammatori
pneumonia
disclosur
johnson
felin
advisori
board
speaker
honoraria
chronic
respiratori
diseas
often
character
chronic
cough
common
dog
purpos
studi
determin
etiolog
chronic
respiratori
diseas
dog
present
persist
chronic
cough
retrospect
studi
clientown
dog
sign
persist
chronic
lower
respiratori
diseas
underw
bronchoscopi
togeth
either
endotrach
wash
etw
bronchoalveolar
lavag
bal
perform
dog
evalu
mean
full
clinic
examin
hematolog
serum
biochemistri
analys
survey
thorac
radiograph
echocardiographi
ecg
indic
bronchoscopi
cytolog
analysi
aerob
cultur
etw
bal
fluid
etw
perform
dog
bal
perform
dog
posit
aerob
bacteri
cultur
identifi
submit
etwbal
fluid
sampl
commonli
isol
bacteria
includ
mycoplasma
sp
bordetella
bronchiseptica
pseudomona
aeruginosa
definit
diagnosi
made
case
chronic
bronchiti
common
diagnosi
median
age
year
follow
airway
tracheal
collaps
bronchomalacia
median
age
year
primari
bacteri
infect
median
age
year
less
common
etiolog
identifi
includ
neoplasia
median
age
year
parasit
infect
median
age
year
eosinophil
bronchopneumopathi
median
age
year
rare
etiolog
identifi
includ
primari
pulmonari
hypertens
primari
ciliari
dyskinesia
excitementinduc
cough
obes
myxodemat
mitral
valv
diseas
found
concurr
dog
studi
conclud
use
structur
combin
survey
thorac
radiographi
bronchoscopi
etw
bal
cytolog
cultur
diagnosi
could
made
major
dog
chronic
respiratori
diseas
disclosur
disclosur
report
canin
steril
steroidrespons
lymphaden
cssrl
uncommon
caus
lymphadenomegali
diagnosi
one
exclubrachycephal
dog
uniqu
upper
respiratori
anatomi
abnorm
breath
pattern
similar
human
obstruct
sleep
apnea
syndrom
osa
oxid
stress
bodi
repres
imbal
product
reactiv
oxid
speci
abil
antioxid
defens
mechan
detoxifi
reactiv
intermedi
oxid
stress
involv
pathogenesi
mani
diseas
includ
hemolyt
anemia
atherosclerosi
tissu
reperfus
injuri
also
carcinogen
potenti
sever
studi
clearli
shown
associ
obstruct
sleep
apnea
syndrom
human
oxid
stress
detail
underli
pathomechan
remain
unclear
due
consider
brachycephal
dog
anim
model
human
osa
studi
design
evalu
oxid
stress
paraoxonas
activ
total
antioxid
statu
tac
brachycephal
dog
brachycephal
airway
obstruct
syndrom
bao
surgeri
compar
control
dog
studi
conduct
dog
bao
control
dog
twenti
bao
dog
evalu
month
surgic
correct
mean
valu
tac
differ
studi
group
follow
control
dog
tac
bao
dog
tac
bao
dog
postsurgeri
statist
signific
differ
tac
level
observ
dog
bao
control
dog
p
statist
signific
differ
observ
tac
level
surgeri
hand
differ
observ
tac
level
bao
dog
accord
type
brachycephal
breed
grade
respiratori
digest
sign
presenc
evert
ventricular
laryng
result
studi
show
statist
signific
differ
tac
valu
control
dog
bao
confirm
oxid
stress
previous
describ
human
even
human
patient
osa
partial
revers
increas
oxid
stress
use
nasal
continu
posit
airway
pressur
treatment
dog
bao
differ
observ
month
surgic
treatment
bao
surgic
treatment
use
reduc
tac
level
probabl
bao
induc
evid
inflammatori
process
dog
human
patient
osa
disclosur
disclosur
report
canin
idiopath
pulmonari
fibrosi
cipf
progress
interstiti
lung
diseas
mainli
affect
west
highland
white
terrier
whwt
cipf
cours
vari
greatli
among
dog
rapid
deterior
slowli
progress
form
surviv
time
onset
clinic
sign
rang
month
sever
year
human
ipf
increas
chemokin
ccmotif
ligand
concentr
bronchoalveolar
lavag
fluid
balf
indic
poor
outcom
serum
concentr
correl
clinic
paramet
lung
function
dog
serum
balf
concentr
shown
elev
whwt
cipf
compar
healthi
whwt
aim
present
studi
investig
whether
serum
concentr
measur
whwt
cipf
diagnosi
use
indic
prognosi
correl
lung
function
paramet
concentr
determin
elisa
canin
quantikin
elisa
kit
r
system
serum
whwt
suspect
cipf
median
age
year
rang
followup
avail
median
followup
time
month
rang
serum
sampl
extend
may
januari
cipf
diagnosi
confirm
thorac
high
resolut
comput
tomographi
lung
histopatholog
examin
whwt
respect
kaplanmei
analysi
conduct
investig
differ
surviv
time
accord
serum
concentr
diagnosi
spearman
analysi
use
assess
correl
serum
concentr
lung
function
paramet
name
distanc
walk
walk
test
arteri
partial
pressur
oxygen
po
among
cipf
whwt
includ
die
euthan
cipfrel
reason
die
euthan
noncipfrel
reason
still
aliv
end
studi
median
surviv
whwt
cipfrel
death
euthanasia
rang
month
diagnosi
serum
concentr
pgml
significantli
associ
shorter
surviv
time
whwt
affect
cipf
p
weak
neg
correl
found
serum
concentr
r
p
n
correl
observ
arteri
po
valu
n
conclus
serum
concentr
provid
prognost
inform
whwt
suffer
cipf
marker
weakli
correl
clinic
lung
function
paramet
avail
present
studi
disclosur
disclosur
report
canin
idiopath
pulmonari
fibrosi
cipf
progress
interstiti
lung
diseas
mainli
affect
west
highland
white
terrier
whwt
studi
intend
describ
thorac
highresolut
comput
tomographi
thrct
find
obtain
cipf
dog
gener
anesthesia
ga
use
glossari
fleischner
societi
compar
imag
obtain
ga
thrct
ga
obtain
sedat
thrct
thrct
imag
whwt
cipf
control
whwt
retrospect
review
three
observ
consensu
specif
thrct
featur
assess
grade
lung
lobe
absenc
mild
moder
sever
global
score
calcul
test
threshold
use
statist
analysi
ground
glass
opac
ggo
observ
cipf
whwt
control
p
control
ggo
mild
localis
mainli
cranial
lobe
cipf
whwt
ggo
mild
moder
sever
dog
respect
without
lobe
predilect
consolid
observ
cipf
whwt
control
p
mild
moder
mosaic
pattern
suggest
air
trap
notic
cipf
whwt
control
p
mild
moder
sever
whwt
respect
without
lobe
predilect
nodul
present
cipf
whwt
control
reticul
subpleur
band
parenchym
band
notic
cipf
whwt
respect
honeycomb
emphysema
pleural
effus
pleural
thicken
never
observ
bronchial
wall
thicken
mild
bronchiectasi
present
cipf
whwt
respect
control
p
p
overal
thrct
qualiti
good
examin
compar
thrct
ga
p
presenc
motion
artefact
higher
thrct
p
frequent
grade
mild
p
thrct
allow
identif
mosaic
pattern
addit
cipf
whwt
consolid
could
identifi
other
differ
identif
gradat
featur
thrct
ga
thrct
conclus
ggo
consolid
mosaic
pattern
bronchial
wall
thicken
main
thrct
featur
cipf
whwt
honeycomb
major
featur
ipf
human
never
observ
suggest
differ
pathophysiolog
two
entiti
thrct
imag
accord
thrct
ga
use
cipf
diagnosi
disclosur
disclosur
report
literatur
mesenteri
lymphaden
lad
mesenteri
lymph
node
abscess
lab
small
anim
scarc
case
file
search
dog
diagnosi
mesenteri
ladlab
base
cytolog
andor
histopatholog
case
identifi
exclud
due
incomplet
data
remain
dog
mix
breed
n
small
munsterland
n
one
breed
nine
dog
male
femal
median
age
month
rang
diagnosi
base
fine
needl
aspir
fna
n
histopatholog
n
n
signific
find
dog
histori
includ
gastrointestin
sign
n
puppi
whose
mother
mastiti
bite
woundsabscess
skin
n
pulmon
stenosi
n
orthopaed
diseas
n
common
present
complaint
lethargi
n
hyperthermia
n
diarrhoea
n
vomitingnausea
n
inappetenceanorexia
n
backabdomin
pain
n
lame
n
diagnost
test
perform
includ
haematologyserum
biochemistri
n
thorac
n
abdomin
n
radiograph
abdomin
ultrasound
n
ctmri
n
fna
organ
n
urinalysi
n
cultur
n
coagul
profil
n
orthopaed
radiograph
n
cpl
n
blood
cultur
n
csfjoint
tap
n
dog
retrospect
divid
group
n
dog
diseas
ladlab
idiopath
group
b
n
dog
diseas
diagnos
simultan
includ
neoplasia
carcinoma
n
lymphoma
n
leiomysarcoma
n
histiocyt
neoplasia
n
prostat
carcinoma
n
gastroenter
n
presum
pancreat
n
purul
monoarthr
n
purul
hepat
spleniti
n
fungal
infect
distant
site
n
mycobacteriosi
n
eleven
dog
receiv
surgic
treatment
antibiot
dog
conserv
medic
manag
consist
support
treatment
antibiot
dog
discharg
aliv
dog
group
hospit
longer
mean
day
sd
dog
group
b
mean
day
sd
p
median
followup
time
day
day
differ
pretreat
antibiot
antiinflammatori
group
ttest
kruskallw
test
show
dog
group
borderlin
significantli
younger
p
significantli
higher
respiratori
rate
p
rectal
temperatur
p
monocyt
count
p
crp
concentr
p
dog
group
b
small
munsterland
odd
ratio
breed
suffer
ladlab
conclus
idiopath
mesenteri
ladlab
seen
young
dog
hyperthermia
gastrointestin
sign
diagnosi
purul
ladlab
fna
exclud
presenc
anoth
underli
pathogenesi
disclosur
disclosur
report
canin
infecti
respiratori
diseas
cird
diseas
complex
caus
differ
viral
bacteri
pathogen
aim
studi
evalu
clinic
laboratori
factor
associ
differ
infecti
agent
dog
includ
show
respiratori
sign
day
consist
cird
noninfecti
respiratori
condit
could
exclud
nasal
pharyng
swab
taken
dog
cird
test
respiratori
pathogen
includ
canin
parainfluenza
viru
cpiv
canin
adenoviru
cav
canin
distemp
viru
cdv
canin
herp
viru
chv
canin
respiratori
coronaviru
crcov
canin
influenza
viru
civ
bordetella
bronchiseptica
b
bronchiseptica
polymeras
chain
reaction
result
clinic
laboratori
data
correl
underli
pathogen
use
fisher
exact
test
chisquar
test
p
cpiv
detect
crcov
six
b
bronchiseptica
dog
patient
show
infect
one
pathogen
signific
differ
age
gender
distribut
three
group
howev
dog
infect
cpiv
like
origin
shelter
p
clinic
data
compar
signific
differ
paramet
depress
fever
cough
nasal
discharg
dyspnoea
abnorm
lung
sound
furthermor
signific
differ
regard
abnorm
erythrocyt
platelet
leukocyt
differenti
count
group
studi
show
dog
cird
clinic
laboratori
paramet
indic
underli
pathogen
furthermor
diseas
sever
seem
depend
infecti
organ
involv
disclosur
disclosur
report
breed
relat
predisposit
bacteri
bronchopneumonia
bp
report
irish
wolfhound
iwh
underli
factor
unknown
howev
immun
deficit
ciliari
dysfunct
aspir
suggest
predispos
factor
purpos
prospect
studi
evalu
lymphocyt
subpopul
iwh
one
previou
bp
compar
result
elderli
iwh
without
previou
bacteri
respiratori
infect
addit
healthi
dog
breed
includ
control
previou
bp
confirm
iwh
median
age
year
interquartil
rang
year
healthi
iwh
n
year
dog
breed
n
year
histori
find
suggest
previou
bp
edta
blood
sampl
collect
dog
healthi
stain
fluoresc
mous
anti
dog
mhc
class
ii
antibodi
abd
serotec
flow
cytometri
analysi
perform
bd
facsaria
ii
cell
sorter
facsdiva
softwar
statist
comparison
group
effect
age
studi
use
analysi
covari
ancova
model
number
leucocyt
differ
significantli
group
total
number
lymphocyt
number
major
lymphocyt
subpopul
bcell
tcell
significantli
lower
healthi
iwh
iwh
previou
bp
compar
dog
breed
lymphocyt
p
p
bcell
p
p
tcell
p
p
tcell
p
p
respect
percentag
number
mhc
class
ii
nonb
lymphocyt
significantli
higher
iwh
group
dog
breed
p
comparison
lymphocyt
number
subpopul
differ
significantli
healthi
iwh
compar
iwh
previou
bp
agerel
declin
total
number
lymphocyt
p
tcell
p
tcell
p
mhc
class
ii
non
bcell
p
notic
group
iwh
previou
bp
preliminari
result
indic
iwh
may
significantli
lower
number
lymphocyt
bcell
well
tcell
dog
breed
studi
need
determin
whether
alter
repres
breed
relat
phenomenon
connect
predisposit
bp
agerel
declin
lymphocyt
total
tcell
tcell
number
detect
iwh
previou
bp
human
age
relat
chang
tcell
associ
increas
suscept
infect
disclosur
disclosur
report
felin
chronic
kidney
diseas
ckd
common
featur
age
cat
angiotensinconvert
enzym
inhibitor
acei
recommend
treat
hypertens
associ
ckd
limit
targetorgan
damag
especi
glomerular
hypertens
addit
intern
renal
interest
societi
iri
guidelin
recommend
prescript
acei
patient
ckd
proteinuria
knowledg
studi
demonstr
effect
long
term
administr
acei
client
own
popul
cat
suffer
ckd
glomerular
filtrat
rate
gfr
aim
studi
evalu
effect
acei
imidapril
prilium
v
etoquinol
sa
gfr
cat
suffer
natur
occur
chronic
kidney
diseas
ckd
month
sixtysix
cat
present
clinic
biolog
sign
ckd
enrol
european
investig
follow
till
month
random
blind
studi
thirtytwo
cat
provid
suitabl
data
gfr
analysi
anim
receiv
imidapril
dosag
mgkgd
receiv
placebo
anim
avail
gfr
valu
day
data
day
exclud
well
anim
iohexol
clearanc
could
determin
follow
censor
month
due
small
sampl
size
statist
comparison
day
month
month
month
cat
sampl
minut
intraven
administr
mg
iohexol
gfr
base
determin
iohexol
clearanc
calcul
phoenix
winnonlin
softwar
statist
analys
perform
sasstat
softwar
gfr
avail
time
point
given
anim
two
treatment
group
compar
gfr
determin
point
use
ancova
analysi
covari
gfr
determin
day
covari
gfr
ae
ae
mlkgmin
imidapril
placebo
group
respect
signific
statist
differ
ae
versu
ae
mlkgmin
imidapril
placebo
group
respect
p
observ
favor
higher
gfr
imidapril
treat
anim
month
higher
gfr
also
observ
imidapril
group
month
month
significantli
differ
placebo
group
daili
long
term
imidapril
treatment
compar
placebo
may
effect
treatment
slow
progress
renal
failur
cat
natur
occur
chronic
kidney
diseas
disclosur
author
employe
vetoquinol
concern
potenti
cytotox
drug
could
harm
expos
worker
special
oncolog
ecvimca
publish
guidelin
order
prevent
risk
howev
data
exist
evalu
real
risk
occupationn
exposur
concern
aim
studi
biomark
use
vincristin
cyclophosphamid
surfac
sampl
collect
consult
room
ward
dedic
chemotherapi
sampl
collect
wet
filter
paper
cm
surfac
object
comput
instanc
sampl
analys
liquid
chromatographi
mass
spectrometr
methodth
limit
quantif
ng
cm
gobject
vincristin
cm
gobject
cyclophosphamid
sampl
consult
room
collect
treat
dog
vincristin
clean
sampl
dedic
ward
collect
clean
stay
treat
dog
aerasobject
test
consult
room
dedic
ward
vincristin
ward
cyclophosphamid
treatment
dog
consult
room
trace
vincristin
detect
floor
laboratori
bench
top
cm
moreov
surfac
auscult
tabl
extern
side
glove
contamin
prepar
administr
vincristin
respect
ngobjet
clean
sampl
consult
room
posit
trace
vincristin
detect
floor
object
wall
otoscop
cm
clean
sampl
ward
posit
trace
vincristin
detect
floor
object
box
wastebin
bowl
ngobjet
clean
anim
treatment
cyclophosphamid
detect
area
test
ngobjet
despit
protect
guidelin
avoid
spread
cytotox
drug
environement
exposur
demonstr
howev
contamin
limit
show
handl
procedur
cytotox
drug
well
control
mostelev
contamin
level
vincristin
notic
extern
side
glove
depsit
use
appropri
materi
worker
pay
particular
attent
glove
withdraw
limit
exposur
small
amount
vincristin
found
inapropri
place
computeur
mous
even
residu
thought
peopl
work
regular
basi
room
activ
chemotherapi
decid
adapt
clinic
practic
evalu
occup
exposur
cytotox
drug
import
step
prevent
incid
heigt
awar
nurs
staff
appli
good
clinic
practic
disclosur
disclosur
report
tumorassoci
inflammatori
respons
effect
enhanc
mammari
tumorigenesi
help
incipi
neoplasia
acquir
hallmark
capabl
human
dog
tcell
migrat
tumor
site
follow
activ
may
essenti
requir
promot
effect
tumor
human
breast
cancer
signal
pathway
ckit
describ
possibl
involv
differenti
migrat
surviv
matur
tcell
inflammatori
cell
tumor
site
order
clarifi
subject
canin
mammari
tumor
cmt
malign
neoplasm
studi
use
immunohistochemistri
compar
intratumor
tlymphocyt
ckit
express
togeth
vegf
microvessel
densiti
mvd
clinicopatholog
characterist
tumor
aggress
cell
high
ckit
immunoexpress
reveal
posit
statist
signific
correl
vegf
r
p
r
p
ckit
respect
r
p
r
p
ckit
respect
statist
signific
associ
p
posit
correl
r
p
tlymphocyt
ckit
also
observ
tumor
high
ckit
express
show
higher
count
tcell
mvd
high
tumor
significantli
elev
p
similar
associ
observ
high
ckitvegf
tumor
p
studi
high
high
ckitvegf
high
tumor
statist
significantli
associ
elev
grade
malign
p
ckitvegf
presenc
neoplast
intravascular
emboli
p
p
ckitvegf
presenc
lymph
node
metastasi
p
ckit
vegf
tumor
high
p
high
ckitvegf
p
high
p
express
associ
shorter
os
time
interestingli
group
tumor
high
ckitvegf
retain
signific
multivari
analysi
aris
independ
predictor
os
result
studi
suggest
tlymphocyt
may
share
common
signal
pathway
ckit
vegf
cmt
progress
may
contribut
increas
angiogenesi
aggress
shorter
os
tumor
disclosur
disclosur
report
epidemiolog
data
publish
felin
larg
granular
lymphocyt
lgl
lymphoma
recent
studi
krick
et
al
describ
clinicopatholog
featur
cat
lgl
lymphoma
comparison
made
cat
diseas
form
felin
lymphoma
therefor
object
studi
assess
differ
preval
signal
breed
sex
age
physic
exam
find
bodi
weight
bodi
condit
score
bodi
temperatur
heart
rate
respiratori
rate
systol
blood
pressur
felv
fiv
statu
cat
lgl
lymphoma
group
type
felin
lymphoma
group
electron
databas
san
marco
veterinari
clinic
search
cat
cytolog
histopatholog
diagnosi
lymphoma
differ
group
assess
ttest
mann
whitney
pearsonchi
squar
pearson
chi
squar
yate
correct
fisher
exact
test
studi
period
sick
cat
seen
clinic
diagnos
lymphoma
group
n
group
n
preval
type
felin
lymphoma
compar
sick
cat
chang
time
rang
per
year
p
overal
preval
ci
lymphoma
lgl
preval
compar
type
lymphoma
chang
time
rang
per
year
p
overal
preval
ci
among
variabl
studi
sex
group
femal
male
group
femal
male
p
age
group
ae
month
group
ae
month
p
significantli
differ
group
sixteen
cat
lgl
lymphoma
test
felvfiv
statu
result
felvand
one
fiv
seventyfour
cat
type
lymphoma
test
felvfiv
statu
result
felv
fiv
five
cat
felvfiv
preval
felv
infect
significantli
lower
p
group
compar
group
differ
preval
fiv
infect
group
lymphoma
lgl
affect
femal
older
cat
compar
type
felin
lymphoma
opposit
type
lymphoma
accord
previou
litteratur
inform
felv
statu
play
role
pathogenesi
felin
lgl
lymphoma
disclosur
disclosur
report
activ
regulatori
cell
treg
known
close
associ
express
transcript
factor
regulatori
cell
distinct
group
lymphocyt
immunosuppress
properti
normal
cell
work
prevent
harm
autoimmun
respons
howev
also
interfer
benefici
immun
respons
antitumor
immun
human
breast
cancer
cell
play
crucial
role
tumor
progress
canin
mammari
tumor
cmt
studi
topic
welldocu
studi
includ
malign
cmt
studi
immunohistochemistri
intratumor
express
togeth
vascular
endotheli
growth
factor
vegf
microvessel
densiti
mvd
antibodi
sever
clinicopatholog
characterist
abund
cell
statist
associ
presenc
tumor
necrosi
p
nuclear
grade
p
poor
differenti
tumor
p
high
mitot
grade
p
high
histolog
grade
malign
p
presenc
neoplast
intravascular
emboli
p
presenc
lymph
node
metastasi
p
intratumor
level
correl
level
vegf
r
p
intratumor
mvd
r
p
addit
tumor
abund
cell
associ
shorter
overal
surviv
os
time
p
result
suggest
treg
cell
play
role
cmt
progress
may
contribut
increas
angiogenesi
aggress
tumor
associ
intratumor
express
shorter
os
anim
suggest
util
treg
cell
activ
prognost
marker
disclosur
disclosur
report
clinic
manifest
canin
viscer
leishmaniasi
canl
nonspecif
includ
progress
weight
loss
anemia
lymphadenomegali
hepatosplenomegali
dermatolog
renal
ocular
alter
cardiac
lesion
result
clinic
sign
scarc
describ
dog
vl
presenc
parasit
cardiac
tissu
involv
report
accordingli
present
studi
aim
evalu
histopatholog
abnorm
cardiac
tissu
dog
natur
infect
leishmania
infantum
chagasi
total
dog
evalu
dog
symptomat
one
present
clinic
sign
cardiac
involv
complianc
feder
law
owner
sign
consent
dog
submit
euthanasia
comprehens
postmortem
evalu
sampl
right
atrium
free
wall
ra
right
ventricl
free
wall
rv
interventricular
septum
iv
left
ventricl
free
wall
lv
collect
evalu
tissu
sampl
fix
formalin
embed
paraffin
section
mm
stain
hematoxylin
eosin
antileishmania
immunohistochemistri
also
perform
studi
approv
ethic
committe
anim
experiment
anim
welfar
protocol
number
histopatholog
chang
observ
least
one
four
evalu
cardiac
region
dog
frequent
cardiac
injuri
inflammatori
reaction
character
presenc
mononuclear
cell
infiltr
differ
degre
evalu
region
ra
one
highest
incid
histopatholog
chang
observ
anim
follow
rv
lv
siv
affect
dog
respect
immunohistochemistri
reveal
amastigot
cardiac
tissu
dog
posit
correl
found
cardiac
lesion
presenc
amastigot
myocardium
p
disclosur
disclosur
report
canin
leishmaniosi
life
threaten
zoonot
diseas
combin
meglumin
antimoni
allopurinol
consid
effect
therapi
canin
leishmaniosi
constitut
first
line
protocol
diseas
allopurinol
parasitostat
drug
use
longterm
maintain
low
parasit
load
avoid
clinic
relaps
tradit
allopurinol
consid
safe
drug
dog
howev
report
indic
xanthinuria
xanthin
urolithiasi
produc
prolong
therapi
allopurinol
dog
aim
prospect
studi
evalu
preval
urinari
advers
effect
allopurinol
treatment
mgkgbidpo
dog
leishmaniosi
diagnosi
made
compat
clinicopatholog
abnormalitit
leishmaniosi
high
leishmania
infantumspecif
antibodi
level
assess
quantit
elisa
leishmaniosi
diagnos
close
followup
day
treatment
includ
physic
examin
baselin
laboratori
test
cbc
biochemistri
profil
serum
electrophoresi
urinalysi
urinari
proteincreatinin
ratio
abdomin
ultrasound
perform
preliminari
result
dog
includ
dog
present
urinari
abnorm
base
biochemistri
profil
urinalysi
abdomin
ultrasound
time
diagnosi
four
present
xanthinuria
n
n
n
two
dog
present
renal
miner
treatment
two
dog
present
bladder
urolithiasi
sinc
treatment
xanthinuria
present
initi
dog
develop
renal
miner
bladder
urolithiasi
dog
renal
miner
urolithiasi
treat
restrict
protein
diet
far
develop
renal
diseas
present
studi
describ
earli
xanthinuria
renal
miner
urolithiasi
advers
effect
due
chronic
allopurinol
treatment
dog
leishmaniosi
neither
miner
analysi
renal
biopsi
perform
confirm
origin
lesion
urinari
abnorm
present
allopurinol
treatment
institut
thorough
monitor
dog
treat
leishmaniosi
combin
urinalysi
abdomin
ultrasound
perform
evalu
urinari
advers
effect
help
clinic
manag
advers
effect
disclosur
disclosur
report
giardia
duodenali
one
import
gastrointestin
parasit
dog
cat
zoonot
potenti
germani
preval
dog
cat
reach
respect
genotyp
two
genet
assemblag
parasit
infect
human
assemblag
b
mammal
includ
small
anim
contrast
parasit
assemblag
c
specif
dog
assemblag
f
cat
object
studi
analys
preval
potenti
epidemiolog
risk
factor
symptom
g
duodenali
infect
dog
cat
detect
g
duodenali
fece
dog
cat
analys
elisa
techniqu
dna
extract
real
time
pcr
well
multilocu
sequenc
type
perform
follow
gene
loci
triosephosph
isomeras
glutam
dehydrogenas
betagiardingen
ssu
rrna
questionnair
possibl
epidemiolog
risk
factor
evalu
statist
analys
perform
use
spss
odd
ratio
kolmogorowsmirnow
test
spearman
correl
fecal
sampl
dog
cat
collect
time
period
month
elisa
test
posit
dog
cat
sixtyseven
giardia
posit
dog
posit
cat
gastrointestin
sign
genotyp
success
dog
sampl
assign
assemblag
follow
assemblag
n
ac
n
ad
n
b
n
bd
n
c
n
cd
n
n
one
posit
cat
sampl
could
genotyp
atyp
identifi
assemblag
signific
correl
giardia
infect
age
clinic
sign
deworm
statu
stay
abroad
found
monocent
studi
preval
rate
dog
cat
detect
good
accord
previou
studi
studi
highlight
high
rate
asymptomat
g
duodenali
infect
anim
potenti
zoonot
assemblag
detect
transmiss
giardia
small
anim
human
vice
versa
exclud
especi
young
deworm
anim
higher
preval
disclosur
disclosur
report
canin
parvovir
enter
remain
common
caus
morbid
mortal
young
dog
goal
studi
document
larg
cohort
affect
dog
analyz
sever
factor
possibl
predictor
fatal
outcom
medic
record
retrospect
search
dog
parvovir
enter
diagnos
posit
fecal
antigen
test
fecal
pcr
dog
includ
medic
record
complet
popul
compar
refer
popul
hospit
time
period
chi
squar
test
sever
factor
analyz
possibl
predictor
death
logist
regress
one
hundr
forti
seven
case
includ
seventi
percent
dog
non
vaccin
puppi
age
month
intact
femal
rottweil
american
staffordshir
terrier
french
beauc
shepherd
dog
overrepres
clinic
sign
vomit
diarrhea
dehydr
present
dog
respect
hyperthermia
anemia
leucopenia
observ
dog
respect
major
affect
dog
hospit
day
mortal
rate
dog
hypoglycemia
admiss
observ
dog
blood
glucos
measur
risk
factor
associ
death
p
studi
predisposit
rottweil
american
staffordshir
terrier
french
beauc
shepherd
dog
observ
hypoglycemia
admiss
predictor
fatal
outcom
disclosur
disclosur
report
canin
parvoviru
cpv
infect
dog
remain
widespread
around
world
still
repres
major
health
threat
puppi
vaccin
manufactur
includ
compon
core
vaccin
packag
recommend
two
inject
week
interv
week
age
despit
broad
vaccin
coverag
number
report
suggest
lack
efficaci
vaccin
dog
report
implic
vaccin
belong
major
manufactur
case
usual
consid
link
interfer
matern
antibodi
matab
abl
persist
beyond
week
age
led
expert
group
recommend
third
vaccin
around
week
age
persist
matab
actual
repres
major
issu
immun
puppi
parvovirosi
inde
matab
titr
higher
haemaglutin
inhibit
hi
test
still
inhibit
vaccin
uptak
wherea
titr
prevent
field
viru
infect
contrast
hi
titr
higher
usual
consid
protect
diseas
viru
excret
immun
gap
therefor
critic
period
puppi
outcom
vaccin
order
evalu
impact
residu
mda
efficaci
standard
primari
vaccin
protocol
perform
vaccin
field
trial
serolog
followup
eightyeight
puppi
week
age
present
veterinari
practic
receiv
inject
week
interv
serolog
perform
elisa
vaccin
averag
matern
antibodi
titr
strongli
correl
age
puppi
primari
vaccin
remain
vaccin
inhibit
level
week
age
averag
titr
increas
significantli
inject
primari
vaccin
group
group
inject
primari
vaccin
individu
variabl
remain
signific
vaccin
uptak
invers
strongli
correl
prevaccin
matab
titr
vaccin
seven
puppi
nt
seroconvert
despit
vaccin
compli
recommend
schedul
vaccin
start
dog
week
complet
week
averag
initi
matab
titr
compar
gener
popul
conclus
trial
support
recommend
addit
inject
primari
vaccin
week
especi
area
high
parvoviru
preval
pressur
high
level
matab
like
transfer
puppi
disclosur
author
employe
merial
dog
pcr
posit
aim
studi
evalu
use
determin
serum
level
creactiv
protein
crp
dog
natur
infect
bacterium
phagocytophilum
possibl
indic
clinic
phase
diseas
pcr
andor
ifa
posit
dog
clinic
present
andor
thrombocytopenia
includ
studi
base
result
dog
divid
group
pcr
posit
dog
ifa
posit
subdivid
accord
titer
level
pcr
neg
dog
posit
control
group
pcr
ifa
neg
dog
clinic
sign
andor
thrombocytopenia
neg
control
groupclin
healthi
pcr
ifa
neg
dog
serum
level
crp
determin
use
lifeassay
canin
crp
lifeassay
lund
sweden
elev
concentr
crp
mgl
determin
pcr
posit
ifa
posit
dog
ifa
titer
coincid
presenc
clinic
sign
commonli
gener
clinic
sign
elev
bodi
temperatur
gastrointestin
problem
andor
mild
sever
thrombocytopenia
assess
crp
concentr
correl
certain
clinic
alter
thrombocytopenia
suggest
crp
concentr
elev
acut
phase
diseas
correl
aforement
chang
therefor
serv
addit
diagnost
paramet
crp
concentr
ifa
posit
dog
regardless
ifa
titer
level
present
clinic
sign
thrombocytopenia
higher
detect
level
mgl
dog
without
clinic
sign
laboratori
alter
may
speak
favor
reinfect
reactiv
persist
infect
least
case
caus
inflamm
found
specif
treatment
would
therefor
reason
case
especi
case
rise
crp
concentr
disclosur
disclosur
report
gallbladd
agenesi
rare
caus
elev
liver
enzym
dog
studi
evalu
featur
dog
six
male
three
castrat
nine
femal
two
spay
suspect
gallbladd
agenesi
ultrasonographi
five
differ
breed
includ
chihuahua
n
toy
poodl
german
shepherd
jack
russel
terrier
shiba
dog
median
age
year
ten
dog
asymptomat
five
dog
show
decreas
appetit
vomit
ascit
seizur
diarrhea
dog
show
elev
liver
enzym
high
alanin
aminotransferas
level
median
ul
ul
dog
high
gammaglutamyl
transpeptidas
level
median
ul
ul
gallbladd
agenesi
confirm
use
laparoscopi
dog
laparotomi
three
liver
biopsi
sampl
obtain
dog
addit
comput
tomographi
cholangiographi
perform
dog
use
multidetector
comput
tomographi
mdct
scanner
follow
intraven
administr
contrast
medium
meglumin
iotrox
obtain
imag
analyz
workstat
reveal
absent
gallbladd
nine
dog
vestigi
gallbladd
three
common
bile
duct
dilat
five
dog
dog
laparotomi
laparoscopi
use
visual
gallbladd
liver
abnorm
includ
malform
lobe
surfac
irregular
acquir
portal
system
collater
visual
confirm
five
dog
also
exhibit
hypoplasia
portal
vein
histolog
examin
conclus
anim
gallbladd
agenesi
asymptomat
studi
indic
good
longterm
prognosi
howev
symptom
associ
portal
hypertens
must
monitor
anim
primari
portal
vein
hypoplasia
disclosur
disclosur
report
assess
systol
arteri
blood
pressur
sap
import
tool
small
anim
intern
medicin
practic
especi
diseas
clinic
condit
caus
hypertens
hypotens
doppler
method
noninvas
sever
advantag
compar
oscillometr
method
studi
effect
bodi
posit
sap
consciou
dog
hypothesi
anim
posit
measur
alter
sap
valu
studi
design
prospect
random
regard
order
posit
measur
one
hundr
twenti
clientown
consciou
healthi
sick
adult
dog
weigh
kg
includ
sap
record
doppler
ultrasonographi
follow
american
colleg
veterinari
intern
medicin
consensu
statement
anim
posit
sternal
recumb
right
later
recumb
dog
lay
owner
lap
order
bodi
posit
raffl
time
measur
five
consecut
measur
bodi
posit
perform
alway
left
forelimb
averag
calcul
sap
valu
higher
sternal
recumb
mmhg
p
p
compar
obtain
owner
lap
mmhg
p
similar
right
later
recumb
mmhg
p
result
suggest
sap
measur
obtain
owner
lap
right
later
recumb
use
clinic
routin
sap
measur
obtain
sternal
recumb
avoid
measur
may
overestim
disclosur
disclosur
report
canin
patient
may
present
blood
pressur
bp
assess
clinic
diseas
associ
system
hypertens
ht
suspect
confirm
popul
may
encompass
patient
normal
bp
true
ht
situat
ht
clinician
aim
identifi
anim
ht
reliabl
minim
fals
posit
prospect
studi
investig
repeat
duplic
withinvisit
systol
bp
assess
consecut
canin
patient
present
bp
assess
small
anim
clinic
duplic
sbp
record
dog
control
group
healthi
dog
duplic
sbp
obtain
control
dog
result
duplic
measur
analysi
doppler
method
use
duplic
assess
oscillometr
method
use
duplic
assess
cuff
sizeloc
consist
within
dog
sbp
mmhg
consid
normal
nml
sbp
mmhg
consid
abnorm
abn
median
rang
elaps
time
duplic
read
minut
obtain
within
minut
correl
elaps
time
chang
sbp
p
equal
lower
median
decreas
dog
mmhg
n
nml
dog
abn
pant
score
compar
group
dog
nml
score
p
dog
stop
pant
tend
decreas
p
withinvisit
repeat
bp
diagnosi
good
dog
nml
appar
fals
posit
diagnos
ht
occur
dog
abn
mmhg
repeat
dog
pant
may
associ
increas
measur
sbp
method
duplic
withinday
measur
may
help
identifi
fals
posit
ht
diagnos
dog
initi
sbp
measur
mmhg
disclosur
disclosur
report
